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Abstract 
Proteome measurements derived from tandem mass spectrometry (MS/MS) are a powerful means to 
detect and quantify known and novel proteins. This methods-based thesis has developed a novel 
peptide spectral library (PSL) that can be applied to detect multiple proteins within complex 
MS/MS datasets, including protein markers of inflammation in ovine plasma. Such biomarkers 
permit better definition of the mammalian response to disease.  
The potential use of the PSL is in targeted proteomics applications such as sequential window 
acquisition of all theoretical fragment ion mass spectra (SWATH)-MS analysis and other targeted 
proteomics techniques requiring a spectral library for quantitation of proteins found in sheep plasma 
or serum. A major advantage of SWATH-MS analysis of proteins is that the current alternative, the 
enzyme-linked immunosorbent assays (ELISA), can only measure a single protein for each kit, has 
to be validated for each species and is costly and cumbersome.  
In light of the field’s current status, this thesis sought to address four key objectives: (1) develop a 
comprehensive method to characterise the ovine circulating acellular proteome; (2) investigate 
various protein fractionation techniques to enhance protein identification yields from plasma and 
serum samples; (3) optimise a bioinformatics workflow for constructing a PSL as a tool for 
identifying proteins and for future proteogenomics uses, and; (4) apply the PSL to samples obtained 
from healthy and ill sheep to identify candidate markers of inflammation.  
To achieve the above objectives, a baseline PSL was established using serum samples from healthy 
sheep. This PSL was broadened using a range of protein fractionation techniques, including acetone 
precipitation, partial organic precipitation with acetonitrile (ACN), combinatorial peptide ligand 
library enrichment (ProteoMiner™, Bio-Rad), as well as off-gel isoelectric focussing. Sample 
fractions were processed to tryptic peptides and analysed using nano-liquid chromatography 
electrospray ionisation tandem mass spectrometry (nanoLC-ESI-MS/MS) on an Eksigent nanoLC 
coupled to a quadrupole time-of-flight (QqTOF) mass spectrometer (TripleTOF 5600+, SCIEX) 
operated in a data-dependent acquisition (DDA) mode. Data from diseased and archived endotoxin-
treated experimental sheep samples, as well as in silico predicted and synthesised peptides of five 
proinflammatory cytokines, namely Interleukin 6 (IL-6), Interleukin 3 (IL-3), Interleukin 1a (IL-
1α), Interleukin 1b (IL-1β) and tumour necrosis factor-alpha (TNF-α) were later processed and 
added to create the encyclopaedic PSL.  
For all DDA experiments, MS/MS data were searched against an Ovis aries UniProtKB (Universal 
Protein Resource Consortium Knowledgebase) database using ProteinPilot™ Software (SCIEX) 
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primarily, and then secondarily using Mascot (Matrix Science) search engine to identify proteins. 
These protein identifications (IDs) were validated using PeptideShaker (CompOmics, Inc) 
proteomics informatics software.  
Following establishment of the PSL, plasma samples from sheep, before and after endotoxin-
treatment, were analysed by data independent acquisition (DIA), namely SWATH-MS. Data were 
analysed using the SWATH™ MicroApp 2.0 (SCIEX) alongside the PSL to profile proteins in 
plasma samples in the two cohorts.  
The primary ProteinPilot™ search identified 41,288 distinct peptides from 3,195,890 spectra at a 
false discovery rate (FDR) threshold of 1%. Together with secondary analysis in Mascot and 
validation in PeptideShaker, these spectra enabled the identification of 398 proteins in the nascent 
PSL. Using PeptideShaker identification results from DDA experiments, the baseline PSL and the 
acetone precipitation experiments yielded 133 and 102 protein IDs, respectively. The ACN 
precipitation workflow resulted in 198 protein IDs. The ProteoMiner™ workflow yielded 305 
protein IDs, representing 56.4% increase in protein IDs, compared to undepleted samples. The off-
gel experiment yielded 70 protein IDs, 15 (21.4%) of which were attributed to fractionation 
compared to 55 protein IDs from crude serum. The diseased and endotoxin-treated sheep 
experiments yielded 183 and 84 protein IDs, respectively, and collectively contributed 80 protein 
IDs not detected in healthy sheep samples. Validated spectrum annotation matches were obtained 
from two peptides each of IL-6, IL-3, IL-1α, IL-1β and TNF-α in the PSL from the in silico 
predicted and synthesised proinflammatory cytokines experiment. 
The use of SWATH analysis enabled the quantitation of 243 proteins in sheep plasma and also 
revealed that the samples of the sheep model were non-identical between individuals and yet they 
were expected to be alike. Forty well-recognised acute phase proteins (APP) were quantitated and 
42 other proteins were potentially endotoxin-induced candidate markers of inflammation.  
This research has developed the first PSL resource designed for measuring the proteinaceous 
portion of blood from healthy and diseased sheep. Through its application, the first use of SWATH-
MS is reported herein to identify candidate protein markers of inflammation in sheep’s plasma. 
Through this work, the feasibility of simultaneously identifying many protein alterations in a cost-
effective manner and with widely available tools has been reinforced, with potential applications in 
veterinary pathology, animal welfare and in screening laboratory animals before inclusion in 
experimental groups to minimise differences. In future, the scope of the PSL can be broadened by 
including proteomic and genomic data from cellular components of blood and other tissues to 
complement ovine genome annotation efforts. 
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CHAPTER 1 
1.0 Introduction to the thesis 
This thesis concerns the development of a platform capable of detecting high and medium abundant 
proteins and their alterations during illness in the liquid fraction of sheep blood using next-
generation tandem mass spectrometry (MS/MS). It describes the construction of a peptide spectral 
library (PSL) for subsequent application in the sequential window acquisition of all theoretical 
fragment mass spectra (SWATH) mass spectrometry (MS)(SWATH-MS) technique
1
 and 
proteomics pipeline development for identifying and quantitating proteins reproducibly across 
samples
1-5
. The proteomics information derived from MS/MS is a powerful tool that can be used to 
profile known and novel proteins
6-8
. This approach is an attractive alternative to antibody enzyme-
linked immunosorbent assay (ELISA) technology, which typically requires a specific kit for each 
protein of interest and can, as a result, be particularly costly, time consuming and often need to be 
validated for each different species
9
. In the case of many biological phenomena including 
inflammation, it is important to provide the investigator with a broader tool to measure the plasma 
or serum levels of a panel of different proteins. Given the limited number of straightforward 
methods to simultaneously identify many plasma, serum or even lymph proteins in large domestic 
animals, the possibility of a robust and cost-effective proteomics approach to do so would be highly 
advantageous. 
Sheep are an important model for biomedical research because their cardiovascular physiology 
closely matches that of humans
10-12
. It is therefore important to have a better understanding of the 
proteome in sheep and the proteomic response to changed physiological status to more effectively 
use this model to study human disease conditions. While there are many parallels between the 
pathophysiology of acute injuries in humans and sheep, the majority of the research is primarily 
human-focussed. Moreover, the studies that have used sheep as their models of injury have been 
sporadic, often with scanty, hastily documented or incomplete information on the detail of the 
evolution of the model with regard to the mediators of the underlying injury. For example, this 
thesis was specifically motivated by a review study that showed a lack of consensus on how 
physiological data was extracted from injured sheep used for scientific purposes in a large number 
of studies
10
, and equivocal and subjective observations emanating from a model of smoke injury in 
sheep
13
 and a model of blood transfusion in sheep with induced endotoxaemia
14
. The incremental 
aspect of the latter study was futile as subsequent observations suggested a noisy background of 
preventable varying peri-experimental practices that were previously unaccounted for in the  
prototypical stages of the original study
15
. The preceding previous studies measured a range of 
parameters, including some proteins, but this was variable and therefore difficult to compare. The 
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proteomic approach measures all the proteins and their respective changes during disease, so can 
better assess and quantify the disease process. It was therefore deemed necessary to provide a robust 
molecular-level insight into understanding and quantitating the salient markers of injury in sheep. 
To address these concerns, it was proposed that learning from blood samples derived from injured 
or sick sheep could form the basis for the development of assays for acute phase proteins (APP) or 
other disease-associated proteins in the future, on the premise that every injury is accompanied by 
proteomic alterations in specific biomarkers. As a foundation, a holistic approach was conceived to 
advance a proteomics method for exploring the liquid fraction of sheep blood, from animals in good 
health and during acute illness. 
The four key objectives of this research project were to: (1) develop a robust and comprehensive 
method to characterise the circulating acellular proteome in ovine serum using nano liquid 
chromatography nano electrospray ionisation tandem mass spectrometry (nanoLC-nanoESI-
MS/MS)
16
, (2) investigate and use various protein fractionation techniques and sample types to 
enhance protein identification yields from plasma and serum samples,  (3) optimise a bioinformatics 
workflow for constructing a PSL as tool for identifying proteins and for future proteogenomics uses 
and, (4) develop an approach that can be used to diagnose proteomic changes in plasma indicative 
of disease in sheep.  
The availability of targeted protein data extraction using SWATH-MS analysis was identified as an 
enabling platform capable of potentially characterising APP in the liquid fraction of sheep blood. 
As a capstone study, SWATH-MS analysis was used alongside a newly constructed PSL to 
interrogate archived plasma samples of sheep in which the subjects were injected with endotoxin 
from E. coli to simulate an acute infection
17
 and determine if this approach can identify proteins and 
their alterations during early-phase acute inflammation.   
The primary output of this thesis is summarised in Figure 1.0. Two data acquisition strategies were 
used throughout – data dependent acquisition (DDA) for constructing the PSL and data independent 
acquisition (DIA) for SWATH-MS
1
 biological sample comparison. The SWATH Acquisition 
MicroApp (SCIEX) was utilised to extract the acquired SWATH-MS data for APP quantitation. 
Considering that DDA is inherently analyte abundance-biased by only selecting the most intense 
ions for fragmentation
18
, it was necessary to have a set of experiments that captured peptide data 
derived from various fractionation approaches during PSL construction to ensure comprehensive 
proteome coverage. On the other hand, SWATH-MS is a ‘fragment all’ technique which quantitates 
proteins in an unbiased manner that was employed for validation of the PSL
5
. Simply put, DDA is 
the traditional shotgun discovery data acquisition, whilst SWATH-MS is a more recent strategy. 
This thesis utilised both of these strategies. 
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Figure 1.0. The main output of this thesis is a high-quality peptide spectral library (PSL). 
Thousands of peptide spectral data were acquired using shotgun proteomic analysis of plasma and 
serum protein samples obtained from several healthy and sick sheep to generate the PSL for 
archiving in the proteomics identifications (PRIDE) database
19
 at the European Molecular Biology 
Laboratory - European Bioinformatics Institute (EMBL-EBI), inclusion in the National Center for 
Biotechnology Information (NCBI), and the Universal Protein Resource Consortium (UniProt)
20
 for 
annotating the sheep genome. Key: m/z = mass to charge ratio of individual peptides. 
The thesis consists of eight chapters, including this Introduction. The literature review is presented 
in Chapter 2. Here, the science of MS-based proteomics is introduced, including developments in 
the human biomedicine field for benchmarking purposes. This is followed by a discussion of the 
status quo of MS assays for the circulating acellular proteome with respect to veterinary species. 
Based on earlier work
17
 and recent reports
16,21,22
, there is a consensus that the ability to 
simultaneously assay many disease- and homeostasis-related proteins would be a welcome advance 
in diagnosing and monitoring animal diseases in clinical settings. Knowledge gaps were identified 
in the literature pertaining to exploring the ovine circulating acellular proteome, including the 
absence of reference MS-based data for sheep
16
, proteogenomics tools such as PSL repositories for 
interrogating plasma and serum proteomes in a targeted manner, optimised bioinformatics 
workflows, and methods for identifying several candidate circulating APPs simultaneously from 
controlled experiments. The lack of optimised sample preparation methods, WDR issues and the 
high cost of running assays were recognised as major impediments in the widespread use of 
proteomics approaches in veterinary science.   
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Chapter 3 presents the generic materials and methods used in the proteomics studies applied in this 
thesis
16
. The generic protocol relies on acetone precipitation
23-26
 as the starting fractionation 
technique for separating proteins from lipids in liquid samples followed by digesting proteins with 
trypsin into peptides and desalting using C18 material to remove salts. Desalting is a small-scale 
reverse phase high performance liquid chromatography (RP-HPLC) process whereby salts are 
eluted while the peptides are concentrated. The process also gets rid of particulate matter (for 
example, sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel pieces). The 
end result of desalting is enhancement of protein identifications from peptide samples. This is 
followed by the provision of the details of nanoLC-nanoESI-MS/MS method employed for data 
acquisition. The chapter forms a common basis for the methodology of Chapter 4 and the modified 
methods included in the materials and methods of Chapter 5. 
Chapter 4 presents a study prototype for characterisation of the circulating acellular proteome in 
healthy sheep, using generic methods (Chapter 3) applied to serum
16
. The serum proteome of sheep 
is relatively unknown and is often extrapolated from what is known in cattle. It is a readily available 
substrate for most experimental and clinical applications as evidenced in recent sheep studies that 
have applied mass spectrometry proteomics. For these reasons, it was considered necessary to 
characterise the serum proteome of sheep before using this tool in this species. This chapter 
therefore represents the feasibility of being able to identify a substantial number of proteins in the 
liquid fraction of sheep blood. The results of this study represent the baseline upon which 
alternative methods of sample preparation are based as described in Chapter 5.  
Chapter 5 presents strategies for enriching the baseline protein data collected in Chapter 4. This was 
achieved by using various sample fractionation techniques and sample types to enhance protein 
identification yields. Protein extraction and identification processes, and comparative studies 
between serum and plasma proteomes are described in seven experiments covering: (a) a 
comprehensive analysis of fractions of acetone-precipitated sheep serum and plasma, which 
evaluates both fractions of acetone precipitation of proteins (this is also necessary in order to 
establish if there is any benefit associated with using either serum or plasma as the analytical 
sample for subsequent targeted data extraction); (b) a comprehensive analysis of fractions of partial 
organic precipitation of sheep serum and plasma proteins using acetonitrile in order to increase the 
acellular circulating proteome coverage via an innovative pseudo-depletion strategy of the most 
abundant plasma/serum proteins because ovine antibody-based protein depletion kits are still 
scarce; (c) the combinatorial peptide ligand library protein enrichment of sheep serum and plasma 
using a ProteoMiner™ Protein Enrichment kit (Bio-Rad), which equalises the protein abundance 
and hence increases the chance of identifying more proteins with MS; (d) the off-gel protein 
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fractionation (isoelectric focussing (IEF)) of serum proteins, which deals with protein sample 
separation using an Agilent 3100 OFFGEL Fractionator from Agilent Technologies before MS 
analysis; (e) the extraction of protein data from ex-diagnostic sheep serum; f) the derivation of 
protein data from serum and plasma samples from endotoxin-treated sheep that had been archived 
from a different study; and (g) in silico prediction of synthetic peptides of five selected 
proinflammatory cytokines of sheep used to assist in identifying corresponding endogenous 
cytokines and also as internal standards for quality during protein identification. 
Chapter 6 presents an optimised bioinformatics strategy bringing together data from Chapters 4 and 
5 to form an encyclopaedic PSL. In this chapter, alternative search algorithms alongside peptide 
sequence files are used for data mining to validate protein identifications. It furnishes the details of 
the absolute numbers of peptide spectra and proteins present in the PSL, thereby constituting the 
foundation for future proteogenomics studies on sheep. 
Chapter 7 describes the application of the nascent PSL to determine if it can be used to diagnose 
proteomic changes indicative of disease in sheep. The PSL together with the SWATH Acquisition 
MicroApp (SWATH Pipeline) were applied to interrogate plasma samples from a sheep model of 
intensive care in which the experimental subjects were exposed to an endotoxin
14
. The aim of this 
clinical capstone study was to detect candidate protein inflammation biomarkers and their 
alterations in the plasma. 
The general discussion, conclusions and future directions of the thesis are presented in Chapter 8, 
followed by the references and appendices. The discussion looks back over the project to highlight 
the successes and challenges by acknowledging that the work performed on sheep blood in this 
thesis is unique. The discussion recognises that the primary output of this method development 
thesis is the novel encyclopaedic PSL, comprising of high-quality annotated spectra for 398 proteins 
derived from the circulating acellular proteome of sick and healthy sheep that subsequent 
researchers may find useful. The work was guided by the goal of identifying protein biomarkers of 
early-phase acute inflammation because doing so helps in defining the predictors of mammalian 
response to illness – which translates into understanding resilience to disease. The reason why 
sheep were used was given as being invaluable production animals that not only contribute to the 
human food chain, but are also a source of natural wool and used for diverse cultural purposes, 
including the fulfilling of sacrificial requirements. The several difficulties and costs associated with 
traditional protein assay methods such as ELISA prompted the development of MS-based proteomic 
assays as an attractive and potentially viable alternative. In the absence of abundant protein 
depletion strategies for samples from majority veterinary species, the problem of the wide dynamic 
range (WDR) between low- and high-abundant proteins can be minimised by combining different 
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proteomics strategies, such as protein fractionation and chromatography
27
. As an upside, this 
nascent PSL was applied as a proof of concept capstone study – with promising results – using 
archived plasma samples from ill sheep with induced endotoxaemia as the model disease state.  
The conclusion points out that this project has delivered the much-needed experimental methods 
benchmarked on studies in humans that can be used for detection of pathology in domestic animals. 
A vital attribute of the contribution of this work is the optimisation of serum and plasma sample 
preparation, which is now available for widespread use. This thesis is the first to have developed a 
novel encyclopaedic PSL for the ovine circulating acellular proteome with the capability of 
identifying a large number of proteins. The work pioneered the use of a SWATH pipeline on a large 
scale to interrogate plasma and serum samples of a sheep model of intensive care
14
. It made it 
possible to distinguish between samples from untreated and endotoxin treated sheep in order to 
identify hundreds of proteins, including quantitating their alterations in the circulating acellular 
proteome. This workflow could be improved by well-controlled sample collection preferably from 
identical subjects under uniform conditions to further enhance the applicability of the present 
findings for future science.   
Included in the future perspectives is the need for a high-capacity trap column and a longer heated 
analytical column to enable the loading of higher amounts of protein to enhance deeper peptide 
analysis. Since this work is looking at new methods of protein detection, it will be necessary for 
future experiments to heavily lean on reproducibility, repeatability and validation experiments. 
There is a need to have several replicates from the samples of the workflows that were used in this 
thesis in order to potentially increase the proteome coverage of the PSL. The off-gel fractionation 
workflow needs to be further optimised and applied for sheep plasma samples as well. By using the 
already acquired data, the PSL can also be built using an alternative workflow such as the Trans-
Proteomic Pipeline (TPP) that permits more control of false discovery rate (FDR) of peptides and 
proteins
5
. The main future applications of the PSL lies in proteogenomics that will require its 
broadening by adding genomic an proteomic data from other organs of sheep in order to be more 
inclusive. There is also need to investigate the effects of intravenous anaesthetic drugs on the 
extraction of proteins from plasma and serum samples as this was assumed to have been a 
contributing factor for the low protein identifications in samples obtained sheep anaesthetised by 
total intravenous anaesthesia (TIVA)
10
. 
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CHAPTER 2 
2.0 Literature review 
2.1 Proteomic assay development for the circulating acellular proteome in veterinary species  
The conventional approaches to analysing proteins in plasma or serum have largely been those that 
are non-specific and measure total protein content only, such as absorbance and Biuret Test-derived 
assays
28
, or specific antibody-depended methods that detect the amount of a single protein
29-31
. 
Mass spectrometry-based proteomic assays are emerging as a promising approach that have the 
advantage of specificity and high throughput of protein analysis
32
, but these assays, especially for 
veterinary species are still limited and need to be developed
16,33
.  
This review focusses on discovery proteomics (also known as bottom-up or shotgun proteomics), 
involving protein fractionation, protease digestion, MS/MS fragmentation of peptides and database 
search, founded on established principles, for analysing the undepleted circulating acellular 
proteome of non-model mammalian organisms
8,32,34-37
. Non-model organisms are defined  as 
“organisms that have not been selected by the research community for extensive study either for 
historic reasons, or because they lack the features that make model organisms easy to investigate 
(e.g. they cannot grow in the laboratory, have a long life cycle, low fecundity or poor genetics)
38.” 
This definition of model/non-model organisms is disputable as indeed, every animal may make a 
good model for studies
39
. Mentioning sheep for example, besides its significance as a model for 
copper poisoning
40
, there is also rich literature for it’s use in surgery (neurology41, orthopaedics42 
and cardiology
10
). The overall goal of this review is to provide the theoretical foundation necessary 
for building a PSL using plasma and serum of sheep  to be applied in targeted proteomic data 
extraction
5
 and for future proteogenomics studies. The review begins by outlining proteomics 
laboratory practices for acquiring reliable results. A discussion on the relevance and challenges of 
plasma and serum proteomics is provided. This is followed by an account on the difficulties 
associated with exploring the circulating acellular proteome, protein separation techniques, the 
basics of MS as an aid in detecting proteins, contemporary proteomics approaches, and 
bioinformatics strategies, including the use of nominated software to help identify known and novel 
proteins. The problems associated with studying non-model species and some potential applications 
of proteomics in veterinary science are also discussed. The conclusion emphasises that there is need 
develop mass spectrometry-based discovery proteomics methods capable of identifying a wide 
range of proteins in the circulating acellular proteome in veterinary species. 
2.2 The significance of studying the circulating acellular proteome  
The circulating acellular proteome occupies an important intersection of proteomics, diagnostics 
8 
 
and medicine
43
. It is partly for this reason that plasma proteins are a major focus in biomarker 
research, to the extent that a specialised database resource has been established for the Human 
Plasma Proteome Project (HPPP)
43
. While assaying circulating acellular proteins has been 
historically crucial in veterinary clinical chemistry
21
, the widely available platforms for this 
purpose, for example handheld refractrometry and automated blood chemistry analysers, are either 
not sufficient or only provide superficial insight into the circulating acellular proteome. Ceciliani et 
al.
21
 state that “proteomics holds the key to unlocking the vision of advancing veterinary pathology 
and diagnostics”, highlighting the need to better characterise the circulating acellular proteome of 
veterinary species.  
Immunoassay-based technologies such as ELISAs are the universal benchmark for validating other 
protein assay methods
29
, because of their high degree of specificity
31
. Protein antibody ELISAs, 
however, are limited by their inability to scale up
31
, the comparatively prohibitive cost of assay 
development
44
, cumbersome multiplexing, long turnaround times, high failure rates
45
 and their 
minimal ability to identify a wide range of proteins
46
. Furthermore, ELISA antibodies can vary in 
availability and quality
31
. In fact, some MS methods could even be better than ELISAs as a 
detection method when determining analyte reference ranges
47
. ELISAs face further competition 
due to the diminished need for high-quality antibodies when using MS proteomic approaches
48
. An 
attractive alternative to ELISAs is the development of targeted MS/MS-based proteomics 
approaches that are capable of profiling a wide range of proteins for a fraction of the cost
49
, 
considerable amenability to multiplexing and shorter turnaround times for assays
9
 as illustrated in 
Figure 2.0. 
 
Figure 2.0. Quantitation of proteins: capabilities of mass spectrometry technologies and antibody 
ELISA. KEY: ELISA – enzyme linked immuno-sorbent assay; MRM –multiple reaction 
monitoring; HRM – high-resolution multiple reaction monitoring; MS – mass spectrometry; 
SWATH – sequential window acquisition of all theoretical fragment-ion spectra. Adapted (with 
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written permission of BIOGNOSYS) from Rinner, O. in 5
th
 Berliner LC/MS/MS Symposium, 
BIOGNOSYS Proteomics - Next Generation, Berlin, Germany, 2013. 
2.3 Difficulties in analysing the circulating acellular proteome  
Despite numerous efforts aimed at the characterisation of the circulating acellular proteome
27,43
, 
challenges still persist for its analysis
44
. As Pernemalm and Lehtio
49
 inferred, “plasma has proven to 
be the most difficult material to work with using current MS-based proteomics techniques”. In 
studies on humans, for example, the circulating acellular proteome comprises just over 20 highly 
abundant proteins that constitute 99% of the total proteins
27,43,49
. These proteins include albumin, 
factor H, apolipoprotein A1, immunoglobulin G, apolipoprotein A2, transferrin, apolipoprotein B, 
fibrinogen, acid-1-glycoprotein, immunoglobulin A, ceruloplasmin, alpha-2-macroglobulin, 
complement C4, immunoglobulin M, complement C1q, alpha-1-antitrypsin, immunoglobulin D, 
complement C3, prealbumin, haptoglobin, plasminogen and thyroxine binding hormone
27
. The 
remaining 1% lower-abundance proteins, which are biologically important  and most sought after, 
create a WDR; the ratio of lowest to highest abundance protein detectable is up to 10 orders of 
magnitude
31,49,50
.  
Sample prefractionation remains crucial to deplete proteins of high abundance in the circulating 
acellular proteome of humans
51
, and there is no evidence to suggest otherwise in veterinary species. 
It is reasonable to assume that the WDR problem also applies to samples from mammalian 
veterinary species. Scientific progress in sample preparation and prefractionation continues to yield 
promising results when coupled with more sensitive instruments for the detection of proteins that 
may have been nearly impossible to discern previously, while simultaneously addressing WDR
31
. A 
number of evolving contemporary proteomic approaches, together with some commonly used 
protein separation and fractionation strategies to address the problem of the WDR, are discussed in 
subsequent sections of this chapter.  
The methods that have been developed for depleting high abundance proteins include protein-based 
approaches such as immunoaffinity depletion with antibodies
52-54
, combinatorial hexa-peptide 
ligand libraries coupled to beads
55,56
 and enrichment of carbonylated proteins by biotinylation of 
oxidised proteins with biotin hydrazide
57
. A second approach is a peptide-based prefractionation 
technique that is used to reduce the complexity introduced by digestion of the plasma proteins
54
, for 
example by enrichment of cystein containing peptides using thiol-affinity resin (cysteinyl-peptide 
enrichment technology)
58
. A third approach is by a combined protein/peptide prefractionation such 
as glyco-affinity enrichment such as lectin affinity
59,60
, hydrazide chemistry
61
 and other 
carbohydrate enrichment for sialylated peptides
62
. A fourth approach to depleting proteins of high 
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abundance is metal affinity-based fractionation that applies immobilised metal affinity 
chromatography technology
63,64
.  Of special mention is the use of stable isotope standards and 
capture by anti-peptide antibodies (SISCAPA)
65
 – this method has been developed to detect and 
quantify low-abundance proteins, with promising outcomes. The advantages of applying any of 
these methods to deplete proteins of high abundance is that that they reduce the complexity of 
samples by minimising the problem of the signal-to-biological-noise ratio
65
, whilst enriching for 
proteins of low abundance. The downside of applying these systems is the additional costs incurred 
for antibodies or kits, more time invested for sample analysis and the loss of analytes due to 
unspecific binding of non-target proteins or peptides
49
. In this project, the combinatorial hexa-
peptide ligand libraries coupled to beads (ProteoMiner™) was applied to some samples (Chapter 5). 
For a detailed insight on this subject, there is an excellent comprehensive review on sample 
fractionation efforts to deplete highly abundant proteins as a way of dealing with challenges during 
global analysis of human plasma proteome elsewhere
49
.  
Due to the considerable complexity of the circulating acellular proteome samples
66
, MS instruments 
that can provide comprehensive analysis of the sample in a single analysis are yet to be developed. 
It is for this reason that protein fractionation is commonly recommended, by splitting of a proteomic 
sample into multiple different fractions or pools so that each one can be individually analysed by a 
separate injection on an LC/MS/MS
67
.  
Some studies have aimed to deplete high-abundance proteins with concomitant enrichment of low-
abundance proteins in horse
68
, cattle
69,70
 and pig
70
 plasma or serum. However, as mentioned earlier 
in the various methods used, some important associated non-targeted proteins could be lost during 
the depletion process
71
. Reports by Di Girolamo et al.
22,72
 and Ceciliani et al.
21
, provide 
comprehensive insights into developments in the field of veterinary proteomics. It appears that two 
dimensional gel electrophoresis (2DE) followed by MALDI-TOF MS is the most-used approach in 
cattle, sheep, pigs, chicken, horses and even fish
22
 for protein characterisation. In recent times 
however, this method has now been surpassed by newer more capable techniques and taken the 
opportunity to apply modern methods developed for human proteomic workflows. The modern 
methods for in-depth proteomic analysis incorporate protein depletion followed by multiple 
fractionation (10 or more fractions) and then analysis by high-resolution LC/MS/MS. In the current 
literature review, a few human and animal studies illustrate the developments and strategies used to 
analyse the circulating acellular proteome – the detected proteins or protein groups are provided in 
Table 2.0.  
An important consideration that should be factored into the analysis of the circulating acellular 
proteome is biological variation or the differences that occur between individuals that samples are 
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derived from due to genetic or environmental differences. It is necessary to design experiments to 
take this variation into account and identify the experimental response of interest for example 
exploring proteomic changes in plasma after the administration of an endotoxin to sheep.  In order 
to minimise these differences, it would ideally be necessary to have genetically identical individuals 
with the same physiological status that are raised under uniform environmental conditions. Unlike 
model animals such as mice, and without cloning, it is relatively difficult to have several genetically 
identical large animals for inclusion in experiments. In practice having animals of the same age, 
breed, sex, age and physiological status are commonly used in experiments.  
Table 2.0. Some examples of analytical strategies used to explore the circulating acellular 
proteomes of human and veterinary species.  
Strategy for proteome analysis 
Number of proteins 
identified or monitored 
Reference 
Various technology platform comparisons for The 
Human Plasma Proteome Project.  
3020, revised to 889 
 
73,74
 
2D-DIGE + LC-MS/MS (Canine 
haemangiosarcoma). 
1 monitored protein 
biomarker 
75
 
Albumin and IgG depletion, 2D-DIGE, MALDI-
TOF-MS or LTQ-MS (Swine fever). 
10 differentially expressed 
proteins  
76
 
MALDI-TOF, iTRAQ, LC-MS/MS (Bovine 
mycobacterial infection). 
110 proteins 
77
 
Depletion + SCX + LC-MS/MS + AIMS. 
1105 protein groups; 1.5%, 
≥2 peptides 
78
 
Peptide N-terminal enrichment using TAILS. 
113 proteins; p-value <0.05, 
≥1 peptides. 
79
 
Combinatorial peptide binding enrichment, 2D- 
DIGE, MALDI-MS or LC-MS/MS. 
15 proteins 
80
 
Combinatorial hexapeptide ligand library 
immobilised on a solid-phase matrix + 2D-DIGE. 
29 proteins 
56
 
SCX + IPAS + LC-MS/MS. 
1709 protein groups; 5 % 
protein and peptide FDR. 
81
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Strategy for proteome analysis 
Number of proteins 
identified or monitored 
Reference 
AEC + 1D SDS-PAGE, SELDI-TOF-MS (Canine 
lymphoma). 
19 biomarker candidate 
proteins. 
82
 
Various MS/MS data submitted to the proteomics 
identification database (PRIDE) and human Peptide 
Atlas using Trans-Proteomic Pipeline
43
. 
1929 protein groups. 
19,83,84
 
Protein size fractionation, HILIC LC-MS/MS, SCX 
MudPIT + size exclusion. 
1955 proteins; 5% peptide 
FDR, ≥1 peptides. 
85
 
Protein size fractionation by IEF and GeLC-MS/MS. 
1957 protein groups; 0.5% 
peptide FDR, ≥2 peptides. 
86
 
SCX + intact-protein analysis system (IPAS) + LC-
MS/MS. 
1961 protein groups; 5% 
protein and peptide FDR. 
87
 
2D-DIGE + MALDI-TOF-MS, LC-MS/MS (Bovine 
respiratory disease). 
2 protein group changes. 
88
 
Albumin and IgG depletion, 2D-DIGE, LC-MS/MS. 
21 differentially expressed 
proteins 
89
 
Glycoenrichment using hydrazide chemistry
61
. 
212 protein groups; 
1%protein FDR; ≥1 
peptides. 
90
 
Peptide N-terminal enrichment. 
222 protein groups; 
1%peptide FDR, ≥1 
peptides. 
91
 
Depletion by affinity chromatography + SCX + 
RPLC + ESI-MS/MS.  
2392 proteins (>94% 
confidence). 
92
 
Dual-stage column, iTRAQ tagging, offline SCX 
chromatography, and LC-MS/MS. 
689 proteins 
93
 
AEC + SELDI-TOF-MS, LC-MS/MS (Sheep liver 
fluke infestation). 
26 candidate protein 
biomarkers. 
94
 
13 
 
Strategy for proteome analysis 
Number of proteins 
identified or monitored 
Reference 
AFP, LAP enrichment, HAP depletion, HSA and 
IgG multi-depletion. 
279 protein groups; > 2 
peptides, 95% confidence. 
95
 
Immunoassay & 2D gel electrophoresis. 289 proteins. 
27
 
Immunodepletion, 2-DE-DIGE, LC-MS/MS. 301 proteins. 
51
 
2D-DIGE + MALDI-TOF-MS, nLC-MS/MS 
(Bovine mastitis). 
34 proteins. 
96
 
Protein size fractionation by depletion + GeLC, 
depletion + SCX, and depletion only. 
342, 251 and 194, 
respectively; 1% peptide 
FDR, ≥2 peptides. 
97
 
Glycoenrichment using non-lectin-based. 
406 protein groups; 1% 
peptide FDR, ≥2 peptides. 
98
 
Glycoenrichment using TiO2 + 2D-chromatography. 
413 protein groups; 1% 
peptide FDR, ≥1 peptides. 
99
 
AEC + SELDI-TOF-MS (Pig reproductive and 
respiratory syndrome). 
47 protein peaks. 
100
 
2 different separations techniques + MS. 490 proteins. 
101
 
2D-DIGE + MALDI-TOF-MS (Bovine serum & 
whey). 
62 protein groups. 
102
 
2D-DIGE + MALDI-TOF/TOF. 
15 to 16 mainly APR 
proteins. 
103
 
Serial/tandem depletion. 
695 protein groups; 5% 
peptide FDR, ≥2 peptides. 
104
 
SCX + 2D LC-MS/MS, MRM (Equine doping). 
70 proteins detected, 49 
proteins monitored. 
105
 
Glycoenrichment using lectin-based N-glyco FASP 
technology
106
.  
800 protein groups; 1% 
protein and peptide FDR, ≥1 
peptides. 
107
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Strategy for proteome analysis 
Number of proteins 
identified or monitored 
Reference 
Albumin and IgG depletion, LC-MS/MS (Pig foot & 
mouth disease). 
8-9 proteins. 
108
 
Two different fractionation methods + MS. 9087 proteins. 
109
 
1D-SDS-PAGE, MALDI-TOF-TOF (Sheep scab 
infestation). 
2 major acute phase 
proteins. 
110
 
2-D MALDI-TOF-MS; CE-IT-MS (Validated on 
sheep lung disease and peri-partum period). 
42 medium-high-abundance 
proteins identified. 
111
 
Combinatorial peptide binding enrichment, 2D-
DIGE, MALDI-MS/MS (Lambs). 
4 differentially expressed 
proteins.  
112
 
Albumin depletion, iTRAQ, SCX LC-MS/MS 
(Bovine plasma & uterine fluid). 
53 proteins FDR <0.10. 
113
 
Undepleted, LC-MS/MS; nLC-PC-IDMS-SRM 
(Chicken ovarian cancer). 
3 proteins identified and 
quantitated. 
114
 
Key: 1D SDS-PAGE: one-dimensional sodium dodecyl sulphate polyacrylamide gel 
electrophoresis; 2D-DIGE:two-dimensional difference gel electrophoresis; AEC: anion-exchange 
chromatography; AIMS: accurate inclusion mass screening; antibody free depletion: LAP: low 
abundance protein, HAP: high abundance protein; HSA; human serum albumin and IgG multi-
depletion; ESI: electro-spray induction; GeLC: in-gel digestion followed by liquid 
chromatography; HILIC: hydrophilic interaction liquid chromatography; IEF: iso-electric 
focussing; IPAS: intact protein analysis system; iTRAQ: isobaric tags for relative and absolute 
quantitation; LC: liquid chromatography; LTQ: linear ion trap quadrupole; MALDI: matrix 
assisted laser desorption ionisation; MRM: multiple reaction monitoring; MS/MS: tandem mass 
spectrometry; MS: mass spectrometry; MudPIT: multi-dimensional protein identification 
technology; nLC: nano-liquid chromatography; RP: reverse phase; SCX: strong cation exchange; 
SELDI: surface-enhanced laser desorption ionisation; TAILS: terminal amine isotopic labelling 
of substrates; TOF: time-of-flight; FASP: filter-aided sample preparation technology; CE: 
capillary electrophoresis; IT: ion-trap; PC: Protein cleavage; IDMS: isotope dilution mass 
spectrometry; SRM: selected reaction monitoring. 
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2.4 Separation strategies for protein analysis  
Numerous studies describe universal sample preparation strategies for proteomic studies of non-
model organisms
7
, such as a recent review by Ceciliani and colleagues
21
. Generally, in discovery 
proteomics, protein samples are first separated by gel electrophoresis and then digested by an 
enzyme (usually trypsin) and the peptides are separated by chromatography before MS 
analysis
21,115
, in order to achieve deeper proteome sequence coverage
8
, as outlined below.  
2.4.1 In-gel separation of proteins 
Sample pre-fractionation using methods such as in-gel separation improves sensitivity to peptide 
detection after digestion during MS analysis
116
. One-dimensional sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (1D SDS-PAGE), since early improvements
117
 based on a 
glycine-Tris buffer system, is an effective electrophoretic technique for separating proteins
116,118
. 
This is based on the principle that protein fractionation in gels occurs due to a protein’s molecular 
weight and/or isoelectric point
116
. This technique is a commonly adapted method for making self-
casting gels, such as that described by Schägger
118,119
 and others
116,120
.  
In-gel digestion of proteins involves the sample initially being fractionated using 1D SDS-PAGE. 
The gel is then sliced into bands that are subsequently subjected to in-gel protease enzymatic 
digestion and the products then analysed by LC-MS/MS
50,116,121-123
, preferably after desalting. 
Despite being widely used, in-gel fractionation is dogged by poor recovery of proteins, poor gel-gel 
reproducibility and difficulties in being automated
116
. For global proteomic approaches in non-
model organisms
36
, as is the over-arching subject of this thesis, 1D SDS-PAGE is the experimental 
fractionation method of choice for discovery proteomics workflows, because it has previously been 
associated with a high number of protein identifications during LC-MS/MS
116
. 
2.4.2 Chromatography  
Chromatography is used to separate peptides from a protein digest to reduce the complexity of the 
sample
32,48,124
. The different forms of chromatography are drawn from the same principle, as they 
all have a stationary phase (solid or liquid supported on a solid) and a mobile phase (a liquid or a 
gas) 
125,126
. The most common column packing material for reversed phase chromatography is C18. 
Reversed phase chromatography relies on hydrophobic interactions and analytes partitioning 
between the stationary organic phase such as C18, C8 or biphenyl and the aqueous mobile phase 
which includes organic modifiers (commonly acetonitrile or methanol).The adsorption of peptides 
on the surface of the octadecyl carbon chain (C18)-bonded silica as they traverse the column, for 
instance, depends on hydrogen bonds, van der Waals forces and solubility
125,127,128
. Peptide 
adsorption can also be varied by changing the solvent, or the temperature or pH of the solvent
126
. 
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There are elegant in-depth reviews focusing on protein and peptide separation chromatographic 
techniques for further reading in Tang et al.
124
, Xie et al.
129
, and Ly and Wasinger
125
, for example. 
High performance liquid chromatography (HPLC) is based on the observation that the 
chromatographic resolution increases as the particle size of the packing material decreases. It 
involves elution of smaller particle-size compounds (for example, peptides) through a pressurised 
capillary column with increased contact surface area
129-133
.Unfortunately, the decrease in packing 
material particle size also leads to large increases in column backpressure. HPLC columns are 
routinely packed with 3 μ particles but the use of even smaller particles has led to the development 
of ultra-high performance liquid chromatography (UHPLC) methods. HPLC is not restricted to 
capillaries and is most commonly performed using metal columns with 2 mm internal diameter or 
larger. The work in this thesis was performed with 75 μ internal diameter capillaries using a nano 
LC. HPLC is faster and allows better separation of peptides in a mixture than unpressurised 
columns
48
 and is amenable to detection methods that are highly automated and extremely 
sensitive
130
. Currently, two types of HPLC are recognised: normal and the reversed phase 
variants
130,134
. Normal HPLC uses a non-polar organic solvent and relies on van der Waals forces 
for adsorption and separation
131
. Reverse phase HPLC (RPLC), on the other hand, uses silica that 
has been made non-polar and a polar solvent such as methanol
126,134,135
 and is renowned for its 
peptide desalting applications prior to MS analysis
125,136
. In another form of chromatography that 
uses ion-exchange, peptides are separated, based on the salt content or pH of the mobile phase by 
way of anion or cation exchange and is often used in combination with other fractionation 
strategies
125
. Multidimensional LC, for example, uses strong cation exchange (SCX) in combination 
with RPLC in packed columns, making it very efficient and currently the most commonly used 
method for peptide separation in bottom-up proteomics approaches
124,129
. 
The time taken for a particular peptide to travel through an HPLC column to the detector is known 
as retention time (RT)
126
. This is unique for each peptide and is measured from when a sample is 
injected into the column to the point at which the display shows a maximum peak detection height 
in the mass spectrometer
137
. The RT is determined by the material of the stationary phase in the 
column, composition of the solvent and column temperature
130,131
. Recently, there has been the 
development of an experimentally derived dimensionless peptide-specific value called indexed 
retention time (iRT) that allows very accurate RT prediction across many platforms; this has many 
applications in targeted proteomics
137
. It is preferable to have a high capacity trap column and a 
long heated analytical column, to enable higher loading of peptides for increased chromatographic 
resolution and increased limits of detection
138
. While a longer column would improve analytical 
performance, a typical mass spectrometer detector will only have an effective 3-4 orders of 
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magnitude of operation and increased loading will have a minimal effect on detecting low 
abundance proteins. The longer column would allow improved resolution and sampling of 
individual peptides, helping solve the problem of sample complexity, but this could also be 
achieved by increased sample fractionation. The peak width of a chromatographic peak is defined 
as the peak's full width at half maximum
139
. The narrower the peaks means that there's better 
chromatographic resolution. In practice, this refers to the median of the peak widths for all the 
identified peptides. Optimum and reproducible LC-MS performance outcomes is when peak widths 
remain in a narrow range over a multitude of runs
139
.  
A common method for detecting eluted peptides from an HPLC process is when it is coupled with a 
mass spectrometer. The output is recorded as peaks, each representing a compound passing through 
the detector
126,140
. Retention times can be used to identify the peptides present in the solution, 
provided that pure internal standards are known under identical conditions as in targeted analyses of 
peptides
140
. The peaks can be used as a way of determining quantities of peptides present in the 
mixture, with the area under the peak being proportional to the quantity of the protein present.
141
 
Based on this property, the RT will be the same, irrespective of the concentration of the compound 
in the mixture. It is therefore possible to calibrate a mass spectrometer so that it can be used to find 
even minute quantities of a peptide
126,140
. The experiments for this thesis used a Nano-HPLC 
(Eksigent Ultra 2D, Eksigent) with a Nanospray III ion source (SCIEX) for nano liquid 
chromatography and nano electrospray ionisation (nanoLC-nanoESI).  
2.5 Mass spectrometry for routine detection of proteins 
A mass spectrometer is an instrument that separates ionised molecules with different mass-to-
charge ratios and determines the amounts of each particle in a mixture
142
. The basic principle of MS 
involves the vaporisation of a sample, causation of ionisation, acceleration, deflection and detection 
of ions
143
. The most common types of ion generation for protein anlaysis are matrix-assisted laser 
desorption/ionisation (MALDI)
144
 and electrospray ionisation (ESI)
145
. MALDI and ESI are two 
forms of soft ionisation that are capable of ionising proteins and peptides while preserving their 
chemical structure intact. The other ionisation methods are plasma desorption (PD)
146
 atmospheric 
pressure chemical ionisation (APCI), atmospheric pressure photoionisation (APPI)
147
, fast atom 
bombardment (FAB) and electron impact (EI) commonly used for environmental work using GC-
MS
148,149
. 
Mass spectrometry is an important method in analytical proteomics and can be used to identify 
molecular peptide ions by their characteristic fragmentation patterns in the mass spectrum
32,141,150
. 
In proteomics, proteins are digested into peptides, dissolved in a polar solvent, ionised and then 
separated according to mass and charge before being conveyed through a detector that quantifies the 
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ions by displaying peptide spectra
31
. Most mass spectrometers used for proteomics nowadays are 
triple quadrupoles, quadrupole time-of-flight (Q-TOF) and Orbitrap instruments
48
, but more 
inventions are likely to surface.  
A quadrupole mass analyser comprises of a set of four conducting rods arranged in parallel 
separated by a middle space, with the opposing pairs of rods electrically connected to each other
151
. 
Ions are separated based on the stability of their flight paths through an oscillating electric field in 
the quadrupole
151
. The electric field is created when a radio frequency (RF) voltage is applied 
between one pair of opposing rods within the quadrupole
151
. A direct current offset voltage is then 
applied to the other pair of opposing rods
151
. Only ions of a certain mass to charge  (m/z) value will 
have a stable flight path through the quadrupole in the resulting electric field, whilst all other ions 
with unsteady paths will not reach the detector
151
. The RF and direct current voltages can be tuned 
in a way that allows the quadrupole to act as a mass filter or analyte-specific detector for ions of a 
particular m/z
151
. The analyser can also be operated to scan for a range of m/z values by 
continuously varying the applied voltages
151
. In summary, by applying voltage ramps and RFs, 
complex magnetic fields are created in quadrupoles that allow ions to be focused and filtered, by 
magnetic fields. 
A triple quadrupole mass spectrometer consists of two quadrupole mass analysers with a collision 
cell sandwiched between
151
. The first quadrupole mass analyser selects the precursor ions
151
. The 
selected precursor ions are then fragmented in the collision cell by a process known as collision-
induced dissociation (CID) in an inert gas such as argon
151,152
 to obtain tandem mass spectra 
(MS/MS)
153
. Product ion patterns and relative ion abundance can be considerably reproducible if 
the CID conditions are consistent
151
. The product ions are analysed or selected by the second 
quadrupole mass analyser, and then passed on to the detector
151
. The precursor and product ion 
pairs are called mass transitions
151
. When the electric field and collision energy are maintained, only 
analyte ions having a specified mass transition (precursor/product ion pair) are able to reach the 
detector, which results in the high specificity of tandem quadrupole mass spectrometric methods
151
. 
This type of data acquisition is called selected-reaction monitoring (SRM) or multiple-reaction 
monitoring (MRM) when numerous transitions are monitored during a chromatographic run
151,154
. 
In mass spectrometry, three methods of ion detection are recognised; these include direct charge 
detection (Faraday cup detector), image charge detection (inductive detector), and secondary 
electron generation (electron multiplier (EM) and microchannel plate (MCP) detectors)
155
. Due to 
the comparatively low sensitivity, direct charge detection is only commonly used in magnetic sector 
instruments. Because inductive detectors use non-destructive detection method, they are critical to 
Fourier-transform instruments, for example Orbitrap mass analysers, where signal averaging of 
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circulating ion cloud is central to the operation of the instrument
155
. Time-of-flight (TOF) ion 
detectors are designed to have large areas, rapid response times to provide good timing resolution 
with correspondingly accurate m/z determinations and high sensitivity, which are best met by the 
EM and MCP detectors, based upon their generation of secondary electrons
155,156
. The TOF detector 
was used in this project. 
Peptide fragmentation processes in collision cells – a key technology used in this thesis creates 
positively charged molecules that are accelerated in a vacuum and deflected by an electromagnet 
and amplified into an electronic display in the form of a stick diagram
126
. Peptides form molecular 
ions in the ionisation chamber of the mass spectrometer that can be mass selected and 
detected
140,157
. When this is coupled with an HPLC output corresponding to when the detector is 
showing a peak, some ions that are passing through the detector at the time can be diverted (mass 
selected) and converted into either a mass spectrum, a chromatographic display or both
140
. This 
gives a fragmentation pattern that can be compared against bioinformatics databases of known 
patterns
65,141,158,159
. This principle is based on that fact that molecular ions are unstable and tend to 
break into predictable fragments in a specific reproducible fashion
150
 as illustrated in Figure 3.0. 
Each line on the stick diagram is a mass spectrum representing a different fragment produced when 
the molecular ion breaks up
126,157
. The tallest line in a molecular ion peak is arbitrarily fractionated 
into 100 parts called the base peak, representing the commonest fragment formed
126
. The  
information from the peaks in the spectrum can then be used to derive the peptide sequence
160
. 
Ideally, the peaks of interest in an MS/MS spectrum are those represented by b- and y-ions, 
corresponding to the prefix of N-terminal (b-ion) and the suffix of C-terminal (y-ion) fragments, 
respectively
160
. In practice however, the MS/MS spectrum contains a compound mixture of peptide 
fragments and uninterpretable 'noise' peaks like those of different ion types such as a-, c-, x-, or z-
ions generated when the peptide is not cleaved at an amide bond
160
. Bioinformatic tools enable 
unknown spectra to be analysed and matched against databases that have libraries for the mass 
spectra
65,141
. The peak with the highest m/z value, represents the relative molecular weight of the 
peptide, or what is referred to as the precursor ion, which allows it to be identified
65
. The mass of 
the ion detected is related to the magnetic field used to impel the ions to reach the detector, enabling 
the number of ions (current) vs m/z to be calibrated based on the 
12
C scale
161
. The relative paths of 
light to heavy ions in a mass spectrometer give accurate information on the relative masses of 
isotopes and their relative abundance (proportions) or intensities. That means that the identity of a 
wide range of compounds can be found without having to know their retention times
126
. 
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Figure 3.0 Fragmentation pattern of the peptide S-S-E-L-V-S-A-N-R from antithrombin-III (Serpin 
C1) as displayed by X! Tandem (The Global Proteome Machine Organization; version CYCLONE 
2010.12.01.1) 
162,163
 after a data dependent acquisition (DDA) experiment using a quadrupole time-
of-flight instrument (TripleTOF® 5600+, SCIEX) on a tryptic digest of healthy sheep serum. The 
highest m/z value represents the relative molecular weight of the peptide precursor ion. 
ProteinPilot™ Software 5.0 (SCIEX) using the Paragon™ Algorithm: 5.0.0.0, 4767164, was initially 
used to search a custom database in order to generate a calibrated Mascot generic format (.mgf) file 
that was eventually fed into X!Tandem for analysis. The red sticks represent y ions which extend 
from the carboxyl or C-terminus of the fragmentation; the blue sticks are b ions representing 
fragment ions extending from the amino or the N-terminus. The sequential numbers b1-b5 and y1-
y8 represent an offset from the previous by the mass of an amino acid.  
2.6 Contemporary proteomics methods for samples from veterinary species 
In this thesis, it was proposed that a typical proteomic method for a non-model organism be adapted 
from quantitative proteomics ideas such as advanced by Bantscheff et al.
48
 and Armengaud et al.
7
 
This comprises sample preparation, protein discovery (discovery proteomics), protein verification 
using both synthetic and endogenous proteins from biological samples in a targeted fashion 
(targeted proteomics), and the testing and optimisation of selected bioinformatics workflows
48
.  
Working with the preceding approach, and once sample preparation workflow is optimised, the 
proteome can then be characterised using high-resolution MS/MS technology with representative 
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tissue samples from healthy normal organisms. As pointed out elsewhere
7
, unlike model organisms, 
non-model organisms make difficult experimental organisms
165
 as more effort is required because 
of the absence of well-defined protein databases, but protocol adaptation and method development 
should be close to identical.  
2.6.1 Discovery proteomics  
Discovery proteomics is a strategy for global proteome analysis
34,49
, using MS technology to detect 
a large number of proteins from multiple experiments
31
. The compilation of data from multiple 
experiments is actually one of the defining properties of discovery proteomics. Work for this thesis 
used a quadrupole time-of-flight instrument (TripleTOF® 5600+ System, SCIEX) that relies on 
DDA following liquid chromatography (LC) for spectral library construction needed for 
downstream analysis (Figure 3.1). 
2.6.2 Targeted proteomics 
Targeted MS proteomics
166
 is a technology that involves building an assay using preselected 
proteins or peptides of interest to provide precise, quantitative and sensitive data important for 
hypothesis-driven questions, with the aid of a triple quadrupole mass spectrometer
31,65,140
. Albeit 
distinct from discovery-based proteomics approaches, targeted proteomics complements untargeted 
shotgun methods
140
 in that it can be used for verification purposes
65
 by bridging the gap between 
antibody-based detection (e.g. ELISA) and discovery-based MS, by focussing experiments on 
important peptides to be fragmented and analysed
31,140
. 
With advances in high-resolution/high sensitivity MS instrumentation such as Q-TOF, Q-Trap, 
Orbitrap
167
, alongside the inclusion of associated techniques like LC and ESI, it is now possible to 
identify and quantitate many proteins in the circulating acellular proteome in a single experiment 
using targeted approaches
65,168-170
. The use of MRM / SRM (defined earlier when discussing 
quadrupoles in section 2.5) being a highly selective and sensitive technique
115,140
, focusses the mass 
spectrometer to detect only a group of chosen analytes
31
 with known fragmentation properties
140
 for 
protein identification and quantitation
43
. This technique is a useful avenue for detecting and 
verifying assays for low-abundance proteins when using high-resolution mass spectrometry
43,65
. 
The triple quadrupole mass spectrometer used for MRM is one of the oldest kinds and their MRMs 
are a “traditional” method when compared to high-resolution mass spectrometry.  
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Figure 3.1. Schematic diagram for discovery and targeted proteomics workflows. Protein 
quantitation method 1 illustrates the principle of the triple quadrupole (QqQ) mass spectrometer 
commonly used for targeted proteomics. Protein quantitation method 2 illustrates the principle of 
quadrupole time-of-flight (QTOF or QqTOF). KEY: MRM-Multiple reaction monitoring; MS-
Mass spectrometry; SWATH-Sequential window acquisition of all theoretical fragment-ion spectra. 
Courtesy of, and with permission from, Dr Pawel Sadowski, Queensland University of Technology. 
When a stable isotope dilution multiple reaction monitoring mass spectrometry (SID-LC-MRM-
MS) approach on a triple quadrupole (QqQ) instrument
171
 is used in conjunction with Skyline 
software
172
, it is possible to verify the most likely protein biomarker candidates for inflammation in 
the circulating acellular proteome of sheep. There is strong benefit to using MRM-based assays, 
considering their sensitivity, reproducibility, robustness
31
 and superior multiplexing capabilities
173
, 
especially in a multispecies-driven industry such as in veterinary diagnostic pathology in future. 
A peptide spectral library (PSL) built from discovery proteomics using a Q-TOF instrument is 
required for targeted quantitative workflows involving sequential window acquisition of all 
theoretical fragment ion spectra mass spectrometry (SWATH) or LC-SWATH-MS, a key 
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technology used in this thesis and MRM. The operation of SWATH is similar to MRM but with 
much wider isolation windows in Q1 (Figure 3.1) where the increased resolution is provided by the 
high-resolution TOF detector. These isolation windows are cycled at a sufficient speed to provide 
MS/MS fragmentation of all analytes present in the sample inside a given mass range during 
SWATH data aquisition
1
. The SWATH algorithm is written to focus on m/z windows instead of ion 
abundance, to allow fragmenting everything without a priori knowledge of the sample
1
.The 
challenge is then to develop software (such as SWATH™ Acquisition MicroApp, SCIEX) that is 
capable of analysing and deconvoluting the complex data. Basically, the discovery analysis that has 
identified a peptides’ precursor ion mass, its fragmentation pattern and its retention time is then 
used to identify specific fragment ions in the correct SWATH window at the correct retention 
time
1
.While the SWATH method is a form of data-independent acquisition (DIA)
174
, like MRM, it 
relies on spectral libraries generated from DDA experiments in order to identify and verify a wider 
range of proteins. Unlike MRM, where peptide targets are predetermined before data acquisition, 
SWATH quantifies all peptides by DIA but also allows choosing of protein targets during 
subsequent data analysis
1
. SWATH acquisition is best suited to target high and medium abundance 
proteins and is known for providing comprehensive sample coverage with negligible reduction in 
quantitative precision
175
.  
The downside of discovery proteomics workflows is the reduced ability to identify proteins of low 
abundance, the need for extensive protein database searches and the complex bioinformatics 
processes required to analyse MS data
31,115
. Both SWATH and MRM workflows require a PSL for 
analyte identification; however, only SWATH requires a library with identical RT parameters as the 
one used during data acquisition. Consequently, this calls for the need to generate a spectral library 
exactly the same way as the ultimate SWATH samples, which can be impractical
176
. A strategy to 
overcome this problem is to use iRT, which allows the RT to be pegged to the peptide (not the 
platform or data acquisition parameters), thereby allowing fast and accurate RT predication for 
downstream applications, including SWATH data extraction
137
. 
2.7 Quantitation of proteins 
Peptide and protein quantitation can be achieved by using either label or label-free approaches for 
absolute or relative quantitation needs
29,48
. The vast majority of quantitation methods are derived 
applications from cellular proteomics
177
. For quantitation purposes, in-gel digestion appears to 
affect recovery of individual peptides compared to in-solution digestion approaches
178
. It is for this 
reason that SWATH and MRM workflows do not currently support in-gel fractionated samples.  
Some examples for the relative quantitation of peptides include: metabolic labelling with amino 
acids in cell cultures – e.g. stable isotope labelling by amino acids in cell culture  (SILAC)179; 
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chemical protein and peptide labelling – e.g., tandem mass tags (TMTs) and isobaric tags for 
absolute and relative quantitation (iTRAQ)
180,181
; label-free quantitation including LC-MS/MS 
analysis of peptides such SWATH
48,176
; and MRM (SRM).
48,49
 As for absolute quantitation, the 
methods that have been developed using the stable-isotope-labelled standard approach include 
absolute quantitation (AQUA)
182
, a concatemer of Q peptides (QCAT)
183
 protein standard absolute 
quantitation (PSAQ)
184
, absolute SILAC 
185
 and FlexiQuant
186
. 
Label-free methods for absolute quantitation of peptides and proteins continue to be developed. 
These include using peptide-to-spectrum matches (also known as spectrum count)
187
, methods 
employing signal intensity, and inductively-coupled plasma mass spectrometry (ICP-MS)
48
. Label-
free methods for peptide and protein quantitation have greater affordability and lack labelling 
contaminants that could interfere with MS analysis
115
. SWATH processing provides quantitation 
while confirming the identity of detectable proteins and peptides
175,188
.  
2.8 Bioinformatics strategies and applications for identifying proteins 
2.8.1 Strategies and computer software applications for identifying proteins  
Mass spectrometry proteomics heavily relies on sophisticated computational strategies to identify 
peptides, by matching the acquired MS data against protein databases
6
. The practice is to have the 
sequence database in FASTA format, with a repository of sequences obtained from reputable 
sources for example the National Center for Biotechnology Information (NCBI) and the Universal 
Protein Resource Knowledgebase (UniProtKB) organisation
20,189
. The acquired MS raw data for 
discovery proteomics workflows is usually processed by the instrument in the first instance into a 
propriety data format. The data is then processed by instrument-bundled or other propriety or open 
access software platforms for protein database searches to identify proteins.  
There are various types of software that can be used to process raw data from the instrument for 
searching databases to identify proteins. Some of these software platforms include MS-GF+
190
, 
SEQUEST
191
,  Andromeda
192
,  Comet MS
193
, MS Amanda
194
, MyriMatch
195
, Morpheus
196
, Tide
197
 
(TurboSEQUEST + Crux
198
), Open Mass Spectrometry Search Algorithm (OMSSA)
199
, 
ProteinPilot™ software (SCIEX) which uses the Paragon™ algorithm164, and Mascot (Matrix 
Science)
200
 software. Other tools that could be used are Scaffold software (Proteome Software 
Inc.)
187
 which incorporates X!Tandem (The Global Proteome Machine Organization)
162,163
, 
PeptideProphet™ and ProteinProphet™  bioinformatics algorithms (Institute for Systems Biology, 
Seattle) to identify proteins
187
; and the Trans-Proteomic Pipeline (TPP)
201
 – an open-source bundle 
of software tools that has been developed for the analysis of MS/MS information
202
. Alternative 
protein identification search engines continue to evolve that are discussed in depth elsewhere
8
. 
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To identify peptides, the experimentally-generated mass spectra are matched against protein 
sequence databases, generating a qualitative list of potential matches, ranked by confidence, of 
proteins that may be present in the sample
21
. Identifying peptides, however, is not without 
challenges, and some remedies have been proposed
6
. Briefly, four cardinal attributes have been 
identified as being crucial to the successful identification of peptides (Table 2.1). In addition to 
these, there is also need for computational strategies for building and using customised protein 
sequence databases, overcoming the challenge of false positive identifications in proteomics, 
reliable prediction of splice-junctions, and correction of sampling bias
6
, just to name a few. 
Table 2.1. Determinants of peptide identification in proteomics studies.*  
No. Attribute 
1 Finding the right balance between completeness and optimum size of protein sequence 
database. The more comprehensive it is, the larger the database size will be, leading to 
the increase in the time required to perform searches. 
2 Applying multiple database search tools to increase sensitivity and specificity 
associated with a given peptide identification strategy. Different search tools may be 
able to assign spectra to peptides that could have been missed by another search tool. 
3 Accessing computational time and resources necessary for data processing, factoring in 
false discovery rate (FDR) estimation or analysis. Proteomics data acquisition, 
processing and data analysis require considerable investment in computing in terms of 
hardware, software and considerable patience in order to process the data.  
4 Having the ability to interpret the data in biological context. There is need to have 
adequate human resources with appropriate training to relate proteomics findings for 
potential application to real-life situations.  
* Drawn from references 
8
 and 
6
. 
In general, the majority of proteomic searching tools are largely unintegrated and remain rather 
labour intensive
159
. One strategy to address the manual task problem is to derive peptide sequences 
using de novo sequencing and homology searching of MS/MS spectra, without the need for a 
sequence database
203
. An excellent lesson on the salient computational and user-level aspects on de 
novo sequencing of peptides has been covered in detail by Chong and Leong
204
. Meanwhile, 
integrated proteomic search tools continue to be developed that can perform all functions, from 
MS/MS matching to genome annotation, on a single platform
8
. One platform that minimises the 
human interface by promoting automation and with the capability of running on personal computers 
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is a software tool called Peppy
159
. Another example is the Proteomic Mapping Pipeline, which has 
easily-customisable proteomic search capabilities for non-model organisms
205
. 
Given the preceding background and together with an optimised bioinformatics workflow, an 
established proteomics method could be applied to interrogate the circulating acellular proteome in 
mammalian veterinary species
17
.  
2.8.2 Gene ontology (GO) enrichment and protein pathway analyses of identified proteins 
Gene ontology (GO) annotation and pathway analysis of proteins is a bioinformatics approach used 
after identifying proteins to assess the biological relevance of the protein data
206
. This is necessary 
as it complements protein quantitation for example in the outcomes from protein fold changes 
during biomarker studies
2,207-209
. Several tools are publicly available for GO enrichments analysis, 
each using unique algorithms such as g:Profiler
210
, BiNGO
211
 that displays data in Cytoscape
212
, 
Ontologizer
213
, GOrilla
214
 and DAVID (The Database for Annotation, Visualization and Integrated 
Discovery) gene functional classification tool
215
, to name only a few. The application of protein 
pathway analytical tools facilitates the visualisation of interactions between genes, proteins and 
other biological molecules to reveal biological pathways and to generate global canonical pathway 
protein interactions
216,217
 that could be fundamental when using animal models to study human 
disease, for instance, because of the conserved nature of pathways
218
. Examples of such pathway 
tools include the commercial Ingenuity Pathway Knowledge Base
31,33,219
 and the open-source freely 
available PANTHER (Protein ANalysis THrough Evolutionary Relationships) software suite
220
.  
2.9 Validation of proteomics results 
The large number of spectra generated by MS proteomics experiments to be matched with peptide 
sequences and subsequent protein identification requires validation in order to minimise false 
identifications. Validation of the data can be performed both at peptide and protein levels
221
. This 
may involve manual inspection, but this is cumbersome and subjective, or by using automated 
analysis software
221
. A useful strategy is to use multiple software that implement probabilistic 
approaches
221
 to analyse the same dataset and select spectral identifications that are shared among 
the various software. It is important to remember that the analysis software only just matches 
patterns between theoretical and experimental data. The optimal form of validation would be to 
synthesise every peptide identified and compare the synthetic form to the hypothetical data. Clearly 
this is not possible for all, but a few of the most important peptides to illustrate that the analysis is 
working. Protein-level validation may take the form of technical and biological replication of the 
experiment and compare the protein identifications
221
, by using  the emerging high resolution MRM 
(HR-MRM) method or the gold-standard specific antbody techniques (ELISA and Western 
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blotting)
222
.     
2.10 Studying non-model mammalian organisms in proteomics 
The proteomics approach for studying non-model organisms is based on the principle of the genetic 
theory. Genes encoded in DNA are transcribed into RNA that is then translated by ribosomes into 
proteins. The (accurate) detection of an endogenous protein in the circulating acellular proteome is 
therefore a confirmation that there is a genetic code for it
223,224
. The availability of accompanying 
genome data is central to the ability to detect proteins. Except for animal species commonly used in 
translational research whose genomes have been largely sequenced (such the mouse) or those of 
veterinary importance (such as the dog, horse, ox, chicken and pig), there is a relative scarcity of 
proteomic data for other animals
21
. Complete genomic data is important because many studies on 
animal models of disease are founded on the premise that every form of disease insult is associated 
with characteristic changes in protein expression
17,225-229
. For animals whose genomes have only 
been recently sequenced, such as sheep
230
, coding errors are still be present, and there may be many 
gaps that need to be annotated. Another problem of working with non-model organisms is that not 
enough is known about the protein change responses to a range of physiological and pathological 
events. This problem is confounded further by the impact of breed differences on response to 
stimuli in many veterinary species. 
As proteomics heavily relies on complete genomic sequencing data, some approaches used in non-
model animals include optimising data analysis steps, combining available database information of 
the target species with related species, testing different software tools and different search 
parameters
6,8
 and assuming that the results will be similar to that of humans. The co-ordinated 
sharing of proteomic data through publicly available repositories such as the ProteomeXchange 
consortium
231
 is invaluable, as it allows constant querying of proteomic data on an open access 
platform.  
2.11 Potential applications of proteomics in veterinary science lies in proteogenomics 
Proteogenomics has been described as a platform that can be used to establish a draft protein 
database of any organism, by providing an avenue for studying difficult experimental organisms
7
. A 
truly comprehensive proteogenomics project is characterised by attributes that encompass genomic 
and proteomics efforts with the end result of annotating the genome
6,8
. High-resolution MS 
techniques for peptide detection enable the prediction of open reading frames of an organism, by 
correlating MS data with genome sequence information based on the expressed protein evidence
8,232
 
from protein samples. This means that, although time-consuming, there is now capacity to identify a 
plethora of proteins with potential biotechnological applications in production and companion 
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animals. Proteomic data can also be used for annotation of genomes of most animals that are yet to 
be fully sequenced
8,232
.  
After identifying proteins, quantitating them can be useful in diagnosing pathological aberrations 
and monitoring disease progression
43
. However, comprehensive MS-based methods to estimate 
serum or plasma levels of various proteins in veterinary species are still lacking. Using a spectral 
counting approach
84
 to build a database to determine normal protein levels for animals could prove 
useful for veterinarians and researchers in future. 
2.12 Conclusions 
Proteomics is a promising tool for veterinary science applications. Method development and 
validated experiments are needed, preferably those benchmarking on studies in humans, to elucidate 
important findings, including the detection of subclinical disease in domestic animals – an 
application that could improve animal welfare. Resilience to disease is an important trait; however, 
the relative paucity of detailed information on the immune response in many veterinary species, 
especially production animals, means that there may be sub-optimal scope for selecting breeding 
stock based on immunological resilience. If specific and reliable markers of immunological 
resilience could be identified, such markers could be used to identify individuals that might be at 
increased risk of infectious disease, and to predict resilient individuals. Such markers could then be 
used to study the heritability of resilience, with the eventual aim of developing a screening panel to 
select resilient breeding stock. Furthermore, a panel of markers could also be used as a surveillance 
tool, to monitor the potential deleterious immunological effects of selecting for performance traits 
such as reproduction or growth rate. Such a strategy would help to inform optimal balanced genetic 
development in flocks. While the outlook appears bright, there is need to optimise sample 
collection/preparation methods, address WDR issues and reduce the cost of running assays, to allow 
the widespread use of proteomics in domestic animal science
21
 and to uncover protein expression 
and characterisation by building and exploiting the capabilities of PSLs in this era of 
proteogenomics. 
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CHAPTER 3 
3.0 Materials and methods 
3.1 Introduction 
This chapter presents the generic materials and methods used in proteomics studies applied in this 
thesis. The generic or universal approach of protein analysis relies on acetone precipitation of 
proteins in order to remove lipids mainly
233
. This is followed by in-solution and in-gel digestion of 
proteins into peptides with trypsin and desalting of peptides prior to LC-MS/MS analysis. The 
effect of desalting of peptides prior to analysis and its reproducibility as a critical element of all 
proteomic experiments was also evaluated. Desalting of peptides is even more crucial when using 
label-free proteomics approaches
176
. The details of nanoLC-nanoESI-MS/MS method employed are 
also provided. Considered together, the procedures covered herein form a common basis for the 
adapted proteomics methods used in the entire thesis.  
3.2 Ethics statement 
The studies included in this thesis were conducted in accordance with the Australian Code of 
Practice for the Care and Use of Animals for Scientific Purposes
234
. Animal tissue samples for 
method development were acquired following approval from Queensland University of Technology 
(QUT) Confirmation number: 1400000591, QV reference number: 46375 and Ethics number TRIM 
10/8428 issued to Serum Australis Pty Ltd (http://www.serumaustralis.com.au), for bleeding live 
sheep and supply of blood products. Tissue from live animal experiments had animal ethics 
approval obtained from the University Animal Ethics Committee of QUT (reference 0800000555), 
which was ratified by The University of Queensland (UQ).  
3.3 Reagents used for sample preparation  
10x Tris/Glycine/SDS Buffer (Bio-Rad, Inc., cat. No. 161-0732), Acetonitrile (LC/MS grade, 
suitable for UHPLC-UV; Fisher Scientific, Optima
®
, cat. No. A955-4), Acrylamide/Bis-acrylamide 
(Sigma-Aldrich, cat. No. A2917), Ammonium acetate (≥ 98%; Sigma-Aldrich, A1542; Lot # 
SLBBF4804V), Ammonium bicarbonate (NH4HCO3) ReagentPlus®, ≥99.0%; Sigma-Aldrich, cat. 
No. A6141), Ammonium Chloride (AJAX Chemicals, UNIVAR
®
), Ammonium persulfate (Bio-
Rad, cat. No. 161-0700), Bicinchoninic acid (BCA Protein Assay Kit; Pierce™, cat. No. 23225), 
Bromophenol Blue (Bio-Rad, cat. No. 161-0404), Disodium ethylenediaminetetraacetate dihydrate 
(EDTA ≥99% pure, Bio-Rad, cat. No. 161-0729); DL-Dithiothreitol (DTT, ≥98% (TLC), ≥99.0% 
(titration); Sigma-Aldrich, cat. No. D0632),  
Formic acid (≥99.5 %, LC/MS grade; Fisher Scientific, Optima®, cat. No. A117-50), Formic acid in 
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acetonitrile (0.1% (vol/vol), LC/MS grade; Fisher Scientific, Optima
®
, cat. No. LS120-4), Formic 
acid in water (0.1% (vol/vol), LC/MS grade; Fisher Scientific, Optima
®
, cat. No. LS118-4), 
Glycerol (for molecular biology ≥99%; Sigma-Aldrich, cat. No. G5516), Hydrochloric acid 
(BioReagent for molecular biology 36.5-38.0%; Sigma-Aldrich, cat No. H1758 ); Iodoacetamide 
(Crystalline HPLC, ≥99%; Sigma-Aldrich, Lot # SLBC7561V, PCode: 1001691393); Mass 
Spectrometry Safe Protease and Phosphatase Inhibitor Cocktail (MSSAFE, Sigma-Aldrich), 
Protease inhibitor cocktail tablets (cOmplete™, Mini, EDTA-free; Roche, Lot No. 10051300), 
Protein gel staining solution (EZ-Run™, Fisher Scientific; cat. No. BP3620), Sodiun dodecyl 
sulfate ≥ 98.5% (Sigma-Aldrich, L4509, Batch # 046K0085), Tetramethylethylenediamine 
(TEMED; Bio-Rad, cat. No. 161-0800), Trifluoroacetic acid (CHROMASOLV
®
 for HPLC, 
≥99.0%; Sigma-Aldrich, cat. No. 302031), Trifluoroacetic acid in water (0.1% (vol/vol), LC/MS 
grade; Fisher Scientific, Optima
®
, cat. No. LS119-212), Trisaminomethane (Tris ≥99.8%; Bio-Rad, 
Inc., cat. No. 161-0716), Trypsin (sequencing grade modified; Promega, cat. No. V5117), Urea 
(Bio-Rad,  cat. No. 161-0730), Liquid chromatography–mass spectrometry (LC-MS) water (LC/MS 
grade, suitable for UHPLC; Fisher Scientific, Optima
®
, cat. No. W6-4), Deionised water 
(Millipore), Albumin standard 2 mg/mL (Bovine Serum Albumin Standard, Pierce™, Thermo 
Fisher Scientific), ExcelGel SDS Buffer Strips (anode and cathode) (GE Healthcare Sciences), and 
IPG Buffer pH 4–7 (GE Healthcare Sciences). 
3.4 Equipment used in the experiments  
Quadrupole time-of-flight mass spectrometer (TripleTOF® 5600+ System, SCIEX) with Nanospray 
III ion source (SCIEX), Nano-HPLC (Eksigent Ultra-2D, Eksigent Technologies, Dublin, CA), 
Centrifuge (Eppendorf, cat. No. 5424R), Mixer (Eppendorf Thermomixer
® 
Comfort), Vortex mixer 
(Ratek, Model VM1), pH meter (Cardy Twin pH Meter, Spectrum Technologies), 
Spectrophotometer (NanoDrop 2000; Thermo Scientific), and Offgel Electrophoresis System (3100 
OFFGEL Fractionator, Agilent Technologies). SpeedVac Concentrator (Christ
®
 cat. No. RVC 2-33 
IR). 
3.5 Consumables used for the experiments 
Protein Enrichment Kit (ProteoMiner™ Small-Capacity Protein Enrichment Kit, Bio-Rad cat. Nos. 
163-3006 and 163-3008), Polyacrylamide gels (Mini-PROTEAN® TGX™ Precast Gels, Bio-Rad, 
cat. No. 4561084), Electrospray emitters (New Objective, cat. No. FS360-20-10-N-20-C12), 
NanoLC analytical column (ChromXP C18 3 µm, 150mm × 75 µm 120 Å, Eksigent Technologies, 
Dublin, CA), NanoLC trap cartridge (ChromXP C18CL 5 µm, 10 mm × 0.3 mm 120 Å, Eksigent 
Technologies, Dublin, CA), Protein low binding tubes (volume 0.5 and 1.5 ml; Eppendorf, cat. nos. 
022431064 and 022431081), 10 µL (0.6 µL bed of chromatography media) desalting pipette tips 
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(Millipore® ZipTips C
18
, Sigma-Aldrich, cat. No. Z720046), 100µL bed desalting pipette tips 
(Pierce™ C18 Tips, Thermo Fisher Scientific, cat. No. 87784), 750 µL Volume polypropylene 
autosampler vials (12 x 32mm Snap Neck Vial, Waters, cat. No. 186005224). 
3.6 Sample preparation for protein analysis 
Frozen sheep serum samples were thawed on ice and then centrifuged at 13,000 g at 4 
o
C for 20 min 
as previously described
16
. The sediment and top layer comprising mainly of lipids and suds were 
discarded, retaining the supernatant. The protein concentration of the supernatant was determined 
with bicinchoninic acid (BCA) protein assay kit (BCA Protein Assay Kit, Pierce™) according to 
the manufacturer’s instructions using a spectrophotometer (NanoDrop 2000, Thermo Scientific). 
The supernatant was then either directly analysed or enriched by acetone precipitation of proteins. 
In some experiments, a protease inhibitor cocktail tablet (cOmplete, Roche) was added into the 
sample after thawing, according to the manufacturer’s instructions in order to evaluate if there was 
any difference in protein yields when a protease inhibitor was present in the samples than when it 
was not
235
.  
3.7 Generic universal sample delipidation by acetone precipitation of proteins 
Proteins in serum were precipitated by adding 4 × (v:v %) of cold (-20 °C) acetone and then 
incubating at -20 °C for 16 h, prior to centrifugation at 4,000 g for 2 min. The supernatant was 
discarded. This method was described as delipidation rather than fractionation as the proteins were 
collected in only a single pool (pellet) at the end of the process. The pellet was washed with cold 
acetone and the suspension was centrifuged at 4,000 g for 5 min at 4 °C. The supernatant was 
discarded and this procedure was repeated one more time. The pellet was then dissolved in freshly 
prepared 8 M urea in 25 mM NH4HCO3 (Sigma-Aldrich) buffer. The mixture was centrifuged at 
4,000 g for 5 min at 4 °C, the supernatant was kept and the insoluble sediment was discarded. The 
protein concentration of the supernatant was determined using the BCA method
28
.  It is important to 
note that although this is a standard method, the use of urea can interfere with downstream 
processes including tryptic digests and gel electrophoresis resulting in poorly resolved gels. 
3.8 Generic in-gel protein fractionation and digestion workflow 
3.8.1 1D SDS-PAGE 
The universal 1D SDS-PAGE procedure adapted in this thesis for protein separation (also referred 
to as in-gel separation of proteins) was based on its established description
117
 and subsequent 
refinements
118,119,236,237
. Briefly, the resolving self-cast 10% SDS-PAGE gels were prepared by 
mixing 3.85 mL of deionised water (Millipore) with 2 mL of 40% acrylamide / 2% bisacrylamide 
mix (final concentrations – 10% acrylamide / 0.5% bisacrylamide), 2 mL of 1.5M tris (pH 8.8), 80 
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µL of 10% SDS, 80 µL of 10% ammonium persulfate and 8 µL of Tetramethylethylenediamine 
(TEMED, Bio-Rad), which was then poured into a casting chamber (Mini-PROTEAN, Bio-Rad) 
and left to set after overlaying the gel with isopropanol. The isopropanol was then removed and the 
stacking 4% SDS-PAGE gels were prepared by mixing 3.15 mL of deionised water (Millipore) with 
0.5 mL of 40% acrylamide / 2% bisacrylamide mix (final concentrations – 5% acrylamide / 0.25% 
bisacrylamide), 2 mL of 0.5 M tris (pH 6.8), 50 µL of 10% SDS, 50 µL of 10% ammonium 
persulfate and 5 µL of TEMED, and then poured on top of the resolving gel followed by insertion 
of plastic comb to mould the loading wells. The gels were left to polymerise for 12 h at RT before 
loading the wells with known quantities of protein samples. A stock solution of 10× running buffer 
was prepared by mixing 30 g of Tris, 144 g of glycine, 10 g of SDS and made up to 1L solution 
using de-ionised water (Millipore) before storage at RT. A 5× sample buffer stock was prepared by 
mixing 1.75 mL of 0.5M Tris (pH 6.8), 4.5 mL of glycerol, 0.5 g of SDS, 1 drop of 2.5mg/mL 
solution of bromophenol blue. The solution was brought up to 10 mL, then aliquoted into 500 µL 
and stored at -20 °C until use. 
To load the gel, a desirable quantity of protein in the sample was aimed at approximately 0.1 µg/µL 
for each stained protein band
118
 in either self-cast or precast polyacrylamide gel (Mini-PROTEAN® 
TGX™ Precast 4-15% Gels, Bio-Rad). A protein standard (Precision Plus Protein™ Dual Xtra, 
Bio-Rad) was loaded into to the first well of every gel for the estimation of the protein molecular 
weight. Protein concentrations of bovine serum albumin (BSA) standard (Pierce) and the samples 
were adjusted so that suitable amounts of protein could be loaded onto the gel with freshly prepared 
20mM solution of dithiothreitol (DTT) in liquid chromatography mass spectrometry (LC-MS) water 
with 1× SDS sample buffer. Gel loading preparations were made in 1,500 µL (or 500 µL, where 
appropriate) Eppendorf tubes and then vortexed briefly before being centrifuged at 4,000 g for 6 s. 
The tubes containing the sample buffer and sample were heated at 56 °C for 3 min to unfold 
proteins prior to loading onto the gel and electrophoretic separation of proteins at a fixed voltage 
(150-180V) for approximately 45 min in a vertical electrophoresis chamber (Mini-PROTEAN 
Electrophoresis Cell, Bio-Rad) powered by PowerPac™ Universal power supply from Bio-Rad. 
The gels were stained with Coomassie brilliant blue (EZ-Run™, Protein Gel Staining Solution, 
Fisher Scientific) according to the manufacturer’s instructions and then photographed using a 
handheld camera (5.7-inch Quad HD Super AMOLED
®
, Samsung; or New 8-megapixel iSight 
camera with 1.5µ pixels with Optical image stabilisation, iPhone 6, Apple Inc.).  
Gel bands were excised into a clean 1,500 µL Eppendorf tube and de-stained using 50% acetonitrile 
(ACN) (Optima
®
, Fisher Scientific) in 25mM NH4HCO3 accompanied by agitation at 750 rpm for 
20 min at RT. This procedure was repeatedly and alternated with washing the gel bands with 25 
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mM NH4HCO3 buffer. Once de-stained, final washing of the gel bands was performed using LC-
MS grade water followed by incubation for 20 min at RT. The water was discarded and the gel 
bands were cut into approximately 1 mm
3
 pieces using a 10 µL pipette tip. Gel bands were 
dehydrated by adding 100% ACN and agitating at 750 rpm for 10 min at RT prior to drying in a 
vacuum centrifuge (SpeedVac Concentrator Christ
®
 cat. No. RVC 2-33 IR), for 10 min. 
In-gel proteins were reduced in order to break disulphide bonds and alkylated to prevent the bonds 
re-forming as originally described elsewhere
238
. Briefly, freshly prepared 10 mM DTT (Sigma-
Aldrich) in 25 mM NH4HCO3 buffer was added sufficiently to cover the vacuum dried gel pieces 
and agitated at 750 rpm for 45 min at 56 °C. Freshly prepared 55 mM iodoacetamide (IAM) 
(Sigma-Aldrich) in 25 mM NH4HCO3 was added to the sample so the volume added was twice that 
of the DTT added in the previous step and agitated for 30 min at RT in the dark. The reagents were 
washed off with 25 mM NH4HCO3 buffer with agitation for 5 min at RT, before centrifuging briefly 
and discarding the supernatant. Gel bands were then dehydrated using 100% ACN and agitated at 
1400 rpm for 10 min at RT. The entire supernatant was discarded prior to drying the gel pieces in a 
vacuum centrifuge (SpeedVac Concentrator Christ
®
 cat. No. RVC 2-33 IR), for 20 min. 
Vacuum-dried gel pieces were incubated on ice for 5 min before adding 0.005 µg/µL solution of 
freshly prepared ice-cold working solution of trypsin (Trypsin Gold, Mass Spectrometry Grade, 
Promega) in 50 mM NH4HCO3 buffer enough trypsin buffer to cover the dry gel pieces
239
 and left 
incubating for a further 30 min until the entire enzyme solution had entered the gel pieces. Gel 
pieces were then covered in 50 mM NH4HCO3 buffer and left to incubate for 16 hrs at 37 °C on an 
agitator at 300 rpm. Digestion was stopped by adding 100 µL of 5% formic acid (FA) (Sigma-
Aldrich). Peptide extraction was performed by agitating the gel pieces at 1,000 rpm for 15 min at 
RT. The peptide-containing supernatant was collected into a clean 0.5 ml low binding Eppendorf 
tube. Gel pieces were further washed by adding 5% FA in 50% ACN and agitating at1000 rpm for 
15 min, before collecting the supernatant. Gel bands were further extracted by adding 100% ACN 
and agitation at 1000 rpm for 15 min at RT. The entire supernatant was collected and then 
completely vacuum-dried prior to reconstitution in 10 µL of 0.1% trifluoroacetic acid (TFA) 
(Sigma-Aldrich) / 2% ACN followed by desalting of peptides. 
3.9 Generic in-solution digestion of proteins workflow 
The method adapted here was based on the one established by Villén and Gygi
123
. Briefly, a known 
quantity of serum or plasma protein sample was thawed and kept on ice at 4 °C was reduced using 
20 mM DTT (to achieve 5 mM final concentration) and the mixture was incubated for 1h at room 
temperature (RT). The mixture was alkylated using 55 mM IAM (to achieve 14 mM final 
concentration) followed by incubation for 20 min in the dark at RT. Alkylation was quenched using  
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DTT  followed by further incubation for 5 min in the dark. The mixture was diluted with 25mM 
NH4HCO3 buffer followed by adding aqueous 70 mM CaCl2 (to achieve 10 mM final 
concentration).  Trypsin (Promega) was added at enzyme to substrate (protein concentration of 
sample) ratio of 1:50. The contents were incubated for 16 h at 37 °C with gentle agitation and then 
cooled to RT. Digestion was stopped using 10% TFA before vacuum concentrating the contents to 
dryness. The dried peptides were reconstituted in aqueous 0.1% TFA/2%ACN before desalting. 
3.10 Generic desalting of tryptic peptide digests 
It is often necessary to remove salts and particulate matter including excess of trypsin from peptide 
digests prior to analysis to prevent blockage of nanoLC columns and also to reduce noise artefacts 
of MS spectra
240-242
. Desalting of tryptic peptide digests was optimised and performed using either 
octadecyl carbon chain (C18) pipette tips (ZipTip® Pipette Tips, Millipore, or Pierce C18 Tips, 
Thermo Fisher Scientific) depending on the filter capacity according to manufacturer’s instructions. 
Briefly, the desalting pipette tip was conditioned using a solution of 50% ACN/0.05% 
trifluoroacetic acid (TFA) in LC-MS grade water and then equilibrated with 2% ACN/ 0.1% TFA in 
LC-MS water. After carefully and gently pipetting the entire sample up and down the membrane for 
at least 10 times, the membrane was washed with 2% ACN/0.1% TFA in LC-MS water. The 
peptides were eluted using 70% ACN/0.1% TFA in LC-MS water, vacuum dried and then 
reconstituted in 10 µL of 2% ACN/0.1% FA in LC-MS grade water and transferred into a 
polypropylene autosampler vial for nanoLC-nanoESI-MS/MS analysis. 
3.11 nanoLC-nanoESI-MS/MS   
3.11.1 Chromatography 
Peptide spectral data from approximately 400 ng – 1 µg of injected tryptic peptides per sample were 
generated using nanoLC-nanoESI-MS/MS on a TripleTOF
® 
5600+ instrument. Peptides were 
separated by performing reversed-phase chromatography using an Eksigent ekspert™ nanoLC 400 
System directly coupled to the MS/MS instrument. The LC platform was setup in a trap and elute 
configuration with a 10 mm × 0.3 mm trap cartridge packed with ChromXP C18CL 5 µm 120 Å 
material and a 150 mm × 75 µm analytical column packed with ChromXP C18 3 µm 120 Å 
(Eksigent Technologies, Dublin, CA). The mobile phase solvents were composed of mobile phase 
A: water/0.1 % FA; mobile phase B: ACN/0.1% FA; and mobile phase C: water/2% ACN/0.1% 
FA. Trapping was performed in mobile phase C for 5 min at 5 µL/min followed by an elution 
configuration across a 90 min gradient using mobile phases A and B at a conserved flowrate of 300 
nL/min. The proportions of both solvents were adjusted at specified time-points of 0, 60, 65, 70, 79, 
80 and 90 min corresponding to 98, 60, 35, 5, 5, 98 and 98 % of solvent A, and 2, 40, 65, 95, 95, 2 
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and 2 % of solvent B, respectively. To minimise retention time drift, the analytical column was 
maintained at 40°C. 
3.11.2 Data dependent acquisition (DDA) 
After chromatography, peptides were injected into the instrument and analysed by DDA. The DDA 
mode of the instrument was set to obtain high resolution (30,000) TOF-MS scans over a mass range 
of 350-1350 m/z, followed by up to 40 (top 40) high sensitivity MS/MS scans of the most abundant 
peptide ions per cycle. The selection criteria for the peptide ions included intensity greater than 150 
cps and charge state of 2-5. The dynamic exclusion duration was set at 12 s to account for the 
difference in chromatographic peak width.  Each survey (TOF-MS) scan lasted 0.25 s and the 
product ion (MS/MS) scan lasted 0.05 s resulting in a total cycle time of 2.3 s. The ions were 
fragmented in the collision cell using rolling collision energy, and collision energy spread (CES) 
was set to 5. The collected peptide ion fragmentation spectra were stored in .wiff format (SCIEX). 
3.11.2.1 DDA data processing  
3.11.2.2 Overview of DDA data processing strategy 
Because of the genome of sheep being incompletely sequenced or annotated, proteins were 
identified by matching tryptic peptides against a composite protein sequence database of sheep, goat 
and ox using ProteinPilot™ in the first instance in order to capture homologous sequences. The 
inclusion of protein sequences from related species is a helpful strategy when exploring and 
establishing foundation proteogenomics data to identify known or novel genes of the non-model 
study subject — in this case sheep6-8,20,189,243,244. Mascot 200 search was subsequently conducted 
using a sheep only sequence database to identify high-scoring proteins and PeptideShaker 
245
 to 
verify protein identifications from the primary search data. 
3.11.2.3 Primary protein sequence database searching 
The acquired MS/MS data from the instrument were extracted and annotated with amino acid 
sequences from a custom built database using the Paragon™ Algorithm164 (ProteinPilot™ Software 
5.0, Revision Number: 4769,  SCIEX). The custom database (55,108 sequences; 34,001,891 
residues) with added common contaminants was assembled in FASTA format downloaded on 15 
April, 2015 from a repository of non-redundant and predicted protein sequences of Ovis aries, Bos 
taurus and Capra hircus sourced from NCBI (National Center for Biotechnology Information – 
http://www.ncbi.nlm.nih.gov/protein/). Another Ovis aries-only custom database (27,393 
sequences, 13,114,569 residues) with added contaminants from the common Repository of 
Adventitious Proteins, cRAP (http://www.thegpm.org/crap/), was assembled in FASTA format on 
26 July, 2016 from UniProtKB (Universal Protein Resource Knowledgebase – 
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http://www.uniprot.org/). For ProteinPilot™ searches, the following settings were selected: Sample 
type: Identification; Cys Alkylation: Iodoacetamide; Digestion: Trypsin; Instrument: 
TripleTOF5600; Special Factors: Urea denaturation; Species: None; Search effort: Thorough ID; ID 
Focus: Amino acid substitution; Results Quality: Detected protein threshold [Unused ProtScore 
(Conf)] ≥ 0.05 with false discovery rate (FDR) selected. Annotations were only retrieved from 
UniProt during composite file searches (i.e. when a group of files were searched concurrently). The 
automatically generated Excel (Microsoft
®
 Excel™ 2010, Microsoft Corporation) spreadsheet 
report from ProteinPilot™ output was manually inspected and then meticulously curated to filter 
out contaminants and protein identifications with 0 (zero) unused confidence scores. The protein-
level FDR analysis report generated automatically in Excel by ProteinPilot™ was used to determine 
identification thresholds. FDR is the number of significant peptide matches in the decoy results 
divided by the number of significant matches in the target results. The report showed proteins 
identified at critical FDR, estimated FDR and numeric receiver operating characteristic (ROC) plots 
of the data from DDA experiments.  The identification threshold was determined as the highest 
number of proteins identified corresponding to 1% critical FDR on the Global FDR fit in the report. 
Only proteins identified at FDR ≤1% with ≥ 2 high-scoring peptides were considered for protein 
lists and for comparative analysis in the first instance.  
The .group file derived from ProteinPilot™ composite search of all samples analysed by DDA were 
used as a reference PSL with SWATH™ Acquisition MicroApp version 2.0 (SCIEX) data 
extraction. The resulting library file contained the following information required for targeted data 
extraction: UniProt accessions, stripped peptide sequences, modified peptide sequences, Q1 and Q3 
ion detection, retention times, relative intensities, precursor charges, fragment types, scores, 
confidence and decoy results.    
The .group file data in ProteinPilot™ were exported as calibrated Mascot generic format (.mgf) and 
mzIdentML (.mzid) format files. The .mgfs were further reformatted by an in-house Perl script 
(www.perl.org) or mgf repair tool (SCIEX)  prior to loading via a Daemon application to Mascot 
search engine (Matrix Science, London, UK; version 2.5.1)
200
. Mascot was set up to search the 
same custom database that was used in ProteinPilot™ with the following search parameters: Type 
of search: MS/MS Ion Search; Enzyme: Trypsin; Fixed modifications: Carbamidomethyl (C); 
variable modifications: Deamidated (NQ), Oxidation (M); Mass values: Monoisotopic; Protein 
mass: Unrestricted; Peptide mass tolerance: ± 10 ppm; Fragment mass tolerance: ± 0.01 Da; Max 
missed cleavages: 1; Instrument type: ESI-QUAD-TOF, and the auto-decoy search option was 
selected. Peak list and identification data from the search were exported in a .dat format for further 
processing. Protein lists were exported in csv format for immediate data evaluation and curation to 
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remove contaminants in Excel spreadsheet. Only proteins identified with 2 or more high-scoring 
peptides were included for further evaluation. 
3.11.2.4 Secondary protein sequence database search and protein identification 
The .mgf and .dat  or .mzIdentML files (from ProteinPilot™ after proprietary source code editing – 
see Chapter 6) were also loaded for protein identification using PeptideShaker Software
245
. Peak 
lists obtained from MS/MS spectra were identified using Mascot
200
. Protein identification was 
conducted against a concatenated target/decoy
246
 version of the Ovis aries (27284, 99.5%) 
complement of the UniProtKB, 27,411 (target) sequences. The decoy sequences were created by 
reversing the target sequences in SearchGUI. The identification settings were as follows: Trypsin 
with a maximum of 1 missed cleavages; 10.0 ppm as MS1 and 0.5 Da as MS2 tolerances; fixed 
modifications: Carbamidomethylation of C (+57.021464 Da),  variable modifications: Deamidation 
of N (+0.984016 Da), Deamidation of Q (+0.984016 Da), Oxidation of M (+15.994915 Da), 
Pyrolidone from E (--18.010565 Da) and Pyrolidone from Q (--17.026549 Da), fixed modifications 
during refinement procedure: Carbamidomethylation of C (+57.021464 Da). All algorithm-specific 
settings are listed in the Certificate of Analysis available in the data files.  
Peptides and proteins were inferred from the spectrum identification results using PeptideShaker 
version 1.13.0
245
. Peptide Spectrum Matches (PSMs), peptides and proteins were validated at a 
1.0% FDR estimated using the decoy hit distribution. All validation thresholds are listed in the 
Certificate of Analysis available in the data files. Post-translational modification localisations were 
scored using the D-score
247
 and the phosphoRS score
248
 with a threshold of 95.0 as implemented in 
the compomics-utilities package
249
. A phosphoRS score above this threshold was considered as a 
confident localisation. Protein identification reports were exported in .xlsx format for evaluation 
and curation in Excel spreadsheet. Only proteins identified with 2 or more verified peptides were 
included for further evaluation.  
3.11.3 Data independent acquisition (DIA) 
Eluted peptides were subjected to cyclic data independent acquisition (DIA) using a generic 
SWATH-MS™ acquisition method (SCIEX) based on its earlier description1.  The instrument was 
operated using a mass range of 100 msec for the survey scan (MS), followed by performing MS/MS 
on all precursors in a cyclic manner using an accumulation time of 0.1 s per SWATH-MS window 
(36 windows total, each 26 m/z units wide) for a total cycle time of 3.75 s. The above parameters 
allowed the collection of at least 6 data points for each chromatographic peak of a peptide to ensure 
a reasonably accurate quantitation.  It should be noted that a typical quantitation requires 
approximately 14 data points over a peak to define it accurately, although this is probably not 
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pratical with a slower method like SWATH-MS. The lower peak definition is associated with 
increased variability of quantitation. 
3.11.3.1 DIA data processing  
The generated raw .wiff instrument files were concurrently imported into PeakView
®
 v.2.2 
Software (SCIEX) with SWATH-MS™ Acquisition MicroApp 2.0 (SCIEX) incorporated for 
spectral alignment and targeted data extraction alongside a loaded PSL that was earlier constructed 
generated from a composite of DDA experiments using sheep serum and plasma acquired on the 
same instrument. 
PeakView Software
®
 performed the mining of extracted ion chromatograms (XICs) and determined 
peak areas for the entire sample set. The XICs of fragment ions from MS/MS spectra of targeted 
proteins and peptides were generated by the SWATH-MS™ Acquisition MicroApp, which also 
integrated the peak areas from the SWATH-MS™ data files.  
The parameters for SWATH-MS™ data extraction were set as follows: up to five peptides per 
protein, up to five transitions per peptide, peptide confidence level of 99%, include shared peptides, 
and extracted ion chromatograph (XIC) width of 50 ppm. The processed data were amenable to 
exportation as quantitative output for the peak area under the intensity curve for individual ions, the 
summed intensity of individual ions for a given peptide, and the summed intensity of peptides for a 
given protein, in .txt format. 
3.12 Statistical analysis of the processed data 
3.12.1 Identified protein lists 
Proteins lists from DDA experiments were presented in spreadsheet and charts (Microsoft
®
 Excel™ 
2010, Microsoft Corporation) and then exported for analysis and visualised using Venny 2.1
250
,  
jvenn
251
 or BioVenn
252
 software version 2007 – 2017, where appropriate.  
Peptide and protein peak areas from DIA experiments were automatically passed to MarkerView™ 
Software version 1.3 (SCIEX) for visualisation, normalisation and statistical analysis. Protein 
identification entries were exported into Excel™ spreadsheet, which facilitated inspection and 
comparative analysis using BioVenn software.  
3.12.2 Gene ontology (GO) – term and protein pathway analysis  
The proteins identified by Mascot searches were subjected to gene ontology (GO) analysis using 
Protein ANalysis THrough Evolutionary Relationships (PANTHER) classification tool
220
. In the 
PANTHER tool, the gene entries were analysed by aligning them to Bos taurus, as the closest 
organism analogous to sheep because Ovis aries entries were not available. The results of GO-term 
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analysis of molecular function, biological process, cellular component, protein class and pathway 
analysis of the detected proteins were displayed in Excel™ charts. 
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CHAPTER 4 
4.0 Characterisation of the circulating acellular proteome of healthy sheep using nanoLC-
nanoESI-MS/MS analysis of serum 
4.1 Abstract 
Unlike humans, there is currently no publicly available reference mass spectrometry-based 
circulating acellular proteome data for sheep, limiting the analysis and interpretation of a range of 
physiological changes and disease states. The objective of this Chapter was to develop a robust and 
comprehensive method to characterise the circulating acellular proteome in ovine serum. 
Serum samples from healthy sheep were subjected to shotgun proteomic analysis using nanoLC-
nanoESI-MS/MS on a TripleTOF® 5600+, SCIEX instrument. Proteins were identified using 
ProteinPilot™ and Mascot software based on a minimum of two unmodified highly scoring unique 
peptides per protein at a false discovery rate (FDR) of 1% by searching a subset of the UniProtKB 
database. PeptideShaker searches were used to validate protein identifications from ProteinPilot™ 
and Mascot.  
ProteinPilot™ and Mascot identified 245 and 379 protein groups (IDs), respectively, and 
PeptideShaker validated 133 protein IDs from the entire dataset. Since Mascot software is 
considered the industry standard and identified the most proteins, these were analysed using 
PANTHER classification tool revealing the association of 349 genes with 127 protein pathway hits. 
These results demonstrated for the first time the feasibility of characterising the ovine circulating 
acellular proteome using nanoLC-nanoESI-MS/MS. This peptide spectral data contributes to a 
protein library that can be used to identify a wide range of proteins in ovine serum. 
4.2 Introduction 
The well-defined serum proteome of humans permits analysis and interpretation of a range of 
physiology changes and disease states
101,253
, but not that of sheep in comparison . To date, the 
serum proteome of sheep is largely extrapolated from cattle, which can be inaccurate despite a 97% 
similarity in protein coding sequences
254
 and different promoters driving the expression of specific 
proteins
255
. Characterisation of the serum proteome of sheep would therefore be useful to quantify 
disease in this species. 
Sheep are a major production species, providing meat and wool, plus are used in a range of 
biotechnological and translational studies
256-260
. Despite this, relatively little is known about the 
responses of sheep to a variety of pathophysiological events. There is therefore a need to 
comprehensively characterise the proteins in ovine serum for better quantitative assessment of 
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disease processes. Blood is relatively easily collected from sheep
22,111,261-263
, but comparatively only 
a small number of proteins have been identified, limiting the capacity to assess disease
111,264
. One 
problem to date is that protein sample preparation in published studies on sheep have been 
inadequate and have generally ignored the full conventions for reporting identified proteins from 
samples
265,266
. Consequently, data are lacking on optimised sample preparation approaches for 
shotgun proteomics workflows using more than one protein sequence search engine to explore the 
circulating acellular proteome of sheep. For example, the number of proteins identified by single 
laboratories using gel fractionation followed by MS from human plasma has been in the region of 
nearly 300 protein IDs)
27
.  In 2005, LC-MS/MS data from multiple sample preparation techniques 
and protein sequence search engines for HPPP from 18 laboratories worldwide collectively 
identified 3,020 plasma proteins based on a minimum of 2-high-scoring peptides
73,267
. This number 
of protein IDs from HPPP studies was subsequently revised to 889
73,74
.  A study that used RP-
HPLC and LC-ESI-MS/MS to analyse and define the human baseline plasma proteome identified 
200 proteins
216
. More recently, protein expression profiles of human plasma proteins using  1D 
SDS-PAGE coupled with nanoLC-ESI-MS/MS in a single laboratory identified 253 proteins after 
desalting of the peptides
268
. A similar approach to that used in the preceding study was considered 
attractive to be used in exploring the circulating acellular proteome of sheep. 
In this chapter, nanoLC-nanoESI-MS/MS was used to analyse peptide samples derived from 
healthy sheep following 1D SDS-PAGE and in-solution digestion. 
4.3 Methods 
4.3.1 Animal care, sample collection, storage and preparation 
Serum samples of  approximately 2 year-old healthy adult female Merino sheep (n=6) with ear tag 
identification numbers 473, 413, 463, 471, 476 and 478 belonging to an experimental colony at 
QUT and the Australian Red Cross Blood Service (ARCBS) were obtained for the development and 
optimisation of a comprehensive proteomic approach for interrogating the circulating acellular 
proteome. The sheep were reared according to established standard operating procedures, described 
elsewhere
10
, in order to minimise variables that are known to modify the proteome such as breed, 
and physiological status for example stress, season, lactation, nutrition, health, pregnancy and 
oestrus status. Sample aliquots of 500 µL were stored in 1.5 mL Eppendorf tubes at -80 °C at the 
ARCBS, Brisbane. The samples were transferred to the wet laboratory at the Molecular Genetics 
Research Facility (MGRF) within Central Analytical Research Facility (CARF), QUT for 
processing. Processed samples were analysed at the Proteomics and Small Molecule Mass 
Spectrometry laboratory at CARF, QUT. 
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4.3.2 Experimental layout and data collection 
In order to characterise the serum proteome of sheep, two universal sample preparation strategies 
described in Chapter 3 for shotgun proteome analysis were employed in three paired sets of 
experiments (first, second and third), using in-gel (1D SDS-PAGE) and in-solution protein 
digestion of serum samples. This was followed by peptide analysis by nanoLC-nanoESI-MS/MS.  
4.3.2.1 1D SDS-PAGE of normal sheep serum workflow 
As a pilot study, an acetone precipitated serum sample obtained from one sheep (Sheep ID 473) was 
processed and subjected to 1D SDS-PAGE to ascertain the feasibility of obtaining protein 
identification data as a basis for constructing a peptide spectral library in future (first in-gel 
digestion). In order to determine the optimum amount of serum protein to load, 2, 10 and 22 µg of 
protein were run in separate wells of the same gel. To determine the amount of protein that needed 
to be loaded on a gel for protein bands to be visualised after using EZ-Run protein stain, 250, 500 
and 2500 fmol of bovine serum albumin (BSA) protein were loaded in separate wells of another gel 
and run. 
In order to increase the protein coverage, a fraction of acetone precipitated serum sample from 
Sheep ID 473 was subjected to 1D SDS-PAGE in two gels run concurrently (second in-gel 
digestion). One gel was loaded with 50 µg and 100 µg of protein in adjacent lanes and the second 
gel was also loaded with 50 µg, 100 µg and 50 µg in adjacent lanes.  
In all the 1D SDS-PAGE experiments above (first and second in-gel digestions), individual gel 
lanes were cut out and divided into 12 portions in a ladder-like fashion and individually digested so 
that the sum total of the proteins in the sample were submitted for analysis, even portions of gel that 
did not appear to contain proteins. This approach enabled the analysis of the entire proteome spread 
over a larger number of injections onto the MS instrument. 
In order to determine the effect of the quantity of protein loaded, acetone precipitation and a 
protease inhibitor on protein coverage, pooled serum  samples from six healthy sheep (Sheep IDs 
413, 463, 471,473, 476 and 478) were processed and subjected to 1D SDS-PAGE in three gels 
(third in-gel digestion). The samples utilised consisted of crude protein (200 µg and 100 µg) in one 
gel with each lane cut out and divided into 6 portions and individually digested. One lane in a 
second gel loaded with 100 µg of crude serum with a protease inhibitor had 6 portions of gel cut 
and digested, another lane loaded with 100 µg of acetone precipitated serum protein with a protease 
inhibitor had 12 portions of gel cut and digested and a third lane loaded with 100 µg of crude serum 
without a protease inhibitor had 6 portions of gel cut and digested. A third gel was loaded and run 
identically as the second gel; the first lane loaded with 100 µg of crude serum with a protease 
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inhibitor had 14 portions of gel cut and digested, the second lane loaded with 100 µg of acetone 
precipitated serum protein had 12 portions of gel cut and digested and a third lane loaded with 100 
µg of crude serum without a protease inhibitor had 6 portions of gel cut and digested. 
4.3.2.2 In-solution digestion of sheep serum workflow 
As a pilot study, 10 µg of acetone precipitated serum sample obtained from one sheep was 
subjected to in-solution digestion to ascertain the feasibility of obtaining protein identification data 
as a basis for protein quantitation in future (first in-solution digestion). In order to determine the 
effect of using unfractionated sample on protein coverage, a fraction of 20 µg of crude serum 
sample from the sheep used in the first in-gel digestion was subjected to in-solution digestion and 
analysed (second in-solution digestion). A third experiment utilised 100 µg of pooled crude serum 
samples from all six sheep (Sheep IDs 473, 413, 463, 471, 476 and 478) for in-solution digestion in 
order to determine the effect of using a higher quantity of protein substrate on protein coverage 
(third in-solution digestion). 
4.3.3 Data archiving 
The mass spectrometry data along with the identification results were deposited to 
ProteomeXchange Consortium
231
 via the proteomics identifications (PRIDE) partner repository
269
 
with the dataset identifiers PXD004989 and DOI: 10.6019/PXD004989. The URL is 
https://www.ebi.ac.uk/pride/archive/projects/PXD004989 and can be accessed with username 
reviewer99399@ebi.ac.uk and password QBFFTGzl.  
4.4 Results 
4.4.1 1D SDS-PAGE 
The results of the first, second and third in-gel digestion workflows are presented in Figures 4.0, 4.1 
and 4.2, respectively. The details of the individual gels are provided in the figure captions. Except 
for Gel B in Figure 4.0, the protein sample lanes of all the other gels were subjected to in-gel 
digestion followed by nanoLC-nanoESI-MS/MS to identify proteins. Protein IDs were obtained 
using ProteinPilot™ to search a UniProtKB composite database of Ovis aries, Bos taurus and 
Capra hircus with a results quality of FDR ≤1%; ≥ 2 peptides for a protein to be considered  
confidently identified as the highest scoring member of the protein group. The Pro Group™ 
Algorithm in ProteinPilot™ assigned one protein the best confidence possible (unused score) 
among protein isoforms, which enabled protein subset differentiation, as well the suppression of 
false positives for protein-grouping analysis
270
. The results were therefore based on protein group 
identifications presented as protein identifications (IDs). 
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↑. Gel A ↑. Gel B 
Figure 4.0. Coomassie-stained 1D SDS-PAGE gels used in first in-gel digestion. Fractions of 
acetone precipitated serum protein from one healthy sheep (Sheep ID 473)  were loaded alongside 
bovine serum albumin (BSA) in Gel A. Gel A suffered a handling artefact to the top right corner of 
the gel. The leftmost well of both gels were loaded with 4 µL of a protein molecular weight 
standard (Precision Plus Protein™ Dual Xtra, Bio-Rad Laboratories). One well in Gel A was loaded 
with 500 fm of BSA standard; other three wells were loaded with 22 µg, 10 µg and 2 µg each of 
sheep serum protein sample, that yielded 120, 19 and 41 protein identifications, respectively. After 
the molecular weight standard, other three in Gel B were loaded with 500 fm, 2500 fm and 250 fm 
each of BSA standard. Arrows show BSA standard. Key: kD = kiloDalton; BSA= bovine serum 
albumin; sheep SP= serum protein; ug=µg; MWt= Molecular weight marker fm=fmol.  
 
  
↑. Gel A ↑. Gel B 
↑. Figure 4.1. Coomassie-stained 1D SDS-PAGE gels used in the second in-gel digestion. Fractions 
of acetone precipitated sheep serum protein samples from one healthy sheep (Sheep ID 473) were 
used. One well in Gel A was loaded with BSA standard (arrow); two other wells had 100 µg and 50 
µg of protein each that yielded 151 and 127 protein IDs, respectively. Three wells in Gel B were 
loaded with 50 µg, 100 µg and 50 µg each of protein that yielded 144, 156 and 141 protein IDs, 
respectively. Key: kD = kiloDalton; BSA= bovine serum albumin; sheep SP = serum protein; ug = 
µg; MWt = Molecular weight; fm = fmol.  The arrow in gel A points at the BSA standard band.  
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↑. Gel A ↑. Gel B ↑. Gel C 
Figure 4.2. Coomassie-stained 1D SDS-PAGE gels used for the third in-gel digestion. Fractions of 
pooled serum protein samples from six healthy sheep were used. Gel A was loaded with 200 µg 
and 100 µg of crude serum separately yielding 40 and 38 protein IDs, respectively. Gels B and C 
were loaded identically with three-100 µg of serum protein that were treated as follows: one well 
had crude serum with a protease inhibitor (SP 100 µg+Pi), the second had acetone precipitated 
serum and a protease inhibitor (SP 100 µg+Pi+Ac) and the third had crude serum only (SP 100 
µg), each category yielded 162, 143 and 114 protein IDs, respectively. Key: kD = kiloDalton; 
BSA= bovine serum albumin (white arrow); sheep SP= serum protein; ug = µg; MWt = Molecular 
weight; fm = fmol; Ac = acetone precipitated serum; Pi = protease inhibitor (cOmplete™, Roche). 
The protein ID results of the first, second and third in-gel and in-solution digestions are summarised 
in Table 4.0. The Pro Group™ Algorithm in ProteinPilot™ assigned one protein the best confidence 
possible (unused confidence) among protein isoforms, which enabled protein subset differentiation, 
reduction of redundant protein IDs as well the suppression of false positives for protein-grouping 
analysis
270
. The results were therefore based on protein group identifications presented as protein 
identifications (IDs).  
In the present set of experiments, proteins were identified by using peptide signatures to search 
custom-built protein sequence databases. Protein ID confidence was determined by the number of 
proteins that were assuredly accepted as correct, having been identified by two or more high-
scoring peptides
271,272
. Overall, a total of 267 confident and unique protein groups were identified 
using ProteinPilot™ by searching a composite UniProtKB database after combining all the three in-
gel digestion workflows (first, second and third in-gel digestions)  from a total quantity of  1,284 µg 
of serum protein obtained from six healthy sheep. The UniProtKB entries for the identified proteins 
are presented in Appendix 4.0.  
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Table 4.0. The number of proteins identified by ProteinPilot™ Software from in-gel and in-
solution digestion of healthy sheep serum samples by searching a composite database. 
Experiment → First digestion Second digestion Third digestion 
Digestion type 
 
In-gel In-sol In-gel In-sol In-gel In-sol 
Serum protein source Ac Ac Ac Crude Ac + Crude Crude 
Total quantity of 
protein analysed  
34 µg 10 µg 350 µg 20 µg 900 µg 100 µg 
Number of protein 
IDs 
120 25 241 100 182 32 
Key: In-sol = In-solution; Ac = Acetone precipitated; IDs = Identifications  
4.4.2 In-solution digestion 
A composite ProteinPilot™ search of all the three in-solution digestion workflow samples 
comprising of 130 µg of serum protein yielded a total of 102 protein IDs. The UniProtKB entries 
for these proteins are presented in Appendix 4.1. 
A comparison between the protein ID list derived from combined first, second and third in-gel 
digestion (in-gel digestion workflow) and  that of  combined first, second and third in-solution 
digestion (in-solution digestion workflow) in BioVenn Software
252
 which collectively yielded 284 
protein IDs is presented in Figure 4.3. The UniProtKB entries of the 17 proteins that were exclusive 
to the in-solution digestion workflow (i.e. proteins were not detected by in-gel workflow) are 
A0A0F6QNP7, W5PSQ7, W5QH45, W5NQW9, G5E604, W5PZF0, W5NWX6, Q1KZF3, 
W5PJZ2, W5QDP8, W5PDR7, W5PN97, W5PXI6, F1N3Q7, C6ZP49, G3N346 and Q3SYR8. 
A combined ProteinPilot search of the pilot data from one sheep and the additional data from five 
sheep for both in-gel and in-solution digestion workflows using a composite Ovis aries, Bos taurus 
and Capra hircus database yielded an overall outcome of 274 protein IDs. Based on comparison 
with previous studies and protein database resources
17,20,110,111,189,263,264,273-280
, there were 67 known, 
207 novel and 83 disease-associated serum proteins identified using this composite database whose 
UniProtKB entries are presented in Appendix 4.2, Appendix 4.3 and Appendix 4.4, respectively. 
The known proteins are those that have been cited in the literature and also have a confirmed status 
in UniProtKB. Novel proteins constitute those that previously appeared as predicted and proteins 
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that had hitherto been inferred by homology. Disease-associated proteins refer to proteins that are 
expressed or alter during pathology in sheep and other species. 
 
 
Figure 4.3. Comparison of lists of 
protein identifications (IDs) derived from 
in-solution versus in-gel digestion using 
BioVenn Software. Protein 
identifications were made by searching a 
composite database of Bos taurus, Ovis 
aries and Capra hircus using 
ProteinPilot™ Software. Only 17 protein 
IDs were exclusive to the in-solution 
workflow compared to 182 protein IDs 
exclusive to in-gel workflow. 
4.4.3 Combined protein identifications from 1D SDS-PAGE and in-solution digestion of serum 
using ProteinPilot™ and Mascot database search engines and PeptideShaker search 
Protein yields from a composite search of all the sample data from the three workflows (first, 
second and third in-gel and in-solution digestion) using a sheep-only UniProtKB database were as 
follows: ProteinPilot: 245 IDs; Mascot: 379 IDs and PeptideShaker: 133 IDs. Again, based on 
comparison with previous studies and protein database resources
17,20,110,111,189,263,264,273-280
,  and 
using  the 379 Mascot protein IDs, there were 77 known, 302 novel and 83 disease-associated 
serum proteins identified using this sheep only database as listed in Appendix 4.5, 4.6 and 4.7, 
respectively. 
The 379 protein IDs from Mascot search were used as a benchmark for further downstream 
analysis. Every sheep protein ID made in Mascot was mapped to a distinct gene. Of all the 379 
protein IDs made by searching the sheep only UniProtKB database, only 70 proteins had been 
annotated based on sequence similarity to other species, whilst 305 proteins were uncharacterised.  
Of the 70 annotated proteins, only annexin A2 (P14639), serum albumin (P12303),  transthyretin 
(B3SV56), nuclear receptor subfamily 1 group D member 1 (A2SW69) and insulin-like growth 
factor-binding protein 2a (Q29400) had been reviewed and therefore included in the Swiss-Prot 
subset of UniProtKB.  The unreviewed, but named proteins are presented in Table 4.1. 
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Table 4.1. Unreviewed but named proteins in UniProtKB identified in serum of healthy sheep   
14-3-3 Protein sigma Gelsolin isoform B 
Adaptor protein complex subunit beta Glutathione peroxidase 
Adenylyl cyclase-associated protein Glyceraldehyde-3-phosphate dehydrogenase 
Adiponectin Growth hormone receptor variant h 
Alpha-1-acid glycoprotein Histone H2a 
Alpha-1-antitrypsin transcript variant 1 Histone H2b 
Alpha-2-HS-glycoprotein Histone H3 
Alpha-mannosidase Histone H4 
Amine oxidase Importin subunit alpha 
Angiotensinogen Large tumour suppressor-like 1 protein 
Antithrombin-III L-Lactate dehydrogenase 
Apolipoprotein E MHC Class II antigen 
Arginase Monocyte differentiation antigen cd14 
Aspartate aminotransferase Olfactory receptor 
Beta-a globin chain Oxysterol-binding protein 
Carbonic anhydrase 2 Pentaxin (pentraxin) 
Carboxypeptidase Peptidyl-prolyl cis-trans isomerase (PPIase) 
Centromere protein C Phosphodiesterase 
Ceruloplasmin Plasminogen 
CGMP-dependent protein kinase Polypeptide N-acetylgalactosaminyltransferase 
Chitinase-3-like protein 1 Proteasome subunit alpha type 
Clusterin Proteasome subunit beta type 
Coagulation factor IX Protein-serine/threonine kinase 
Condensin complex subunit 2 Protein-tyrosine-phosphatase 
Conglutinin 1 Prothrombin 
Corneodesmosome protein Superoxide dismutase [Cu-Zn] 
C-X-C motif chemokine Thyroxine-binding globulin 
Dipeptidase Transaldolase 
DNA polymerase Tubulin alpha chain 
Factor H Tubulin beta chain 
Fibrinogen alpha chain Uricase 
Fibulin-1 VH region chain 
Fructose-1,6-bisphosphatase 1  
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4.4.4 GO-term analysis of proteins identified in serum of healthy sheep   
The 379 proteins identified by a composite Mascot search of the first, second and third in-gel and 
in-solution digestion of serum proteins from healthy sheep were subjected to GO-term analysis 
using PANTHER classification tool
220
. In the PANTHER tool, the gene entries were analysed by 
aligning them to Bos taurus, as the closest organism analogous to sheep because Ovis aries entries 
were not available. The PANTHER analysis resulted into 349 bovine aligned gene entries as listed 
in Appendix 4.8. 
The results of GO-term analysis of molecular function, biological process, cellular component, 
protein class and pathway analysis of the detected proteins are provided in Figure 4.4. Looking at 
the molecular function domain of the proteins alone based on the GO-term results (Panel A), 
catalytic activity was dominant of the 264 function hits. From the protein IDs that had names, at 
least 27 of them were specifically classified as enzymes from protein database searches. It is evident 
from these results that there is a hierarchy in the biological processes of the 586 process hits (Panel 
B). The cellular component GO domain (Panel C) for serum from healthy sheep had 214 hits in 
total. The protein class GO domain (Panel D) had 386 class hits, with enzyme modulation topping 
the list. Among the 49 prominent protein pathways that were displayed in PANTHER from the 
analysed genes, 14 were represented by over 3.0% contribution to the revealed pathway pool (Panel 
E). 
4.5 Discussion and conclusion 
This chapter reports the development of a proteomics baseline profile of healthy sheep serum by 
analysing peptides derived from in-solution digestion and 1D SDS-PAGE using nanoLC-nanoESI-
MS/MS. The major outcome was that 379 proteins were identified, compared for example to 42 
proteins from serum of sheep with mild respiratory disease during peripartum period
111
 and a single 
protein (serum amyloid A) in sheep with scrapie
264
. Both of these cited earlier sheep studies used 
two dimensional (2-DE) surface enhanced laser desorption/ionisation time of flight mass 
spectrometry (SELDI-TOF MS) and LC-MS/MS.  
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Figure 4.4. Gene Ontology (GO) and pathway analysis of Mascot protein IDs in healthy sheep 
serum. The GO – term domains are: A–molecular function, B–biological function, C– cellular 
component, and D–protein class. E–pathway analysis. 
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In species other than sheep, for example in various studies that analysed human sera, up to 490
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proteins were identified using multidimensional separation coupled with MS. This suggests that 
with improved sample fractionation and adequate protein sequence database resources, there is 
scope to identify more proteins in the circulating proteome of sheep. There is also a report that 
assessed three different lots of foetal bovine serum by NanoLC-MS/MS analysis in which 79, 90, 
and 91 proteins were identified
281
. The preceding study recognised that there is variability in the 
protein content of different lots of foetal bovine serum – a commonly used growth medium for cell 
cultures, which affects the consistency of cell growth. The lot with a higher number of protein IDs 
was associated with higher cell growth rate
281
. Identification of these proteins is important clinically 
to determining health or altered physiology, such as stress
111
. 
The use of 1D SDS-PAGE in this study facilitated serum protein samples to be fractionated to 
reduce protein complexity prior to nanoLC-nanoESI-MS/MS analysis
282
. The first in-gel digestion 
experiment enabled the determination of the quantity of protein from samples and the amount of the 
BSA standard that needed to be loaded onto the gel to ensure that protein bands were visible and 
clearly defined (Figure 4.0). Loading a larger quantity of protein onto the gel was necessary to 
discover as many proteins as possible using DDA
1
. However, the 2 µg lane yielded 41 protein IDs 
in the first in-gel digestion (Figure 4.0), while the 10 µg-lane yielded 20 protein IDs and the 22 µg 
lane yielded 121 protein IDs. The 10 µg lane was analysed initially and the 2 µg and 22 µg lanes 
were analysed 6 weeks later once the extractions had been optimised and the instrument tuned.  
The second in-gel digestion (Figure 4.1) increased the protein coverage by loading more protein 
into the gel wells using a fraction of the acetone precipitated serum sample used in the 1
st
 in-gel 
digestion.  The 100 µg (2 replicates) and 50 µg (3 replicates) protein loads in the 2
nd
 in-gel 
digestion workflow yielded comparable numbers of protein IDs for each of the loaded quantity of 
protein. This suggests that reproducibility of the amount of protein loaded into the gel lanes had 
been achieved
282
.  The second in-gel digestion was an improvement of the 1st in-gel digestion by 
having replicates and having increased quantities of loaded protein per lane, using the same serum 
sample of 1st in-gel digestion from Sheep ID 473. 
The 1D SDS-PAGE preparation of one gel in the third in-gel digestion had a number of visual 
artefacts (Figure 4.2). The distortion in the 10-15kD region of Gel A could have been attributed to a 
defect in the gel possibly due to inconsistency in gel polymerisation creating artefact bands
117
, 
overloading and/or the presence of a pocket between the gel and the cassette housing that allowed 
the protein samples to leak out the gel
283
. This could have also contributed to the low number of 
protein yields made from this gel, compared to the 100 µg × 2 lanes in Gels B and C.  This could  
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be because considerably less protein was extracted from the gels in some samples than others. A 
couple of variables were also introduced in this experiment, in addition to the quantity of proteins 
loaded on to the gel wells as planned. The analysis of fractionated crude serum that had a protease 
inhibitor yielded a higher number of protein IDs, compared to the acetone precipitated sample that 
also had a protease inhibitor. This suggests that a considerable number of proteins were present in 
the acetone precipitation supernatant that was discarded. The discardment of the supernatant from 
acetone precipitation is a routine practice during generic or universal sample preparation for 
proteomic analysis
24
.  
As for the in-solution digestion workflow, the number of protein identifications from analysing 100 
µg of crude serum protein was low when compared with 20 µg. The sample for the first in-solution 
digestion using 10 µg of acetone precipitated serum that was drawn from one healthy pilot sheep  
yielded even a lower number of protein IDs. This sample was prepared and analysed at the same 
time as the 10 µg sample of the first in-gel digestion discussed earlier. Protein detection was 
therefore likely to have been affected by unoptimised experimental processes at the time prior to 
running on the MS instrument. The number of protein IDs from second in-solution digestion using 
20 µg of crude serum from the same sheep was considered substantial and comparable to those of 
other studies
77,79,96,100,102,105,111,113
. Unexpectedly however, the third in-solution that utilised 100 µg 
of pooled crude serum from six sheep under the same experimental conditions much lower yield of 
protein IDs. It is thought that this result was possibly due to the inhibition of trypsin by the presence 
of intravenous agents in the pooled sample from the anaesthetic cocktail used to anaesthetise the 
sheep, as this was not the case with the pilot sheep sample in which the sheep was not anaesthetised 
during sample collection. 
BioVenn Software
252
 was utilised for visualisation of the data presented in Figure 4.3. This tool 
enabled the comparison of a protein identification list derived from in-gel digestion with that from 
in-solution digestion by displaying the data in an area-proportional Venn diagram. It showed protein 
IDs that were exclusive to in-solution and in-gel, and those common between the two digestions.  
Of the 17 protein IDs that were exclusive to in-solution digestion workflow, five were mapped to 
the ox, two to the goat and the remaining 10 IDs were for sheep. Despite having known genes, the 
vast majority of the identified proteins were either uncharacterised or unreviewed in UniProtKB. 
Another interesting observation was that the combined list of 284 protein IDs from in-gel and in-
solution digestion displayed in BioVenn Software was marginally higher than the 274 IDs from a 
composite ProteinPilot™ search of the same datasets. It is likely that the subsequent composite 
ProteinPilot™ search helped to further group proteins, thereby improving the confidence of protein 
IDs by minimising false protein identifications – a known challenge when searching a multi-species 
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protein database to identify proteins. 
The data showed different numbers of protein identifications from different samples which was not 
entirely unexpected as repeat injections of the same sample will give slightly different results every 
time due to the stochastic nature of the peak picking process. In that sense, the individual data 
presented may have not been adequetly useful. It can be argued that perhaps not enough 
experiments were performed to judge the true variability of the different sample preparation 
methods, given the potential variability of the acquisitions. It is necessary to point out the level of 
potential variability here, since this could prove critical in Chapter 7 that deals with label-free 
quantitation. On the other hand, repeat injections are not necessarily considered critical for the 
purposes of constructing a spectral library, given the inherent stochastic nature of the peak picking 
process of DDA experiments. Nevertheless, prior to conducting the experiments serious attempts 
were made to assess how reproducible sample preparation and data acquisition were, in particular 
from in-solution digests of BSA standards and replicate analyses of  ß-galactosidase from E. coli for 
in-house quality control of the instrument. This was done in order to assess the satisfactory 
reproducibility of repeat injections of individual samples (data not shown). 
The comparatively conservative number of protein IDs made by PeptideShaker search is because 
the protein entries were identified using only validated unique peptides. This stringent feature of 
using only unique peptides for protein identification is not readily obvious in either ProteinPilot™ 
or Mascot in a user-friendly manner, whose protein ID entries were based on at least two high-
scoring peptides per protein only, on the assumption that the peptides were unique to the protein. 
For this reason, PeptideShaker was selected as the most appropriate protein ID validation software 
that was used for the ultimate construction of the PSL of the circulating acellular proteome of sheep 
in Chapter 6. 
In this preliminary study however, the results from Mascot search were embraced and utilised for 
further analysis because this software platform has been used in previous studies on sheep
111
 and it 
is widely used by the proteomics community. Mascot software is considered the industry standard, 
because it implements a vast array of applications necessary for protein identification
284
. As of 
September, 2016, the 379 protein IDs complete with UniProtKB accessions was probably the 
highest number of sheep serum proteins to date using nanoLC-nanoESI-MS/MS. This study can 
therefore be considered the first to provide a comprehensive MS/MS protein sequence data of serum 
proteins of normal sheep and by contributing to the efforts of annotating genes and charactering 
sheep proteins. Despite most of the protein IDs not being characterised in UniProtKB, their 
mapping to known genes and the available mass spectrometry-derived peptide sequence data 
alongside verification on more than one software platforms, constitute strong supportive evidence 
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that the identified proteins do exist.  The downside of the Mascot search is that it does not provide a 
user-friendly protein sequence output that can be readily tabulated as in the case of ProteinPilot™ 
IDs. For this reason, only protein names and UniProtKB entries were utilised mostly for the 
purposes the present study. The different search engines produced different results by searching the 
same database possibly because of the disparate manner in how their algorithms work. In addition, 
the sheep genome has not been fully defined compared to that of humans or mice by which these 
software programs were benchmarked upon.  
Regarding GO-term analysis, the significance of many of the enzymes that dominated catalytic 
activity in the molecular function domain (Figure 4.4 A), remains to be documented in sheep, but 
the functions of some are known. For example, adenylyl cyclase-associated protein regulates cofilin 
function, the actin cytoskeleton, and cell adhesion
285
. Alpha-mannosidase participates in 
glycoprotein synthesis and endoplasmic reticulum quality control
286
. It has been reported to be 
downregulated in locoweed (Oxytropis sericea) in sheep
287,288
, for example. The functions of other 
identified enzymes drawn from
189,289-318
 are provided in Appendix 4.9.  
Serum samples of healthy adult female Merino sheep were utilised for this chapter. It is quite 
possible that a relatively low representation of the growth process domain in the biological process 
GO-term was because the serum samples were derived from adult sheep. Also, the cellular 
component fractions could possibly vary depending on the physiological status of the sheep – which 
remains yet to be determined and documented. It can be argued that hormonal changes and the 
influence of age contribute to observations of serum proteome profiles and this should be accounted 
for. For instance, studies in sheep have shown that diurnal variations in metabolic and stress-
responsive hormones do occur
319
.  
In the present study, there were mechanisms in place to mitigate the effects of stress on the 
laboratory sheep. The sheep were reared together and acclimatised to their housing and handling by 
people as a standard management practice prior to blood sampling
10,15
. Also, there was no variation 
in calorie intake because feed was supplemented as required
10,15
 in order to mitigate the well-
established phenomenon of seasonal weight loss – a well-established major nutritional stress factor 
in sheep
320
. During agistment, there were wethers that belonged to other experiments of the research 
group, but there were no entire males to cause ‘ram effect’ that could have caused surges in 
reproductive hormones
321
, for example. Nevertheless, gonadotropic activity would have occurred 
naturally in the ewes to cause hormonal changes
322
, perhaps even with a synchronised 
hypothalamic-pituitary-ovarian axis in all the ewes, as this phenomenon is known to occur 
naturally
323
. All the sheep were approximately 2 years old and were therefore, practically in the 
same metabolic and physiological state during blood sampling. Also, the sheep belonged to an 
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ovine model of blood transfusion
14
, so most preventable adverse attributes had been catered for. 
It can be argued that it would have been better to apply the GO classification to the larger data set 
presented later in the thesis, rather than to the relatively smaller number of identifications in this 
chapter. On the contrary however, this prototype study is discrete in that it contains only protein 
identifications derived from analysing serum of healthy sheep. This can be considered to represent 
the baseline proteome. Later datasets contain protein IDs derived from analysing both serum and 
plasma, and also include data from naturally ill sheep and sheep with experimentally induced 
endotoxaemia, which would make it difficult to separately evaluate the GO classification profiles of 
protein IDs derived only from healthy individuals.  
The knowledge from this prototype study has illuminated a considerable number of bovine-aligned 
gene entries associated with protein pathways that can be valuably exploited by animal model 
studies using sheep serum as their analyte. A downside of the present study is that no males were 
represented in the dataset. Future studies should take into account hormonal changes and be gender 
and age inclusive in order to capture broad aspects of the proteome that could have been missed. 
Secondly, all of the experiments were DDA discovery experiments of single injections using 90 min 
(1.5 h) LC gradients. It can be argued that this may not have given optimal analytical depth, but it 
was adequate for feasibility studies to enable the construction of a peptide spectral library and the 
best match for the SWATH experiments that are detailed in Chapter 7. As long as method 
optimisation processes have been accomplished, there is no contraindication for not using single 
injections for building a spectral library.  A longer LC gradient would have allowed for gaining a 
deep analysis of protein samples. However, from other published studies using the SCIEX 
workflow as in this thesis, a 90 min gradient has been popularly used, especially when building 
spectral libraries to be used by SWATH on the same instrument. And also, a longer LC gradient can 
be a very slow process, given how SWATH works. In future, a longer gradient and the use of repeat 
injections with exclusion lists should be included in the methods. 
Thirdly in hindsight, if the analysis and discussion provided scope for inclusion of information on 
the number of individual peptides identified and the % of MS/MS spectra that led to peptide 
identifications, then the true value of this data and its analysis would be apparent in order to provide 
opportunities for further future method optimisation. These data can be mined to provide much 
greater detail on how efficient the acquisition process was and add some interesting discussion 
points. For example, information on the width of the chromatography peaks is useful and can be 
obtained from XIC of the MS survey scan. It would have been ideal to provide a more detailed 
comparison of the results, for example which proteins were common to which search engines, how 
many individual peptides were identified per protein. The downside of this is that presenting these 
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data here would exceed the word count requirements for this thesis. Nevertheless, this information 
is publicly available at https://tinyurl.com/y7697fde and can also be accessed and have the analysis 
reproduced from the PRIDE archive link provided in the methods section as per the recommended 
publication norms of proteomics datasets. 
In conclusion, this chapter has demonstrated for the first time that it is feasible to identify several 
hundred sheep serum proteins using a traditional sample preparation approach followed by nanoLC-
nanoESI-MS/MS analysis. By utilising the PANTHER tool, this serum-derived prototype of the 
ovine circulating acellular proteome revealed the association of 349 genes with 127 protein pathway 
hits. When used with protein quantitative data that includes plasma samples, these findings have the 
potential to be applied as the foundation for establishing the baseline normal ovine serum proteome 
for comparison with samples from sick sheep. Following on in Chapter 5 are descriptions of plasma 
and serum sample preparation methods that enhance peptide extraction and improve protein 
identifications.  
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CHAPTER 5 
5.0 Strategies for enhancing peptide extraction from the liquid fraction of sheep blood for 
protein identification by nanoLC-nanoESI-MS/MS analysis 
5.1 Abstract 
Separation of proteins in a plasma or serum sample is a critical component of comprehensive 
proteomic analysis. In this chapter, several approaches to separating proteins were investigated. The 
protein yields from using plasma or serum as the analyte protein sample source were also compared. 
The protein fractionation techniques used included comprehensive acetone precipitation, partial 
organic precipitation with ACN, combinatorial peptide ligand library protein enrichment and off-gel 
fractionation. All fractionated samples were also subjected to 1D SDS-PAGE. 
The protein fractions from the samples were then subjected to shotgun proteomics analysis and the 
resulting proteins were identified, as previously described in Chapter 3. Using Mascot IDs as the 
standard, combinatorial peptide ligand library protein enrichment yielded the most protein IDs, 439, 
which represented 207 additional protein IDs to those from undepleted samples. ACN precipitation 
workflow resulted in 376 protein IDs, with plasma contributing the highest number of exclusive 
protein IDs. Acetone precipitation yielded 136 protein IDs, with serum fractions yielding a higher 
number of protein IDs than plasma did. The least sensitive standalone technique was off-gel 
fractionation, which yielded 84 protein IDs, compared to 55 protein IDs from unfractionated serum.  
These results represent the first comprehensive comparative analysis of various protein sample 
fractionation techniques for separation of proteins from the liquid fraction of sheep blood. 
Combinatorial peptide ligand library protein enrichment of plasma and serum samples was 
associated with the highest number of protein ID yields. 
5.2 Introduction 
Protein-level fractionation prior to subsequent separation using chromatography and analysis of the 
resulting tryptic peptides is a well-recognised strategy to enhance protein ID yields in shotgun 
proteomics workflows
67,116,324-327
. This chapter describes four protein sample preparation strategies 
to enhance peptide extraction from protein samples derived from the liquid fraction (the circulating 
acellular proteome) of sheep blood for protein identification, in addition to 1D SDS-PAGE. The 
paragraphs that follow provide some background to the application of these strategies.  
Acetone precipitation of proteins in solution is a commonly used procedure to fractionate plasma 
and serum analytes prior to proteomic investigations
328
. Like other organic solvents, acetone causes 
precipitation through hydrophobic aggregation, by changing the solvation of the protein with 
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water
23
. The efficiency of any precipitating agent depends on the physicochemical characteristics of 
the protein
329
. In most cases, the supernatant fraction after precipitation is seldom required and is 
discarded
330
. The precipitate, containing concentrated proteins, is retained to be used for 
downstream proteomic analysis. It is therefore noteworthy that only a few previous studies have 
examined the usually discarded supernatant fraction
330
. As an aim of the present study, then, the 
comprehensive analysis of fractions of acetone-precipitated sheep plasma and serum would provide 
new insights into the evaluation of the efficiency of acetone precipitation. There is a downside to 
acetone precipitation in that it has been known to modify certain peptides that become evident after 
subsequent proteolysis of the precipitate fraction, which could compromise proteomics outcomes
331
. 
In addition, depending on the structure of individual proteins, precipitation is known to alter the 
protein composition of samples
329
. The intent to explore in detail what might still be left in the 
supernatant was a nested aim within the broader aim of examining the acetone-precipitation 
technique in comparison with other techniques.  
Partial organic precipitation of proteins using ACN
332-336
, followed by analysis of both fractions, is 
an innovative approach used to increase acellular circulating proteome coverage via a pseudo-
depletion strategy of the most abundant proteins
337
. This approach is attractive because optimised 
ovine antibody-based protein depletion kits are still difficult to source. For instance, the ACN 
precipitation workflow of the method previously described by Mostovenko et al.
337
 and that of 
Bluemlein and Ralser
338
, which evaluated the effects of pH and protein concentration in human 
plasma samples resulting in substantial protein yields, could be used to explore samples from sheep. 
In one of the previous studies
337
, a higher number of protein IDs was achieved following ACN 
precipitation at a pH of 5. A higher pH of 9 was not associated with any benefit with respect to 
depletion of abundant proteins, with the added disadvantage that the pellets were difficult to 
resuspend
337
. By adapting these earlier studies
337,338
, it would be possible to ensure a deeper 
coverage of the circulating acellular proteome of sheep in the present study. 
On the basis of recent studies, combinatorial peptide ligand library protein enrichment 
(commercially available as the ProteoMiner™ kit) is poised to become a promising and vital 
inclusion in sample preparation workflows for proteomic analysis
56,72,80,339
. Although there are 
many studies of this enrichment approach performed on human plasma, its application on samples 
from blood fractions of domestic animals, especially sheep, are poorly described. In a study that 
compared ovine and bovine milk whey proteomes by MS analysis, the use of ProteoMiner™ 
enrichment resulted in increased proteome coverage, in comparison to undepleted samples
339
. As an 
aim of this chapter, it was considered necessary to evaluate the effect of depletion of highly 
abundant proteins in the circulating acellular proteome of sheep using ProteoMiner™, prior to 
59 
 
nanoLC-nanoESI-MS/MS analysis. 
Another approach to protein separation is off-gel fractionation (isoelectric focussing)
340
. This is a 
composite of in-gel and in-solution methods of protein sample separation, whereby proteins are not 
trapped in-gel, but are recovered in solution before downstream analysis, such as mass 
spectrometry
116,340
. In principle, this method takes advantage of an immobilised pH gradient strip, 
together with a pI gradient, for analyte separation
116
. This approach has been widely used in 
fractionating human peptide samples
341
 and in proteins
116,340
. The method has been suggested as 
suitable for discovery protein analysis of human plasma
340
 and has been used, for example, in a 
study that compared an animal cell lysate and its tryptic peptide digests
342
. The use of off-gel 
fractionation has recently been reported in the sample preparation of meat products
343
 and sheep 
milk whey
339
, but reports on its use on the liquid fraction of blood are not available. Moreover, 
except for one report detailing its use on protein analysis of buffalo and goat meat
344
, the inclusion 
of 1D SDS-PAGE in off-gel workflows is not commonly described in the literature. One 
experiment in this chapter aimed to apply off-gel fractionation to undigested sheep serum and to 
subject the fractions to 1D SDS-PAGE, with a view to increasing protein coverage and to visualise 
protein bands from the fractions. 
In light of the preceding context, a set of experiments was carried out that used four different 
protein fractionation approaches applied across several hundred samples, aiming collectively to 
ensure comprehensive proteome coverage and compare their protein yields.  
5.3 Methods 
5.3.1 A comprehensive analysis of fractions of acetone-precipitated sheep plasma and serum 
Freshly collected pooled plasma in acid citrate dextrose
345,346
 and serum samples from 20 healthy 
adult sheep were obtained from Serum Australis Pty Ltd under refrigeration conditions at 4
o
C 
(Table 5.0). In order to characterise proteins, the crude analytes (untreated plasma and serum), 
acetone precipitates and supernatant fractions of plasma and serum samples were subjected to 1D 
SDS-PAGE (for protein band visualisation only – these gels were not submitted for MS analysis) 
and in-solution digestion (for protein analysis), as described in the generic methods in Chapter 3. A 
separate precast gel was used for plasma and serum 1D SDS-PAGE workflow (Figure 5.0). Proteins 
from the in-solution acetone-precipitation workflow were identified using ProteinPilot™ software 
by searching a composite (sheep, ox and goat) NCBI database in the first instance. This was done 
for comparative purposes only to benefit investigators who prefer performing searches using the 
NCBI database. Proteins were then definitively identified using ProteinPilot, Mascot and 
PeptideShaker, by searching a sheep-only UniProtKB database for inclusion in the PSL. 
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Table 5.0. Details of healthy adult sheep that provided plasma and serum samples obtained 
from Serum Australis (SA). 
No. Sheep ID Sex Body Weight No. Sheep ID Sex Body Weight 
 Plasma Serum 
1 30 Male 70 kg 11 147 Male 70 kg 
2 20 Male 65 kg 12 133 Female 70 kg 
3 186 Male 65 kg 13 117 Female 65 kg 
4 162 Female 60 kg 14 92 Male 70 kg 
5 127 Female 60 kg 15 NT Male 70 kg 
6 22 Male 60 kg 16 50 Female 65 kg 
7 123 Female 65 kg 17 198 Male 60 kg 
8 135 Female 65 kg 18 128 Female 60 kg 
9 119 Female 65 kg 19 184 Male 60 kg 
10 107 Female 60 kg 20 137 Female 65 kg 
5.3.2 A comprehensive analysis of fractions of partial organic precipitation of sheep plasma 
and serum proteins using acetonitrile 
A tripartite experiment was designed to determine the effect of pH, protein dilution and partial 
organic precipitation, using ACN on pooled plasma and pooled serum of healthy sheep, on protein 
ID yields (Figure 5.0). Samples (500 µL) of plasma and serum were centrifuged at 17,500 g at 4°C 
for 1 minute and then six aliquots (50 µL) were made from each of the supernatants. The pH of the 
pooled sheep serum supernatant was 7.6 (control), while that of two additional aliquots was 
adjusted to 3.3 or 8.6 by titrating with acetic acid or by adding 16 drops of 200 mM NH4HCO3 
buffer, respectively. For the pooled sheep plasma, the pH was 7.72 (control), while that of two 
additional aliquots was adjusted to 3.01 by titrating with acetic acid, and to 8.86 by adding 13 drops 
of 200 mM NH4HCO3 buffer directly to the sample aliquots, respectively. To investigate the effect 
of protein concentration on isolation and detection, three other aliquots were diluted 1:10 (v:v %) 
with 100 mM ammonium acetate buffer to achieve corresponding pHs of the plasma and serum 
workflows.  
For protein precipitation, ACN was mixed with the serum or plasma samples 1:1 (v:v %). The 
samples were vortexed vigorously three times at 1,400 g for 5 seconds, and then incubated for 10 
minutes on a vortexing platform at 400 g at RT. Vortexing and sonication steps were repeated twice 
before the samples were centrifuged at 17,500 g at 4°C for 10 minutes. After precipitation, the 
supernatants were collected into 1,500 µL Eppendorf tubes. The pellets and supernatants were 
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separated and vacuum dried at 37°C in a SpeedVac Concentrator (Christ
®
 cat. No. RVC 2-33 IR). 
The dried precipitates and supernatant fractions were vigorously vortexed and sonicated in 100 μL 
and 30 μL of 6 M urea dissolved in 25 mM NH4HCO3 buffer, respectively. The protein 
concentration was then determined using the BCA protein assay method. Each sample 
corresponding to a given pH and dilution was aliquoted in 20 µg quantities in duplicate for in-gel 
digestion (a) and in-solution digestion (b), as illustrated in Figure 5.3. The samples were then 
subjected to generic 1D SDS-PAGE and in-solution digestion prior to nanoLC-nanoESI-MS/MS. 
To determine the reproducibility of the in-gel experiments and to compare ACN-precipitated 
samples under different pH conditions, 20 µg of crude serum (control) was loaded alongside 20 µg 
× 4 lanes of acetone-precipitated serum and 20 µg × 4 lanes of serum supernatant fractions in one 
gel. Similarly, 20 µg of crude plasma (control) was loaded alongside 20 µg × 4 lanes of acetone-
precipitated plasma and 20 µg × 4 lanes of plasma supernatant fractions in another gel. Both gels 
were subjected to generic 1D SDS-PAGE. 
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Figure 5.0. Experimental design for acetonitrile precipitation of proteins in serum and plasma from 
healthy sheep for in-depth proteome coverage for the PSL. Key: ACN = acetonitrile; PPT = 
precipitate; PPTion = precipitation; w/f = workflow. 
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5.3.3 Combinatorial peptide ligand library enrichment of sheep plasma and serum  
A protein enrichment kit (ProteoMiner™, Bio-Rad Laboratories) was used to prepare pooled 
samples of plasma and serum from healthy sheep according to the manufacturer’s instructions, with 
an additional adapted step for elution (Figure 5.1). Briefly, a spin column was placed in a capless 
collection tube and centrifuged at 1,000 g for 30–60 seconds to remove the storage solution 
supplied with the kit. The collected material was then discarded. The bottom cap of the column was 
replaced, followed by adding 600 μL of wash buffer. The column was rotated end-to-end several 
times over a 5-minute period. The bottom cap was removed and the column was placed in a capless 
collection tube and centrifuged at 1,000 g for 30–60 seconds to remove the buffer, followed by 
discarding the collected material. The preceding procedure was repeated up to this point, followed 
by removing the cap, placing the column in a capless collection tube and then centrifuging at 1,000 
g for 30–60 seconds to remove the wash buffer. The collected material was discarded and the 
bottom cap on the spin column was replaced. At this point, the column contained 100 μL of settled 
beads, ready for sample binding. The elution process was repeated six times before pooling the 
collected elutes for desalting and downstream analysis. One more elution cycle (bead elute) for in-
solution digestion was carried out to identify any proteins left behind by the first standard elution 
cycle. 
5.3.4 Off-gel fractionation of serum proteins 
In this set of serum sample preparation experiments, proteins were separated using the OFFGEL 
Fractionator (Agilent 3100, Agilent Technologies). All fractionation procedures used the default 24 
cm fractionation program, as described in the manufacturer’s instructions, except for the use of 
glycerol. For 24 separations, 400 μg of protein from crude serum samples SC449–SC472 (C1–C24), 
and 400 μg protein from acetone-precipitated serum samples SC473–SC496 (A1–A24) pooled from 
ten healthy sheep were brought to 3.6 mL with carrier ampholytes (GE Healthcare Life Sciences), 
in line with the manufacturer’s specifications (0.96% v/v final concentration). After the 
immobilised pH gradient strips were swollen, the samples were loaded and the wells were sealed as 
per the standard protocol. The pre-defined 24–well focussing protocol (OG24PE00) was then run 
until 60 kilovolt hours was achieved, at which time focussed proteins were held with 10 μA current. 
From each of the 24 fractions of 400 µg samples of crude (SC449-SC472) and acetone-precipitated 
serum (SC473–SC496) from the fractionator, 100 µL was subjected to in-solution digestion. Five 
microlitres of solution from each well was recovered for in-gel digestion and subsequently merged 
into two samples, SC665 (crude serum) and SC666 (acetone-precipitated serum), prior to analysis. 
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Figure 5.1. Experimental design for combinatorial peptide ligand library protein enrichment sheep 
plasma and serum prior to in-gel and in-solution digestion of proteins preceding nanoLC-nanoESI-
MS/MS. Key: GLB = gel loading buffer; vol = volume; MWt. = molecular weight; P qty = protein 
quantity; SC = investigator initials followed by sample number or batch of samples in brackets. 
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5.4 Results 
5.4.1 A comprehensive analysis of fractions of acetone-precipitated sheep plasma and serum 
5.4.1.1 1D SDS-PAGE 
Coomassie-stained 1D SDS-PAGE preparations of acetone precipitation and fractionation studies of 
plasma and serum are presented in Figure 5.2. Note the differences between precipitate and 
supernatant bands, as well as the band differences in the lower molecular mass regions between 
plasma and serum fractions. 
Representative individual gel lanes for each precipitate/supernatant fraction pairs, crude plasma and 
serum protein loadings depicted in Figure 5.2 A and B were spliced and drawn together for visual 
comparison (Figure 5.2 C). Overall, the acetone-precipitated fractions had the most intense gel 
bands. Plasma fractions had visible bands in the 10kD region (red rectangular box in APP and CP 
gel lanes) that were less obvious in the serum lanes. Acetone-precipitated serum lanes had visible 
bands in the 15 kD region (brown rectangular box in the APS gel lane) that were apparent in other 
gel lanes. The serum supernatant band was more visible in the 37kD region than was the plasma 
supernatant.  
5.4.1.2 In-solution digestion 
For protein quantification, in-gel digestion appears to affect recovery of individual peptides moreso 
than in-solution digestion
178
. For this reason, only in-solution samples of this acetone-precipitation 
workflow were further analysed for protein identification. 
5.4.1.3 Composite ox, goat and sheep NCBI protein database search results in ProteinPilot™ 
Protein IDs from the acetone-precipitation workflow are highlighted in Figure 5.3. There were 23 
out of 142 protein IDs exclusive to the serum supernatant and 16 out of 125 protein IDs exclusive to 
the plasma supernatant. Of the combined 39 protein IDs in supernatants of both plasma and serum, 
only six were common to both supernatants. Overall, the analysis of both fractions of plasma and 
serum – and their respective crude analytes – resulted in 154 protein IDs. 
  
66 
 
 
Figure 5.2. 1D SDS-PAGE preparations of acetone precipitation and fractionation studies using 
pooled serum (A) and plasma (B) samples from 20 healthy adult sheep. A comparison of gel bands 
of lanes spliced from gel (A) and gel (B) are illustrated in (C). The left-most and right-most wells of 
both gels A and B were loaded with 4 µL of a protein molecular weight standard (Precision Plus 
Protein™ Dual Xtra, Bio-Rad Laboratories). The second well from the right of each gel was loaded 
with a BSA standard (5,000 fmol). Other wells were loaded with 20 µg of protein samples each, as 
follows: Gel A – crude serum, serum precipitate of acetone × 3 replicates, and serum supernatant 
from acetone precipitation × 3 replicates; Gel B – crude plasma, plasma precipitate of acetone × 3 
replicates, and plasma supernatant from acetone precipitation × 3 replicates. KEY: MWt. = 
molecular weight marker; CS = crude serum; APS = acetone-precipitated serum; SS = supernatant 
of serum after acetone precipitation; PS = supernatant of plasma after acetone precipitation; APP = 
acetone-precipitated plasma; CP = crude plasma. 
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A B 
Figure 5.3. Protein identifications (IDs) in ProteinPilot™ software using a composite ox, goat and 
sheep NCBI protein database following acetone precipitation and analysis of both the precipitate 
and supernatant fractions of plasma and serum from healthy sheep. Substantial numbers of protein 
IDs were present in the supernatant fractions. Key: A = serum workflow; B = plasma workflow. 
5.4.1.4 UniProtKB sheep protein database search results for ProteinPilot, PeptideShaker and 
Mascot 
The results of searching a sheep-only UniProtKB database are presented in Figure 5.4. Panel A 
shows the comparison of protein IDs in crude plasma and serum with their respective acetone-
precipitated fractions using ProteinPilot, PeptideShaker and Mascot. ProteinPilot yielded the most 
protein IDs across the board, followed by Mascot and then PeptideShaker. The protein numbers 
were comparable in acetone-precipitated factions of plasma and serum, but not in supernatants. 
More proteins were identified from crude plasma than from crude serum, and this difference was 
particularly marked when PeptideShaker was used. Acetone-precipitated serum fractions yielded a 
higher number of protein IDs than did plasma, regardless of which search engine was employed. 
Protein IDs from PeptideShaker were compared (Figure 5.4 B–G). To highlight the differences, 
entries from UniProtKB are provided for protein IDs that were exclusive to individual fractions 
only. Panel B shows the results of the comparison of IDs in crude serum, crude plasma, acetone 
precipitate of serum proteins (Serum PPT), acetone precipitate of plasma proteins (Plasma PPT) and 
their respective supernatants (Serum SUP and Plasma SUP) in samples from healthy sheep. The 
entire acetone-precipitation workflow experiment yielded 105 validated protein ID hits in 
PeptideShaker, 20 of which were collectively exclusive to crude serum, Serum PPT, Plasma PPT, 
Serum SUP and Plasma SUP (Figure 5.4 B). 
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There were 60 protein IDs made from crude serum and crude plasma, with the latter yielding more 
proteins that were exclusive (Figure 5.4 C). Of these 60 IDs, 6 proteins (P68116, C8BKD1, 
W5QDP8, W5NXM1, W5QA07, B3GS77) were exclusive to crude serum and 19 (W5NQ46, 
P02075, W5PHP7, W5P812, W5Q5A6, A5YBU9, W5NUJ7, P32262, W5PHI7, W5PID9, 
F2YQ13, W5P1J8, W5PFC9, W5QH50, W5NXP3, W5Q2E1, W5PJZ1, W5PW21, W5PGT6) were 
exclusive to crude plasma. Acetone-fractionated serum yielded 91 protein IDs. Of these, 4 (4.4%) 
proteins were exclusive to the precipitate of serum and 27 (29.7%) were exclusive to the serum 
supernatant. 
Unlike for serum fractions, as described above, acetone-fractionated plasma yielded 82 IDs, with 
the supernatant yielding 20.7% unique IDs and the precipitate fraction 17.1% unique IDs (Figure 
5.4 E). A comparison of the acetone precipitates of plasma and serum resulted in comparable 
numbers of protein IDs (Figure 5.4 F). There were 79 protein IDs in the combined Serum PPT and 
Plasma PPT. Of these 79 IDs, 14 (17.7%) protein IDs were exclusive to the serum precipitate, while 
15 (19%) protein IDs were exclusive to the plasma precipitate. 
Acetone-precipitation supernatant fractions of both plasma and serum had a combined total of 96 
protein IDs, 28 (29.2%) of which were exclusive to the serum supernatant fraction, while 9 (9.4%) 
were exclusive to the plasma supernatant (Figure 5.4 G).The entire acetone-precipitation workflow 
experiment yielded 136 protein IDs in Mascot.  
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Figure 5.4. Comparison of protein identifications (IDs) from the acetone-precipitation workflow 
(A), and PeptideShaker IDs of the respective fractions of acetone precipitation (B, C, D, E, F and 
G). Key: IDs - identifications; PPT = precipitate; PPTed = precipitated; SUP = supernatant. 
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5.4.2 A comprehensive analysis of fractions of partial organic precipitation of sheep plasma 
and serum proteins using acetonitrile 
5.4.2.1 1D SDS-PAGE  
The analysis of the fractions of plasma and serum derived from ACN precipitation subjected to 1D 
SDS-PAGE are presented in Figure 5.5.  
 
Figure 5.5. 1D SDS-PAGE images of crude and ACN-precipitated fractions of plasma and serum 
from healthy sheep under different pH conditions and protein concentrations. Each gel lane in A, B, 
C, D, E and F (except the BSA lane) was loaded with 20 µg of fractionated sample. Crude serum 
(E) or plasma (F) was loaded in the second lane as a control. Key: MWt. = molecular weight; KD = 
kilodalton; ^ = gel image above; + = with; – = without; ACN = acetonitrile; PPT = precipitate of 
acetonitrile precipitation; BSA = bovine serum albumin standard (5,000 fmol); SUP = supernatant 
of acetonitrile precipitation.  
71 
 
There were distinct differences in protein bands between ACN precipitates, supernatants, protein 
concentrations, pH and crude samples of plasma and serum (panels A, B, C and D). Comparative 
precipitate and supernatant bands were reversed in appearance between serum (panel E) and plasma 
(panel F) in the reproducibility experiments.  
The gel lanes from 1D SDS-PAGE of ACN precipitation workflow for serum (A and B) and plasma 
(C and D) in Figure 5.5 were analysed for proteins using ProteinPilot, PeptideShaker and Mascot 
search engines (Figure 5.6). The numbers of protein IDs detected are shown in panel A for serum 
and panel B for plasma. The protein IDs in C and D were those of combined ACN precipitates of 
plasma and serum fractions, respectively, at three different pH conditions and protein 
concentrations, using the three protein search engines.  
5.4.2.2 In-solution digestion 
The protein IDs in panels E and F in Figure 5.6 were those of in-solution digestion of ACN- 
precipitated sheep plasma and serum fractions, respectively. A pH of 8.6 favoured protein 
identification in both plasma and serum. The protein IDs shown in G and H were generated from 
the Mascot search engine for in-solution digestion only, and a composite of in-solution and in-gel 
digestion of combined ACN-precipitated sheep plasma and serum fractions (PPT and SUP), 
respectively, at different pH conditions and protein concentrations. There were subtle differences in 
the number of proteins identified between ACN precipitates, supernatants, protein concentrations, 
pH and crude samples of plasma and serum. Overall, the number of protein IDs in plasma was 
marginally higher than those in serum. 
The number of protein IDs generated by Mascot of a composite of 1D SDS-PAGE of ACN 
precipitation workflow samples of sheep serum (ACN_Gel_Serum) and plasma 
(ACN_Gel_Plasma) are shown in panel I. Of the 338 protein IDs from the combined in-gel 
experiments of plasma and serum, the majority were from plasma. Similarly, the protein IDs from a 
composite of in-solution digestion of ACN precipitation workflow samples of sheep serum 
(ACN_Sol_Serum) and plasma (ACN_Sol_Plasma) are shown in panel J. The analysis of in-
solution digested samples resulted in a total of 185 protein IDs. The number of protein IDs of a 
composite of 1D SDS-PAGE of ACN_Gel_Serum, ACN_Gel_Plasma, ACN_Sol_Serum and 
ACN_Sol_Plasma are shown in K. Overall, the entire ACN precipitation workflow resulted in 376 
protein IDs. Plasma yielded the largest number (30.3%) of exclusive protein IDs. 
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Figure 5.6. Protein identifications and comparisons of ACN precipitation workflow. Key: PPT = 
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precipitate; SUP = supernatant; ACN = acetonitrile, ACN_Gel_Serum = proteins identified from in-
gel digested serum; ACN_Gel_Plasma = proteins identified from in-gel digested plasma; 
ACN_Sol_Serum = proteins identified from in-solution digested serum; ACN_Sol_Plasma = 
proteins identified from in-solution digested plasma.  
5.4.3 Combinatorial peptide ligand library protein enrichment of sheep plasma and serum  
5.4.3.1 1D SDS-PAGE  
Figure 5.7 shows the application of ProteoMiner™ abundant protein depletion technology to sheep 
plasma and serum. The images of the 1D SDS-PAGE workflow following ProteoMiner™ 
depletions are presented in Figures 5.7 A and B. The annotated images of Coomassie-stained 1D 
SDS-PAGE gels of crude and ProteoMiner™ depleted fractions of plasma and serum from healthy 
sheep are represented by panels A and B, respectively. Crude serum and crude plasma were loaded 
using 110 µg of protein per lane. Depleted samples mixed at 1:1 (v:v %) with gel loading buffer 
were loaded at 10 µL/lane for ProteoMiner™ plasma and serum elutes. Although both gels A and B 
were loaded identically and under uniform conditions, including electrophoresis in the same tank, 
there were noticeable gel-related aberrations in the stained gel outcomes. The MWt. marker 
migrated into the 2
nd
 gel lane, while the BSA band shifted to the MWt. lane, visible under the 75 kD 
mark in gel B. The 2
nd
 lane of depleted plasma in gel A was faint, while the 3
rd
 lane of depleted 
plasma in gel B was missing entirely. These gel-related aberrations affected the visual outcome of 
some protein bands. All the loaded lanes (MWt. marker, BSA, crude serum, crude plasma, three 
replicates of each of crude plasma and serum) were represented in gel A, except that the second and 
third plasma lanes appeared faint and distorted, respectively. The gel lanes for plasma and serum for 
the two gels were analysed for proteins using three different search engines, and the results are 
presented in Figures 5.7 C and D. The distortion of the 3
rd
 plasma lane did not impact on the 
number of protein IDs, but the faint 2
nd
 plasma lane had a comparatively low number of protein IDs 
(Figure 5.7 C). In gel B, there was marked distortion in appearance of the bands of MWt. marker 
and BSA lanes; the MWt. marker drifted into the BSA lane and the 3
rd
 depleted plasma lane was 
missing altogether, due to a defect in the outer gel well that caused the sample to be lost (Figure 5.7 
D). Except for some horizontal stretching in appearance in the 71 kD region for crude serum and 
crude plasma lanes, and a vertical streak in the 3
rd
 depleted serum lane, the rest of the bands in all 
the lanes were comparable with those of gel A. The slightly more intense vertical streak in the 3
rd
 
depleted serum lane of gel B was possibly caused by a larger aggregation of sample settling in a 
pocket in an uneven gel well. 
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Figure 5.7. Evaluation of ProteoMiner™ using plasma and serum of sheep. Key: A and B = 1D 
SDS-PAGE workflow; C = protein identification (ID) results of plasma; D = protein ID results of 
serum; E = comparison of crude plasma and serum protein IDs; F = comparison of crude and 
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depleted analytes with protein IDs made from secondary elution; G = Number of protein IDs in 
ProteinPilot, PeptideShaker and Mascot; H = comparison of Mascot protein IDs of crude and 
depleted plasmas and serum.  
Proteins were identified using ProteinPilot, PeptideShaker and Mascot (Figure 5.7 C, D and E). 
Protein IDs were compared between 1D SDS-PAGE and in-solution sample digestion, and depleted 
samples were compared to controls (crude serum and crude plasma). The protein IDs for gels A and 
B are shown in panels C and D, respectively. The combined protein IDs for gels A and B are 
presented in panel E.  
5.4.3.2 In-solution digestion 
Protein IDs from the in-solution workflow are shown in Figure 5.7 F. Depleted plasma and serum 
had a higher number of protein IDs than did the crude respective undepleted analytes. There were 
substantial numbers of proteins identified in the secondary elution, with IDs from serum being 
marginally higher than IDs from plasma. For in-solution digested samples, ProteinPilot yielded the 
most protein IDs, with Mascot performing less well in this regard. Crude serum, primary depleted 
serum elution and secondary depleted serum elution had 62, 130 and 41 ProteinPilot IDs, 
respectively. Crude plasma, primary depleted plasma elution and secondary depleted plasma elution 
had 46, 130 and 24 ProteinPilot IDs, respectively.  
A comparison of the protein IDs in all three search engines is provided in panel G. The distribution 
of protein IDs made in Mascot across all samples is shown in panel H. Overall, Mascot was 
superior to ProteinPilot and PeptideShaker in identifying proteins after combining in-gel and in-
solution digestion results (Figure 5.7 G). Using ProteoMiner™ resulted in 439 protein IDs from the 
entire workflow. These IDs comprised 207 additional protein IDs (66 + 53 + 88 IDs) to the 
undepleted samples, of which 15% (66 IDs) and 20% (88 IDs) were exclusive to depleted serum 
and depleted plasma, respectively (Figure 5.7 H).  
5.4.4 Off-gel fractionation of serum proteins 
5.4.4.1 1D SDS-PAGE  
Panels A to F of Figure 5.8 represent the results of Coomassie-stained 1D SDS-PAGE preparations 
of 24 protein solution harvests from off-gel fractionation of 400 μg of pooled crude serum (CS1–
CS8, A; CS9–CS16, B; CS17–CS24, C) and pooled acetone-precipitated serum protein (AS1–AS8, 
D; AS9–AS16, E; AS17–AS24, F). Prior to nanoLC-nanoESI-MS/MS, CS1–CS8, CS9–CS16 and 
CS17–CS24 gel lane digests were pooled into one sample (SC665) and AS1–AS8, AS9–AS16 and 
AS17–AS2 gel lanes digests were pooled into another sample (SC666). The combined pooled 
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samples (SC665 and SC666) resulted in 57 protein IDs in Mascot. 
 
Figure 5.8. Off-gel fractionation workflow using sheep serum. Coomassie-stained 1D SDS-PAGE 
preparations of 24 protein solution harvests from off-gel fractionation of 400 μg of pooled crude 
serum A = CS1–CS8; B = CS9–CS16; C = CS17–CS24; and pooled acetone-precipitated serum 
protein D = AS1–AS8; E = AS9–AS16; F = AS17–AS24; G = Comparisons of protein ID yields 
from ProteinPilot, PeptideShaker and Mascot in the entire off-gel workflow; H = Comparison of 
Mascot protein IDs from the contributing workflow elements. Key: BSA = bovine serum albumin 
standard (5,000 fmol) arrow; CS = crude serum; AS acetone-precipitated serum; IDs = 
identifications; PPT = precipitate. 
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5.4.4.2 In-solution digestion 
The individual off-gel fractions (CS1–CS24 and AS1–AS24) of in-solution digests were merged 
into the respective sample categories. Comparisons of protein ID yields from ProteinPilot, 
PeptideShaker and Mascot in the entire off-gel workflow are presented in Figure 5.8 G. Using 
Mascot as an example because of this software’s popular standing in the industry, this workflow 
contributed 29 (34.5%) protein IDs (3 + 4 + 22 IDs) compared to crude serum (control). Eighty-four 
proteins were identified in this entire workflow (Figure 5.8 H). 
The ultimate goal of this thesis was to construct a PSL using only high-quality data from validated 
peptide IDs derived from PeptideShaker search as detailed in Chapter 6. Comparisons of protein 
IDs for the different sample preparation methods using this software platform are illustrated in 
Figure 5.9.  The 133 protein IDs reported in Chapter 4 were essentially from an acetone 
precipitation workflow, and 7 of these protein IDs were unique to this workflow. The ACN 
precipitation workflow yielded 198 protein IDs, 37 of which were unique to this workflow. 
ProteoMiner™ fractionation yielded protein 305 IDs, 145 of which were unique to this workflow, 
and the Off-Gel fractionation yielded 70 protein IDs, 3 of which were unique this workflow. Of the 
fractionated samples, it is evident that the ACN precipitation workflow produced novel protein IDs 
that were not also discovered through ProteoMiner™. 
 
Figure 5.9. Comparison of protein ID yields 
using PeptideShaker software from different 
sample preparation techniques of sheep 
plasma and serum. Acetone precipitation 
(Acetone_PPT) was compared with 
acetonitrile precitipation (ACN_PPTion), 
ProteoMiner and Off-Gel workflows. 
ProteoMiner enrichment produced the highest 
number of protein IDs. ACN_PPTion,  
produced novel protein IDs that were not 
discovered through ProteoMiner™. 
5.5 Discussion and conclusion 
The overall goal of this chapter was to explore strategies for enhancing peptide extraction from 
sheep plasma and serum samples in order to identify more proteins and to determine which 
workflow gave the most yields. The results of this chapter produced a large body of data that has 
significantly increased the protein identification and analytical depth from what was achieved in 
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Chapter 4. A considerable effort went into comparing the different techniques using the UniProtKB 
sheep-only database by applying the analytical strategy described in the methods in order to acquire 
useful data to build a PSL from the circulating acellular proteome of sheep. The discussion that 
follows covers the observations that were made in the four approaches described.  
In the present study, the output from the acetone-precipitation experiment represents the first 
comprehensive examination of sample (serum versus plasma) and technique (acetone-precipitation) 
variables on downstream protein identification yields in samples derived from the liquid fraction of 
sheep blood. This set of observations is important in that it will assist investigators who wish to 
choose either plasma or serum for their studies to make informed decisions on which medium to use 
if considering acetone precipitation in the sample preparation pipeline.  
It is now evident that supernatant fractions of acetone-precipitated samples contain a considerable 
number of proteins that are not captured in the other fractions. The proteins that remained in the 
supernant fractions were likely to be those that failed to aggregate by the known hydrophopic 
mechanism induced by organic precipitation
23,329
. The distinct gel band enrichment regions from 
acetone preciptation of these samples (for example, the 10–15 kD region of plasma precipitate, the 
17 kD region of serum precipitates and the 30 kD region of serum supernatant in 1D SDS-PAGE 
preparations; Figure 5.0) are interesting findings that could be useful in studies targeting proteins in 
these molecular weight regions. The enriched 10–15 kD region band in the plasma fractions could 
be α- and β-globulin347, suggesting that there may have been some degree of haemolysis in the 
plasma, or possibly that this band is a characteristic unique to plasma. A common protein in the 30 
kD region in human blood is peroxiredoxin
347
, and this could be the case for sheep blood too. These 
highlighted differences between plasma and serum samples have not been reported previously. 
A composite NCBI protein sequence database containing ox, goat and sheep was also used in this 
workflow, in conjunction with the ProteinPilot search engine, to capture homologous sequences. It 
was necessary to have protein identification data from this database because of the wide use of its 
non-redundant protein sequences in several other studies
348
. Multispecies protein sequence 
databases are known to be associated with increased false positive protein identifications, and in 
some cases yield spurious results that make protein ID difficult, due to highly homologous 
sequences and isoform variations of proteins
348
. However, the use of related-species composite 
protein sequence databases is widely advocated, especially for non-model organisms whose 
genomes have not yet been fully sequenced
7
. This is because the traditional approach for non-model 
organism proteomics is to have a protein sequence database derived from annotated genome(s), 
either from the non-model organism itself (sheep in this case), from the most closely related 
organism that has been sequenced or from a composite of closely related organisms, to be able to 
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interpret the data
7
. The UniProtKB database was chosen for the definitive protein searches because 
its use is preferred and supported by protein search engines for downstream processes, such as 
PeptideShaker
245
 and Scaffold
187
.  
From these repeatable results, it is evident that the serum supernatant from acetone preciptation 
yields a comparatively higher number of protein IDs (30%) exclusive to this fraction than does the 
plasma supernantant (Figure 5.4 G). The higher number from serum confirms that the fractionation 
of samples reduces the complexity of samples and improves the protein number available for 
identification
337,349
, especially after taking into consideration that serum is a fraction of plasma. The 
depletion of clotting factor proteins, including high-abundance fibrinogen, possibly played a role in 
identifying more proteins in serum than in plasma. This is because the removal of any high-
abundance proteins improves protein detection yields
18
. These results are the first known studies 
with regard to acetone precipitation of sheep plasma and serum to show that supernatant fractions 
contain a considerable number of proteins. Proteins in supernatant fractions are missed during 
routine proteomic analysis, yet these proteins could be potentially important biomarkers, 
particularly in many animal models whose proteomes have not been fully characterised. 
The ACN precipitation experimental workflow was adapted from earlier studies
337,338
. In the present 
study, a higher number of protein IDs was achieved from both the plasma supernatant and pellet at a 
higher pH of 8.86 than in other pH conditions (Figure 5.5 H). This observation contrasts with that 
of an earlier study in which ACN treatment in a higher pH did not improve protein yields
337
. The 
novelty here was the simplification of the mode of adding optimally standardised quantities of 
acetic acid and ammonium bicarbonate solutions to adjust the pH of the samples. In addition, the 
1D SDS-PAGE results were superior in that they exhibited characteristic differences in protein 
bands. For example, the reversal in the appearance of ACN-treated plasma and serum and their 
respective supernatants in the reproducibility experiments (Figure 5.5 E and F) have not been 
previously reported. The protein bands in the ACN precipitate fractions of serum were more 
pronounced than were the supernatant fractions. By contrast, the protein bands in the ACN 
precipitate fractions of plasma were lighter than were the supernatant fractions. This suggests that 
treatment with ACN enriches a wider spectrum of protein species in the plasma supernatant fraction 
than in the serum supernatant, based on the band appearance of the 1D SDS-PAGE preparations. 
Conversely, treatment with ACN enriches a wider spectrum of protein species in the serum 
precipitate fraction than in the plasma precipitate fraction, based on the band appearance of the gels. 
It would have been interesting to analyse and compare the protein yields from the gel lanes and 
bands; this is a consideration for future studies.  
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While plasma produced the most protein IDs overall in the ACN precipitation workflow, it was 
serum at pH 8.6 that stood out prominently in showing the combined effect of pH and sample 
dilution with buffer, especially in the in-gel digestion workflow, on protein IDs. In the 1D SDS-
PAGE experiments, plasma yielded twice as many (39.1%) exclusive protein IDs as did serum 
(21%), whereas the number of exclusive protein IDs was comparable for plasma and serum in the 
in-solution workflow. This observation suggests that it is important to consider 1D SDS-PAGE 
when designing DDA protein discovery workflows. If the goal of the experiment is to identify as 
many proteins as possible (for example, in the generation of a PSL), then the inclusion of 1D SDS-
PAGE of plasma is suggested, because this is associated with a wider protein coverage. Therefore, 
within pH limits that are yet to be defined, the overall conclusion from this experiment is that with 
ACN precipitation, a higher pH, coupled with sample dilution, appears to favour protein IDs when 
both fractions of ACN precipitation are analysed. 
Taking into consideration the preceeding discussion, it can be advanced that ACN precipitation 
workflow was more successful with numerous small proteins becoming more abundant in the 
supernatants (Figure 5.5). The most abundant proteins (albumin and immunoglobulins) still 
dominated the gels, indicating that the dynamic range problem had not been properly resolved. The 
data acquisition in this chapter was not only devoted to the analysis of proteins that had been 
successfully identified in Chapter 4 that utilised only serum derived from healthy experimental 
female sheep colony belonging to QUT and the ARCB in Brisbane. The samples used were sourced 
from healthy commercially farmed sheep from Serum Australis Ltd. in NSW and it involved the 
analysis of both serum and plasma from male and female sheep as described in the methods. This 
therefore represented a different set of physiological conditions that could have influenced the 
composition of the circulating acellular proteome. 
The combinatorial peptide ligand library protein enrichment experiments evaluated a commercial 
kit called ProteoMiner™, using sheep plasma and serum as the protein source. This is because this 
kit has been reported as having the capabilities of capturing and facilitating the detection of low-
abundance proteins in complex samples
72. The findings of ProteoMiner™ use in the present study 
were consistent with the increase in protein IDs observed in one other study that used it on ovine 
and bovine whey
339
, meaning that this approach of enrichment improves protein ID outcomes. An 
important consideration in this workflow is that the standard method was modified by including an 
additional elution cycle for the beads using the buffer in order to determine if substantial proteins 
were left behind during the standard elution recommended by the manufacturer of the kit. 
Overall, the effect of ProteoMiner™ was evident in the band appearance of 1D SDS-PAGE 
workflow and this was reflected in the number of protein IDs (Figures 5.7 C, D, E and F). There 
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was noticeable enrichment of a band in the 25 kD region for the depleted fractions of plasma and 
serum (Figures 5.7 A and B). The 15 kD region band present in the crude plasma lanes were barely 
visible in the depleted fractions in both gels. These differential observations are important in that 
they could be used to target proteins of interest if depletion or enrichment is required, depending on 
the experimental goal. Observations from the in-solution digestion workflow mirrored those of in-
gel digestion. Most importantly, a considerable number of proteins were present in the beads after 
the standard elution recommended by the manufacturer of ProteoMiner™.  
In this ProteoMiner™ workflow, depleted plasma was a superior substrate to serum with respect to 
the number of proteins identified following tryptic digestion, as evidenced by ProteinPilot and 
Mascot search engine searches. This observation should not be interpreted as plasma being superior 
to serum or vice-versa; rather, it simply means that ProteoMiner™ was better-optimised for plasma 
than for serum, as per the manufacturer’s recommendation that it should be used on plasma 
samples.  
The off-gel fractionation workflow was evaluated using crude and acetone-precipitated sheep serum 
as well as 1D SPD-PAGE. Despite being smudged, the Coomassie staining of the 1D SDS-PAGE 
gel bands had a characteristic pattern depending on the off-gel fraction analysed (Figures 5.8 A to 
F). The contents of the buffers, including the relatively high urea concentration in the fractions 
commonly used as per the protocol of this workflow, possibly contributed to the diffuse appearance 
of the lane boundaries and smudging. Nevertheless, there were distinct protein bands in the 71 kDa 
region for crude serum gels from fractions CS10–CS22. For example, one particular band was most 
intense in the C11 fraction and then had faded gradually by the CS22 fraction. There were 1–2 other 
faint bands around the same 71 kDa region in fractions CS13–CS16. These 71 kDa-region bands 
were not present in the gels loaded with acetone-precipitated serum fractions. This suggests that 
acetone precipitation played a role in depleting the albumin fraction responsible for the appearance 
of bands in this region. Even though 1D SDS-PAGE data were not shown in the study by 
Maheswarappa and colleagues
344
, a single band in the 71 kDa region was observed in the present 
study.  
The low number of proteins identified following in-gel digestion of the off-gel fractionated samples 
was reflected in the poorly resolved gel bands. Again, it is possible that the high urea content and 
the buffers could have interfered with tryptic digestion of the recovered intact proteins. For this 
reason, the samples were pooled together for protein database searching. This was also the case 
with in-solution digestion samples, for which the raw data sample files were pooled for protein 
sequence database searching. In addition, off-gel fractionation workflow was considered 
exploratory, with a view to including this workflow in the proteomics workflows of the QUT-
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CARF laboratory. After this initial experiment, the next step would have been to evaluate peptides 
derived from the digestion of crude and acetone-precipitated serum by off-gel fractionation prior to 
nanoLC-nanoESI-MS/MS; however, this was outside the scope of the current work. For 
comparison, a similar evaluation would also be done for plasma. Nonetheless, this workflow 
contributed peptide data that enabled the identification of 84 proteins in Mascot (Figure 5.8 H) and 
70 protein IDs in PeptideShaker (Figure 5.9) for the purposes of inclusion in the PSL in Chapter 6. 
In a poorly defined serum proteome such that of sheep, 70 high quality protein IDs  is considered 
substantial as compared to an earlier study
111
. From information available in UniProtKB, the three 
proteins that were unique to the Off-Gel workflow in PeptideShaker identifications were W5P627 – 
an  uncharacterised protein pointing to GSN gene with possible molecular functions of actin, 
calcium and myosin II binding; P68116 – a characterised fibrinogen beta chain protein derived from 
FGB gene with known biological processes that include adaptive immune response, blood 
coagulation and innate immune response; and W5PZI0 – an uncharacterised protein pointing to 
LOC101113728 gene locus which is possibly clusterin that is known to be a chaperone protein in 
human literature. Considering that an interest of this thesis was about characterising the proteome of 
the liquid fraction of sheep blood, with specific emphasis on the application of the PSL to identify 
proteins that take part in inflammation (Chapter 7), the identification of a characterised protein 
involved in blood coagulation that was not picked up by other workflows, albeit only one, was in 
itself, a significant addition to the PSL. This means that there should now be sufficient peptide 
spectral data to enable the development of an MRM assay for identifying ovine fibrinogen beta 
chain protein (P68116) in future.  To illustrate this observation further, cattle for example, currently 
have nearly 6,000 characterised proteins in UniProtKB as opposed to only 457 sheep proteins. By 
taking this close species comparison into consideration, it was necessary to retain every unique 
protein ID derived from this workflow to contribute to the PSL, without dismissing the entire 
experiment, despite the sub-optimal overall number of protein ID yields that could have been 
otherwise interpreted as a negative experimental outcome, as compared to protein ID yields from 
ProteoMiner™ and ACN workflows.  It is also important to note that there are currently no other 
comparable studies have used this workflow on sheep serum to be benchmarked on. 
This chapter was probably the most successful chapter in the entire thesis but there could still be 
reservations regarding the strategy that was adopted. The ideal strategy should have been the 
depletion of abundant proteins followed by a high-level fractionation strategy. Presently, there are 
no antibody based protein depletion products that have been produced for sheep. However, a 
previous generation of plasma depletion products based on cibachrom blue and protein A/G are 
available (ProteoPrep® Immunoaffinity Albumin & IgG Depletion Kit, (PROT-IA)). At the outset, 
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this project implemented the analysis of the undepleted circulating acellular proteome of sheep in 
the foundation study in Chapter 4 in order to have a baseline serum proteome data for comparison 
with fractionated protein samples. Therefore, this chapter was the cradle of experimenting on 
depletion and fractionation of the circulating acellular proteome samples of sheep using several 
known effective strategies that have been used in other studies, including horses
68
 and cattle
69,70
 and 
pigs
70
. This ambition could be explored further in future if there is access to sufficient financial 
resources to purchase these kits, which in part, could explain the missed opportunity for this thesis. 
In summary, the experiments described in this chapter have provided the first in-depth insight into 
alternative sheep plasma and serum sample preparation approaches with the goal of protein 
identification by nanoLC-nanoESI-MS/MS that improved on traditional methods. In addition to 
using different protein sequence database search algorithms to ID proteins, each of the four 
experimental workflows added a novel dimension of sample preparation. The acetone-precipitation 
experiment added previously unreported protein ID data from supernatant fractions. The ACN 
experiments provided protein data due to the effects of higher pH and sample dilution, as well as 
analysing both fractions of ACN precipitation as factors that favour protein IDs from samples. The 
additional elution step for ProteoMiner™ showed that a considerable number of proteins were 
present in the beads after the standard elution recommended by the manufacturer. The off-gel 
fractionation experiments added data from 1D SDS-PAGE. In terms of protein yields using Mascot 
IDs as the standard, ProteoMiner™ enrichment contributed the highest number, followed by ACN 
precipitation, acetone precipitation and off-gel fractionation, in that order. Based on the  
observations made in this chapter, it is suggested that ACN precipitation and ProteoMiner™ 
workflows being the methods that worked best, should be preferentially included in future sample 
preparation workflows. Following on, in Chapter 6 is a description of the construction of the PSL 
from data drawn from this chapter and Chapter 4, which also results in the determination of the 
number of proteins from a composite of all the DDA experiments. 
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CHAPTER 6 
6.0 Bioinformatics strategy for assembling an encyclopaedic peptide spectral library derived 
from plasma and serum samples of sheep 
6.1 Abstract 
This chapter describes the bioinformatics approach used for the construction of a PSL using peptide 
data derived from healthy sheep in Chapters 4 and 5. Data from diseased and endotoxin-treated 
sheep, as well as synthesised in silico predicted peptides of some proinflammatory cytokines, were 
analysed and added to generate a comprehensive PSL. The objective was to form a PSL that can be 
applied in targeted proteomics workflows to simultaneously analyse several proteins. 
The first step in the identification of proteins using bioinformatics is the requirement for a protein 
sequence database for search algorithms to utilise. The PSL was assembled by searching MS/MS 
data from a composite of 501 input .mgf files derived from DDA experiments against a generated 
custom Ovis aries UniProtKB database using ProteinPilot™, resulting in the identification of 563 
proteins and 41,288 distinct peptides from 3,195,890 spectra at 1% FDR. The same dataset was 
searched using Mascot search engine and validated using PeptideShaker software which identified 
398 proteins. ProteinPilot™, Mascot and PeptideShaker, collectively identified 1,103 proteins from 
spectral data derived from both plasma and serum samples. Only the high-quality data from 
PeptideShaker identifications were retained for construction of the PSL.  
These results represent the first encyclopaedic PSL constructed entirely from the liquid fraction of 
sheep blood, with data drawn from healthy and sick individuals. If implemented, this PSL could be 
of practical significance to veterinary science in future for identifying proteins of sheep and closely 
related species such as cattle and goats. The functions of these proteins and how they relate to each 
other can then help in understanding various physiological perturbations and to the scientific 
community seeking to use sheep as a model for studying human disease. 
6.2 Introduction 
This chapter describes a bioinformatics strategy for the construction of a PSL from the liquid 
fraction of sheep blood (the circulating acellular proteome) and its enrichment from DDA data. 
Bioinformatics refers to the use of various computer applications to organise and understand the 
molecular information in a biological context
350
. The generation of this PSL was motivated by the 
lack of such a tool for exploring large numbers of plasma and serum proteins. The overarching 
objective was to construct a comprehensive peptide spectral repository that could be applied to 
wide-ranging downstream MS/MS protein assays.    
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The previous chapters have identified a large number of peptide sequences and these now need to 
be associated with specific proteins.  Once validated, a spectral library can permit identification of 
proteins in subsequent plasma or serum samples by using software tools capable searching MS/MS 
data to rapidly identify proteins.  Spectral libraries can be also be utilised for validating pepetide 
and protein ID results of searches performed using tools such as ProteinPilot and X!Tandem. 
Spectral library search strategy has emerged as a promising alternative for peptide identification, in 
which MS/MS spectra are directly compared against a reference library of confidently assigned 
spectra
351
. This approach relies heavily on a comprehensive set of known spectra that have been 
assigned to amino acid sequences
351
. The PSL is central to the discovery of novel peptides and 
proteins – a previously unobserved spectrum can be identified by comparing it to all prospective 
hits in the library for the most similar match
352
. This makes proteomics information derived from 
MS/MS a powerful tool for profiling proteins
6-8,351
. A well curated PSL can also improve the 
identification of known and novel proteins, including those with post-translation modifications 
(PTM) because spectra of unmodified peptides are in principle similar to the spectra of PTM-
modified peptides
353
. 
This chapter brings together DDA data from Chapters 4 and 5 that were derived from analysing 
healthy sheep plasma and serum samples. The PSL was also enriched with data derived from 
analysing samples from sick sheep. Having data from healthy and diseased sheep is considered 
essential to assemble an inclusive and comprehensive PSL that can be a reference tool or databank 
for future targeted proteomic investigations, including those where pathophysiology is a major 
focus
351,354
 – which is key to the quality and usefulness of the PSL.  
Peptide data from plasma and serum of endotoxin-treated sheep from earlier studies
14,15
 was also 
acquired. The inclusion of this sample set was crucial, because the capstone study (Chapter 7) 
employed the PSL to evaluate proteome profiles of sheep plasma samples of sheep exposed to 
endotoxin
14,15
. As a preparatory step, it was essential to acquire tryptic peptide data from samples of 
endotoxaemic sheep for inclusion in the PSL for downstream SWATH applications of the PSL.  
Finally for the validation of the approach to protein identification and enrichment of this PSL, in 
silico predicted synthetic peptides of selected proinflammatory cytokines of sheep were injected 
into the instrument, analysed and added. Cytokines are regulators of mammalian responses to 
injury
17,355
. In human medicine, proinflammatory cytokines such as IL-1 and TNF-α  are known to 
escalate the pathological effects
355
, and this is expected to apply to sheep as well. Many cytokines 
have low abundancy in circulation and often escape identification by global proteomics 
approaches
356
. The detection of cytokines in the plasma and serum of veterinary patients has 
traditionally relied on species-specific antibody ELISAs as evidenced in studies in dogs,
357,358
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cats,
359
 cattle,
360,361
 and sheep
362
, but these are not amenable to multiplexing
356
. Owing to the 
relatively considerable expense of using individual ELISAs for each protein assay in veterinary 
species, an attractive alternative is to generate spectral data from predicted unique peptides of 
selected sheep proinflammatory cytokines. This strategy makes the PSL potentially useful in 
simultaneously quantifying the levels of many cytokines in a single assay in future, by using 
experimentally derived spectral data not currently available in MS/MS repositories
356
. 
To assemble the PSL, all DDA data were analysed in ProteinPilot™ in the first instance. The 
handling of protein identification information after being derived from raw data using the 
Paragon™ algorithm164 in ProteinPilot™ is detailed in this chapter. Data were exported for 
secondary protein identification using Mascot and X!Tandem search engines and the results of the 
searches conducted using the above three search engines were validated by PeptideShaker 
bioinformatic software. By using an established target-decoy approach, PeptideShaker by default, 
enables it to to merge peptide/spectrum matches of multiple search engines thereby giving it a better 
edge of improved confidence and sensitivity in peptide and protein ID outcomes  as compared to 
using a single search platform
363
. 
6.3 Methods 
6.3.1 Generation of a custom sheep UniProtKB protein sequence database   
A step-by-step method that was used to generate a sheep-only protein sequence file from 
UniProtKB in FASTA format is illustrated in APPENDIX 6.0. This database provided protein 
sequence information that was utilised by search engines and protein ID validation software to 
assign peptide signals to spectra.    
6.3.2 Data sources for the assembly of the peptide spectral library  
The encyclopaedic PSL was assembled by combining DDA data derived from a composite of eight 
nanoLC-nanoESI-MS/MS experiments. In the first instance, ProteinPilot™ was used to search data 
from each experiment separately against the generated sheep protein sequence database. Data from 
the resulting individual group files were exported as .mgf files which were inturn searched 
concurrently in ProteinPilot™ software to generate a composite .group file, a corresponding .mgf 
file and a protein list. The individual .mgf files were also searched using Mascot search engine to 
generate a composite protein list and corresponding .dat files. PeptideShaker was then used to 
validate protein hits as illustrated in Figure 6.0, and detailed below. 
6.3.2.1 Peptide data from healthy sheep plasma and serum samples 
The foundation data for constructing the PSL was obtained from serum proteome characterisation
16
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in Chapter 4 which also represents the baseline PSL (Experiment 1) in Figure 6.0. Additional data 
were drawn from Chapter 5 in which there was enhanced peptide extraction from both plasma and 
serum samples (Experiments 2, 3, 4 and 5). 
 
Figure 6.0 Experimental workflow – A; A summary of the number of proteins identified from the 
individual experiments in Panel A that contributed to the peptide spectral library – B.   
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6.3.2.2 Peptide data from sick sheep serum 
Data from serum samples of sick sheep with a range of different conditions were obtained from 
UQ’s School of Veterinary Science clinical pathology laboratory (Experiment 6). The samples were 
subjected to in-solution and in-gel digestion using generic methods as described Chapter 3 to yield 
peptides for analysis as presented in APPENDIX 6.1. There were 21 proteins that were identified in 
Chapter 4, but not in sick sheep serum suggesting that these proteins probably diminish during 
illness. 
6.3.2.3 Peptide data from plasma and serum of endotoxin-treated sheep  
Data from plasma and serum samples of sheep treated with endotoxin based on earlier 
observations
15
 were added to the PSL (Experiment 7). The samples were subjected to 1D SDS-
PAGE and in-solution digestion and analysed to extract peptide data as detailed in APPENDIX 6.2. 
6.3.2.4 Data from in silico predicted synthetic peptides of selected proinflammatory cytokines 
Peptide data of five candidate proinflammatory cytokines of sheep were selected as targets, based 
on reports in the literature
17,291,364-367
, for inlcusion in the PSL (Experiment 8), by using an 
established approach
368,369
. Homologous peptide sequences between Bos taurus and Ovis aries of 
IL-6, IL-3, IL-1α, IL-1β and TNF-α were obtained from UniProtKB/Swiss-Prot or  the non-
redundant protein database of NCBI and imported into Skyline software
172
. The description of 
obtaining data from the selected peptides is presented in APPENDIX 6.3.  
6.3.3 Validation of protein identifications in the PSL    
6.3.3.1 ProteinPilot™ search  
The .mgf files derived from the primary searches of the experiments in Figure 6.0 A were subjected 
to a composite ProteinPilot™ search using a sheep-only UniProtKB database as described in 
Chapter 3 to generate a single .group file – which is in itself, a PSL when using the SCIEX SWATH 
protein analysis pipeline, and a protein list. 
6.3.3.2 Mascot search 
The .mgf files from the primary search of all the experiments illustrated in Figure 6.0 A were 
submitted to Mascot Server v2.5.1 for searching using a Daemon client. The concatenated 
target/decoy database was configured to be compliant with PeptideShaker
245
 as well, prior to being 
uploaded to the Mascot Server. The Mascot searches were conducted as described in Chapter 3 
using the parameters shown in Figure 6.1. The same UniProtKB protein sequence database used by 
the ProteinPilot™ was used in these searches.  
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Figure 6.1. Mascot Daemon user interface showing submission parameters for searches in Mascot 
Server v2.5.1 using a concatenated target/decoy database that was configured to be compliant with 
PeptideShaker searches as well. Note that the Decoy database box was unselected – a requirement 
for the results output to be compatible with downstream PeptideShaker searches.  
6.3.3.3 PeptideShaker search 
The mzIdentML files from the primary searches in ProteinPilot™ in Figure 6.0 A and .dat files 
from Mascot searches were loaded into PeptideShaker to validate the protein IDs using the same  
UniProtKB database used by ProteinPilot™, by applying the same search parameters and protein 
identification criteria as described in Chapter 3. Native mzIdentML (.mzid) format files created in 
ProteinPilot™ were not supported in PeptideShaker. This required code substitution by way of 
editing the mzIdentML files in order for the downstream file processing in PeptideShaker to 
function (Figure 6.2). The protein ID results were exported into Microsoft
®
 Excel™ for evaluation. 
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Figure 6.2. Fixing native mzIdentML file to work in PeptideShaker using Notepad++. According to 
a technical brief from SCIEX, PeptideShaker required the MS:1001171 score flag to identify 
peptide spectrum matches (PSM) scores in mzIdentML (*.mzid) files, meanwhile the native 
mzIdentML from ProteinPilot has MS:1001167. Therefore, MS:1001167 was replaced with 
MS:1001171 in all the mzIdentML files prior to loading into PeptideShaker. The mzIdentML files 
were opened in either Notepad++ editor (notepad-plus-plus.org) or (EditPro editor (Alentum 
Software Ltd) for larger files). In Notepad++, the score flag replacement was performed by going to 
‘Search’ menu (or Ctrl+H) to activate the ‘Replace’ dialog above, followed by the steps 1, 2 and 3 
(red arrows) and the files were saved and ready to be processed in PeptideShaker. 
6.3.3.4 Analysis of synthetic peptides to validate protein identifications and search parameters  
Synthetic peptide standards of five cytokines (two unique peptides per cytokine) were spiked into a 
subset of samples and analysed on the instrument and then appended to the library to confirm the 
validity of search parameters and the bioinformatics pipeline, for quality control of DDA 
experiments as described in APPENDIX 6.3. No peptides were missing in the results generated 
from all the three search platforms used, including PeptideShaker at 1% FDR, which confirmed the 
validity of bioinformatics pipeline and its parameters. 
6.4 Results 
6.4.1 Generation of a sheep-only custom UniProtKB protein sequence database  
The custom concatenated target/decoy protein sequence database that was generated consisted of 
54,786 sequences; 26,229,144 residues. 
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6.4.2 ProteinPilot™ search results 
The protein identification statistics from searching all the input files from eight DDA experiments 
illustrated in Figure 6.0 in ProteinPilot™ are presented in Figure 6.3. 
 
Figure 6.3. Screenshot of protein identification statistics in ProteinPilot™ after searching 501 .mgf 
files from eight experimental workflows using a UniProtKB database for the assembly of the 
peptide spectral library. These results represent a crude overview that includes decoy protein hits 
and contaminants such as keratin. A decoy protein is a protein identified against a decoy (nonsense) 
protein sequence database. A contaminant protein is a protein that did not originate from the sample 
but was introduced during sample processing. 
Within ProteinPilot™ software, reports were automatically created in spreadsheet format 
(Microsoft
®
 Excel™) that included the protein search summary  as illustrated in Figure 6.4.  
The exported protein list was inspected and curated as described in the generic methods in Chapter 
3. Briefly, proteins with zero confidence, decoy (reversed) protein identifications and hits from the 
cRAP database (http://www.thegpm.org/crap/) were removed (Figure 6.5) by using a similar 
method as previously described in another earlier study
13
. Only proteins with 2 or more high-
scoring peptides were considered for further analysis. 
Data were also exported in mzIdentML and .mgf formats to be used by Mascot and PeptideShaker 
searches for spectral and protein ID validation. 
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Figure 6.4 Protein search summary report in ProteinPilot™ Software showing identification yields and database search properties of assembled data 
from sheep serum and plasma of eight data dependent acquisition (DDA) experiments using a TripleTOF 5600 (SCIEX) instrument for the 
construction of a peptide spectral library (PSL). The protein identification yield at 1% global false discovery rate (FDR) was considered further. This is 
an automatically generated report. 
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Figure 6.5. Inspection of  a protein list output from ProteinPilot™ Software  for the peptide spectral 
library showing the removal of proteins (light blue rows) with zero (0) unused confidence and hits 
from the common Repository of Adventitious Proteins (cRAP) database 
(http://www.thegpm.org/crap/).  
After curating the protein list manually, ProteinPilot™ yielded 564 protein IDs from the entire PSL 
based on maximum FDR of 1% and a minimum of 2 high-scoring distinct peptides per protein for 
identification. The full list of these protein IDs is presented in APPENDIX 6.4.  Only 25 of the 564 
(4.4%) sheep proteins identified by ProteinPilot had been reviewed in UniProtKB. The UniProtKB 
entry numbers of the reviewed proteins are P14639, P29701, Q9XT27, P12303, P02083, Q7M2U8, 
P00922, A2SW69, P49920, O77642, Q28579, P02190, P11839, Q29400, Q06435, P67976, 
P62262, Q5MIB5, P09670, P68253, P49929, Q9XSM0, P23383, P50413 and P62297. 
6.4.3 Mascot search results 
After Mascot searches, protein identification lists at significance threshold of p<0.05 which equates 
to 1% FDR were exported via the report builder option in csv format for the immediate evaluation 
of the protein IDs as shown in Figure 6.6.  The csv files were opened in spreadsheet (Microsoft
®
, 
Excel™) for inspection and removal of cRAP database proteins before merging the output files. 
Only proteins identified by at least 2 or more high-scoring and unique peptides were considered for 
further analysis.  Also, .dat files were exported for further processing in PeptideShaker workflow as 
required. After merging all the results from the Mascot searches, a total of 830 proteins were 
identified. The UniProtKB entries for the identified proteins are presented in APPENDIX 6.5. 
 
94 
 
 
Figure 6.6. Mascot search results user interface showing the procedure (red arrows) for exporting 
protein lists in csv and .dat file formats.  Using a significance threshold of p<0.05 (in the format 
controls) or target decoy of 1% FDR (in decoy search summary) to generate protein IDs lists, the 
Report Builder tab was clicked (1), followed by Export as CSV tab (2) directly into Microsoft
®
 
Excel™ for evaluation. The Export tab was clicked again to export Mascot .dat file (3) and .mgf 
peak list file to be utilised by PeptideShaker as required. 
6.4.4 PeptideShaker search results 
The protein lists from the searches in PeptideShaker of the individual experiments in Figure 6.0 
were merged in Microsoft
®
 Excel™.  A total of 398 proteins were identified based on 1% FDR and 
2 high-scoring validated unique peptides per protein. The full list of UniProtKB entries for the 
identified proteins is presented in APPENDIX 6.6. 
6.4.5 Consensus protein identifications from ProteinPilot, Mascot and PeptideShaker searches 
The protein lists from ProteinPilot™, Mascot and PeptideShaker searches were compared as 
illustrated in Figure 6.7. The UniProtKB entries of the cumulative 1,103 proteins identified in the 
PSL by the three search engines are presented in APPENDIX 6.7. 
6.4.6 Data archive for the PSL 
The MS data, with validated spectra along with the identification results were exported from 
PeptideShaker and deposited to ProteomeXchange Consortium
231
 via the proteomics identifications 
(PRIDE) partner repository
269
 with the dataset identifiers PXD005002 and DOI: 
10.6019/PXD005002. The URL is https://www.ebi.ac.uk/pride/archive/projects/PXD005002 and 
can be accessed with username reviewer82838@ebi.ac.uk and password woBane0z. 
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Figure 6.7. Comparison of the results of ProteinPilot™, Mascot and PeptideShaker searches 
showing protein identification yields using data from sheep serum and plasma of eight data 
dependent acquisition (DDA) experiments using a TripleTOF 5600 (SCIEX) instrument for the 
construction of the peptide spectral library (PSL). A total number of 1,103 proteins were identified 
collectively using all the three software platforms by searching  subset of a sheep-only UniProtKB 
protein sequence database. Only the 398 validated high-quality protein identifications from 
PeptideShaker were retained for the PSL. 
6.5. Discussion and conclusion  
The initial part of this chapter presented details for the generation of a custom sheep-only 
UniProtKB protein sequence database by providing a step-by-step approach.  Readers will find this 
useful, because many studies either do not provide explicit details for creating their in-house protein 
sequence databases for conducting protein searches, or it is probably assumed that it is common 
knowledge. The resulting database had fundamental use in the various protein sequence search 
algorithms employed in this thesis. As of October 2016, only 455 (1.67%) sheep proteins in the 
entire UniProtKB protein sequence database of 27,293 proteins had been reviewed (APPENDIX 
6.0, Step No. 3). This was a small number of proteins compared, for example, to the bovine protein 
sequence database that had 6,870 out of 32,159 (21.4%) reviewed proteins
20
. Apart from having a 
reviewed status, the number of characterised sheep proteins was even lower. Despite the largely 
unreviewed and uncharacterised sheep proteins in UniProtKB, the utilisation of the principle of 
conserved genes between related species enables the use of the reasonable assumption that the 
known proteins and genes in the ox for example, are analogous to those of sheep
20,254,370
.   
96 
 
Both canonical and isoform protein sequences were selected for inclusion into the database during 
its generation. The preceding strategy of protein sequence inclusion was to broaden the database 
due to the exploratory or method-development nature of the project of this thesis. In addition, given 
that the sheep genome annotation is still a work in progress
230,273
, information on sheep protein 
functionality is still largely deficient
339
 and it is therefore reasonable to utilise as much related 
protein data available as possible to identify sheep proteins. The use of databases containing not 
only the canonical, but also known isoforms of proteins has a small impact on the number of 
reported proteins
371
. Protein isoforms are however known to complicate protein inference during 
downstream bioinformatics analysis, as noted by the developers of PeptideShaker
245
.   
The reviewed proteins belong to the Swiss-Prot subset of UniProtKB and their protein identification 
tags have the suffix ‘>sp’ in the FASTA database20,189. All the unreviewed proteins belong to the 
TrEMBL subset of the UniProtKB, and have the suffix ‘>tr’ in the FASTA database. Each protein 
in this chapter was identified by their UniProtKB subset tag (sp/tr) followed by the entry number, 
accession number, protein name (where available), organisms species (OS), gene (GN) evidence of 
protein existence (PE) and sequence version (SV)
20,189
. According to UniProtKB, there are five 
levels of evidence for PE; 1 = protein level means the protein has been detected by mass 
spectrometry and/or ELISA, 2 = detection of protein transcript, 3 = inference from homology, 4 = 
predicted protein, and 5 = uncertain
20
. For example, the notation for Transforming growth factor 
beta-1 FASTA is >tr|W5PC52|W5PC52_SHEEP Transforming growth factor beta-1 OS=Ovis aries, 
GN=TGFB1 PE=3 SV=1. Similarly, the notation for Tumour necrosis factor FASTA is 
>sp|P23383|TNFA_SHEEP Tumour necrosis factor OS=Ovis aries GN=TNF PE=2 SV=2.  
It was necessary to append FASTA sequences of protein contaminants in the database to enable 
them to be identified and filtered out during the generation of protein lists for performing data 
analysis
372
. Here, cRAP FASTA sequences (http://www.thegpm.org/crap/index.html) were used. 
There are also other repositories whose contaminants could have been used, however, these are 
focused mainly on human and yeast samples for example the CRAPome expandable repository of 
contaminants
372
. 
The second part of this chapter concerned the validation of protein identifications in the PSL using 
alternative software platforms and also by analysing synthetic peptide standards.  Mascot and 
PeptideShaker bioinformatic platforms were also used to analyse the same dataset. The PSL was 
enriched with peptide data obtained from sick sheep serum (APPENDIX 6.1). This workflow that 
used ex-diagnostic sick sheep serum captured a different protein set to that from healthy sheep, 
thereby supporting the hypothesis that there will be proteins not captured from healthy sheep. 
According to Mascot results, this workflow, that included sick sheep and healthy sheep (control), 
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contributed peptide data that enabled the identification of 314 proteins for enriching the PSL . 
Peptide data was also obtained from archived plasma and serum samples of endotoxin-treated sheep 
from a published model for transfusion-related acute lung injury (TRALI)
14
 and from samples of the 
incremental arm of that study
15
 (APPENDIX 6.2). Peptide recovery from these samples was lower 
than expected compared to the other experiments discussed here that also contributed data to enrich 
the PSL. It was for this reason that this experimental set was repeated in order to rule out the 
influence of other factors such as sample preparation. It is probable that there were substances in the 
samples that interfered with peptide extraction, considering that the samples were obtained while 
the sheep were receiving total intravenous anaesthesia with a cocktail of anaesthetics
10
, which is an 
important finding in this thesis. The substances in the anaesthetic cocktail comprised of alfaxalone, 
ketamine, fentanyl and butorphanol, which may have affected protein extraction, possibly by 
inhibiting trypsin. A possible hypothesis is that these interfering substances could have possibly 
even caused protein proteins to alter structurally in a manner that prevented the ability of trypsin to 
function normally to enhance protein digestion
373
.  The presence of these substances in the samples 
may have co-precipitated with the proteins during acetone precipitation, thereby causing the poor 
definition of protein bands in most of the 1D SDS-PAGE experiments (APPENDIX 6.2). Another 
suggested possible hypothesis to explain the low number of proteins extracted from this workflow 
is that the anaesthetic agents could have interfered with the BCA protein assay (a simple assay but 
more prone to interferences than other protein assays), leading to an overestimation of protein 
concentration in the samples. If less protein was being prepared for digestion, then the amount of 
peptides detected in the samples would be less. But then it can also be argued that this was unlikely 
to have been the case because 1D SDS-PAGE gel images clearly showed that there were sufficient 
quantities of protein loaded in the gels, given that every gel had a visible BSA control band that had 
far less amount of protein (5,000 fm) loaded. Considering that this study utilised archived samples 
from an unrelated study conducted many years ago by the ARCBS/QUT and UQ’s School of 
Medicine, there was no opportunity to have control samples from non-anaesthetised sheep. 
Consequently, experiments should be performed in future that include spiking the suspected 
anaesthetic agents into identical plasma samples to determine if this observed effect is reproducible.  
Also, it would be interesting to have both a positive control, such as a molecular marker band from 
the same gel as the samples, and a negative control such a blank gel piece, analysed together to rule 
out any technical issues
373
 prior to determining the presence of interfering substances in the 
samples. Alternative digestion strategies such as FASP digestion
233
, could also be used to remove 
interfering substances from the samples. Overall, this endotoxin-treated sheep workflow contributed 
peptide data of at least 100 protein IDs for PSL enrichment. 
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Considered collectively, the sick sheep and end endotoxaemic sheep workflows added 80 proteins 
to the PSL pool as shown in Figure A6.2(b) (APPENDIX 6.2). This therefore underscores the 
rationale for having added data from non-healthy sheep to contribute to the PSL. 
Constructing an effective PSL that can potentially have capabilities of being applied to identify 
several proteins simultaneously necessitates having information of certain known peptides of 
targeted proteins; for example, by selecting only unique peptide sequences to a single cytokine and 
also peptide fragmentation information, a suitable data acquisition strategy and instrumentation. 
The representative results of one out of two top-ranking unique peptides each from five cytokines of 
sheep that were predicted in silico presented in APPENDIX 6.3 were full MS/MS mass spectra 
acquired on a TripleTOF 5600+ instrument identifying each of the unique peptides of the selected 
cytokine present in the PSL. The collected full MS/MS scans produced high-quality MS/MS spectra 
for the PSL. In addition, the labelled peptides will provide an additional robust internal standard for 
the peptides during future use of the library.  
The goal of the in silico prediction of cytokine peptides was to generate peptide fragmentation data 
for inclusion in the PSL and to validate protein identifications. During inflammation or infection, 
members of the proinflammatory cytokine families of IL-1, IL6 and TNF-α are released from 
macrophages and monocytes, which in turn stimulate the acute phase response, leading to a chain of 
events in the inflammatory cascade, while IL-3, which belongs to colony stimulating factor family, 
is known to have overlapping functions that collectively modulate inflammation
17
. Cytokines are 
biological mediators of physiological responses to disease and the immune system
17,374,375
. They 
recognise and modulate the response of an organism to infection by regulating activation, 
replication, chemotaxis and apoptosis of immune cells
17
. 
The MS/MS spectra of the in silico predicted peptides were ideal as they all resulted in validated 
spectrum annotation matches by being recognised as unique peptides to the selected cytokines. 
Having the ability to identify endogenous low-abundance selected cytokines (for example, in 
samples derived from sheep plasma and serum using the PSL alongside targeted proteomics 
bioinformatics software platforms)
356
, is a substantial achievement of the present work.  The 
presence of spectral data for the selected peptides makes the library considerably valuable, as it can 
be used to identify these selected important markers of inflammation using targeted proteomics 
approaches that could potentially rival antibody ELISA technology in future. 
An important feature of this chapter was the description of the fine details of the assembly of the 
PSL that illustrated the  validation of 398 proteins by PeptideShaker from a pool of 1,103 proteins 
collectively identitied by other software. This strategy brought together data of interesting proteins 
from the three individual search platforms that resulted in a total of 438 proteins that were identified 
99 
 
by at least two search engines. Of these protein identifications, 251 were highly confident hits as 
they were identified by all three search engines. The other 187 protein identifications were 
moderate confidence hits. The remaining 665 protein low confidence hits that were identified by a 
single search engine only (Figure 6.7). Whilst the merging of protein identifications of several 
search platforms does not always increase the number of proteins identified, this strategy is 
supported because it increases the number of peptides per protein
371
. It is however quite possible 
that other search engines could identify further subsets of proteins in the nascent PSL in addition to 
what was identified by ProteinPilot, Mascot and validated by PeptideShaker. When interpreting the 
results from multiple protein identification search platforms, it was important to ensure that protein 
hits were truly unique other than from the redundant information in the FASTA file. The datasets 
were also processed using correct input parameters and by applying FDR statistics. 
In conclusion, the bioinformatics strategy and data assembly processes described in this chapter 
constitutes the first encyclopaedic PSL constructed entirely from the liquid fraction of sheep blood, 
with peptide data drawn from healthy and sick animals. The use of more than one search engine 
enabled the identification and validation of an unprecedented number of proteins in the PSL. If 
implemented, this PSL could be of practical significance to veterinary science in understanding 
various physiological perturbations involving proteins in the liquid fraction of blood, and to the 
scientific community seeking to use sheep as a model for studying human disease. This nascent 
PSL was needed for protein quantitation using SWATH-MS in Chapter 7 and it could also be useful 
for proteogenomics applications in future. 
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CHAPTER 7 
7.0 Application of the peptide spectral library for identifying plasma proteins involved in 
early-phase acute systemic inflammation  
7.1 Abstract 
Identifying proteins involved in systemic inflammation in plasma is fundamental to diagnosis and 
monitoring response to treatment. The availability of targeted protein data extraction using 
SWATH-MS analysis provides a prospect for developing a platform capable of detecting numerous 
proteins in plasma simultaneously, many of which are not routinely measured. In this chapter, 
SWATH-MS analysis was used to evaluate the effectiveness of the PSL developed in Chapter 6 to 
characterise the response in sheep to endotoxaemia. Plasma samples were available from a study in 
which sheep were injected with endotoxin (lipopolysaccharide (LPS)) from Escherichia coli and 
blood collected (before the plasma separated) before and after 75 min after LPS exposure. The 
proteins in these plasma samples were identified by LC-SWATH-MS, with 243 proteins able to be 
quantified in plasma from healthy and endotoxaemic sheep. Forty-one of these proteins are known 
to be involved in the inflammatory process, while a further 42 proteins may also be involved in 
early-phase acute systemic inflammation.  This is the first time SWATH-MS analysis has been used 
to distinguish proteins that may be used to diagnose and characterise early-phase acute systemic 
inflammation in sheep.  
7.2 Introduction 
Sheep have an important role in food, fibre and scientific research as models for human 
disease
10,376,377
, yet there is only limited information about inflammation-related plasma proteins in 
this species. There are some reports that have proposed methods for identifying circulating proteins 
involved in early-phase acute systemic inflammation in sheep or related species using SWATH-
MS
17
. Having the ability to profile multiple proteins involved in inflammation is fundamental in 
understanding acute pathophysiology in animals
17,22,110,111,378,379
.  
Prior to this, ovine antibody immunoassays have been used for protein detection in plasma 
samples
21,22,380,381
. However, this is cumbersome, relies on a different kit for each protein (and 
therefore is expensive) and often has to be validated for the species of interest. A proteomics 
approach using a PSL permits large numbers of proteins to be simultaneously identified and 
quantified, significantly increasing the ability to monitor changes in pathophysiology
382
. In this 
chapter, a subset of the novel PSL developed as part of this thesis in Chapter 6 was used to identify 
proteins and potentially their alterations in plasma of sheep during early-phase experimentally 
induced endotoxaemia. Here, SWATH-MS
383,384
 approach using SWATH™ MicroApp Software 
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(SCIEX) for data extraction alongside the PSL, was applied to interrogate a small number of 
archived plasma samples from a separate study
14,385
 in which sheep were exposed to acute 
Escherichia coli lipopolysaccharide (LPS) endotoxaemia as the disease model in order to achieve a 
comprehensive analysis of proteins
1,383
 and to determine if plasma proteins involved in early-phase 
acute inflammation can be detected. The intent was to use these proteins to distinguish between 
normal sheep and sheep with endotoxaemia as a proof of concept. As a prospect, this approach 
could potentially complement antibody-based methods for protein detection and quantitation
188
. 
Additionaly, the MS/MS data will be much welcome in aiding the characterisation of sheep proteins 
in publicly available protein sequence repositories for future biotechnological applications.  
7.3 Methods  
7.3.1 Background of the experimental sheep selection and endotoxin treatment procedures 
The plasma samples used for this study were obtained from a primary study whose animal ethics 
clearance details are found in the generic methods section in Chapter 3. The experimental sheep 
selection and procedures were as previously described
15
 and included here as APPENDIX 7.0. In 
brief, the primary study used LPS to prime the immune system after allocating sheep to receive an 
infusion containing LPS from E. coli serotype O55:B5 (Sigma-Aldrich, Castle Hill, NSW, 
Australia)
14
. The samples were obtained opportunistically from archived samples stored during the 
study. Following on here is the proteomics analysis of the archived plasma samples from healthy 
and endotoxaemic sheep experiments of that study
14
 as cited earlier
15
.  
7.3.2 Sample selection, preparation and nanoLC-nanoESI-MS/MS analysis.  
The primary studies from which the plasma samples were derived from did not have MS-based 
proteomics analysis as part of the experimental protocol
14,385
.  Six sheep per group (3 groups in 
total) were sampled from all the sheep enrolled in the original studies
14,385
, based on the 
observations of the report in APPENDIX 7.0.  This number of samples was determined with the 
consideration of acquiring representative samples across the cohorts of the different sheep traits 
(Wool production, Parasite resistance and the unknown sheep trait (SYSS))
15
. The samples 
comprised of pre- and post-endotoxin treatment time-points (Table 7.0). The samples were taken at 
baseline and after 75 min of LPS endotoxaemia
15
. Sample aliquots containing 100 µg of plasma 
protein were prepared for protein analysis by following the generic in-solution digestion of proteins 
workflow and desalted prior to nanoLC-nanoESI-MS/MS analysis on a TripleTOF
®
 5600 
instrument using SWATH-MS™ acquisition method as described in the in Chapter 3.  
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Table 7.0. Sheep plasma samples used in SWATH-MS analysis experiments.  
 
Sheep ID and Trait 
Plasma Samples (Lab No./[protein](µg/µL) vol. (µL)) 
Before LPS Rx After LPS Rx 
90 (Wool) SC569 (86.4) 1.3 SC570 (77.6) 1.3 
97 (Wool) SC573 (68.8) 1.5 SC574 (74.4) 1.3 
100 (Wool) SC577 (68) 1.5 SC578 (76.8) 1.3 
101 (Wool) SC581 (57.6) 1.7 SC582 (88) 1.1 
102 (Wool) SC585 (82.4) 1.2 SC586 (84.8) 1.2 
103 (Wool) SC589 (73.6) 1.4 SC590 (88) 1.1 
66 (Parasite) SC593 (72) 1.4 SC594 (65.6) 1.5 
67 (Parasite) SC597 (84) 1.2 SC598 (80) 1.3 
71 (Parasite) SC601 (74.4) 1.3 SC602 (76.8) 1.3 
72 (Parasite) SC605 (67.2) 1.5 SC606 (72) 1.4 
74 (Parasite) SC609 (73.6) 1.4 SC610 (69.6) 1.4 
75 (Parasite) SC613 (56) 1.8 SC614 (85.6) 1.2 
602 (SYSS) SC617 (84) 1.2 SC618 (69.6) 1.4 
710 (SYSS) SC621 (76) 1.3 SC622 (77.6) 1.3 
719 (SYSS) SC625 (83.2) 1.2 SC626 (84.8) 1.2 
729 (SYSS) SC629 (82.7) 1.2 SC630 (67.2) 1.5 
814 (SYSS) SC633 (94.4) 1.1 SC634 (87.2) 1.1 
815 (SYSS) SC637 (90.4) 1.1 SC638 (58.4) 1.7 
Key: Table headers represent sheep identities (ID), production traits, laboratory sample numbers 
(Lab No.), protein concentration [protein] (µg/µL) in parentheses after acetone precipitation and 
dissolution of the protein pellet in 8 M urea/25 mM NH4HCO3 and volume (vol) (µL) that 
contained 100 µg of plasma protein from 18 sheep in groups of six, based on strain/experimental 
category showing samples taken before and after E. coli LPS endotoxin treatment (Rx). 
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7.3.3 Set-up of the SWATH-MS analysis experiment and workflow 
The plasma samples representing the time-points before and after treatment with endotoxin of each 
individual sheep in Table 7.0 of the primary experiment together with the summary of the workflow 
are provided in Figure 7.0.  
 
Figure 7.0. Identification of candidate early-phase inflammation-related proteins in plasma samples 
of endotoxaemic sheep. Samples were obtained from 18 adult merino ewes that were grouped based 
on strain cohort: Wool production (Wool), Parasite resistance (Parasite) and Stockyard sourced 
sheep of unknown strain (SYSS) from a study in which the subjects were treated with E. coli 
lipopolysaccharide (LPS) endotoxin
15
. The samples represented baseline time point i.e. the one 
before treatment (Before Rx) and the other after treatment (After Rx). Each of the samples were 
individually analysed using the SWATH-MS pipeline. Only eight paired samples met the criteria 
for further comparative analysis for protein quantitation during this proof of concept study. The 
individual raw data files (.wiff and .wiff.scan) appear in QUT Proteo dive archive with SC in each 
sample name replaced by the prefix 20150624_SC_SWATH-MS_.  
This study aimed to analyse plasma samples from 18 experimental sheep representing one time 
point before and the other after endotoxin treatment which would have resulted in 36 samples in all. 
In the end however, only 16 samples derived from 8 sheep were used owing to considerably low 
peptide signals due to possible effects of anaesthetics (as discussed in Chapter 6) in a set of samples 
for an entire cohort of sheep and the TIC characteristics in some of the samples, leading to their 
exclusion from further analysis for protein identification (see Figure 7.0). The aberrant TICs could 
have been attributed to inadvertent contamination or to some extent due to batch effects
386,387
 during 
sample collection in the primary study.  The use of TICs to evaluate the similarity of analytical 
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peptide samples based on reproducible overlapping morphology of the traces is simple and 
straightforward and it has previously been used in SWATH-MS studies
188
. An alternative objective 
approach would have been to extract known peptides from the samples and evaluate their 
covariance in order to select the data files for further analysis. With further exclusion of samples 
that were considered outliers after PCA-DA, five pairs (10 samples) were used to the definitive 
protein quantitation. 
7.3.4 Peptide spectral library clean-up and SWATH-MS analysis parameters 
The PSL was imported into PeakView
®
 using the SWATH-MS™ MicroApp in the first instance as  
described elsewhere
388
. This was followed by loading the .wiff files for SWATH-MS processing. 
The library was inspected for contaminants and decoy (reversed) proteins and unselected if they 
were found. A decoy protein is a protein identified against a decoy (nonsense) protein sequence 
database. A contaminant protein (such as keratin) is a protein that did not originate from the sample 
but was introduced during sample processing.  Peptide retention times were recalibrated by 
selecting peptides identified with the best (cleanest) six transitions in their XICs (Figure 7.1) and 
mass spectrum showing MS/MS hits in the PSL (pink sticks) and extracted ions from SWATH data 
(blue sticks) (Figure 7.2) from proteins common across all samples and then applied to generate a 
calibration curve (APPENDIX 7.1).   This was followed by entering the processing settings for 
filtering peptides. The SWATH-MS™ MicroApp is a plugin to PeakView® software that is 
embedded in the “Quantitation” tab on the menu. Navigating to, and clicking on SWATH-MS 
processing in the dropdown Quantitation menu activated the screen that is illustrated in APPENDIX 
7.2. 
 
Figure 7.1. Example of XICs of a selected identified calibration peptide TYDSYLGDDYVR. 
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Figure 7.2. Tandem mass spectrum – MS/MS (pink sticks) of the doubly charged calibration 
peptide – TYDSYLGDDYVR that was used to extract corresponding ions from SWATH data (blue 
sticks) 
7.3.5 Data analysis 
Peptide and protein peak areas were automatically imported into MarkerView™ Software version 
1.3 (SCIEX) for visualisation. Prior to further analysis, data were normalised using Median Peak 
Ratios feature. Each sample was normalised to the raw file SC_SWATH-MS_569.wiff that was 
derived from analysing the healthy sheep sample SC569 (reference sample) for the peaks which the 
samples had in common. The underlying assumption for this normalisation approach was that all 
samples contained many ‘background’ peaks in common with the respective reference sample389. 
For each sample, the ratios of the peak areas (for the sample and the reference sample) were 
calculated for all peaks which were greater than 1% of the largest peak. The median ratio from the 
previous step was then used as the scaling factor for each sample. In the event of less than ten peaks 
in common between the two samples, normalisation was not performed and the scale factor was set 
to 1.0.   
After normalisation of the data, supervised principal component analysis  also known as PCA 
discriminant analysis (PCA-DA) was performed. This approach was chosen because of prior 
knowledge of how the samples were treated (i.e. before and after endotoxin treatment) to define and 
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improve sample separation in the resulting scores plots. Data were displayed as charts. The PCA-
DA scores plot displayed the scores for the first principal component against the second. Similarly 
the PCA-DA loadings plot displayed loadings for the first principal component against the second.  
In order to identify proteins that potentially altered during endotoxaemia, peak areas of proteins 
constituted from individual peptides in the samples before, and after endotoxin treatment were 
compared using the paired t-test tool in MarkerView™ Software after automatically excluding 
outliers. Protein identification entries were exported in .xlsx format (Microsoft
®
 Excel™) into 
spreadsheet. Data were displayed in the default MarkerView™ Software spreadsheet output with 18 
protein-level categories as headings, namely: row (numerical identification), index (protein 
abundance hierarchy), peak name (UniProtKB protein accession number), m/z (not applicable in  
this dataset), retention time (not applicable in this dataset), protein group (protein name and status 
in UniProtKB), use (application of the protein data for statistical comparison – true), the 
conventional paired t-test outputs (t-value, p-value, mean 1, mean 2, median 1, median 2, sigma 1, 
sigma 2), delta (observed numerical change in protein concentration), fold change (a standardised 
measure of quantitative change in protein concentration, and log (fold change). The spreadsheet 
data format enabled user-level inspection, further curation and annotation of the protein IDs. Protein 
sequences of identified uncharacterised or unnamed proteins were retrieved from UniProtKB 
database and then analysed individually and named using the Basic Local Alignment Search Tool 
(BLAST) in NCBI database. For the scope and purpose of this thesis as a proof of concept study, 
only filtered data that included the UniProtKB accession number, gene name, NCBI name, protein 
status, UniProtKB name and fold change of individual proteins after treatment of the sheep with 
endotoxin from E. coli were presented in the results.  
7.4 Results 
7.4.1 Outcome of sample comparison and protein data  
PeakView
®
 Software was used for an initial examination of consistency and quality of collected 
data. The summed peptide signals (total ion chromatograms, TICs) of samples as displayed in this 
software are presented in Figure 7.3. 
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Figure 7.3. Total ion chromatograms (TICs) of peptides representing before (upper panel) and after 
(lower panel) endotoxin treatment in sheep plasma samples. There were 18 paired samples for 
comparison represented in both panels.  
After all the raw data sample files were examined in the graphical interface of PeakView
®
 software, 
it became apparent that there was considerable variability in the appearance of the TICs whereas 
more consistent, almost overlapping TIC signals were expected since the samples were derived 
from an original study that assumed that the study subjects and therefor the samples, had similar 
characteristics
14
. An interesting observation during the inspection of TIC morphology data was that 
most of the TICs with comparatively low peptide intensities that peaked at the hydrophilic end of 
the TIC were those of the SYSS cohort of sheep (Figure 7.3).  Based on the preceding observation 
and the background that SYSS sheep had a different anaesthetic protocol
15
, these data files and  
other files whose TICs differed considerably from the rest were excluded from further analysis. 
This resulted in the final analysis of eight paired samples (Figure 7.4).  
In order to determine if there were any associations or correlation between the samples, the 
remaining 16 samples (8 pairs) that met the inclusion criteria based on TIC characteristics and 
uniform anaesthetic protocol were subjected to supervised PCA discriminant analysis (PCA-DA) in 
MarkerView™ Software as illustrated in Figure 7.5. 
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Figure 7.4. Total ion chromatograms (TICs) of peptides representing before (upper panel) and after 
(lower panel) endotoxin treatment in sheep plasma samples after filtering out aberrant and those 
with low peptide intensities. There were 8 paired samples for comparison represented in both 
panels.  
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A B 
Figure 7.5. Supervised PCA of 16 SWATH-MS-analysed plasma samples and protein data in MarkerView® software after normalisation. The samples 
comprised of eight treatment pairs representing before and after endotoxin treatment (Rx) time-points. The score plot (A) summarises the relationship 
between the samples and the loadings plot (B) illustrates the protein peak patterns identified in the samples in the score plot. The data points on the 
PCA-DA scores plot were colour-coded showing before and after endotoxin treatment. The blank data points (while circles) were considered to be 
outliers based on plot characteristics. In the loadings plot, the peaks for after endotoxin treatment were denser that those before treatment. 
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7.4.2 Identification of proteins and their potential alterations in plasma of endotoxaemic sheep 
Up to 243 proteins were identified and quantitated by SWATH-MS analysis by comparing plasma 
samples from healthy sheep (i.e. before treatment with endotoxin) and sheep with endotoxaemia. 
The signals of high-scoring individual peptides were extracted which enabled the identification of 
proteins and the comparison of their peak areas, for example a peptide of serotransferrin (Figure 
7.6) and pentaxin (C-reactive protein) (Figure 7.7). 
  
A 
  
B 
Figure 7.6. Quantitation of serotransferrin. Panel A shows an example of XICs of SAGWNIPMGR  
extracted from SWATH using five fragment ions specific to this particular selected peptide  of 
serotransferrin in sheep plasma before and after treatment with endotoxin. Panel B shows a 
comparison of SWATH signal (blue) for one particular sample to library MS/MS signal (pink), 
which confirms the ID of the peptide. Serotransferrin is known to decrease during inflammation. 
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A 
  
B 
Figure 7.7. Quantitation of C-Reactive protein. Panel A shows an example of XICs of AFVFPK - a 
selected identified peptide of pentaxin (C-Reactive protein) in sheep plasma before and after 
treatment with endotoxin. Panel B shows the corresponding mass spectrums of this doubly charged 
AFVFPK peptide in Panel A which confirms the ID of the peptide. C-Reactive protein is known to 
increase during inflammation. 
The full details of proteins that were quantitated by SWATH-MS analysis alongside their fold-
chage values are listed in Table A7.5 in APPENDIX 7.3.  For the purposes of this proof of concept 
study, within the limitations of only 75 minutes of induced endotoxaemia in sheep, any protein that 
had a fold change above or below 1.0 based on t-test results was considered to have the tendency of 
protein alteration criteria during endotoxaemia as compared to healthy status, i.e. before the sheep 
were treated with endotoxin. It is therefore reasonable to suggest that known and potentially 
inflammation-related proteins showed the most alteration during endotoxaemia and had peak area 
ratios far greater or far less than 1.0. 
Some 40 well-recognised proteins involved in systemic inflammation and their corresponding gene 
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names in parentheses that were quantitated  include albumin (ALB), serotransferrin (TF), amine 
oxidase (AOC3), C-X-C motif chemokine (PF4), alpha-2-glycoprotein 1, zinc-binding (AZGP1), 
angiotensinogen (AGT), apolipoprotein M (APOM), apolipoprotein B (APOB), fibrinogen alpha 
(FGA), fibrinogen beta chain (FGB), alpha-1-antiproteinase precursor (SERPINA1), ceruloplasmin 
(CP), L-lactate dehydrogenase B chain (LDHB), alpha-1-microglobulin/bikunin precursor (AMBP), 
apolipoprotein A-1 (APOA1), Alpha-1-acid glycoprotein (ORM1), antithrombin-III (SERPINC1), 
haptoglobin (LOC101102413), alpha-1-macroglobulin (A2M), Serum amyloid A4 protein 
(LOC101120613), apolipoprotein A4 (APOA4), apolipoprotein F (APOF), Pentaxin (CRP), 
apolipoprotein H (APOH), apolipoprotein C3 (APOC3), Plasminogen (PLG), apolipoprotein A2 
(APOA2), lipopolysaccharide binding protein (LBP), Alpha-1B-glycoprotein (A1BG), mannan 
binding lectin serine peptidase 2 (MASP2), apolipoprotein D (APOD), alpha 2-HS glycoprotein 
(AHSG), retinol-binding protein 4 (RBP4), beta-2-microglobulin (B2M), monocyte differentiation 
antigen (CD14), inter-alpha-trypsin inhibitor heavy chain 1 (ITIH1), inter-alpha-trypsin inhibitor 
heavy chain 2 (ITIH2), inter-alpha-trypsin inhibitor heavy chain 3 (ITIH3), inter-alpha-trypsin 
inhibitor heavy chain 4 (ITIH4) and apolipoprotein E (APOE). 
In addition to proteins that are already well-recognised to be involved in acute systemic 
inflammation, there were 42 other proteins that showed considerable alteration during early-phase 
acute endotoxaemia either by increasing or decreasing – these proteins could potentially be 
recognised as markers of inflammation in future. These candidate proteins extracted from Table 
A7.5 in APPENDIX 7.3, with their corresponding gene names in parentheses followed by their fold 
change values that occurred during early-phase acute endotoxaemia were: tRNA methyltransferase 
11 homolog (TRMT11) 16.2, family with sequence similarity 105 member A (FAM105A) 15.9, 
sentrin-specific protease 8-like (LOC101116576) 6.2, lysine methyltransferase 2A (KMT2A) 5.1, 
family with sequence similarity 13 member B (FAM13B) 4.4, T cell receptor delta variable 2 
(TRDV2) 3.1, elongation factor 1-alpha 1-like (EEF1A1)2.8, Titin (TTN) 2.7, Histone cluster 2 
H2A family member b (HIST2H2AB) 2.6, ceramide synthase 4 (CERS4) 2.6, platelet basic protein 
(PPBP) 2.5, angiopoietin like 6 (ANGPTL6) 2.5, serpin family A member 5 (SERPINA5) 2.5, 
leukocyte cell derived chemotaxin 2 (LECT2) 2.4, proline rich 14(PRR14) 2.3, glucose-6-phosphate 
isomerase (GPI) 2.3, antigen WC1.1 (WC11) 2.2, casein alpha s1 (CSN1S1) 2.2, insulin like growth 
factor 2 (IGF2) 2.2, leucine rich repeat LGI family member 2 (LGI2) 2.2 choline O-
acetyltransferase (CHAT) 2.2, pentraxin 3 (PTX3) 2.1, proteasome subunit alpha 2 (PSMA2) 2.1, 
osteoglycin (OGN) 2.1, enolase 1 ENO1 2.0, cystatin C (CST3)1.9, short palate, lung and nasal 
epithelium carcinoma-associated protein 2B-like (LOC101107619) 1.9, zinc finger protein 512B 
(ZNF512B) 0.6, inter-alpha-trypsin inhibitor heavy chain 3 (ITIH3) 0.6 myeloblastin (PRTN3) 0.6, 
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alpha globin chain (HBA1) 0.6, junction plakoglobin (JUP) 0.5, haemoglobin, beta (HBBA) 0.5, 
complement factor D (CFD) 0.5, insulin-like growth factor binding protein acid labile subunit 
(IGFALS) 0.5, myosin light chain 1 (MYL1) 0.5, lysozyme C, milk isozyme (LOC101102714) 0.5, 
fibulin 5 (FBLN5) 0.5, biotinidase (BTD) 0.4, Histone H2B type 1 (LOC101108086) 0.4, quiescin 
sulfhydryl oxidase 1 (QSOX1) 0.4, Beta-C globin (LOC100134870) 0.4 and alanyl aminopeptidase, 
membrane (ANPEP) 0.3. 
7.5 Discussion and conclusions 
This study used a sensitive method previously reported in human studies to analyse and identify 
plasma proteins that alter during acute endotoxaemia (i.e. biomarkers of acute inflammation).  The 
ultimate goal was to develop a pipeline, using a PSL, as a proof of concept that is able to support 
quantitation a long list of proteins in sheep plasma that could be fished in future studies for acute 
inflammation biomarker candidates.  
This chapter also discusses problems with the analytical samples that were used, for example the 
possible presence of intravenous anaesthetic drug residues in the samples that could have interfered 
with protein extraction from plasma samples. It outlines the potential future applications of this 
research effort as a considerable addition to the  quantitative profiling of proteins involved in early-
phase acute inflammation and their alterations.  
The plasma samples used represented the early phase of induced endotoxaemia in experimental 
sheep of archived samples from a previously published ovine model of intensive care on acute 
pulmonary injury
14
. A subset of the nascent PSL assembled in Chapter 6 was used alongside the 
SWATH-MS approach to interrogate the samples to identify proteins and their alterations during 
endotoxaemia. As label-free quantitation is not a trivial process, inherent analytical challenges were 
identified and optimisation experiments were performed to ensure that any alterations identified 
awere not due to technical variation. Validation of the adopted analytical procedure was performed 
prior to the actual application of the method to evaluate the plasma samples. Replicate LPS treated  
samples were analysed by injecting every sample three times and they produced equivalent results 
and did not themselves show up significant changes (data not shown).   
Changes in plasma proteins are useful to study in animal models of disease involving 
inflammation
17,390,391
 and can assist in defining the course of disease processes and the response to 
treatment
17,378
. It should be noted that in clinical practice, normally relative changes in plasma 
protein concentration are commonly considered, although proteomics also permits comparison of 
absolute changes. Because such proteins are used to inform (or select) medical interventions, they 
are useful yardsticks in monitoring disease pathophysiology if their profiles are determined
17,392
 and 
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having the ability to do so en masse in future if the current approach ever gets to be applied 
clinically would therefore be paramount. The advantage of this would be that the analysis of many 
proteins simultaneously helps to understand more physiological perturbations compared to when 
only individual or small numbers of biomarkers are monitored.    
According to reports in the literature, the number of proteins recognised to be involved in systemic 
inflammation by being either up-or downregulated is in the lower hundreds
17,378,390,391
. The findings 
from the present study on sheep plasma suggest that in addition to recognised APPs that were 
induced by LPS, a substantial number of other proteins tended to suggest altered intensities during 
endotoxaemia. In this study, circulating albumin – which is known to be a negative APP was 
increased, albeit by only 1.1 fold. During inflammation albumin usually decreases because it is 
mobilised by the liver to synthesise other proteins involved in the immune response
393
. A possible 
hypothesis to explain the observed subtle increase here is that there was a momentary upregulation 
of albumin during early phase acute inflammation before perhaps subsequently decreasing, 
considering that acute endotoxaemia had been established in the sheep for only 75 minutes. 
The major APPs in sheep are haptoglobin and serum amyloid A, while alpha 1β- glycoprotein and 
C-reactive protein are regarded as moderate APPs
17,390
. In the present study, serum amyloid A-4 
(LOC101120613) increased 1.4 times in response to LPS, whereas haptoglobin (LOC101102413) – 
which still remains to be unequivocally characterised by MS-based proteomics in sheep, increased 
by 1.2 times and alpha 1β- glycoprotein increased by 1.2 times. It should be noted, however, that 
different diseases may induce different acute inflammation protein profiles
378
, meaning that the 
current model of endotoxaemia may not be representative of all acute systemic inflammation 
disease states. Furthermore, the current study collected samples only 75 minutes after endotoxin 
administration, so this could be considered as only being representative of an early phase of 
inflammation.  
The proteomic profiling of acute inflammation profiling using MS/MS is still an emerging field in 
the veterinary science
390
 and further work is required to determine the biological or clinical 
relevance
17
.  A major advantage of the current (proteomic) approach is that many of the protein 
changes following LPS treatment are mediated by cytokines
17,394
 
374,375,395,396
 and these, including 
C-X-C motif chemokine (PF4), pro-platelet basic protein (PPBP), leukocyte cell-derived 
chemotaxin-2 (LECT2), and possibly interleukin-1 beta (IL1b) can also be measured, but they could 
have been below limits of detection or beyond the capabilities of the technology that was used, due 
to the considerable WDR created by abundant proteins.   
This study had limitations, including the fact that the samples were collected opportunistically from 
a specific group of sheep initially for two desirable animal production traits: Endoparasite resistance 
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(Parasite) and wool production (Wool). These traits may have influenced the extent of response or 
the specific proteins altered in response to treatment of the sheep with endotoxin. Repeating this 
study with other types of sheep and disease processes would therefore be prudent.  
Another limitation was that protease inhibitors were not added to samples to minimise endogenous 
protease activity. Furthermore, the sheep were anaesthetised using total intravenous anaesthesia 
whereby chemical residues in blood may  have interfered with protein extraction as compared to if 
inhalation anaesthesia were used. It can also be argued that there could have been technical 
problems in the acquisition of the data because of the disqualification of  nearly half the dataset due 
to lower signals. While these problematic changes were sufficiently large to be noted, there may 
have been more subtle differences that were in other samples that may have been significant but 
went undetected. It is also important to note that the plasma samples that were utilised in this study 
were for a single time-point only, representing protein alterations in samples drawn after 75 min 
from the commencement infusion of LPS after instrumentation (tracheostomy for ventilation and 
invansive cannulation of blood vessels) of the sheep and during anaesthesia. This may have 
provided limited information about protein changes before instrumentation or after this period. For 
example in other studies, serum amyloid A and haptoglobin have been monitored over longer 
periods, up to days after the initial challenge
397,398
.  It would therefore have been interesting to have 
more blood collections over the 12 – 24 hr period following LPS administration.  
In this study, a number of proteins were identified as having altered concentrations after LPS 
treatment. The data were presented in a comprehensible manner to satisfy the objectives of this 
proof of concept study that utilised archived plasma samples and this was within the scope of the 
thesis as explained in the methods above. Each protein had up to 5 different peptides that were 
measured as proxies for the protein. Unfortunately, because of the protein-level output of the 
results, the use of SWATH™ Acquisition MicroApp in conjunction with MarkerView™ Software 
pipeline from SCIEX employed in this study did not permit the user to evaluate the average change 
in concentration or standard deviations of individual peptides. Nevertheless, the data should allow 
other investigators or reviewers to objectively assess its value in its current form and also after the 
data are made available in a public archive, especially having reported protein alterations as fold 
change values, representing before and after treatment of the sheep with LPS from E. coli.  
Much as the functionality of the PSL has been demonstrated, it is important to note that the results 
of the identified protein alterations during acute endotoxaemia have not been validated and should 
be best considered as preliminary or proof of concept only. Given that the study was carried out 
using plasma, the possible validation strategies are by antibody enzymatic analysis, western blotting 
and possibly HR-MRM as discussed earlier in Chapter 2. There are currently very limited validated 
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antibody and enzymatic assays for sheep and therefore, validating these results would be a life-long 
study and is out of scope for this thesis. However, in a limited number of cases such as serum 
amyloid,  some cytokines and haptoglobin, quantitative assays are available and routinely used. In 
future, these could be used and compare the results with ELISA or colorimetric assays, in the case 
of haptoglobin. Proteins that do change due to LPS have previously been documented elsewhere
17
, 
so this could be used to compare with the proteins detected in this thesis.   
In conclusion, this is the first time a SWATH-MS analysis pipeline has been used to investigate 
plasma samples of a large animal model to quantitate a large number of proteins simultaneously. Up 
to 243 proteins were quantitated, with 40 proteins identified as APPs and a further 42 proteins 
potentially related to early-phase systemic inflammation. These findings have major implications in 
veterinary pathology and animal welfare
17
, particularly when considering that this technology could 
be further developed to be more reliable and useful to rival  the current gold standard for protein 
identification – immunoassays, plus that it can also analyse proteins for which there is not kit 
available.  
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CHAPTER 8 
8.0 General discussion, conclusions and future directions 
8.1 General discussion 
Key points: 
 The development of a peptide spectral library from ovine blood is considered an excellent area 
of research. Given that the technology is now relatively well developed through the analysis of 
other species, the project was largely an analytical challenge. The scale of the work required to 
perform a comprehensive analysis of the proteins present in the ovine circulating acellular 
proteome is such that it is compatible with an original contribution, and the information 
gathered adds to the sum of knowledge known about human plasma/serum proteome analysis. 
 The primary output of this method development thesis was the compilation of a novel 
encyclopaedic PSL, comprising high-quality spectra of 398 proteins derived from plasma and 
serum of sick and healthy sheep, using shotgun proteomics. Headway was made in optimising a 
bioinformatics approach to validate the developed proteomics package. This PSL can be used 
for targeted protein data extraction, using strategies such as SWATH-MS assays for the 
identification of a wide range of proteins
259,399
 and proteogenomics applications. The work 
performed in this project was unique in that it was performed on sheep blood and its real value 
is in having the highest quality data that subsequent researchers may find useful. 
 The work in this thesis aimed to identify proteins involved in early-phase acute inflammation 
because doing so helps in defining the predictors of mammalian response to illness
17
. This in 
turn translates into understanding resilience to disease, and in monitoring progression of disease. 
The project explored a timely molecular approach to understanding injury in sheep by focussing 
on proteomic characterisation of potential circulating acute phase markers. This was achieved 
by applying a subset of the nascent PSL on samples from healthy and ill sheep to detect 
candidate markers of inflammation after 75 minutes of exposure to endotoxin. To this end, a 
considerable number of candidate markers of inflammation were identified simultaneously for 
the first time in the liquid fraction sheep blood, using SWATH quantitation.  
 Several difficulties and costs associated with traditional protein assay methods, such as ELISA, 
make MS-based proteomic assays an attractive alternative. In the absence of abundant protein 
depletion strategies for samples from a majority of veterinary species, the problem of the WDR 
between low- and high-abundant proteins can be minimised by combining different proteomic 
strategies, such as protein fractionation and chromatography
27
. It is evident that working with 
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non-model organisms calls for the need to optimise bioinformatics steps in order to minimise 
false positive protein identification and ensure a high degree of assay sensitivity. On the basis of 
currently available protein detection approaches, the SWATH technique appears to be 
preferable for quantifying known and novel proteins on a large scale
1,3-5,17
. A high-capacity trap 
column and a long (e.g. 50 cm) heated analytical column or changing nanoflow column to 
capillary flow columns, for example, would enable the loading of higher amounts of protein to 
improve chromatographic resolution and enhance the detection of more proteins by the MS 
instrument. In addition, MS-based proteomic studies of non-model organisms require 
considerable time-consuming computing resources because of limited or incomplete protein 
sequence databases and the need for manual curation of the output data (human interface).  
 This proteomics approach using the nascent PSL, which has room for further optimisation, was 
applied in a proof of concept study – with promising results – using ill sheep with induced 
endotoxaemia as the model disease state. The PSL is considered to be one of  the most 
developed and comprehensive to be derived from the circulating acellular proteome sheep and 
has several potential future applications.  
 Overall, four objectives were addressed in this thesis, namely  (1) the development a feasible 
proteomic method to characterise the ovine acellular circulating proteome, (2) construction of a 
PSL repository for serum and plasma, (3) optimisation of a bioinformatics approach to validate 
the developed proteomics package and (4) application of the method to potentially detect 
candidate markers of inflammation in plasma.  
 In this chapter, an opportunity is provided to look back over the project and highlight the 
successes and challenges of the methods that were described in the thesis and what their 
outcomes mean on a broader scale. Further, the discussion relates to how the number of proteins 
identified from the various strategies compare with other animal studies and those of humans in 
the literature by describing what was done to ID proteins and explains why these steps enhanced 
the ID of proteins. An explanation is also given of how the software programs for identifying 
the proteins were selected. The discussion then moves to the practical application of the 
methods for identifying proteins in sheep plasma and an investigation into how the relative 
expression of the proteins could be used to detect alterations in pathophysiology. The optimal 
workflow for the analysis of plasma proteins in sheep blood is discussed as comprising of 
depletion, effective fractionation and analysis on high-resolution MS instrument. An account on 
what would have been done differently in hindsight (lessons learnt) is provided, including 
experiments that should be performed to discover more about the inflammatory response in 
sheep given the limited observations from SWATH experiments in Chapter 7. Later, it is 
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proposed that proteomics could be used to investigate species differences in response to disease 
and why some individuals are more or less susceptible to disease insult. 
Despite the progress that has been made in the field of human plasma and serum proteomics, a 
review of the literature in Chapter 2 of this thesis highlighted the existence of many knowledge gaps 
in our understanding of the circulating acellular proteome of veterinary species. Considerable work 
still remains to be done in defining various proteomes of veterinary species, as most are non-model 
organisms
7,38
. This is important because MS-based proteomics approaches are heavily reliant on the 
extent of sequencing and annotation of the genome of the species under study
67,400,401
. Some well-
established aspects of circulating acellular proteomics in veterinary species, with references to 
human studies, were introduced and discussed in the literature review. The arguments presented 
there were focussed entirely on the developments relevant to the scope of this thesis, such as the 
well-established challenges posed by the WDR encountered when analysing proteins derived from 
shotgun proteomics pipelines and suggested approaches for dealing with it. This background was 
sufficient to enable the formulation of an appropriate choice and development of the ultimate 
methodology for the thesis project.  
The methodology developed for this thesis was founded on generic methods used in plasma and 
serum proteomic studies that were described in Chapter 3
16
. It relied upon commonly used 
processes of sample preparation, such as acetone precipitation and desalting, for the clean-up of 
proteins prior to analysis. Because proteomic sample preparation is tedious and error-prone but 
crucial for the generation of reliable results
402
, it was considered necessary to benchmark to and 
build this initial aspect of the project upon existing works in order to obtain comparable and 
reproducible results
403
 prior to the innovations applied in the subsequent chapters. Hence, this thesis 
focussed upon sample preparation strategies to enhance protein identification in plasma or serum 
for construction of the PSL and its subsequent application in the proof of concept in Chapter 7.  
Desalting of peptides prior to MS analysis was considered a priority step during sample preparation 
because of the large number of samples (over 900) processed for this project. The effect of desalting 
of peptides prior to analysis and its reproducibility as a critical element of the entire proteomic 
method was evaluated. Early observations identified a substantial workflow bottleneck regarding 
the manual desalting of many samples reproducibly during method optimisation stage. Chapter 3 
workflow therefore represented a fundamental keystone methodology for the generation of the draft 
reference ovine serum-based baseline acellular circulating proteome described in Chapter 4
16
.  
The observations made in Chapter 4 highlight the feasibility of establishing a reference serum 
proteome for sheep, thereby addressing the first objective of the thesis
16
. Previously, there were 
limited data and no studies exploring an optimum MS-proteomics approach suitable for veterinary 
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species. Once the feasibility of establishing a baseline PSL was realised, this ambition was 
broadened to further explore the circulating acellular proteome and additional enrichment and 
enhancement of its contents. This was accomplished by an array of strategic protein sample 
preparation approaches described in Chapter 5. 
The characterisation of the baseline circulating acellular proteome was accomplished by adaptation 
of two universal sample preparation strategies for proteome analysis
233
, namely, by separation and 
tryptic digestion of in-gel trapped
404,405
 and in-solution proteins
35,123
. The peptides derived from the 
protein digestions were then subjected to separation by chromatography before being MS/MS 
analysed. The MS/MS data were then processed using multiple vendor-specified algorithms 
bundled in a number of bioinformatics software programs to aid in identifying proteins from the 
tryptic peptides. Consequently, the baseline acellular circulating proteome was characterised 
following the development and optimisation of proteomic methods using serum samples obtained 
from healthy laboratory sheep through discovery proteomics experiments that included in-gel and 
in-solution digestion workflows. Taking into consideration the conventions for reporting detected 
proteins
265,266
, the platform used in this study showed the capability of simultaneously detecting 
hundreds of key serum proteins using sheep as a model.  
Pathway analysis is used to reveal the association between identified proteins and  their known 
pathway interactions
216
. The Ingenuity Pathway Knowledge Base, for example, displays 
interactions between genes, proteins and other biological molecules to reveal biological pathways 
and to generate global canonical pathway protein interactions
216,217
. By utilising the PANTHER 
pathway analysis tool
220
 in this thesis, the serum-derived prototype of the ovine circulating acellular 
proteome revealed the association of 349 genes with 127 protein pathway hits
16
. The viability of 
this workflow was accomplished using generic methods, which cemented the first step in the 
construction of the PSL. These results were considered as a prototype for the normal ovine 
circulating acellular proteome based on serum that could then be used as a reference benchmark 
tool for testing protein alterations during physiological perturbations, such as during illness, in any 
ovine model. A similar approach for determining the baseline proteome could be applied to other 
veterinary species. The advantage of understanding better how animals such as sheep respond to 
inflammation with long-term benefits has long been recognised
17
. 
In Chapter 5, the assorted sample preparation strategies facilitated the capture of as much 
incremental peptide information as possible under different conditions, to enable the subsequent 
construction of a novel encyclopaedic PSL in Chapter 6 – the primary thrust of this thesis by 
conglomerating data from seven experiments to enrich the baseline proteome established in Chapter 
4. Considering biotechnical work on human plasma as the benchmark
406
, and by drawing parallels 
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to it, this work has demonstrated that it is possible to construct an in-depth PSL for characterising 
the circulating acellular proteome of a non-model species using serum and plasma samples from, 
for example, healthy and sick sheep. In order to fulfil the requirements of the second objective of 
the thesis, the prime aspects of its construction are highlighted in the discussion that follows. 
Acetone precipitation of proteins is a well-established sample preparation procedure
24
 that is usually 
performed to rid samples of substances in the supernatant that interfere with protein analysis
25,26
. 
However, there are few studies that have investigated the supernatant fraction that is usually 
routinely discarded, even though some proteins are lost in the process
407
. For instance, one 
particular study observed that a substantial number of proteins were present in the supernatant of 
acetone precipitated rat brain homogenate that were not present in the precipitate
407
. These findings 
are consistent with those of the present study, where considerable numbers of proteins were present 
in the supernatant after acetone precipitation of sheep serum and plasma, some of which were 
unique to this fraction. For the purposes of building a PSL, it is suggested that both fractions of 
acetone precipitation samples be analysed in future.   For example, there is a possibility of proteins 
with specific qualities i.e. those that fail to precipitate by known mechanisms
23,329
, that aggregate in 
the supernatant and that could be important for biomarker studies. It is therefore reasonable to assert 
that some previous studies have been biased by excluding families of proteins with particular 
chemistry that did not favour precipitation with acetone. This is a very important finding of the 
present work. 
The rationale for partial organic precipitation using ACN during sample preparation was to reduce 
the footprint of abundant proteins, such as albumin, globulins and lipoproteins, thereby enriching 
the less abundant protein species in the supernatant
332,337,408,409
. This approach was attractive for this 
thesis because it has been trialled in samples from several species, including humans
337
, with 
promising results of improved protein identification, but data for sheep were lacking. The findings 
of the experiments from this thesis support the use of ACN precipitation for enhanced protein 
identification capacity. A notable observation in the present study which differed from an earlier 
report
337
 is that more protein detections were made in buffer-diluted ACN treated samples with a 
higher pH than with a lower pH. This could be because a higher pH favours the digestion of protein 
by trypsin into tryptic peptides
410
. Overall, ACN precipitation workflow improved protein detection 
considerably compared to untreated samples derived from sheep plasma and serum and should be 
considered for inclusion in pipelines that seek to deepen the proteome coverage of their DDA 
experiments.   
Combinatorial peptide ligand library plasma treatment has been known to enlarge the visibility of 
medium to low abundant proteins and has potential in biomarker research
411
. This technology has 
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made headway in preparing samples derived from animals; for example, it was used to deplete 
plasma samples of cattle during biomarker studies for Johne’s disease412 and investigation of type 2 
diabetes in mice
413
. It has been utilised in a number of human study pipelines, such as in 
identification of candidate biomarkers for hepatitis B–associated liver cirrhosis in humans414 and 
other conditions
415-417
,  all with improved numbers of proteins identified. This thesis thus utilised 
ProteoMiner™ technology to acquire protein data for sheep serum and plasma for the first time and 
was by far the most successful experiment.  
Off-gel fractionation was trialled in the present study, with the goal of gaining additional 
information on the analytes – compared to other fraction methods – because it has been reported 
that it performs better than SDS-PAGE when analysing human plasma samples
418
. Other than a 
recent study on sheep whey, there are currently no other studies that have used this fractionation 
approach on sheep serum or plasma. The advantage of off-gel fractionation is that crude protein 
samples can be analysed, as well as peptides. In this thesis, only serum was used but future studies 
could also acquire data from plasma for inclusion in the PSL to cover proteins that were not in 
serum. 
In principle, PSLs are to be derived from a wide range of observed high-quality MS/MS spectra 
from DDA experiments that are as inclusive as possible for future investigations when mining the 
library
5
. For this reason, it was imperative to include peptide data from the serum of ill sheep (both 
naturally sick and experimentally induced endotoxaemia) in order to establish a comprehensive 
library that would capture proteins that might only be upregulated during systemic illness. The 
endgame here was to have a library that focussed upon the inflammation/systemic states angle – this 
was more the emphasis than exploring more general biology. 
The PSL contains peptide sequences of five pro-inflammatory cytokines that were synthesised and 
added. These synthetic cytokines acted both as quality control internal standards to ensure that data 
were processed correctly for protein identification and will in future hopefully aid in detecting 
endogenous cytokines that are usually in low abundance.   In addition, the library is considerably 
more extensive than any publicly available animal PSL, such as those present in the PRIDE 
Archive
19
, and it is potentially versatile due to its homology with bovine protein sequences. The in 
silico predicted and synthesised peptides for the five cytokines were in fact selected on the basis of 
their homology between sheep and cattle. The PSL could therefore be adapted as a building block to 
complement existing and future efforts for construction of a plasma- and serum-derived bovine 
PSL. Although a synthetic library can result in additional proteins hits and be very useful, it is 
significantly more expensive and more time-consuming to construct because it requires in silico 
prediction of the best and high-scoring unique peptide candidates. An impediment associated with 
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combining libraries derived from samples of different species, although beyond the scope of this 
thesis, is the uncertainty concerning how bioinformatic platforms, such as PeakView, Skyline or 
similar, interpret homologous peptides.  This would inevitably call for the non-trivial task of 
manually going through large peptide lists in order to retain only high-scoring peptide and protein 
homologues while minimising redundant sequences in the library. Even with a single species PSL 
such as the one constructed for sheep in this thesis, it is still necessary to mine it using multiple 
search platforms in order to establish its protein and peptide content. The spectra of peptides from 
the five synthesised cytokines were visible in the graphical interface of PeptideShaker, confirming 
their presense in the PSL. Given the strigency in validating protein IDs, it is for this reason that a 
bioinformatics strategy using this software platform was utilised in this thesis in order to retain only 
high-quality data for the PSL.  
This being a method development project, several optimisation experiments were necessary to 
realise the goal of being able to identify proteins isolated from the circulating acellular proteome of 
sheep. This was achieved by the trialling of various alternative approaches for proteome analysis 
and bioinformatics tools, as detailed in Chapter 6. The choice of the software platforms used in this 
thesis was determined by (1) the requirement of the primary instrument bundle – in the case of 
ProteinPilot™ and TripleTOF 5600+ instrument; (2) availability of a high performance computing 
host for the Mascot Server at QUT; (3) cost and quality of the software (PeptideShaker is free, open 
source and has the ability to interpret data from different search engines
245
); and 4) human resource 
expertise and supervisory support.   
One software package with capabilities for validating protein identifications on a single platform 
that was trialled is Scaffold Software
187
 (data not included). It enabled the comparison of different 
sample datasets and search engines
187
. Within Scaffold, X! Tandem
162,163
 protein identifications 
were compared to Mascot
200
 identifications. In addition, Scaffold intrinsically used peptide prophet 
and protein prophet algorithms to identify proteins
187,419
. Scaffold takes into consideration the 
universal determination of FDR when using decoy databases for protein sequence searches
420
. 
Protein inference in Scaffold depends on the basis of spectral counting prior to the assembly of the 
identified peptides
421
. This same approach has previously been used in protein identification and 
validation studies of uterine luminal fluid during early pregnancy in sheep
370
. Later in the project, 
the size of the library exceeded the capacity of the available computing resources at QUT to fully 
utilise this potentially useful bioinformatics tool; nevertheless, some notable observations were 
made. Scaffold identified 377 proteins in the PSL compared to 564 protein IDs made by 
ProteinPilot, 830 IDs made by Mascot and 398 IDs made by PeptideShaker, as reported in Chapter 
6.  In terms of the number of protein IDs, the performance of Scaffold was therefore comparable to 
124 
 
that of Mascot but since Mascot is widely considered the quasi-industry standard and the most 
widely used protein sequence search engine
284
, it would be reasonable to benchmark Scaffold 
searches to those of Mascot.  
The findings from the baseline proteome study (Chapter 4)
16
, represented the identification of 
medium to high abundance protein IDs in serum within the capabilities and limitations of the 
available software platforms at the time. It would have been more desirable to derive quantitative 
data from the analysed samples of that study. The use of Scaffold would have determined the 
differences in protein identifications and relative quantities between normal and sick sheep serum 
samples from this dataset, for example. Some research efforts have used a similar approach to 
evaluate sheep serum proteome, such as the one that investigated scrapie
264
 and another that 
investigated respiratory disease
111
. The study on scrapie utilised SELDI-TOF-MS and LC-MS/MS 
and was able to detect elevated levels of serum amyloid in infected sheep compared to normal 
sheep. The earlier study was able to distinguish the scrapie group from the healthy control sheep
264
.  
In the latter study, two-dimensional electrophoresis (2-DE) map analysis followed by SELDI-TOF 
was used to compare healthy sheep serum profiles with those of sheep with respiratory disease, 
which detected alterations in at least six known acute phase proteins
111
. In comparison, the approach 
of the present study has the potential to analyse several proteins simultaneously. The currently 
available reports of proteomics studies on the liquid fraction of blood with this same approach are 
few in number, as most reports are focussed on other body fluids of ruminants
370,112,293,339,379,422-424
. 
The present study is therefore a valuable addition to literature on the plasma and serum of sheep. 
One advantage of using Scaffold is that it is possible to browse or view protein alterations that are 
comparatively up- or downregulated or those that do not show any changes between normal and 
diseased serum states, for example. It is also possible to determine fold changes using the statistical 
analytical tool, which can be useful in determining candidate biomarkers. The level of significant 
protein alterations can also be determined using this platform. The stated features that Scaffold has 
are currently lacking in the ProteinPilot™, Mascot and PeptideShaker software platforms that were 
used in this thesis. The utility of a single bioinformatic analytical platform to validate proteins is an 
area for future research endeavours. 
The concurrent use of ProteinPilot™, Mascot and PeptideShaker to interrogate the same dataset of 
PSL samples facilitated an optimum evaluation of the number of proteins in the PSL for this 
particular project. The three tools collectively identified over 1000 proteins in the PSL. Whenever 
computing, financial and time resources permit, it makes reasonable sense to utilise various 
software platforms to analyse a given PSL, because each tool has additional peculiar ways 
(algorithms) of identifying proteins that may not be shared by others. This is because each platform 
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employs a different technique for spectrum identification
425
. Considering all efforts to improve 
protein identifications from samples, it is recommended to combine results from multiple search 
strategies
425
. It is therefore quite possible that if other software tools are used to analyse the present 
PSL derived from the ovine circulating acellular proteome, the collective number of identified 
proteins could even be higher.  The difference in the ability of the different software packages to ID 
proteins is a significant finding of this thesis. The proteins missed or detected by specific software 
platforms is therefore dependent on the algorithms used by the different packages. 
This nascent PSL was applied in a proof of concept capstone SWATH-MS study using archived 
plasma samples from sheep with induced endotoxaemia in Chapter 7 with promising results. The 
key outcomes of the capstone study was the  quantitation of 243 proteins in plasma of endotoxaemic 
sheep which includes 40 established APPs and at least additional 42 proteins that appear to correlate 
with early-phase acute systemic inflammation.  This illustrated the relevance and practical 
applications of the PSL relating to detection of plasma proteins, thereby fulfilling the fourth 
objective of this thesis.  The other downstream relevance of Chapter 7 is the possibility of its 
application to observe any differences between the normal and disease states in terms of proteins 
found. It can however be argued that the experiment performed in Chapter 7 was limited in part 
because it used archived samples collected several years ago from a completely different study on 
sheep that was not designed for MS proteomics for the purpose of evaluating the PSL only. In order 
to discover more about the inflammatory response in sheep, future experiments should be designed 
with MS proteomics objective in mind, and with appropriate controls, use of identical sheep, 
appropriate sample collection, current sample preparation methods, well-researched analytical 
strategy, together with a comprehensive and consistent data analysis process. However this is a 
methods thesis, with the method development having greater prominence than clinical outcomes. 
Elaborating on clinical outcomes is an appropriate way to explore the potential applications of the 
developed method, which is in line with the current trend of protein biomarker studies.  
Sheep are an excellent model for translational research, particularly since the sheep genome is yet to 
be completely sequenced
230
. Furthermore, the relatively low cost per head and ease of handling 
make sheep an attractive potential model for translational studies. An important next step in 
capturing this potential is the establishment of a proteogenomics study model to accurately define a 
sheep’s response to stimuli, such as acute injury, before sheep can be used successfully as a model 
for other species, including humans. Aside from the obvious wider benefits to society, there is a 
clear link between biomedical potential and opportunity for industry, because supply of sheep to 
translational study investigators would represent an additional marketing avenue for the producer.  
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8.1.1 Lessons learnt 
A successful proteomic analysis requires the adoption of a well-researched analytical strategy at the 
beginning of the project, along with a comprehensive and consistent data analysis process. Mass 
spectrometry run time is often limited by demand for the required technology, as well by as the cost 
of accessing it. It is vital that a solid analytical framework is also supported by adequate access to 
trained personnel with appropriate expertise and interest in veterinary proteomics. Successful 
proteomics workflows are therefore dependent upon a range of important factors, and it is vital that 
project teams collectively consider these factors and plan accordingly. 
As canvassed in the review of literature in this thesis, the optimum strategy for in depth proteomic 
analysis of plasma proteins requires that the following conditions are met: a) depletion of abundant 
plasma proteins, b) efficient fractionation of the proteins present in the sample into many different 
pools, and c) the analysis of these samples on a modern high-resolution mass spectrometer. The 
utilisation of sheep blood in this project was met with challenges, particularly because specific 
abundant protein depletion kits that have been developed for analysing human and mouse blood 
could not be used for depletion of these proteins from sheep plasma. There were, however, other 
options that were not explored in this project due to unprecedented financial and time limitations, 
despite them being used in other animals
68,69
.  For example, the use of the ProteoMiner™ kit 
provided an effective abundant protein depletion strategy, although it could only be used for a 
relatively small part of the overall project workflow due to cost and time considerations. Once 
depletion is accomplished, the sample is then split into multiple fractions for individual analysis. 
This was achieved, in part, by the use of 1D SDS-PAGE, whereby the gel lanes were divided into 
several fractions and analysed individually to achieve adequate fractionation. An attempt was also 
made using the Agilent OFFGEL Fractionator, however, this experiment was unsuccessful and this 
platform was not pursued further. Another available option that was not explored in this thesis was 
the use of offline SCX fractionation. By comparing and contrasting ACN precipitation results with 
the gel output from the ProteoMiner™ bead system (Figure 5.7), it is evident that this latter system 
led to the greatest number of protein identifications. Perhaps this system process might have been 
explored in greater detail by varying the sample loading quantity. It is possible that a greater 
quantity of sample loaded might enhance the overall workflow by permitting the identification of 
more proteins. 
During the early stages of the project, a predicted approach to peptide identification, incorporating 
amino-acid substitution with reduced identification stringency, coupled with the utility of multiple 
databases and search engines was used to maximise the likelihood of protein identifications. Such 
an explorative strategy casts a wide net, and from the outset seeks to achieve sensitivity at a cost to 
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specificity. It was therefore essential that the downstream workflow sought to validate preliminary 
results through the use of synthesised peptide standards. After this, a more stringent data processing 
strategy that included detecting spiked-in synthetic peptides was employed to minimise the chances 
of false identifications. The strategy incorporated interrogation of a sheep-only UniProtKB 
database. The rationale of using multiple search engines to search a single database underpinned an 
important hypothesis for this work; that the search engine itself represents a significant variable in 
the overall proteomics workflow. Employing a range of different search engines allowed for 
informed comparison, and highlighted strengths and weaknesses of each different search engine.  
As the goal of this project was to develop a PSL for use by future researchers, there was the 
obligation to include only those peptides that had been identified under the most rigorous 
conditions, and to highlight which combination of techniques, platforms and search engines yielded 
the highest quality output. For this reason, only identifications from PeptideShaker compiled from 
all experiments were retained for assembling the PSL. 
Spectra from synthetic peptides of cytokines were developed to be used for SISCAPA-MRM-MS 
(https://espace.library.uq.edu.au/view/UQ:347312 – data not shown). This approach was later 
abandoned due to time constraints and scope of the PhD project and therefore, spectra were simply 
added to the PSL to enhance its analytical depth. SWATH technology has advanced the proteomics 
frontier, because it facilitates the rapid quantitation of a large number of proteins. However, it is 
only useful for quantitation of more abundant proteins, largely due to wide dynamic range 
constraints encountered by the technology. Currently, it is known that unenriched protein samples 
pose particular difficulties when using the SWATH platform, notably where quantitation is sought 
for proteins that exist below 10 ng/ml. The five endogenous cytokines that were emulated by means 
of synthetic peptides exist at concentrations well below this, which explains why none of them were 
identified by DDA without enrichment. The background to the synthesis of these cytokines was led 
by the informed understanding that their concentrations are expected to elevate following induced 
acute endotoxaemia. It was intended to include these cytokines in the overall analysis; however this 
aspiration did not take into consideration the major dynamic range limitations of the current 
SWATH technology, and therefore such a goal could not be achieved in the scope of this thesis. 
Nevertheless, these synthetic cytokine peptides were useful for in-house purposes only in 
determining if SWATH data processing parameters were correct. It is also important to note that 
endogenous cytokines (as well as many other proteins present in the PSL) were not detected using 
SWATH which was expected, given their low abundance. Theoretically, mass spectrometry can be 
used to detect plasma protein alterations during illness, however it is true that the most important 
and specific changes generally occur in proteins of low abundance. This therefore warrants their 
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enrichment to enable detection. 
8.2 Conclusions 
Proteomic analysis of the circulating acellular proteome, and modern mass spectrometry data 
acquisition approaches such as SWATH-MS, comprise a promising field that has a wide variety of 
applications in veterinary science. This project has delivered the foundation of the much-needed 
experiments benchmarked on studies in humans that can be used for detection of pathology in 
domestic animals. A vital attribute of the contribution of this work is the optimisation of serum and 
plasma sample preparation, which is now available for widespread use.  
A platform capable of identifying several hundred sheep serum proteins using nanoLC-nanoESI-
MS/MS using serum from healthy sheep has now been developed. This approach can now be used 
with protein quantitative data to potentially establish baseline proteomes of healthy domestic 
animals to be applied in comparison with samples from sick individuals and most importantly, it is 
a useful tool for quantifying proteins in closely related mammals (e.g. cattle and goats). 
This thesis is probably the first to have developed a novel encyclopaedic PSL for the ovine 
circulating acellular proteome with the capability of identifying a large number of proteins. If 
implemented, this proteogenomic tool could be of practical significance for veterinary science in 
understanding physiological perturbations in the liquid fraction of blood, and for the scientific 
community seeking to use sheep or related species as a model for studying human disease. The use 
of multiple protein sequence database search engines enabled the identification and validation of 
proteins in the PSL constructed from the liquid fraction of sheep blood.  
This work pioneered the use of a SWATH-MS pipeline on a large scale to interrogate archived 
plasma samples of a sheep model of intensive care. It made it possible to distinguish between 
samples from untreated and endotoxin treated sheep in order to quantitate several proteins, 
including their alterations in the circulating acellular proteome. It also confirmed that the samples of 
the sheep model were non-identical. The several proteins quantitated during induced endotoxaemia 
suggest the potential practical outcome of this approach, by showing proteins that were potentially 
upregulated or downregulated during early-phase acute inflammation.  
In summary, this project has developed a novel encyclopaedic PSL using the liquid fraction of 
sheep blood. It can be asserted that this work has clearly pioneered the basis for the exploration of 
the circulating acellular proteome of sheep – a non-model organism – although there are still many 
proteins that remain to be characterised.  
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8.3 Future directions 
The research questions that formed the premise of this thesis arose from previous work (see 
Introduction to the thesis). Similarly, the findings of the experiments conducted and described in the 
thesis have generated new research ideas.  
In continuing this line of research, it will be necessary to take note of the existence of certain 
experimental factors when interpreting the results. For example, the LC-MS conditions used for the 
thesis were standard, based on the protocols developed for the instrument that largely ran peptide 
samples from humans and model organisms. At this stage, it is not possible to ascertain if peptide 
samples from sheep plasma and serum would require different instrument settings. Overall, the 
thesis focussed on optimisation of sample preparation and set a foundation for the development of a 
bioinformatics pipeline for data analysis on the assumption that all peptides can be analysed 
similarly, irrespective of the species of origin. In future, a high-capacity trap column and a longer 
heated analytical column (50 cm, for example) or a combination of a capillary flow rates and 
capillary columns would enable the loading of higher amounts of protein for deeper peptide 
analysis. This could be utilised together with variable SWATH windows to collect cleaner signals 
with reduced interference and a more sensitive MS platform, such as the TripleTOF 6600 (SCIEX) 
instrument, that has a better dynamic range. Further optimisation of the digestion procedure (for 
example introducing FASP digestion instead of in-solution digestion) could provide more 
reproducible data and improved protein coverage. On the bioinformatics front, an application of de 
novo sequencing approaches could potentially enable annotating more spectra and to permit more 
proteins to be quantified. 
The experiments that were associated with the majority of protein identifications during DDA runs 
were ACN precipitation and ProteoMiner™ workflows. There is a need to have several replicates 
from the samples of these workflows in order to potentially increase proteome coverage for 
inclusion in the PSL. The off-gel fractionation workflow needs to be further optimised and applied 
for sheep plasma samples as well.  
The PSL of the ovine circulating acellular proteome was built using a workflow based on the 
commercial tools developed by SCIEX. This workflow had limited avenues for user interface to 
permit the editing of critical factors such as FDR determination and automatic filtering of cRAP and 
other unwanted protein entries, except in the SWATH MicroApp user interface. In order to further 
enhance and make the PSL more versatile, it would be reasonable to process the data using an 
alternative workflow like that of the established TPP and OpenSWATH workflow
5
. 
There is need to perform GO analysis using the high-quality protein IDs in the PSL. I deally, this 
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would be followed by a discussion on how the results could include certain classes of proteins 
present in plasma/serum and possibly the failure to detect proteins that are already known to be 
present most likely due to dynamic range limitations. 
Because the current PSL was built using only the liquid fraction of sheep blood, it will be prudent to 
broaden its capabilities by including data from cellular components of blood and other tissues. 
Representative tissues for genomic and proteomic analysis could be obtained from the nervous 
(brain), musculoskeletal (muscles and bone), integument, lymphatic (lymph nodes), respiratory 
(lungs), endocrine (adrenals, thyroid, pituitary) or gastro-intestinal tissues (intestines, pancreas, 
liver) and gonads of sheep. This will enable the drafting of an inclusive protein database. Genomic 
information derived from this composite of experiments alongside the proteomics data would be 
fundamental in complementing the efforts of the ovine genome annotation. Also, future experiments 
should be designed with the consideration of SWATH-MS proteomics analysis pipeline in mind in 
order to achieve reproducibility in the samples as evident from bovine samples (unrelated, but 
reliant on the methods and findings of this thesis) analysed at QUT Laboratory (Sadowski, P., 
Personal Communication).  For example, automated robotic liquid handling is proposed to perform 
certain steps of the workflow during sample preparation that could improve reproducibility by 
eliminating errors that could be introduced by humans. The ultimate immediate future application 
for advancing the scope of the findings of these additional proteomics experiments has been 
identified to be in proteogenomics studies. 
The foundation of the present work has been exploratory in nature by looking at innovative methods 
of protein detection. It will therefore be necessary for future experiments to be designed to repeat, 
reproduce and validate what has been observed thus far. Most importantly, there is a need to have 
several replicates from the samples of the workflows used in this thesis in order to potentially 
increase the proteome coverage of the PSL. 
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Appendices 
APPENDIX 4.0.  The UniProtKB accession numbers of 267 proteins from a ProteinPilot 
search of a composite database search of Bos taurus, Ovis aries and Capra hircus database of 
combined first, second and third in-gel digestion samples.  
P14639, W5Q7J0, W5PF65, Q2UVX4, W5NSA6, W5P6F4, W5NUX8, W5P4S5, D6PZY4, 
W5PH95, W5NY95, W5QDG8, W5P3R3, W5NX51, W5PTG9, W5NQW4, W5NRG7, W5P627, 
W5PZS7, W5NPK5, W5QAB1, W5P0Q4, C8BKD1, W5PTR4, W5NXW9, W5PW21, W5Q124, 
W5P5I3, W5NSH2, W5P1J8, W5PGT6, W5P8R7, W5PH81, W5PBY2, Q1RMN8, W5QH50, 
W5PFC9, W5QH46, W5PHP7, W5NY46, W5QH56, W5QH54, W5NTW3, E1BH06, E1BKT9, 
W5NWM2, W5PXX3, W5P101, W5PID9, W5Q0X5, W5NYJ9, W5PXU6, W5PXI3, W5PJZ1, 
W5PDR5, W5Q268, W5NRI1, Q8SPJ1, W5PI61, W5Q9A2, I6W7A2, W5P812, W5PKA9, 
W5P338, W5QI29, W5P3J3, W5Q750, W5Q4Q3, Q3LRQ1, W5PHI7, W5PXC8, W5PE53, 
W5PGT9, W5NRR7, W5PZI1, Q29437, W5P7S6, W5PDE5, W5PD71, W5QGG0, W5PEI4, 
G3N0V0, W5Q0L2, Q1KYZ7, W5PHP8, P12303, W5QFP0, W5QGP4, Q06AV9, G3MZE0, 
W5P4C6, B5B304, W5NXP3, Q28745, W5NRH2, W5Q0R1, W5PFJ0, Q2KJF1, Q28161, 
W5PPQ8, W5PYG2, W5QAA3, W5QGD1, A2P2H9, G5E5V0, Q32PJ2, A6QP30, F1MIW8, 
V6F9A2, W5P2Q8, W5PDS4, W5Q2E1, W5QGB5, W5P229, Q32S29, F1N514, P04272, A2I7N1, 
Q09TE3, W5PLL2, A8YXZ2, I3WAE6, A6QPP2, W5NYF4, Q3SWW8, W5NX96, W5Q3K6, 
W5PD84, W5Q961, W5PDQ9, A6QM09, W5QAR2, E1BFN5, F1MLW8, W5QBW5, F1MLP3, 
W5PDP6, G8JL00, A4IFI0, W5Q0V2, W5P880, W5NXJ3, W5PVL4, W5PAB5, X4ZFS1, 
W5Q5A6, F1MH40, E1BNR0, W5Q9D5, Q29439, H6WVW6, W5QE21, W5PJ97, W5QA54, 
W5PTU7, D6PX64, W5PIJ5, A7MAZ5, W5NZ47, W5PDN1, Q0P5K6, W5PGS4, W5P3H8, 
W5PSM6, E1BI98, W5Q3R0, F1MCF8, W5PZH5, E1BB91, W5NVM6, W5QH21, O46544, 
E1BF59, W5QAA1, W5PG63, Q9XT27, A6NBZ0, G5E5V1, P17690, W5NUW3, W5Q4Z3, 
W5PVH9, G3MXG6, W5Q038, Q9MZS8, W5PJ66, W5PB04, W5Q517, W5PD62, W5P2V6, 
G8JKZ8, W5PB46, W5NS93, G3MWI3, W5PMY0, W5PW62, A5D9D2, W5QIK8, F1N3M0, 
W5PZM1, W5PTL2, W5PB07, W5Q5H8, W5P1X9, W5QFL0, P00974, W5NPN4, E1BBS9, 
E1BD43, W5NUU8, W5PC09, W5PIC9, W5NVT0, W5PK04, W5NQ91, Q29RQ1, W5NTD9, 
I7CT57, W5NQP5, W5NZQ2, W5QCX2, E1B9D7, Q2KI85, G3X6N3, F2YQ13, Q28085, P34955, 
F1MMP5, E1B726, Q95121, Q3ZEJ6, G3X6I0, W5QFH1, W5Q5N5, Q6LBN7, A5YBU8, 
A5PJT7, Q5GN72, Q05B55, W5PAL4, W5NWU4, E1BC09, E1B9F8, W5QJ27, F6RAG5, 
W5PQH2, W5QID7, W5Q5T2, A5D7A2, W5P7M5, Q9TTA5, W5PIA1, A7MBB0, W5PB00, 
Q32T06, W5Q7R8, Q3ZCH5, E1BFG1, W5Q7Z7, E1BLN6, W5QHN0, Q1A2D1, W5P9U4, 
E1BCV0, W5P964, C5ISA2 and W5Q505. 
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APPENDIX 4.1. The UniProtKB accession numbers of 102 proteins from a ProteinPilot 
search of a composite database search of Bos taurus, Ovis aries and Capra hircus database of 
the first, second and third in-solution digestion samples.  
P14639, W5PF65, W5NSA6, W5NX51, W5PTG9, A0A0F6QNP7, W5P3R3, W5QH56, W5PSQ7, 
W5PZS7, W5P4S5, W5P101, W5NXW9, W5Q268, W5PH95, W5QAB1, C8BKD1, D6PZY4, 
W5QH45, W5PJ97, W5NY95, W5NRG7, W5PTR4, W5NWM2, W5PHP7, W5P5I3, W5P0Q4, 
W5P812, W5PID9, W5PZI1, W5PBY2, W5NQW9, W5Q0X5, Q28745, W5P1J8, W5NY46, 
W5NRI1, W5NTW3, G5E604, W5QDG8, W5NPK5, W5QH50, W5NRH2, W5PXC8, Q2KJF1, 
W5PZF0, W5NWX6, Q1KZF3, P12303, W5PPQ8, W5Q9A2, W5QH54, W5P6F4, W5PH81, 
W5P627, W5PW21, W5PXU6, V6F9A2, W5PJZ2, W5P8R7, W5QDP8, W5PDR7, W5PD71, 
W5NSH2, W5PGT9, W5PN97, W5PXI6, W5QGP4, F1N3Q7, W5QI29, F1MLW8, E1BFN5, 
W5PGT6, W5NYJ9, G3MZE0, W5NZ47, W5Q124, O46544, W5NXP3, W5Q750, W5Q4Q3, 
F1N514, W5Q961, W5PTL2, W5PIC9, W5PI61, W5P3J3, W5PDE5, W5Q2E1, P17690, W5QFP0, 
Q9XT27, C6ZP49, Q1RMN8, Q95121, W5PHI7, G3X6I0, W5PAL4, F1MCF8, G3N346, Q3ZCH5 
and Q3SYR8. 
APPENDIX 4.2. The UniProtKB accession numbers of 67 previously known proteins 
identified from a ProteinPilot search of a composite database search of Bos taurus, Ovis aries 
and Capra hircus database of the combined first, second and third in-gel and in-solution 
digestion samples. 
P14639, Q2UVX4, D6PZY4, C8BKD1, E1BH06, E1BKT9, Q8SPJ1, Q1RMN8, I6W7A2, 
Q3LRQ1, Q29437, P12303, G3N0V0, Q06AV9, Q2KJF1, B5B304, Q28161, A2P2H9, Q32PJ2, 
A6QP30, P04272, A8YXZ2, Q09TE3, I3WAE6, Q3SWW8, A6QPP2, F1MCF8, A6H7J7, 
X4ZFS1, H6WVW6, E1BNR0, F1MZ96, D6PX64, A7MAZ5, Q32T06, E1BI98, Q0P5K6, 
P00974, E1BB91, O46544, E1BF59, Q3MHN5, Q9XT27, A6NBZ0, P17690, Q9MZS8, G8JKZ8, 
A5D9D2, F1N3M0, Q3ZCH5, E1BD43, Q2KI85, G3X6N3, F2YQ13, Q28085, P34955, Q95121, 
Q6LBN7, A5PJT7, Q5GN72, Q3SYR8, Q05B55, A5D7A2, Q9TTA5, A7MBB0, A4IFI0 and 
C5ISA2. 
APPENDIX 4.3. The UniProtKB accession numbers of 207 novel proteins identified from a 
ProteinPilot search of a composite database search of Bos taurus, Ovis aries and Capra hircus 
database of the combined first, second and third in-gel and in-solution digestion samples. 
W5PF65, W5Q7J0, W5NSA6, W5P6F4, W5P3R3, W5NUX8, W5P4S5, W5PTG9, W5NX51, 
W5NY95, W5QDG8, W5PH95, W5NQW4, W5NRG7, W5P627, W5QH56, W5PZS7, W5QAB1, 
W5NPK5, W5PTR4, W5P0Q4, W5NXW9, W5P5I3, W5PW21, W5Q124, W5NSH2, W5NWM2, 
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W5QH50, W5P1J8, W5QH45, W5PBY2, W5P8R7, W5PGT6, W5PHP7, W5P101, W5PH81, 
W5NY46, W5PFC9, W5NTW3, W5QH54, W5PID9, W5Q268, W5NYJ9, W5PXX3, W5Q0X5, 
W5PJZ1, W5PXI3, W5PXU6, W5NRI1, W5PDR5, W5P812, W5PJ97, W5PI61, W5Q9A2, 
W5QI29, W5P3J3, W5Q4Q3, W5Q750, W5PXC8, W5P338, W5PKA9, W5PZI1, W5PGT9, 
W5PHI7, W5PE53, W5PD71, Q1KYZ7, W5NRR7, Q28745, W5PEI4, W5QFP0, W5P7S6, 
W5PDE5, W5QGP4, W5QGG0, W5Q0L2, W5PHP8, W5PPQ8, W5P4C6, W5NXP3, W5NRH2, 
W5Q0R1, G3MZE0, W5PFJ0, E1BFN5, W5Q2E1, W5PYG2, W5QAA3, F1MIW8, G5E5V0, 
W5QGD1, F1N514, V6F9A2, W5PDS4, W5P2Q8, W5Q961, W5QGB5, W5P229, Q32S29, 
W5PZF0, W5PLL2, W5NWX6, W5NZ47, W5NYF4, W5NX96, W5Q3K6, W5PD84, W5PDQ9, 
A2I7N2, W5QAR2, W5QBW5, F1MLP3, W5PDP6, G8JL00, W5Q0V2, W5P880, W5PN97, 
W5NXJ3, W5PVL4, W5PAB5, W5QE21, W5Q5A6, W5Q9D5, Q29439, W5QA54, W5PTU7, 
W5NS93, W5PIJ5, W5PDN1, W5PGS4, W5P3H8, F1MLW8, W5PSM6, W5Q3R0, W5NVM6, 
W5QH21, W5PW62, W5PZH5, W5QAA1, W5PAL4, W5PG63, G5E5V1, W5NUW3, W5Q4Z3, 
W5PVH9, G3MXG6, W5PXI0, W5Q038, W5PJ66, W5PB04, W5Q517, W5PTL2, W5PD62, 
W5P2V6, W5PMY0, W5PB46, G3MWI3, W5QIK8, W5PB07, W5Q5H8, W5P1X9, W5QFL0, 
W5NPN4, E1BBS9, W5NUU8, W5PC09, W5PIC9, W5NVT0, W5NQ91, F1N045, W5NTD9, 
W5PIA1, W5NZQ2, W5NQP5, W5QCX2, E1B9D7, F1MMP5, E1B726, G3X6I0, C6ZP49, 
W5QFH1, W5Q5N5, A5YBU8, W5QDP8, W5NWU4, E1BC09, E1B9F8, W5QJ27, F6RAG5, 
W5PQH2, W5QID7, W5Q5T2, W5P7M5, W5PZM1, W5PK04, W5PB00, W5Q7R8, E1BFG1, 
W5Q7Z7, E1BLN6, W5QHN0, Q1A2D1, W5P9U4, E1BCV0, W5P964, W5Q505 and W5PDG4. 
APPENDIX 4.4. The UniProtKB accession numbers of 83 disease-associated proteins 
identified from a ProteinPilot search of a composite database search of Bos taurus, Ovis aries 
and Capra hircus database of the combined first, second and third in-gel and in-solution 
digestion samples. 
P14639, W5PF65, W5Q7J0, W5P4S5, W5NX51, W5NRG7, W5P627, W5QH56, W5PZS7, 
W5QAB1, W5PTR4, C8BKD1, W5P0Q4, W5NXW9, W5PW21, W5P1J8, W5NTW3, W5QH54, 
W5PJZ1, W5PXU6, I6W7A2, W5Q4Q3, W5PXC8, W5PD71, Q1KYZ7, W5NRR7, Q28745, 
W5PEI4, W5QFP0, Q29437, P12303, W5P7S6, W5QGP4, W5Q0L2, Q06AV9, Q2KJF1, G5E5V0, 
A2P2H9, W5QGD1, V6F9A2, W5PDS4, P04272, W5PZF0, Q09TE3, W5PLL2, I3WAE6, 
Q3SWW8, W5PDQ9, A2I7N2, A6QPP2, W5QBW5, W5PVL4, W5Q5A6, W5PTU7, W5NS93, 
W5P3H8, W5PZH5, Q9XT27, P17690, W5NUW3, W5Q4Z3, Q9MZS8, G8JKZ8, W5PB07, 
W5Q5H8, W5P1X9, Q3ZCH5, E1BD43, W5PC09, W5PIA1, W5NQP5, G3X6N3, P34955, 
F1MMP5, E1B726, Q5GN72, Q3SYR8, Q05B55, E1BC09, W5PZM1, Q1A2D1, W5P9U4 and 
W5P964. 
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APPENDIX 4.5. The UniProtKB accession numbers of 77 previously known serum proteins 
identified from a Mascot search of an Ovis aries protein sequence database of the combined 
first, second and third in-gel and in-solution digestion samples. 
W5QAA1, W5QG16, A0A0M4KDI9, W5P7S6, I1WXR3, W5QH56, W5PS45, W5P1J8, 
W5NYJ9, A2SW69, W5PTR4, W5P1Q0, W5PI61, W5PWY0, W5NUG0, Q1KYZ7, W5PTU7, 
W5PAM4, W5PA54, W5P4S0, W5QCP0, W5NTD9, W5PZI1, W5PLL0, W5PWU1, I0CF13, 
D4P8S5, W5PZF0, D6PX64, W5NZB4, W5Q828, D6PZY4, W5Q5H8, W5QDP8, W5PFR8, 
F2YQ13, W5PDJ6, W5PDG3, A0MPT5, A8DR93, W5PHK5, W5QAH2, W5QFL0, W5PHH3, 
W5PGW2, B3GS77, Q29400, U3N1L1, W5QGD1, A0A0P0QND2, Q06AV9, B3SV56, W5Q9H4, 
W5Q7C0, W5PD71, K4P1S5, W5QGW8, W5P3R3, W5PDT4, W5NS93, W5PC09, W5P9U4, 
W5QD30, W5QIY3, W5QE19, W5P987, W5Q2D7, C8BKD1, P14639, W5NQP5, W5NRR7, 
W5P7X3, P12303, C5ISA2, W5PPT6, W5PWL1 and A2P2H1. 
APPENDIX 4.6. The UniProtKB accession numbers of 302 novel serum proteins identified 
from a Mascot search of an Ovis aries protein sequence database of the combined first, second 
and third in-gel and in-solution digestion samples. 
W5QFE4, W5NX51, W5QFP0, W5PJ97, W5NWM2, W5NPN4, W5PDC8, W5QBW5, W5PF65, 
W5QDH9, W5PXC8, W5QGG0, W5QGP4, W5PQL6, W5Q4Q3, W5PYG2, W5PGT9, W5P812, 
W5Q4W5, W5NTL7, W5PWW5, W5PV54, W5PDS4, W5Q2U7, W5Q754, W5PX97, W5PW21, 
W5P6U4, W5QAB1, W5P5I0, W5PAB5, W5PBY0, W5NSH2, W5P880, W5Q4P0, W5Q3K6, 
W5PZY7, W5PXU6, W5PKV4, W5QC26, W5P2U2, W5NVN1, W5QH54, W5NS65, W5P691, 
W5Q749, W5QAX3, W5P9B0, W5Q268, W5Q2E1, W5PXI0, W5NSA6, W5PDE5, W5P9V7, 
W5NRI1, W5PID9, W5PDR5, W5P8R7, W5PXI3, W5P0Q4, W5Q5C2, W5PH81, W5P4C6, 
W5PGS0, W5QJ00, W5P336, W5NRG7, W5PIK2, W5QCP9, W5QAA3, W5P101, W5P6F4, 
W5PPN5, W5PEI4, W5NY95, W5QFK2, W5P229, W5Q9D5, W5QHH3, W5PGT6, W5PG63, 
W5PPQ8, W5PKA9, W5PVG5, W5QAR2, W5Q224, W5P3J3, W5PJZ1, W5PVL4, W5PXX3, 
W5Q0R1, W5NXW9, W5QH21, W5NY46, W5QJ69, W5PD12, W5NYG1, W5QI29, W5P3H8, 
W5QH45, W5P7L5, W5Q0L2, W5PFJ0, W5PTG9, W5Q038, W5QH06, W5PIJ5, W5Q5A6, 
W5PVX0, W5NVC1, W5P0B2, W5PT48, W5NX89, W5P041, W5PD15, W5PYQ3, W5NY68, 
W5PW62, W5Q1W4, W5NUL7, W5PEL1, W5P1Y8, W5QA54, W5PG04, W5PMY0, W5Q9B7, 
W5PSM6, W5NYF4, W5P895, W5PG55, W5P3A7, W5QCH5, W5NXR3, W5Q2R6, W5PDQ3, 
W5P3G6, W5PTL2, W5QDW7, W5PJE4, W5P9W4, W5PAE2, W5Q910, W5QBN7, W5QF95, 
W5QBT8, W5PZ27, W5NRV1, W5P0P1, W5NV45, W5Q950, W5PG50, W5NVT0, W5PN97, 
W5P988, W5QFP2, W5PB04, W5P640, W5PKN2, W5PLJ9, W5PD62, W5PDQ6, W5PDY2, 
W5PEJ5, W5NZQ2, W5QG19, W5PXN1, W5PQM7, W5PJP9, W5PQ53, W5PYL5, W5QIW7, 
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W5Q8Y3, W5PWT9, W5PDN1, W5P808, W5QIK8, W5NX74, W5Q9L9, W5PH55, W5Q5F0, 
W5NSI7, W5PJ85, W5PD75, W5P8Y7, W5P143, W5NT24, W5NTQ9, W5PL69, W5QET9, 
W5Q370, W5Q9P0, W5PA78, W5P092, W5PHI3, W5Q620, W5PPJ4, W5PVG2, W5PZH5, 
W5P9V5, W5PZK2, W5PG36, W5QC28, W5P2V3, W5PP29, W5NUU7, W5PIG7, W5P9A6, 
W5QBV7, W5PKK4, W5P1D3, W5PAJ9, W5Q564, W5PZJ0, W5P1N7, W5PTE9, W5QE21, 
W5QIM3, W5PEY4, W5P985, W5QD80, W5PX18, W5P4X7, W5PK74, W5Q0N1, W5PLC4, 
W5PQ63, W5PKW9, W5P9C3, W5QI75, W5PV57, W5NW67, W5PQH3, W5Q5W3, W5Q5R2, 
W5NSZ2, W5Q517, W5PJ66, W5PZW5, W5QH43, W5Q6L3, W5QHC2, W5Q5P5, W5P4R6, 
W5PQH2, W5NT03, W5PC99, W5Q7J0, W5Q7R8, W5QH50, W5P5T4, W5Q7T8, W5PE53, 
W5PIC9, W5Q7Z7, W5PHP8, W5Q4B1, W5PDQ9, W5PVH9, W5Q961, W5PES2, W5Q4Z3, 
W5PDP6, W5NX96, W5Q9A2, W5NQJ8, W5P248, W5P2I4, W5PD84, W5NSV3, W5NWX6, 
W5NPK4, W5NQ85, W5PME8, W5P2L1, W5NXV2, W5PGS4, W5QHD7, W5P964, W5PUG1, 
W5P149, W5PZ65, W5PHA9, W5P2Y4, W5NZ47, W5QCX2, W5P8T8, W5PY75, W5PB46, 
W5PUJ4, W5Q0V2, W5Q9K6, W5PNU9, W5NXI6, W5PA64, W5NQM5, W5NSH6, W5PXV7, 
W5PPT3, W5P1X7, W5Q0U9, W5PGZ8 and W5P5V0.  
APPENDIX 4.7. The UniProtKB accession numbers of 83 disease-associated serum proteins 
identified from a Mascot search of an Ovis aries protein sequence database of the combined 
first, second and third in-gel and in-solution digestion samples. 
P14639, W5PF65, W5Q7J0, W5P4S5, W5NX51, W5NRG7, W5P627, W5QH56, W5PZS7, 
W5QAB1, W5PTR4, C8BKD1, W5P0Q4, W5NXW9, W5PW21, W5P1J8, W5NTW3, W5QH54, 
W5PJZ1, W5PXU6, I6W7A2, W5Q4Q3, W5PXC8, W5PD71, Q1KYZ7, W5NRR7, Q28745, 
W5PEI4, W5QFP0, Q29437, P12303, W5P7S6, W5QGP4, W5Q0L2, Q06AV9, Q2KJF1, G5E5V0, 
A2P2H9, W5QGD1, V6F9A2, W5PDS4, P04272, W5PZF0, Q09TE3, W5PLL2, I3WAE6, 
Q3SWW8, W5PDQ9, A2I7N2, A6QPP2, W5QBW5, W5PVL4, W5Q5A6, W5PTU7, W5NS93, 
W5P3H8, W5PZH5, Q9XT27, P17690, W5NUW3, W5Q4Z3, Q9MZS8, G8JKZ8, W5PB07, 
W5Q5H8, W5P1X9, Q3ZCH5, E1BD43, W5PC09, W5PIA1, W5NQP5, G3X6N3, P34955, 
F1MMP5, E1B726, Q5GN72, Q3SYR8, Q05B55, E1BC09, W5PZM1, Q1A2D1, W5P9U4 and 
W5P964. 
APPENDIX 4.8. List of 349 bovine aligned gene entries derived from inputting 379 Ovis aries 
protein entries in the PANTHER classification tool.  
CA2, MYCBP2, F2, LRG1, OAS2, MAN2B1, KCTD19, PSMA4, PSMB2, KLKB1, CNTRL, F10, 
PLXNA3, APOH, CPB2, SERPING1, HGFAC, VTN, GPX3, fH, PLG, SRSF7, C1S, PLA1A, F12, 
EXOC3L1, VDAC1, RRP1B, XPO1, TAF2, TALDO1, JUP, SELENBP1, VCL, BRIX1, C7, 
RPS27A, GC, TTC28, LRP2, CTSA, TMEM62, C2CD2L, CGN1, HABP2, TF, PDE3A, A2M, 
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ITIH4, FABP5, IGFBP5, CCHCR1, VDAC2, DOPEY2, BLMH, ZNF804A, PHYHIPL, ALKBH1, 
MACF1, DNM1, CDH13, ITIH2, LCP1, AHSG, PSMA1, HPX, ABCA13, ATRN, NCAPH, C6, 
AVL9, KPNA5, ITIH3, NFATC2, SERPIND1, TTR, FSIP2, ECM1, AFG3L2, NR1D1, DHX37, 
FAM72A, HSPA8, LUM, CFD, CTTN, POGZ, CPN1, SMCHD1, ORM1,OMD, INTS4, MBL2, 
SYNCRIP, PRG4, SKA1, TNXB, LRRC15, F13B, RBP4, EME1, IQSEC2, SETBP1, GHR, 
MYO7A, TGM3, CWC22, NSL1, VWF, HSP90AA1,HSPCA, DSP, C9, SEPP1, LAP3, AHNAK, 
TUBA4A, NOX1, FZD6, F13A1, PSMA5, AMBP, OTOF, CASP14, GGH, PF4, ASB2, SFN, 
PCOLCE, SERPINF2, SMURF1, ADIPOQ, ERCC6, IDE, KIF27, CLEC3B, CEP104, C1QB, C8B, 
PLTP, PEPD, CTNNBL1, ANPEP, MYO1B, TBC1D23, CDH5, BTD, MGAM, PLEKHM1, 
NEK5, APC2, SERPINA5, MASP1, ADGRF2, AP1B1, GOT2, COL6A3, GC, PLEKHG1, 
SYNGAP1, CHMP4C, MROH6, C1QA, C8A, THBS1, MST1, THBS4, RASGRF1, FGG, 
C11orf63, DYM, SHANK1, A1BG, LARP6, TUBB, Lats1, SAMM50, HEPHL1, IFT172, PROS1, 
IGFBP2, LRRC9, APOA1, EPG5, C1QC, ANXA2,ANX2, SERPINA7, IFT140, F5, IGHM, 
BTBD9, ABHD14B, AZGP1, HRG, SERPINF1, POLA1, ZMYM4, PRKG2, TBC1D5, DPEP2, 
PHKA1, NTN4, PSMA6, PPIA, MST1, CCAR2, APOD, Crisp3,CRISP3, TBC1D32, ALOX5, 
LRRK2, NCAM1, C1R, FGA, COL6A1, CFI, UHRF1BP1L, WDR47, CHI3L1, LDHB, CDSN, 
MBIP, FBP1, SNX25, SERPINC1, TF, APOF, DSG1, TRMT11, TXNL4B, LRRC17, ACTG1, 
TICRR, CDK5R1, AP1B1, RYR1, AASDH, C1orf204, GALNT13, FBXO3, PTPRC, TRPM4, 
ALMS1, GSN, HIST1H1D, IGF2R, OSMR, ARG1, FETUB, APOB, ZNF638, ENO1, VPS9D1, 
CDH19, DSG4, CAP1, APOC3, HCFC1R1, SERPINB13, PRG4, CRABP2, DSC3, C2, CP, 
DNAH17, IGFALS, PROC, MASP2, TGM1, CRP, AFM, INPP5B, AGT, CSMD1, OMD, SAFB2, 
WHSC1L1, KNG1, BTAF1, TCN2, HIVEP1, ANKRD11, MOB3B, KLHL8, F9, ITGA6, CD14, 
COLEC11, PSMA7, FCGBP, ZNF248, SART3, APOE, DSC1, FBLN1, CABYR, PDE4DIP, 
FNBP1L, G6PC, SUSD1, DNAH2, PLA2G7, SERPINB5, PLEC, C5, NUP155, ALB, MANSC1, 
IGHE, FAM78B, CCDC89, PGLYRP2, FLG2, GAPDH, ADAM15, TTN, PKP1, TFRC, ICOSLG, 
DRP2, LBP, CFP, GPLD1, CCDC177, XIRP2, HIST1H2AD, PON1, GOLIM4, PIGR, PSMA3, 
PKN3, SERPINB12, SERPINA1, BST1, ANK1, APOA4, LMNA, VNN1, BROX, NACA, APOM, 
SERPINA10, KIAA1751, OSBPL6, GRK7, ABCC5, SHBG, CD44, RND3, APOA2 and C4BPA. 
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APPENDIX 6.0. Generating a UniProtKB sheep-only protein FASTA sequence database 
Figure A6.0. Steps for generating a UniProtKB sheep-only protein FASTA sequence database 
Step 1. Navigate to www.uniprot.org and type Ovis aries and then search (red arrows). 
 
 
Step 2. Under popular organisms on the left side of the screen, select Sheep (red arrow). 
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Step 3. Click Download (1), Download all (2), Uncompressed (3), Format (4), FASTA (Canonical 
& isoform)(6), and then Go (6). 
 
 
Step 4. Saving the downloaded sequence fasta file: Take note of the file name (1), Save File, click 
OK (3). 
 
 
 
184 
 
Step 5. Open the FASTA file in a text code editor such as Notepad++ or EditPad and inspect. 
 
 
Step 6. Download and append common Repository of Adventitious Proteins (crap.fasta) sequences 
to the open FASTA file from http://www.thegpm.org/crap/, by following the arrows 1, 2, 3 and 4. 
Add indexed retention time (iRT) peptide sequences and save the FASTA file. Create a 
concatenated target/decoy database from this FASTA file using PeptideShaker.   
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APPENDIX 6.1. Extraction of protein data from ex-diagnostic sheep serum  
Ex-diagnostic frozen serum samples from nine sheep that presented with a range of different 
conditions were obtained from UQ’s School of Veterinary Science clinical pathology laboratory 
(UQ.O) (Table 6.1). These samples (SC502–SC510), a pooled variant representing all samples 
(SC511) and a pooled variant representing healthy free-range sheep samples (SC512) as a control, 
were subjected to in-gel digestion and in-solution using generic methods as described Chapter 3. 
Table A6.1. Sick sheep serum samples for the derivation of peptide data for PSL enrichment. 
UQ.O 
ID 
UQ lab no 
Unique Lab 
sample ID 
Crude serum 
protein (µg/µL) 
Reconstituted acetone-
precipitated 
serum protein (µg/uL) 
1 66943 SC502 65 76 
2 67737 SC503 57 64 
3 68327 SC504 78 72 
4 68354 SC505 78 64 
5 68364 SC506 56 80 
6 68447 SC507 47 76 
7 68494 SC508 69 68 
8 70192 SC509 69 80 
9 70802 SC510 - 80 
10 Pooled (1-9) SC511 - 76 
11 Pooled SA SC512 - 15 
Key: UQ; The University of Queensland; UQ Lab; UQ School of Veterinary Science clinical 
pathology laboratory; UQ.O; serum samples from UQ Lab; SA: serum samples from healthy sheep 
from Serum Australis Pty Ltd. 
The results of Coomassie-stained 1D SDS-PAGE gels used for acetone-precipitated serum samples 
from sick and healthy sheep are presented in Figure A6.1 A and B, and protein IDs are presented in 
panel C.   The gels in panel A and panel B were used for fractionating reconstituted acetone-
precipitated pooled serum from healthy sheep (SA11) and serum from sick sheep (UQ.O 1 to UQ.O 
10). The two gels had a lane each loaded with 4 µL of a molecular weight (MWt.) marker and BSA 
standard (arrows). Sample lanes were loaded with 200 µg of protein. Note the differences in 
appearance of the bands for each sample and the replicates of UQ.O 10 in the two gels. 
Panel C of Figure A6.1 shows the protein IDs from in-gel digestion of sick sheep serum samples 
(SC502–SC510, SC511 [pooled]) and a control in ProteinPilot, PeptideShaker and Mascot search 
186 
 
engines; meanwhile, the protein IDs for in-solution digestion workflow are shown in panel D. The 
number of protein IDs from in-gel digestion was marginally higher than those yielded by in-
solution digestion.  
The results of protein IDs for in-solution digestion are presented in Figure A6.1 D. The combined 
number of protein IDs in the Mascot search engine from in-gel and in-solution digestion from the 
entire workflow are provided in Figure A6.1E.    
The total number of combined protein IDs yielded by Mascot from in-gel and in-solution digestion 
of serum samples from sick sheep (SC502–SC511 [UQ.O1-UQ.O9]) and a pooled control sample 
(SC511) from healthy sheep are shown in Figure A6.1 E. Except for two samples (SC502 and 
SC506), the number of protein IDs were comparable for all other samples. The overall outcome of 
this entire workflow, using the Mascot platform, was the identification of 314 proteins. 
It was evident from the results of 1D SDS-PAGE that profiles of the individual samples had distinct 
differences based on the appearance of protein bands in the individual case lanes compared to the 
control sample from healthy sheep (Figure A6.1 A and B). The pooled sick sheep serum sample 
replicates (UQ.O10) were comparable within the gels, but there was an inter-gel difference in the 
appearance of the bands. Despite the gels being prepared and run identically together in the same 
tank, the protein bands of the UQ.O10 sample in gel A appeared dense and diffuse, and yet the 
bands were well separated in the three replicate lanes in gel B. Intrinsic gel properties or a variation 
in the physical nature of the sample during loading could have contributed to this visual difference 
(for example, gel A was loaded before gel B). This illustrates a known challenge of 1D SDS-PAGE: 
inter-gel reproducibility
116
. 
The numbers of protein IDs from in-gel and in-solution workflows from sick sheep serum samples 
were comparable, averaging approximately 125 IDs in the combined results of each individual 
sheep (Figure A6.1 C and D). ProteinPilot™ had the highest number of IDs, followed by Mascot 
and then PeptideShaker.  
The UniProtKB accession numbers of the 183 protein IDs from PeptideShaker for inclusion in the 
PSL were W5Q7J0, W5NSA6, W5NX51, W5PF65, W5Q5H8, W5NRI1, W5P0Q4, P14639, 
W5NRG7, W5NQ46, W5P6F4, W5NWM2, W5NQW4, W5QDG7, W5Q124, W5PW21, P32262, 
Q9XT27, W5Q5A6, W5PZI1, P02075, W5PJ97, W5PHP7, A5YBU9, F2YQ13, W5PTG9, 
W5NXW9, W5PI61, W5NTW3, W5NY46, W5PJZ1, W5PFC9, Q1A2D1, P20757, W5NSH2, 
P29701, W5QAB1, W5P1J8, W5PXC8, W5P5I0, W5Q9A2, W5Q0X5, W5PKA9, P12303, 
W5PID9, W5PHI7, W5PGT6, W5PXI3, W5PD71, W5P7S6, W5Q9D5, B6UV62, W5QFP0, 
W5P101, W5QBW5, W5P3R3, W5PGT9, W5Q0L2, W5PTU7, P52210, W5P1X9, W5QH46, 
W5QH54, W5Q961, P02190, C8BKD1, W5PE53, W5QI29, D6PZY4, W5NWX6, W5QH50, 
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W5NXP3, W5Q4Q3, W5PYG2, P42819, W5NZ47, W5PHP8, W5NPK5, W5NRH2, W5P812, 
W5PDJ6, C8BKC5, W5QGD1, W5Q0R1, W5PIA1, A2SW69, Q1KYZ7, W5PVL4, W5PJR0, 
W5Q749, W5Q2E1, W5NTT7, W5PDS4, W5PDE5, W5P336, P50450, W5PH81, W5P3J3, 
W5Q268, W5NS74, O46544, W5QA64, W5NXP6, W5PBY0, W5PUC1, Q29439, W5QA54, 
W5NYF4, C5IS96, W5Q4Z3, W5PJG0, W5QGP4, W5QA07, W5NUJ7, A2P2H1, W5NUU7, 
B0BL71, A0A0U1YZ59, W5PJ69, W5Q3K6, W5NXM6, W5PDQ9, W5PEI4, W5QDF3, 
W5PDR5, W5NXJ3, W5P880, W5NX96, W5PZH5, W5PPQ8, W5Q7Z7, W5Q7R8, P68056, 
W5QDP8, W5PN97, W5PS88, W5PJR5, W5PDP6, W5P5W9, D6PX64, W5P9J8, W5PG63, 
W5NQP5, W5PV54, W5PLL0, P49920, D7RIF5, W5P4C6, W5PLC9, Q4TVY4, W5PUJ4, 
W5PJ66, W5NXM1, W5NR06, W5NU00, W5Q2U7, W5PI92, W5PAJ9, W5PLQ1, W5NQ21, 
W5PD62, A0A077JGJ6, P11839, W5P481, W5Q7T8, C5IJA0, W5NYA7, H9CJU6, W5PD84, 
P0C276, W5QFQ0, W5PK04, A9YUY8, W5NYA1, W5NV73, W5QBV7, C0LQH2, K4P494, 
W5P5K9, W5PPG6, W5P323, A0A0H3V7A0 and W5Q723. 
This workflow added 71 proteins that were not identified in Chapter 4 – the analysis of  the 
circulating acellular proteome of healthy sheep, apart from 112 protein IDs that were common 
between the two workflows. The UniProtKB accession numbers of the sick sheep-associated 
proteins are W5Q5H8, W5NQ46, P02075, F2YQ13, Q1A2D1, B6UV62, P52210, W5P1X9, 
W5QH46, P02190, P42819, W5PDJ6, C8BKC5, W5PIA1, W5PJR0, W5NTT7, W5NS74, 
W5QA64, W5NXP6, W5PUC1, W5QA54, C5IS96, W5PJG0, W5QA07, W5NUU7, B0BL71, 
W5PJ69, W5NXM6, W5QDF3, W5PDR5, W5PZH5, P68056, W5PN97, W5PS88, W5PJR5, 
W5P5W9, W5P9J8, W5PG63, W5NQP5, P49920, D7RIF5, W5PLC9, Q4TVY4, W5PUJ4, 
W5NR06, W5NU00, W5Q2U7, W5PI92, W5PAJ9, W5PLQ1, W5NQ21, W5PD62, A0A077JGJ6, 
P11839, W5P481, W5Q7T8, C5IJA0, W5NYA7, H9CJU6, W5QFQ0, W5PK04, A9YUY8, 
W5NV73, W5QBV7, C0LQH2, K4P494, W5P5K9, W5PPG6, W5P323, A0A0H3V7A0 and 
W5Q723. 
Also, there were 21 proteins that were identified in Chapter 4, but not in sick sheep serum 
suggesting that these proteins probably diminish during illness. The UniProtKB accession numbers 
of these proteins were W5P8R7, W5PXU6, W5PXX3, W5P4S0, W5P9B0, W5PHH3, B5B304, 
W5QGG0, W5QAA3, W5PIJ5, W5PIC9, W5PVH9, W5PWE9, W5NVM6, W5PTE9, P30035, 
W5P229, W5QH45, W5P3H8, W5P2V3 and W5QAR2. 
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Figure A6.1. Extraction of protein data from ex-diagnostic sheep serum. A and B = Coomassie-
stained 1D SDS-PAGE preparations for fractionating acetone-precipitated pooled serum from 
healthy sheep (SA11) and serum from sick sheep (UQ.O 1 to UQ.O 10); C = protein identifications 
(IDs) from  in-gel digestion; D = protein IDs from in-solution digestion; E = total number of protein 
IDs from in-solution and in-gel digestion of the individual, pooled and healthy control samples. 
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APPENDIX 6.2. Derivation of peptide data from plasma and serum of endotoxin-treated 
sheep 
Plasma and serum samples of sheep that were treated with endotoxin were used for this experiment 
(Table A6.2). The  samples were categorised based on trait/strain or experimental group of the 
sheep model of intensive care based on earlier findings
15
. The samples were subjected to 1D SDS-
PAGE and in-solution digestion as described in the generic methods in Chapter 3.  
Table A6.2. Plasma and serum samples pooled from 24 sheep in groups of six showing 
samples taken before and after endotoxin treatment for in-solution and in-gel workflows.
 †
  
Experiment/Samples→ 
Workflow 
B4 E. Rx 
Plasma 
After E. Rx 
Plasma 
B4 E. Rx 
Serum 
After E. Rx 
Serum ↓Sheep trait/Strain 
Wool production 
In-solution SC537/717 SC538/718 SC539/719 SC540/720 
In-gel SC553/734 SC554/735 SC555/736 SC556/737 
Parasite resistance 
In-solution SC541/721 SC542/722 SC543/723 SC544/724 
In-gel SC557/738 SC558/739 SC559/740 SC560/741 
SYSS 
In-solution SC545/725 SC546/726 SC547/727 SC548*/728 
In-gel SC561/742 SC562/743 SC563/744 SC564/745 
Saline  
(endotoxin control) 
In-solution SC549*/729 SC550/730 SC551/731 SC552/732 
In-gel SC565/746 SC566/747 SC567/748 SC568/749 
†
 The experiments were repeated due to sub-optimal protein recoveries, thus the double sample 
numbers; for example, SC537/717. Key: B4 = before; E. = endotoxin; Rx = treatment; SYSS = 
stockyard sourced sheep; SC = unique laboratory sample identification (investigator initials 
followed by sample serial number); * = No peptide peaks detected. 
Coomassie-stained 1D SDS-PAGE gels of pooled plasma and serum samples from 24 sheep from a 
sheep model of intensive care are presented in panels A, B, C and D of Figure A6.2(a). The gel 
grouping was based on the sheep trait/strain or experimental groups (4 groups × 6 sheep): A –wool 
production, B – parasite resistance, C – SYSS (unknown strain/trait), D – SYSS saline (sham 
challenge; unknown strain/trait).  The results represent samples drawn before and after treating the 
sheep with endotoxin (A, B & C), and experimental controls that received saline (D). Sample lanes 
were loaded with 200 µg of protein in duplicate. Note the differences in P1P lanes (gel A), BLP 
lanes (gel C) and BLS lanes (gel D). Serum lanes had an intense band in the 15 kD region that were 
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less distinct in plasma lanes. Protein yields from 1D SDS-PAGE are shown in panel E, which 
shows that protein extraction from the first 1D SDS-PAGE was better than that from the second. 
 
Figure A6.2(a).  Protein data of endotoxin-exposed sheep workflow. Coomassie-stained 1D SDS-
PAGE gels of pooled plasma and serum samples from 24 sheep from a sheep model of intensive 
care based on strain: A = wool production; B = parasite resistance; C = stock yard sourced sheep 
(SYSS)(unknown strain/trait); D = SYSS saline (sham challenge); E = protein IDs from in-solution 
workflow of the first (SC537–SC552) and second (SC717–SC732) digestions of samples from 
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sheep exposed to endotoxin in ProteinPilot, PeptideShaker and Mascot; F = Mascot protein IDs 
from the entire workflow of endotoxin-treated sheep. Key: Rx = treatment; BLP = before endotoxin 
Rx (plasma); P1P = after endotoxin Rx (plasma); BLS = before endotoxin Rx (serum); P1S = after 
endotoxin Rx (serum); IDs = identifications; In-Sol_Endotoxin = protein IDs from combined 1st 
and 2nd in-solution digestion of endotoxin workflow; In-Gel_Endotoxin = protein IDs from 
combined 1st and 2nd in-gel digestions of the endotoxin workflow. 
Figure A6.2(a) E shows the number of protein IDs from the in-solution workflow of the first 
(SC537–SC552) and second (SC717–SC732) digestions of samples from sheep exposed to 
endotoxin in ProteinPilot, PeptideShaker and Mascot. Protein yields from the second in-solution 
digestion were better than the first. Mascot identified 100 proteins in the combined in-solution (In-
Sol_Endotoxin) and 1D SDS-PAGE (In-Gel_Endotoxin) from the entire workflow of endotoxin-
treated sheep, including controls, as shown in Figure A6.2(a) F, and PeptideShaker identified 84 
proteins.  
The 84 PeptideShaker protein IDs in UniProtKB from this workflow for inclusion in the PSL were 
W5Q5H8, P14639, P29701, W5NSA6, W5PF65, W5NRI1, W5QDG7, W5NX51, W5NQ46, 
Q9XT27, W5Q5A6, F2YQ13, W5Q7J0, W5PW21, W5PHP7, W5NRG7, P32262, A5YBU9, 
P12303, W5PTG9, W5P1J8, W5NTW3, W5NQW4, W5PZS7, W5NU00, W5P6F4, W5QAB1, 
P21621, W5PJ97, W5NXW9, W5P3R3, W5NSH2, W5NWM2, W5PJZ1, W5NRH2, W5PID9, 
W5NY46, O46544, W5PPQ8, W5Q124, P20757, W5P0Q4, W5Q4Q3, Q1A2D1, W5P101, 
W5QH46, W5PZI0, P42819, A2P2H1, W5PDE5, W5Q0X5, W5PXC8, W5NPK5, W5QH50, 
C8BKD1, D6PZY4, W5PD71, W5PFC9, W5QH54, W5PG63, W5PHI7, B6UV62, Q1KYZ7, 
W5Q1R5, W5NXP3, P29455, Q28579, P30035, W5QAR2, W5PVL4, W5PE53, W5Q0L2, 
W5NXM1, W5QA64, W5NYA1, Q7M2U8, W5NXJ3, W5PGT6, W5QFP0, W5P0H0, W5PJG0, 
W5NZ47, W5QI29 and P23383. Of these protein IDs, only 63 were common between proteins 
identified in Chapter 4 that were derived from evaluating the circulating acellular proteome of 
healthy sheep, and  those from endotoxaemic sheep. As compared with protein IDs in Chapter 4, a 
total of 69 protein IDs were not identified in endotoxaemic blood, but there were additional 20 
protein IDs generated from this workflow. The UniProtKB accession numbers of these 20 proteins 
are W5Q5H8, W5NQ46, F2YQ13, W5PZS7, W5NU00, P21621, Q1A2D1, W5QH46, W5PZI0, 
P42819, W5PG63, B6UV62, W5Q1R5, P29455, Q28579, W5QA64, Q7M2U8, W5P0H0, W5PJG0 
and P23383.  
Considered collectively, the sick sheep and endotoxaemic sheep workflows contributed 80 proteins 
to the PSL pool (Figure A6.2(b)). 
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Figure A6.2(b). Comparison of protein IDs from the analysis of 
the circulating acellular proteome of healthy sheep compared 
with IDs drawn from sick sheep (UQ.O) and sheep treated with 
endotoxin from E. coli (UQ.E). The UQ.O and UQ.E workflows 
collectively contributed 80 protein IDs to the PSL that were not 
detected in healthy sheep (Chapter 4). 
 
APPENDIX 6.3. Generation of in silico predicted synthetic peptides of selected 
proinflammatory cytokines 
Briefly, complete tryptic peptide sequences of homologous peptide sequences between Bos taurus 
and Ovis aries of IL-6, IL-3, IL-1α, IL-1β and TNF-α suitable for Fmoc synthesis or solid phase 
peptide synthesis
426
 were predicted by in silico digestion with the aid of Skyline software
172
. The 
basic selection criteria was that peptide candidates were allowed a maximum of one missed tryptic 
cleavage site while excluding reactive cysteine and methionine residues and histidine where 
possible, in order to avoid higher charge states during electrospray ionisation. The length of 
peptides was limited to 8 - 15 amino acids to assure reasonable yield in peptide synthesis. Two top-
ranking unique peptides per protein with capabilities of being detected by mass spectrometry that 
met this basic selection criteria were chosen as targets for proteomics experiments with Skyline. 
Each of the 10 target peptides was then synthesised by Mimotopes Pty Ltd, (Clayton, Victoria, 
Australia) in automated synthesisers using the mild Fmoc chemistry method. The peptides were 
synthesised as unlabelled and K [13C6: 15N2]-labelled by introducing stable isotope labels: heavy 
lysine (K)-containing 
13
C and 
15
N atoms were incorporated at the C-terminal tryptic residue (Table 
A6.3). The heavy and light peptides were mixed in equimolar proportions and 1000 fmol were 
spiked into 16 samples (SC717-SC732) or analysed directly in one sample (SC733) using the 
TripleTOF 5600+ instrument in a DDA mode as decribed in Chapter 3, to collect fragment ion 
spectra (full MS/MS scans) as illustrated by the examples in Figure A6.3.  
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Table A6.3. Unlabelled and K[13C6: 15N2]-labelled H- and -OH termini synthetic peptides of 
five sheep cytokines.  
Peptide Hydrophobicity 
index 
Molecular 
Weight 
Length Peptide sequence 
K*= (1042) labelled 
Cytokine 
1 0.295 914.1 8 LLLTTPEK 
Interleukin 6 
2 0.037 1108.2 9 MQSSNEWVK 
3 -0.020 1473.6 14 ITPSPEGSLNSDEK 
Interleukin 3 
4 0.214 1625.8 15 AFMTFATDTFGSDSK 
5 0.074 1245.4 11 FMSLDTSETSK 
Interleukin 1a 
6 0.055 1267.4 11 SAHYSFQSNVK 
7 0.352 1202.5 11 QVVSVIVAMEK 
Interleukin 1b 
8 0.049 1541.7 14 GDTPTLQLEEVDPK 
9 0.154 909.1 8 IAVSYQTK 
TNF-α 
10 0.344 857.1 8 VNILSAIK 
11 0.295 922.2 8 LLLTTPEK* 
Interleukin 6 
12 0.037 1116.3 9 MQSSNEWVK* 
13 -0.020 1481.6 14 ITPSPEGSLNSDEK* 
Interleukin 3 
14 0.214 1633.8 15 AFMTFATDTFGSDSK* 
15 0.074 1253.4 11 FMSLDTSETSK* 
Interleukin 1a 
16 0.055 1275.4 11 SAHYSFQSNVK* 
17 0.352 1210.5 11 QVVSVIVAMEK* 
Interleukin 1b 
18 0.049 1549.7 14 GDTPTLQLEEVDPK* 
19 0.154 917.1 8 IAVSYQTK* 
TNF-α 
20 0.344 865.1 8 VNILSAIK* 
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Figure A6.3. Representative MS/MS spectra of one unique in silico predicted and synthesised 
peptide each of five proinflammatory cytokines present in the peptide spectral library as displayed 
in PeptideShaker Software.  
 
APPENDIX 6.4. The UniProtKB entries of 564 proteins identified by ProteinPilot™ Software 
in the peptide spectral library. 
 P14639, W5PWE9, W5PH95, W5PF65, P29701, W5NX51, W5NSA6, W5PSQ7, W5NXW9, 
W5QDG7, W5NRI1, W5PTG9, W5NPK5, W5QCY8, Q28743, W5P0Q4, Q1A2D1, D6PZY4, 
W5NQW4, W5PMR1, O46544, A2P2G4, W5PJ97, I1WXR3, W5PZS7, W5Q5H8, W5PBY0, 
W5NQ46, Q9XT27, W5P4S0, W5Q5A6, A6NBZ0, W5NRG7, W5NUJ7, W5QAB1, W5PHI7, 
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A0A0F6YFJ0, W5NY46, W5NWM2, W5Q7J0, P12303, W5Q0X5, W5P3R3, W5PID9, W5NRH2, 
P02083, W5NY95, F2YQ13, W5PTR4, C8BKD1, W5NVM6, W5P627, W5P101, W5NXP6, 
W5NZ47, W5PW21, W5P1J8, O02762, W5PHP7, W5PZF0, W5NTW3, W5NSH2, W5PFC9, 
W5NXM1, W5QAN8, W5Q268, W5QDP8, Q7M2U8, W5Q6D3, W5PI61, W5PGT6, W5PH81, 
W5Q6U2, W5QFP0, W5PKA9, W5P812, W5PFP1, W5Q6A0, W5PPQ8, W5Q7Z7, W5P5I0, 
W5P3J3, W5QGP4, W5QI29, W5PD71, W5NWX6, A0A0F6VY37, W5NUW3, W5NVB2, 
W5P338, W5NYJ9, W5QH54, W5NXP3, W5QH45, W5PXI3, W5NWU4, W5Q9A2, W5NXJ3, 
B7TJ06, W5PG63, W5PDS4, W5PE53, W5PDR5, W5PXC8, W5QH50, W5PTL2, Q29439, 
W5Q2K7, D7RIF5, W5Q4Q3, W5Q505, W5Q9D5, W5P7S6, W5NVG2, W5PN97, W5NS48, 
W5QA07, B5B304, W5Q961, W5Q2U8, W5PDQ9, W5PDP6, W5PGT9, W5PTU7, W5PAJ9, 
W5PDJ6, W5QA64, W5PZK7, W5Q6G0, P00922, W5QBW5, W5PXX3, W5Q0L2, W5Q754, 
W5P880, W5Q749, W5PCA0, W5PVL4, W5NPI9, W5PHP8, W5Q3K6, W5PJG0, W5Q9K1, 
W5PZ55, W5Q2E1, C8BKC5, W5NZH3, W5P988, W5PD62, W5Q3I7, W5PIA1, W5Q517, 
W5P4C6, W5P9V5, D7R7V6, W5PIN8, W5P229, W5PD84, W5PPT6, W5NRR7, C5ISA2, 
A2SW69, W5PEI4, W5PAB5, P49920, W5QAW7, A5YBU8, W5QGD1, O77642, Q06AV9, 
W5PYG2, W5QC41, W5QIK8, W5Q0R1, C5IS96, W5PI92, W5P9B0, W5P1X9, W5NYF4, 
W5P1W2, W5PJR0, W5PDN1, W5QFR6, M4WG34, W5NUS6, K4P494, W5P195, W5PZH5, 
W5PTS4, W5QGG0, W5QCY7, Q28579, A0A077JGJ6, W5PLL2, P02190, W5PSM6, W5QH21, 
W5PQD8, W5PJ66, P11839, W5QBD7, Q7JFW9, W5PB04, W5NUI0, W5PFJ0, C7EDS5, 
W5PB46, W5NX96, W5NPN4, A0A0U1YZ59, W5P2V3, W5NU34, W5PGS4, W5NV45, 
W5NRV6, W5NTG5, W5PLB7, W5PEY4, Q29400, W5P5W9, W5Q4Z3, W5QAA3, W5PHA3, 
W5P9J8, W5Q7T8, W5Q5L6, W5PJ69, Q06435, W5NQP5, W5NTT7, C0LQH2, W5P4W8, 
W5Q2U7, W5Q038, M4WGF1, W5P430, D6BJI0, W5PV69, W5NXN8, W5QET9, W5P915, 
W5PUC1, W5Q0V2, W5PVM3, W5QA54, W5PUU8, W5PYX7, W5PJR5, P67976, W5PBS4, 
W5NY50, D6PX64, W5NX91, W5Q224, W5PV74, W5PH03, W5NSF6, W5QFL0, W5QFR8, 
W5PC09, P62262, W5PTR5, W5P3A7, W5PLF8, D5HKJ4, W5P565, W5PQ96, W5PES2, 
W5PQH2, W5NSR4, W5PH45, W5PD87, Q5MIB5, P09670, W5NXM6, W5PVH9, W5Q0Y3, 
W5PZT3, W5NZQ2, W5Q723, W5NSZ2, W5Q9K6, W5NS65, A9YUY8, W5QDM2, W5PSZ5, 
W5P082, W5NYP8, W5PCP3, W5P9W4, W5NWH4, W5PDG4, W5NZW5, P68253, B0LRN3, 
W5PTZ9, W5P448, W5QEL6, W5P663, W5QJ27, W5NUU7, W5Q7C7, W5NS93, W5PSC8, 
W5NRA9, W5NTB3, W5PLV2, W5QE46, B3GS77, W5PIC9, W5PTE9, W5QCP9, W5P5V0, 
W5PEM0, W5PG55, W5QIV5, W5PWY0, W5QIW1, W5QE21, W5P8T8, W5QJB0, W5QAI5, 
W5PQK6, W5Q8B1, W5PPG6, W5QIG9, P49929, W5PZ65, W5PDF4, W5PBM4, W5QBV7, 
C5IJA0, W5PB07, W5PIG7, W5P481, W5P094, W5NZU3, W5PJC2, A8DR93, W5PMH6, 
W5P323, W5P044, W5PKC9, W5P3Q3, W5PJA0, W5QD30, W5P9U4, W5NT47, W5QGV5, 
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W5P3H8, W5P491, W5P620, W5PBN5, W5QHS2, W5P671, W5QGX2, W5P9V7, W5PEP7, 
W5PQA8, W5P0B2, W5PIN6, W5P0I5, W5NQ91, W5Q2A8, W5PZJ5, W5P311, W5NUP9, 
W5PAM4, W5PPN8, W5QBT3, W5NV73, W5P742, W5PG95, W5PYQ3, W5PF71, W5PS88, 
W5PIJ5, W5NR63, W5P5K9, W5PG36, W5NYA7, W5P060, W5Q9P7, W5PER5, W5Q3T5, 
W5P352, W5Q6D6, W5PKQ5, W5PDD0, W5PZ59, W5NTD9, W5PJV7, W5P644, W5PR13, 
W5PA19, W5QE19, Q4LBE5, W5P1N0, W5P326, W5PL69, W5P0X0, W5PIC7, W5P7M5, 
W5QG17, W5Q0G8, W5Q809, W5P731, W5NUL9, W5PMA2, W5P0T8, W5NQK0, W5NZ75, 
W5QBR9, W5P5F4, W5NRL0, W5QID7, W5PTL7, W5NXZ1, W5PEB0, W5Q1R4, W5PA64, 
W5P2Y4, W5PTU9, Q9XSM0, W5PHT8, W5QF71, W5Q097, W5PXH5, W5Q5D7, W5Q9L9, 
W5QIM9, W5Q6B0, W5PQ53, W5NPH5, W5P1Y8, W5Q0L1, W5PCI1, W5PEL1, W5Q8J9, 
W5P7G7, W5QDT2, W5NW13, A5YBV0, P23383, W5PGZ8, W5P2M3, W5NY22, W5PRG8, 
W5PEJ5, W5P7B1, W5NUA9, W5PXL4, W5PMY0, W5PNM5, W5QGV4, W5NW78, W5Q0G0, 
W5NS18, W5PSL9, W5QI70, W5QIY3, W5NZJ3, W5NX11, W5Q670, W5QGM7, W5QIL2, 
W5P689, W5PYR8, W5QD37, W5Q759, W5NXK9, W5PNP1, W5PMI8, W5PLP6, B2LU28, 
W5PNI5, W5Q8Z1, W5QEV3, W5PAT6, W5NS44, W5P964, W5PGS0, W5PXB4, W5Q254, 
W5PP57, W5PBX6, W5PTS2, W5Q5D8, W5QGN4, W5PE89, W5P908, W5QAJ7, W5PBH6, 
W5P8V3, P50413, W5PVY5, W5PGA9, W5PU57, W5QAK3, W5PQT7, W5PVW3, W5PIW6, 
W5NYJ2, W5P5V2, W5QBV3, W5QGN6, W5PVX3, W5Q6L3, W5Q3D0, W5Q0U9, W5PCG5, 
W5QDG4, W5PM28, W5PHX1, W5P8G7, W5NWD0, W5P7E0, W5PUU0, W5QF94, W5QBE7, 
W5PW91, W5PKF3, W5PJH9, Q7M355, W5QG48, W5NR00, W5NSE9, W5NU20, W5PS94, 
W5NR56, W5PD49, W5PKZ0, W5P8Y7, W5NS27, W5NQD5, W5QH53, W5P2S9, W5P6T2, 
W5PAJ2, W5Q540, W5PWG6, W5PVG2, W5PGC2, W5PM15, W5PBC2, W5NSA5, W5QGB7, 
W5QBD4, W5PKQ7, W5PVV7, W5PWQ1, W5PDQ0, W5PTZ3, W5PCK5, W5P578, W5PBU5, 
W5PLC9, P62297, W5P0H0, W5NYM6, W5P3D1, W5PKF8, W5P691 and W5PMS1. 
APPENDIX 6.5. The UniProtKB entries of 830 proteins identified by Mascot in the peptide 
spectral library. 
W5Q7J0, P14639, W5NSA6, W5PF65, W5P6F4, W5Q754, W5NUX8, W5P5T4, W5NY95, 
W5P4S0, D6PZY4, W5P3R3, W5NRI1, W5NRG7, W5PTG9, F2YQ13, W5Q7Z7, W5NX51, 
W5QAB1, W5PW21, W5P8R7, C8BKD1, W5PTR4, W5NSH2, W5PGT6, W5P0Q4, W5P5I0, 
I1WXR3, W5PH81, W5PBY0, W5QH45, W5Q2U7, W5QH50, W5NXW9, W5P1J8, W5NWM2, 
W5NY46, W5QH54, W5PXX3, W5QFK2, W5NYJ9, W5PXI3, W5Q5C2, W5QH56, W5P101, 
W5PXU6, W5PI61, W5P336, W5Q268, W5PID9, W5PDR5, W5Q7R8, W5PFJ0, W5QI29, 
W5P2U2, W5PJZ1, W5P812, W5P3J3, W5Q749, W5PEI4, W5PKA9, W5QGG0, W5Q4Q3, 
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W5PZI1, W5Q9A2, W5P248, W5PXC8, W5QAX3, W5PHP8, W5QFP0, W5QH06, W5PQL6, 
W5PE53, W5Q0L2, W5PGT9, W5NRR7, W5Q4B1, W5P691, Q1KYZ7, W5PD71, W5Q9D5, 
W5P7S6, Q06AV9, W5Q038, W5Q224, W5QFE4, P12303, W5PDE5, W5QDP8, W5QCP9, 
W5P6U4, Q28743, W5P229, W5P880, W5PWW5, W5QGP4, W5Q2E1, W5P4C6, W5PV54, 
A2SW69, W5Q4P0, W5PPQ8, W5PJ97, W5Q0R1, W5PPN5, W5QJ00, W5NVN1, W5P2I4, 
W5QHH3, W5Q961, W5PVL4, W5QAH2, W5QAA3, W5PHH3, W5NX96, W5QGD1, W5PD84, 
W5Q7T8, W5P3H8, W5PDC8, W5PIK2, W5QC26, A2P2H1, W5Q3K6, W5PDP6, W5PIC9, 
W5PZY7, W5PVH9, W5P9B0, W5QFL0, W5NS65, W5PAB5, W5PG63, W5PGS0, W5PD12, 
W5QCP0, W5P9V7, W5Q4W5, W5QJ69, W5QDH9, W5PKV4, W5NTL7, W5NYG1, W5NQJ8, 
W5P7L5, W5PDQ9, W5Q4Z3, W5PYG2, W5PDS4, W5PLL0, W5QBW5, W5QH21, W5QAR2, 
W5PZF0, W5PVG5, I0CF13, W5NPN4, W5PX97, W5PXI0, W5PES2, W5NTD9, W5PJ85, 
W5PQM7, W5PEL1, W5NSV3, W5PJE4, W5NUU7, W5P640, W5PP29, W5PWT9, W5Q2D7, 
W5PXN1, W5Q1W4, W5Q620, W5PYL5, W5PAE2, W5PME8, W5PJP9, W5PG04, W5PG50, 
W5PZK2, W5P0B2, W5PAM4, W5PY75, W5PKN2, A0MPT5, W5NZ47, A0A0M4KDI9, 
W5NYF4, W5PTU7, W5Q0V2, W5PSM6, W5PB46, W5P2V3, W5Q5A6, W5PB04, W5PPT6, 
W5PZ65, W5QG19, W5QCX2, W5P149, W5P895, W5PC09, W5NS93, W5P964, W5PYQ3, 
W5NZQ2, W5PG36, W5QAA1, W5PN97, W5PS45, W5PTL2, W5P9W4, W5NTQ9, W5PDY2, 
W5P3A7, W5NUG0, W5NQ85, W5PDQ6, W5Q9L9, W5NXR3, W5PEJ5, W5Q2R6, W5NY68, 
W5Q828, W5PVG2, W5QDW7, W5P092, W5Q9P0, W5QBT8, W5NX74, W5PHI3, W5P041, 
W5PA54, W5PIG7, W5Q8Y3, W5Q5F0, W5NT24, W5NWX6, W5PIJ5, W5QIK8, W5PGW2, 
W5NQP5, D6PX64, W5NXI6, W5Q5H8, W5NVT0, W5P988, W5QIW7, W5P9V5, W5PGS4, 
W5P2Y4, W5P9U4, W5QF95, W5PVX0, W5Q9K6, W5PDN1, W5PD15, K4P1S5, W5NPK4, 
W5QFP2, W5QET9, W5PMY0, W5P8Y7, W5PHA9, W5Q910, W5PUG1, W5PM86, W5QHD7, 
B2ZA84, W5PZ27, W5Q9B7, W5PA64, W5PW62, W5PZH5, W5P8T8, W5PD75, W5P143, 
W5NV45, W5PL69, W5PUJ4, W5PWU1, W5NUL7, W5Q370, W5Q7C0, W5PWL1, W5PLJ9, 
W5P0P1, W5PQ53, W5PDQ3, W5PH55, W5PDG3, W5P808, W5QC28, W5PT48, W5QBN7, 
W5PPJ4, W5Q950, W5P1Y8, B3SV56, W5P3G6, W5QGW8, W5NX89, W5QCH5, W5NSI7, 
U3N1L1, W5PA78, W5NRV1, W5PNU9, W5NVC1, W5P1Q0, Q7M371, W5P2L1, W5PHK5, 
W5Q9H4, W5NXV2, W5P9A6, W5QA54, W5PG55, W5PD62, W5P9C3, W5PAJ9, W5PJ66, 
W5PTE9, W5NSZ2, W5QD30, W5Q517, W5P4X7, W5P7X3, W5QHC2, W5QBV7, W5QE21, 
W5QIY3, W5QG16, W5PKW9, W5PQH2, W5PXV7, Q29400, W5PWY0, A8DR93, W5QH43, 
W5PPT3, W5P1D3, W5P4R6, D0VWZ0, W5P987, W5PV57, B3GS77, W5PGZ8, W5Q6L3, 
W5PQH3, W5QD80, D4P8S5, W5P5V0, W5P985, W5Q0N1, W5NZB4, W5NT03, W5Q5W3, 
W5PX18, A0A0P0QND2, W5QIM3, W5PZJ0, C5ISA2, W5QI75, W5PC99, W5NQM5, W5PDJ6, 
W5Q5P5, W5P1N7, W5PLC4, W5PK74, W5Q564, W5QE19, W5P1X7, W5Q0U9, W5PKK4, 
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W5PQ63, W5NW67, W5PDT4, W5Q5R2, W5NSH6, Q5XUI1, W5PEY4, W5PZW5, W5PFR8, 
W5NQ46, Q1KYZ6, W5PHP7, W5NTW3, Q28745, P02075, W5QDG7, W5NQW4, O46544, 
A5YBU9, W5NPK5, W5NRH2, W5P1L7, P30035, W5PIA1, W5PZ55, P68116, C8BKC5, 
W5Q9H1, W5QA07, O02762, W5P3Q3, W5NY78, K4P494, B5B304, W5QA64, B0BL71, 
W5Q5V4, W5NSC7, W5Q293, W5NXP3, W5PHI7, A5YBU8, A2P2G1, W5Q3I7, W5PXZ3, 
P68214, A3QP67, W5NYG7, W5QHS2, W5QD06, W5Q0D7, W5PME2, W5Q124, W5PWE9, 
Q9XT27, W5PZS7, W5P627, W5NU00, Q7M2U8, W5Q0X5, W5NUJ7, Q1A2D1, W5NQ45, 
W5NVB2, W5P060, Q29439, P09670, P49920, W5NR06, C5IS96, W5Q369, W5P9J8, W5Q226, 
A4ZVY6, W5NUW3, W5PXE2, W5P620, W5PBX1, W5P9L8, W5PTB4, W5PKH2, W5NYP8, 
W5PBN5, P0C276, W5NTB3, W5Q2A5, W5PI10, W5PD87, W5NR63, W5PEC1, W5P881, 
W5PHG0, W5Q0Y3, W5NQ51, W5PNI5, W5NQ38, W5QF60, W5NUS6, W5Q367, W5NTL6, 
B0LRN3, W5P5K9, W5P4K7, W5P8L9, W5NVM6, W5PI92, W5PFI7, W5Q5D7, W5PP57, 
W5P8S5, W5NYA7, W5P671, W5PPK7, W5P2D1, C0LQH2, Q28893, W5PE96, W5NZW9, 
W5Q0C0, W5PQQ8, W5Q1N4, W5Q3J3, W5PGV3, W5Q5I4, W5PLU0, W5PZM1, W5QJ31, 
W5NQB8, W5Q5V9, W5P596, W5QEF4, W5Q7H9, W5PZQ8, W5NPR6, W5PKP8, W5PJ43, 
W5P4E6, W5Q9T3, W5PSI1, W5PD73, R4R2H5, D6BJI0, W5PMS1, W5NQ08, W5PNY6, 
W5PTU9, W5Q417, W5NYR7, W5P0C1, P32237, W5PY00, W5Q4E1, W5P078, W5NVG4, 
W5PY15, W5P4S8, W5QGN6, W5PZR6, H2DGR2, W5QA34, W5Q8B1, D5HKJ4, W5NVW9, 
D0VWY9, W5PLN7, W5NSR4, W5Q8S4, W5PZU0, W5PFY4, W5NRZ7, W5PIN4, W5P094, 
W5PAI7, W5NST9, W5PM69, W5PL67, W5PJR0, W5PCA0, W5Q4U7, A2VBC7, I3RWJ0, 
W5P673, W5PF26, Q9XSM0, B9VGZ6, W5NVY5, W5P6L3, W5PL06, W5PMF4, W5P736, 
W5PIU1, W5PFD3, W5NSB9, W5QJA2, W5NU34, W5NY22, W5PV93, P50413, W5Q9T2, 
W5Q7I2, W5PH95, W5PTS4, W5PZI0, W5Q6R7, W5PLB7, W5NQW9, W5Q9K1, W5NVG2, 
W5QH46, W5NZH3, W5QC41, W5QCY7, W5Q0F3, W5NS74, W5PEL7, W5P195, W5QC38, 
Q5MIB5, C7EDS5, W5NTJ3, A0A077JGJ6, W5PE90, P22793, W5Q5L6, W5NTE3, W5PT09, 
W5NPI9, W5QIV5, W5PF71, W5PV74, W5PAG8, W5NY50, W5PDF4, W5PN84, W5QDM2, 
P62262, W5NUY7, W5PH03, W5PVM3, W5PSC8, W5PQK6, W5PPG6, Q1RPQ7, W5PMH6, 
W5Q2K6, W5PT68, W5QFP3, W5PT38, W5PXV3, W5PJC2, W5NQ22, H9CJU6, W5NT47, 
W5PHT8, W5NU40, W5PZT3, D3IU20, W5PLQ1, W5NSF6, W5QE46, W5PK67, W5NRP7, 
W5QCK9, W5PGT0, W5PSM2, W5PSP1, W5PWH2, W5QB36, W5PKG7, W5P2R3, W5P5W9, 
W5QE14, W5PLV2, W5PC67, W5QDT2, W5PQD8, W5PXA3, W5P915, W5PBG2, K4P231, 
W5NYX4, W5PPZ8, W5PIF0, W5NXZ4, W5PBM4, W5QBD7, W5Q670, W5PBX6, W5QIL2, 
W5PSX0, W5P657, W5P1Y5, W5QA91, W5NX11, W5PEM0, W5NRF4, W5QIG9, W5Q3N2, 
W5PMZ6, W5P0X0, W5PCQ3, W5QDP7, W5PB37, W5P300, W5NRS4, W5NW52, W5QGM9, 
W5PIV4, W5PRK9, W5NX57, W5PGV9, W5Q6W6, W5QGQ0, W5NZR2, W5NXK6, W5P7W5, 
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W5NZU3, W5NQ21, W5PZC0, W5PHE6, W5PN22, W5P0W5, B5DC89, W5PI70, W5QIW1, 
W5NZJ3, D7RH37, W5PEP7, W5P1U6, W5PYK0, W5PZ59, W5QCG2, W5PFW3, M4T8F1, 
W5QGM7, W5PNG2, W5PCR1, W5Q9P7, W5PI34, W5Q0L1, W5P1T7, W5Q043, W5QA42, 
W5NW86, W5PLB4, W5PJA0, W5PB07, W5NY84, W5PBY1, W5PBS4, W5Q334, W5P377, 
W5Q5H7, W5PVU5, W5PD49, W5QDT9, W5PWR1, W5NRA9, Q28884, W5PTS0, W5PM28, 
W5QF71, W5PLB6, C5IJA0, W5QDN3, Q7M355, W5Q6C4, W5PAI3, W5PA65, W5PK97, 
W5PYT3, W5PR03, W5P148, A0A0A7ETA6, W5PHI8, W5PW49, W5P7I2, W5P393, W5Q1J8, 
W5Q8M7, W5Q5C7, W5QI89, M4WG34, W5PR13, W5PG12, W5PX41, W5NYZ0, W5Q6W3, 
W5Q1R5, W5PJE0, W5NYX8, P02083, W5P1W2, W5P1X9, P42819, P02190, W5PUC1, 
W5QDF3, W5Q723, A4ZVY8, W5PJ69, W5NXM6, W5Q5L3, P67976, W5NTT7, D7RIF5, 
A2I7L0, W5NXJ3, W5P082, A0A0U1YZ59, W5PS88, W5PGC9, P07846, W5QAH1, W5NU63, 
W5PKC9, W5QFQ0, W5P481, A2P2I3, W5NVS8, W5Q684, W5PJG0, W5P323, P17607, 
A9YUY8, W5P656, A0A0H3V7A0, W5QD47, W5P044, W5QJ62, W5QAM3, W5PLC9, 
W5QIV1, W5PIW6, W5PYI1, W5PVY5, W5NQ83, W5QDH3, W5PZ95, W5PX84, Q30DP7, 
W5PIF6, W5NQ91, W5NTZ6, W5PGG9, W5Q4B0, W5NRC0, W5PSB1, W5QDR0, W5QGQ3, 
W5Q627, W5P525 and W5NYJ2. 
APPENDIX 6.6. The UniProtKB entries of 398 proteins identified by PeptideShaker in the 
Peptide spectral library.  
W5NSA6, W5Q7J0, W5NX51, W5PF65, W5NRI1, W5P6F4, W5NRG7, W5NSH2, W5PHP7, 
W5NQW4, W5QDG7, W5NWM2, W5NY46, W5PW21, W5PTG9, W5NTW3, W5Q124, 
W5P0Q4, W5PJZ1, W5QAB1, P32262, W5NXW9, P20757, W5PID9, W5Q7Z7, W5PGT6, 
W5P5I0, W5Q4Q3, W5P1J8, W5QH54, W5QH50, W5PFC9, W5Q0X5, W5P8R7, W5PXC8, 
W5PKA9, W5P101, P29701, C8BKD1, W5Q749, W5PJ97, W5Q9A2, W5Q7R8, W5PD71, 
W5NRH2, W5PDR5, W5PE53, W5Q0L2, W5QI29, W5NPK5, W5PGT9, P12303, W5PXI3, 
W5P3J3, W5QFP0, P50450, W5PHI7, A2P2I0, W5PH81, W5P336, W5Q2E1, W5P7S6, 
W5QGG0, W5NXM1, W5NXP3, W5Q9D5, W5P9B0, W5PD84, A2SW69, W5Q0R1, W5PV54, 
W5P812, W5Q2U7, W5Q268, W5P4S0, W5PPQ8, O46544, W5PDQ9, W5QDP8, W5PHP8, 
W5PHH3, D6PZY4, W5PEI4, Q29439, W5PDE5, W5QGD1, W5P229, W5Q3K6, W5PXX3, 
W5PDS4, W5NWX6, W5QGP4, Q1KYZ7, W5PAB5, W5Q5H8, W5NUU7, W5Q0V2, W5Q4Z3, 
W5PBY0, W5PYG2, W5NS65, W5QE21, W5QCP9, W5NYF4, W5Q961, W5PDP6, W5NQP5, 
A0A0U1YZ59, W5NX96, W5P627, W5QIK8, W5Q5A6, W5NXP6, W5P2V3, W5NXJ3, 
W5QBW5, W5P060, W5Q038, W5QAR2, W5PQH0, W5P323, W5NS93, W5P880, W5P640, 
B6EBS6, W5P988, O77642, W5P9U4, P14639, W5QIM3, W5PIJ5, W5P4C6, W5P2Y4, W5PLF8, 
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W5PDN1, W5Q6A0, W5NUJ7, W5P3R3, P02075, W5NQ46, W5PZI1, W5PIA1, W5QH45, 
A5YBU9, B6UV62, W5P9V5, W5NZ47, P30035, W5QA64, Q7M2U8, P68056, P00922, 
W5QA07, B3GS77, W5PZ55, W5PJ66, W5NU00, W5PDJ6, W5NYA1, W5QA54, B0BL71, 
F2YQ13, W5PSQ7, Q9XT27, W5PTU7, W5PI61, C8BKC5, W5QH46, A2P2H1, W5P9J8, 
W5PN97, W5PLL0, P49920, C5IS96, W5PD87, P0C276, W5PG63, W5PD62, W5P430, W5PZS7, 
D7RIF5, W5PI92, W5PAJ9, W5NYA7, W5P671, W5NU34, W5NTB3, W5P5K9, D6PX64, 
W5PJR0, W5PES2, W5PSM6, W5QDR0, W5Q0Y3, W5PIW6, A3QP67, Q1A2D1, W5QBV7, 
W5NR63, W5Q2A5, W5PVL4, W5Q419, W5PJH9, P50413, W5Q0G0, W5PM28, W5NVT0, 
W5QA34, W5PQS3, W5NUS6, W5PZA0, W5P8T8, Q9XSM0, W5PEW5, W5PWU7, W5Q0U9, 
B5B304, W5NR06, K4P494, W5QE46, W5PLQ1, W5NQ08, W5QCX2, W5PMS1, W5Q2N2, 
W5NSZ2, W5NZ71, W5QEC3, W5NWL0, P68116, W5PZI0, P52210, W5PTS4, W5QDG8, 
W5NQW9, W5Q687, W5NVG2, W5Q9K1, W5Q6L8, W5QC41, W5NTJ3, W5NZH3, W5Q6D3, 
W5PB46, C5ISA2, W5NS74, W5Q517, Q70TH4, W5Q0F3, W5Q3I7, Q5MIB5, W5PEY4, 
D7R7V6, W5PV74, W5NS48, W5Q5L6, W5PZH5, W5QH21, W5PN84, W5NPN4, W5PT38, 
W5NY50, W5PDF4, W5P195, W5PH03, W5PEL7, W5PMH6, W5QET9, W5PF71, W5PLV2, 
W5QDM2, W5PLB7, W5Q224, A0A077JGJ6, W5PVM3, W5PSC8, W5QA42, P22793, W5Q6E8, 
W5PUG1, A9YUY8, W5PTR5, W5NV45, W5PZ59, W5NZQ2, W5NUI0, W5PPT6, W5PJC2, 
P79360, W5PQD8, W5QD30, W5QB36, W5PB07, A9P323, W5PBM4, W5Q1C7, W5PZT3, 
P68253, P11839, K4P231, P29361, W5Q5D7, W5NSF6, W5PMY0, A5YBU8, W5NSB0, 
W5PZ65, W5Q888, W5PWU4, W5P0E1, W5QHL7, W5PUJ4, W5PEM0, W5Q5Z3, Q6TMG6, 
W5NQ21, W5QEL6, W5QDT2, W5P352, W5QIW1, W5QAJ7, W5PG36, W5PEP7, W5NSR5, 
W5QGM7, W5NRL0, P62262, W5PLN8, W5QIL2, W5PTE9, W5PBS4, W5QE19, W5QEV3, 
W5PZF7, W5PB04, W5PJA0, W5QIY3, W5P9W4, W5PTL2, P50415, W5P7G7, W5PS94, 
W5PSZ4, W5QHS2, W5P8W6, W5NZU3, W5NRA9, W5PHI4, W5QDS5, W5PDG5, P68251, 
C8BKD8, W5NX11, W5QAI5, W5PFI7, W5QFS0, W5NS09, W5NXZ1, W5PYQ3, W5P0X0, 
W5PW91, W5Q972, W5PH51, W5PDV8, W5P5S5, W5PTS2, W5NY78, C5IJA0, P21621, 
P42819, W5Q1R5, P29455, Q28579, W5P0H0, W5PJG0, P23383, W5P1X9, P02190, W5NTT7, 
W5PUC1, W5PJ69, W5NXM6, W5QDF3, W5PS88, W5PJR5, W5P5W9, W5PLC9, Q4TVY4, 
W5P481, W5Q7T8, H9CJU6, W5QFQ0, W5PK04, W5NV73, C0LQH2, W5PPG6, 
A0A0H3V7A0, and W5Q723. 
201 
 
APPENDIX 6.7. The UniProtKB entries of 1,103 proteins in the peptide spectral library from 
a combined identification by ProteinPilot, Mascot and PeptideShaker. 
P14639, W5PF65, W5NX51, W5NSA6, W5NXW9, W5QDG7, W5NRI1, W5PTG9, W5NPK5, 
W5P0Q4, Q1A2D1, D6PZY4, W5NQW4, O46544, W5PJ97, W5PZS7, W5Q5H8, W5PBY0, 
W5NQ46, Q9XT27, W5P4S0, W5Q5A6, W5NRG7, W5NUJ7, W5QAB1, W5PHI7, W5NY46, 
W5NWM2, W5Q7J0, P12303, W5Q0X5, W5P3R3, W5PID9, W5NRH2, F2YQ13, C8BKD1, 
W5P627, W5P101, W5NZ47, W5PW21, W5P1J8, W5PHP7, W5NTW3, W5NSH2, W5Q268, 
W5QDP8, Q7M2U8, W5PI61, W5PGT6, W5PH81, W5QFP0, W5PKA9, W5P812, W5PPQ8, 
W5Q7Z7, W5P5I0, W5P3J3, W5QGP4, W5QI29, W5PD71, W5NWX6, W5QH54, W5NXP3, 
W5QH45, W5PXI3, W5Q9A2, W5NXJ3, W5PG63, W5PDS4, W5PE53, W5PDR5, W5PXC8, 
W5QH50, W5PTL2, Q29439, D7RIF5, W5Q4Q3, W5Q9D5, W5P7S6, W5NVG2, W5PN97, 
W5QA07, B5B304, W5Q961, W5PDQ9, W5PDP6, W5PGT9, W5PTU7, W5PAJ9, W5PDJ6, 
W5QA64, W5QBW5, W5PXX3, W5Q0L2, W5P880, W5Q749, W5PVL4, W5PHP8, W5Q3K6, 
W5PJG0, W5Q9K1, W5PZ55, W5Q2E1, C8BKC5, W5NZH3, W5P988, W5PD62, W5Q3I7, 
W5PIA1, W5Q517, W5P4C6, W5P9V5, W5P229, W5PD84, W5PPT6, C5ISA2, A2SW69, 
W5PEI4, W5PAB5, P49920, A5YBU8, W5QGD1, W5PYG2, W5QC41, W5QIK8, W5Q0R1, 
C5IS96, W5PI92, W5P9B0, W5P1X9, W5NYF4, W5PJR0, W5PDN1, W5NUS6, K4P494, 
W5P195, W5PZH5, W5PTS4, W5QGG0, A0A077JGJ6, P02190, W5PSM6, W5QH21, W5PQD8, 
W5PJ66, W5PB04, W5PB46, W5NX96, W5NPN4, A0A0U1YZ59, W5P2V3, W5NU34, 
W5NV45, W5PLB7, W5PEY4, W5P5W9, W5Q4Z3, W5P9J8, W5Q7T8, W5Q5L6, W5PJ69, 
W5NQP5, W5NTT7, C0LQH2, W5Q2U7, W5Q038, W5QET9, W5PUC1, W5Q0V2, W5PVM3, 
W5QA54, W5PBS4, W5NY50, D6PX64, W5Q224, W5PV74, W5PH03, W5NSF6, P62262, 
W5PES2, W5PD87, Q5MIB5, W5NXM6, W5Q0Y3, W5PZT3, W5NZQ2, W5Q723, W5NSZ2, 
W5NS65, A9YUY8, W5QDM2, W5P9W4, W5NUU7, W5NS93, W5PSC8, W5NRA9, W5NTB3, 
W5PLV2, W5QE46, B3GS77, W5PTE9, W5QCP9, W5PEM0, W5QIW1, W5QE21, W5P8T8, 
W5PPG6, W5PZ65, W5PDF4, W5PBM4, W5QBV7, C5IJA0, W5PB07, W5P481, W5NZU3, 
W5PJC2, W5PMH6, W5P323, W5PJA0, W5QD30, W5P9U4, W5QHS2, W5P671, W5PEP7, 
W5PYQ3, W5PF71, W5PS88, W5PIJ5, W5NR63, W5P5K9, W5PG36, W5NYA7, W5P060, 
W5PZ59, W5QE19, W5P0X0, W5P2Y4, Q9XSM0, W5Q5D7, W5QDT2, W5PMY0, W5QIY3, 
W5NX11, W5QGM7, W5QIL2, P50413, W5PIW6, W5Q0U9, W5PM28, W5PLC9, W5PMS1, 
W5P6F4, W5P8R7, W5P336, W5Q7R8, W5PJZ1, W5PZI1, Q1KYZ7, W5PDE5, W5PV54, 
W5PHH3, A2P2H1, W5PLL0, W5QAR2, W5P640, W5QCX2, W5NVT0, W5PUG1, W5PUJ4, 
W5QIM3, P02075, A5YBU9, P30035, P68116, W5NY78, B0BL71, A3QP67, W5Q124, W5NU00, 
W5NR06, P0C276, W5Q2A5, W5PFI7, W5NQ08, W5QA34, W5PZI0, W5NQW9, W5QH46, 
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W5Q0F3, W5NS74, W5PEL7, W5NTJ3, P22793, W5PN84, W5PT38, H9CJU6, W5PLQ1, 
W5QB36, K4P231, W5NQ21, W5QA42, W5Q1R5, P42819, W5QDF3, W5QFQ0, A0A0H3V7A0, 
W5QDR0, P29701, W5PSQ7, W5NXP6, W5PFC9, W5NXM1, W5Q6D3, W5Q6A0, W5NS48, 
P00922, D7R7V6, O77642, Q28579, P11839, W5NUI0, W5P430, W5PJR5, W5PTR5, W5PLF8, 
P68253, W5QEL6, W5QAI5, W5NV73, W5P352, W5NRL0, W5NXZ1, W5P7G7, P23383, 
W5Q0G0, W5QEV3, W5PTS2, W5QAJ7, W5PW91, W5PJH9, W5PS94, W5P0H0, W5PWE9, 
W5PH95, Q28743, I1WXR3, P02083, W5NY95, W5PTR4, W5NVM6, O02762, W5PZF0, 
W5NUW3, W5NVB2, W5NYJ9, W5Q754, W5PCA0, W5NPI9, W5NRR7, Q06AV9, W5P1W2, 
M4WG34, W5QCY7, W5QBD7, W5PFJ0, C7EDS5, W5PGS4, Q29400, W5QAA3, D6BJI0, 
W5P915, P67976, W5QFL0, W5PC09, W5P3A7, D5HKJ4, W5PQH2, W5NSR4, P09670, 
W5PVH9, W5Q9K6, W5P082, W5NYP8, B0LRN3, W5PIC9, W5P5V0, W5PG55, W5QIV5, 
W5PWY0, W5PQK6, W5Q8B1, W5QIG9, W5PIG7, W5P094, A8DR93, W5P044, W5PKC9, 
W5P3Q3, W5NT47, W5P3H8, W5P620, W5PBN5, W5P9V7, W5P0B2, W5NQ91, W5PAM4, 
W5Q9P7, W5NTD9, W5PR13, W5PL69, W5PA64, W5PTU9, W5PHT8, W5QF71, W5Q9L9, 
W5PQ53, W5P1Y8, W5Q0L1, W5PEL1, W5PGZ8, W5NY22, W5PEJ5, W5NZJ3, W5Q670, 
W5PNI5, W5P964, W5PGS0, W5PP57, W5PBX6, W5PVY5, W5NYJ2, W5QGN6, W5Q6L3, 
Q7M355, W5PD49, W5P8Y7, W5PVG2, W5P691, P32262, P20757, P50450, A2P2I0, W5PQH0, 
B6EBS6, B6UV62, P68056, W5NYA1, W5Q419, W5PQS3, W5PZA0, W5PEW5, W5PWU7, 
W5Q2N2, W5NZ71, W5QEC3, W5NWL0, P52210, W5QDG8, W5Q687, W5Q6L8, Q70TH4, 
W5Q6E8, P79360, A9P323, W5Q1C7, P29361, W5NSB0, W5Q888, W5PWU4, W5P0E1, 
W5QHL7, W5Q5Z3, Q6TMG6, W5NSR5, W5PLN8, W5PZF7, P50415, W5PSZ4, W5P8W6, 
W5PHI4, W5QDS5, W5PDG5, P68251, C8BKD8, W5QFS0, W5NS09, W5Q972, W5PH51, 
W5PDV8, W5P5S5, P21621, P29455, Q4TVY4, W5PK04, W5NUX8, W5P5T4, W5QFK2, 
W5Q5C2, W5QH56, W5PXU6, W5P2U2, W5P248, W5QAX3, W5QH06, W5PQL6, W5Q4B1, 
W5QFE4, W5P6U4, W5PWW5, W5Q4P0, W5PPN5, W5QJ00, W5NVN1, W5P2I4, W5QHH3, 
W5QAH2, W5PDC8, W5PIK2, W5QC26, W5PZY7, W5PD12, W5QCP0, W5Q4W5, W5QJ69, 
W5QDH9, W5PKV4, W5NTL7, W5NYG1, W5NQJ8, W5P7L5, W5PVG5, I0CF13, W5PX97, 
W5PXI0, W5PJ85, W5PQM7, W5NSV3, W5PJE4, W5PP29, W5PWT9, W5Q2D7, W5PXN1, 
W5Q1W4, W5Q620, W5PYL5, W5PAE2, W5PME8, W5PJP9, W5PG04, W5PG50, W5PZK2, 
W5PY75, W5PKN2, A0MPT5, A0A0M4KDI9, W5QG19, W5P149, W5P895, W5QAA1, 
W5PS45, W5NTQ9, W5PDY2, W5NUG0, W5NQ85, W5PDQ6, W5NXR3, W5Q2R6, W5NY68, 
W5Q828, W5QDW7, W5P092, W5Q9P0, W5QBT8, W5NX74, W5PHI3, W5P041, W5PA54, 
W5Q8Y3, W5Q5F0, W5NT24, W5PGW2, W5NXI6, W5QIW7, W5QF95, W5PVX0, W5PD15, 
K4P1S5, W5NPK4, W5QFP2, W5PHA9, W5Q910, W5PM86, W5QHD7, B2ZA84, W5PZ27, 
W5Q9B7, W5PW62, W5PD75, W5P143, W5PWU1, W5NUL7, W5Q370, W5Q7C0, W5PWL1, 
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W5PLJ9, W5P0P1, W5PDQ3, W5PH55, W5PDG3, W5P808, W5QC28, W5PT48, W5QBN7, 
W5PPJ4, W5Q950, B3SV56, W5P3G6, W5QGW8, W5NX89, W5QCH5, W5NSI7, U3N1L1, 
W5PA78, W5NRV1, W5PNU9, W5NVC1, W5P1Q0, Q7M371, W5P2L1, W5PHK5, W5Q9H4, 
W5NXV2, W5P9A6, W5P9C3, W5P4X7, W5P7X3, W5QHC2, W5QG16, W5PKW9, W5PXV7, 
W5QH43, W5PPT3, W5P1D3, W5P4R6, D0VWZ0, W5P987, W5PV57, W5PQH3, W5QD80, 
D4P8S5, W5P985, W5Q0N1, W5NZB4, W5NT03, W5Q5W3, W5PX18, A0A0P0QND2, 
W5PZJ0, W5QI75, W5PC99, W5NQM5, W5Q5P5, W5P1N7, W5PLC4, W5PK74, W5Q564, 
W5P1X7, W5PKK4, W5PQ63, W5NW67, W5PDT4, W5Q5R2, W5NSH6, Q5XUI1, W5PZW5, 
W5PFR8, Q1KYZ6, Q28745, W5P1L7, W5Q9H1, W5Q5V4, W5NSC7, W5Q293, A2P2G1, 
W5PXZ3, P68214, W5NYG7, W5QD06, W5Q0D7, W5PME2, W5NQ45, W5Q369, W5Q226, 
A4ZVY6, W5PXE2, W5PBX1, W5P9L8, W5PTB4, W5PKH2, W5PI10, W5PEC1, W5P881, 
W5PHG0, W5NQ51, W5NQ38, W5QF60, W5Q367, W5NTL6, W5P4K7, W5P8L9, W5P8S5, 
W5PPK7, W5P2D1, Q28893, W5PE96, W5NZW9, W5Q0C0, W5PQQ8, W5Q1N4, W5Q3J3, 
W5PGV3, W5Q5I4, W5PLU0, W5PZM1, W5QJ31, W5NQB8, W5Q5V9, W5P596, W5QEF4, 
W5Q7H9, W5PZQ8, W5NPR6, W5PKP8, W5PJ43, W5P4E6, W5Q9T3, W5PSI1, W5PD73, 
R4R2H5, W5PNY6, W5Q417, W5NYR7, W5P0C1, P32237, W5PY00, W5Q4E1, W5P078, 
W5NVG4, W5PY15, W5P4S8, W5PZR6, H2DGR2, W5NVW9, D0VWY9, W5PLN7, W5Q8S4, 
W5PZU0, W5PFY4, W5NRZ7, W5PIN4, W5PAI7, W5NST9, W5PM69, W5PL67, W5Q4U7, 
A2VBC7, I3RWJ0, W5P673, W5PF26, B9VGZ6, W5NVY5, W5P6L3, W5PL06, W5PMF4, 
W5P736, W5PIU1, W5PFD3, W5NSB9, W5QJA2, W5PV93, W5Q9T2, W5Q7I2, W5Q6R7, 
W5QC38, W5PE90, W5NTE3, W5PT09, W5PAG8, W5NUY7, Q1RPQ7, W5Q2K6, W5PT68, 
W5QFP3, W5PXV3, W5NQ22, W5NU40, D3IU20, W5PK67, W5NRP7, W5QCK9, W5PGT0, 
W5PSM2, W5PSP1, W5PWH2, W5PKG7, W5P2R3, W5QE14, W5PC67, W5PXA3, W5PBG2, 
W5NYX4, W5PPZ8, W5PIF0, W5NXZ4, W5PSX0, W5P657, W5P1Y5, W5QA91, W5NRF4, 
W5Q3N2, W5PMZ6, W5PCQ3, W5QDP7, W5PB37, W5P300, W5NRS4, W5NW52, W5QGM9, 
W5PIV4, W5PRK9, W5NX57, W5PGV9, W5Q6W6, W5QGQ0, W5NZR2, W5NXK6, W5P7W5, 
W5PZC0, W5PHE6, W5PN22, W5P0W5, B5DC89, W5PI70, D7RH37, W5P1U6, W5PYK0, 
W5QCG2, W5PFW3, M4T8F1, W5PNG2, W5PCR1, W5PI34, W5P1T7, W5Q043, W5NW86, 
W5PLB4, W5NY84, W5PBY1, W5Q334, W5P377, W5Q5H7, W5PVU5, W5QDT9, W5PWR1, 
Q28884, W5PTS0, W5PLB6, W5QDN3, W5Q6C4, W5PAI3, W5PA65, W5PK97, W5PYT3, 
W5PR03, W5P148, A0A0A7ETA6, W5PHI8, W5PW49, W5P7I2, W5P393, W5Q1J8, W5Q8M7, 
W5Q5C7, W5QI89, W5PG12, W5PX41, W5NYZ0, W5Q6W3, W5PJE0, W5NYX8, A4ZVY8, 
W5Q5L3, A2I7L0, W5PGC9, P07846, W5QAH1, W5NU63, A2P2I3, W5NVS8, W5Q684, 
P17607, W5P656, W5QD47, W5QJ62, W5QAM3, W5QIV1, W5PYI1, W5NQ83, W5QDH3, 
W5PZ95, W5PX84, Q30DP7, W5PIF6, W5NTZ6, W5PGG9, W5Q4B0, W5NRC0, W5PSB1, 
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W5QGQ3, W5Q627, W5P525, W5QCY8, W5PMR1, A2P2G4, A6NBZ0, A0A0F6YFJ0, 
W5QAN8, W5Q6U2, W5PFP1, A0A0F6VY37, W5P338, W5NWU4, B7TJ06, W5Q2K7, 
W5Q505, W5Q2U8, W5PZK7, W5Q6G0, W5PIN8, W5QAW7, W5QFR6, W5PLL2, Q7JFW9, 
W5NRV6, W5NTG5, W5PHA3, Q06435, W5P4W8, M4WGF1, W5PV69, W5NXN8, W5PUU8, 
W5PYX7, W5NX91, W5QFR8, W5P565, W5PQ96, W5PH45, W5PSZ5, W5PCP3, W5NWH4, 
W5PDG4, W5NZW5, W5PTZ9, W5P448, W5P663, W5QJ27, W5Q7C7, W5QJB0, P49929, 
W5QGV5, W5P491, W5QGX2, W5PQA8, W5PIN6, W5P0I5, W5Q2A8, W5PZJ5, W5P311, 
W5NUP9, W5PPN8, W5QBT3, W5P742, W5PG95, W5PER5, W5Q3T5, W5Q6D6, W5PKQ5, 
W5PDD0, W5PJV7, W5P644, W5PA19, Q4LBE5, W5P1N0, W5P326, W5PIC7, W5P7M5, 
W5QG17, W5Q0G8, W5Q809, W5P731, W5NUL9, W5PMA2, W5P0T8, W5NQK0, W5NZ75, 
W5QBR9, W5P5F4, W5QID7, W5PTL7, W5PEB0, W5Q1R4, W5Q097, W5PXH5, W5QIM9, 
W5Q6B0, W5NPH5, W5PCI1, W5Q8J9, W5NW13, A5YBV0, W5P2M3, W5PRG8, W5P7B1, 
W5NUA9, W5PXL4, W5PNM5, W5QGV4, W5NW78, W5NS18, W5PSL9, W5QI70, W5P689, 
W5PYR8, W5QD37, W5Q759, W5NXK9, W5PNP1, W5PMI8, W5PLP6, B2LU28, W5Q8Z1, 
W5PAT6, W5NS44, W5PXB4, W5Q254, W5Q5D8, W5QGN4, W5PE89, W5P908, W5PBH6, 
W5P8V3, W5PGA9, W5PU57, W5QAK3, W5PQT7, W5PVW3, W5P5V2, W5QBV3, W5PVX3, 
W5Q3D0, W5PCG5, W5QDG4, W5PHX1, W5P8G7, W5NWD0, W5P7E0, W5PUU0, W5QF94, 
W5QBE7, W5PKF3, W5QG48, W5NR00, W5NSE9, W5NU20, W5NR56, W5PKZ0, W5NS27, 
W5NQD5, W5QH53, W5P2S9, W5P6T2, W5PAJ2, W5Q540, W5PWG6, W5PGC2, W5PM15, 
W5PBC2, W5NSA5, W5QGB7, W5QBD4, W5PKQ7, W5PVV7, W5PWQ1, W5PDQ0, W5PTZ3, 
W5PCK5, W5P578, W5PBU5, P62297, W5NYM6, W5P3D1 and W5PKF8. 
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Abstract 
Recent observations show that some sheep appear to be more susceptible to the effects of 
Escherichia coli lipopolysaccharide (LPS) endotoxin than others despite being the same age and 
breed. This incidental observation made during a study with a translational benefit to human 
emergency medicine prompted further investigations focused on the background of the base model 
(sheep) and peri-experimental practices. A predetermined dose of 15 µg/kg of LPS from E. coli 
serotype O55:B5 was planned to be infused into a number of sheep to prime their immune system 
prior to blood transfusion studies. Some sheep subsequently received a lesser dose of LPS due to 
unexpected heighted susceptibility to endotoxin. It was hypothesised that genetic, environmental or 
managemental practices could have been contributing factors to this observation. Sheep that were 
more robust to endotoxin were raised in open pasture, whereas the more susceptible ones were 
essentially from a controlled scientific breeding colony. Epigenetic factors need to be considered 
when designing protracted large animal experiments as these aspects can influence the host’s 
response to endotoxin challenge. It is suggested that an understanding of the proteogenomics of 
serum or plasma could help to understand LPS morbidity in sheep and similar pathology in other 
mammals, including humans. 
KEY-WORDS: Selective resistance to endotoxin; Sheep; Escherichia coli; Lipopolysaccharide 
(LPS); disease challenge; Large animal models; serum and plasma proteogenomics. 
Introduction 
Recent reports indicate that some sheep appear to be more susceptible to the effects Escherichia 
coli lipopolysaccharide (LPS) endotoxin challenge than others, regardless of having the same 
characteristics
1,2
. This unexpected observation was made during the continuation of primary studies 
that had different objectives and involved simulation of infection in sheep prior to blood transfusion 
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using LPS
1-3
 in a laboratory environment.  Given this background, it is reasonable to hypothesise 
that genetic, environmental, managemental and peri-experimental practices could have been 
contributing factors to the observation apparent selective susceptibility of sheep to endotoxin.  
Endotoxin is commonly used to mimic infection in experimental animals. Whilst there are 
guidelines for scientists whose work involves the use of animal models in research establishments 
around the world, the basic understanding of the factors associated with predisposition to, and/or 
simulation of infection in animals may be short of emphasis in the overall scheme of peri-
experimental processes, particularly when large animals are involved. Infection is when a 
microorganism invades a susceptible host, starts to multiply and gets established
4
.  It takes time for 
signs of the infection to appear after a pathogen enters the host’s body.  The pathogen has to 
overcome the host’s defences, before it can be considered established. Therefore, the injection of 
endotoxin especially directly into blood vessels may not be an accurate model for infection
1
. Even if 
infected, the host may still resist the development and establishment of an infection the by way of 
active immunity. Immunity may be inherited or due to antibody stimulation via vaccine or previous 
exposure to the disease, leading to freedom from clinical signs of disease after challenge
5
. 
The aim of this paper is to report observations made based on a sheep model that appeared to show 
differential resilience to LPS endotoxin alongside controls during priming of the immune system 
with LPS from E. coli in a protracted primary study with a different trajectory of objectives in 
translational medicine. It also reports findings on studies on the background, source, genetic 
selection information and management practices of the sheep, with the expectation of using 
archived samples for proteogenomic studies in future. Some early observations on the base model 
from the primary study have been published
3
, however, incremental data from the primary study are 
beyond the scope of the present report. An understanding of the apparent selective susceptibility or 
morbidity to LPS in sheep may help to understand or predict similar pathology in other mammals, 
including humans. The knowledge could also provide useful insights that may be applicable to other 
food animal producers by way of predicting disease susceptibility of their livestock. 
 
Materials and methods 
Ethical approval 
Animal ethics approval for the sheep studies used in the manuscript was obtained from the 
University Animal Ethics Committee of the Queensland University of Technology (QUT) – 
reference 0800000555 and ratified by The University of Queensland. The studies were conducted in 
accordance with the Australian Code of Practice for the Care and Use of Animals for Scientific 
Purposes
6
. 
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Study design 
This was an observational experimental study based on incidental findings of a primary study with 
different objectives using sheep that showed selective resistance to the effects of endotoxin. The 
investigative component of the present study was based on the premise that the archived serum and 
plasma samples from experimental sheep of the primary study, could be useful in providing clues to 
the observed differential susceptibility to endotoxin with the help of targeting circulating acute 
phase proteins (APP) and micro ribonucleic acids (miRNAs) using proteogenomic approaches. 
Whilst it is conceivable that improper sample storage may lead to protein degradation, however, as 
of yet, there are no studies that have investigated the effects that deep frozen samples at -80
o
C 
storage and handling could have on the outcome of downstream processes using mass spectrometry 
for example
7
.  
A pseudo-randomisation protocol was used to allocate animals into experimental groups in the 
primary study as previously described
3,8
. The incremental part of the primary study was continued 
under the same protocol.  In brief, for each experiment, sheep were selected at random and then 
assigned to a pre-determined experiment according to a planned schedule and proportional numbers 
of animals in the groups. Each group was allocated sheep throughout the entire period in which the 
study was conducted in order to minimise the effects of any seasonal variation of the different 
batches. The sheep were then subjected to pre-experimental complete veterinary clinical 
examination that included body temperature, pulse, respiratory (TPR) and body weight parameter 
checks as previously described
2
. In brief, the sheep were restrained in a sling cage and the ventral 
aspect of the neck is shaved to facilitate venous vascular access. 
Experimental animals and procedures 
Background of animals 
An animal bio-data request was made to the Biological Research Facility (BRF) housed within the 
Medical Engineering Research Facility of the Queensland University of Technology (QUT-MERF). 
The information request was essential in order to trace the background and source of the 
experimental sheep enrolled for the primary studies, based on ear tag number identification of the 
sheep prior to agistment between January 2009 and May 2013. Detailed documentation including 
strain, breed, genetic line information and management practices (vaccination, drenching, mulesing, 
docking history and other relevant standard operating procedures as appropriate) was tracked and 
processed including further records from the sheep vendors and BRF as appropriate. This 
information was necessary in order to investigate the relative importance of genetics, managemental 
and environmental factors that could help to piece together and explain the variation in LPS 
susceptibility in experimental sheep of the primary study. A field visit to the commercial sheep 
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agistment property that QUT-MERF was the lessee was made in order to capture relevant farm 
information and document on the pasture, housing and management practices. 
Animal selection 
Animal selection and experimental procedures for the primary study have previously been described 
1,3
. In brief, batches of approximately 2-year old healthy adult Merino ewes (Ovis aries) were 
agisted as a flock in an open pasture farm to be used as part of, and a continuation of previously 
described primary studies
3
. The sheep were handled as per standard operating procedures that have 
been described in detail elsewhere
2
 and briefly outlined below.   
Housing and husbandry 
All the sheep were reared at a farm with improved pastures, natural shade from trees with free 
access to water before being transferred to a purpose-built animal experimental laboratory of the 
Queensland University of Technology
2
.  
Pre-anaesthetic care 
Within two weeks of experiments, animals were housed at a purpose built animal facility and 
managed as previously described
2,3
 . Briefly, the sheep were fed proprietary sheep pellets, lucern 
and had free access to water. Shelter was provided in built concrete-floored sheds in which the 
sheep had free access. Shade was also provided by large trees in the paddocks and the sheep 
interacted freely with each other. Animals were fasted overnight (for approximately 24 h) with free 
access to drinking water until two hours before the procedure.  
Anaesthesia, monitoring and assessment of LPS priming 
The sheep were anaesthetised and maintained under ICU conditions. The management of 
anaesthesia, mechanical ventilation, supplemental oxygen, hydration and infusion have been 
described
2,3,8
. Briefly, a central venous line was placed in the external jugular vein (EJV) of the 
awake sheep. This catheter was used for intravenous (IV) administration of the pre-medication, 
induction agents, drugs, fluids and total intravenous anaesthesia (TIVA). The sheep were pre-
medicated with midazolam (0.5 mg/kg) and buprenorphine (0.01mg/kg) by slow IV injection. An 
8Fr sheath was placed in the opposite EJV for subsequent placement of a pulmonary artery catheter. 
General anaesthesia was induced with alfaxalone (3 mg/kg) IV. In early experiments
3,9
, anaesthesia 
was induced maintained by intravenous ketamine/midazolam anaesthesia supplemented with 
butorphanol if indicated. In later experiments
8
, anaesthesia was maintained with ketamine, 
midazolam, fentanyl and alfaxalone combination. Animals were placed in right lateral recumbency 
and monitored as reported earlier
2,3,8
. For the purposes of this report, only the first 2 h and 15 min 
after completion of instrumentation of the sheep are relevant. 
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An hour of stabilisation was allowed after which baseline monitoring parameters were noted, and 
then 40 min thereafter, LPS priming events and monitoring followed as illustrated in Figure A7.1.  
 
Figure A7.1. Schematic of Escherichia coli lipopolysaccharide (LPS) endotoxin-treated sheep 
showing LPS assessment time points. The sheep were anaesthetised, instrumented and monitored 
under intensive care unit (ICU) to conditions. After an hour and 40 mins, a saline solution 
containing 15µg/kg of LPS was infused at 0.5 µg/kg/min (a) over a period of 30 min (b), or as it 
turned out unexpectedly in the case of sheep that were more susceptible to LPS, the infusion was 
stopped in the LPS titration zone between (a) and (b) due to early onset of signs of LPS 
endotoxaemia. After completion of the LPS infusion, the sheep were monitored to a predetermined 
time-point (c). The sheep then proceeded to the primary study beyond the scope of this study. 
To study the effects of LPS, 76 sheep were allocated to receive 30 ml infusion containing LPS as 
previously described
3,8,9
. In brief, a 15 µg/kg dose of the endotoxin LPS from Escherichia coli 
serotype O55:B5 (Sigma-Aldrich, Castle Hill, NSW, Australia) was chosen and infused at 0.5 
µg/kg/min to prime the sheep’s immune system before proceeding with the requirements of the 
primary study. The monitoring of the systemic effects of LPS (endotoxaemia) was based on a 
predetermined assessment criterion of priming guided by global haemodynamics, alveolar–arterial 
gradient (A–a gradient) of oxygen and the ratio of partial pressure arterial oxygen and fraction of 
inspired oxygen (PaO2/FiO2 ratio) as described previously
3,8
. Briefly, relative to baseline readings, 
endotoxaemia was confirmed by >50% increase in mean pulmonary artery pressure (MAP) and at 
least one of the following: >10% decrease in mean arterial pressure, >10% increase in heart rate 
(HR), >10% decrease in cardiac index (CI) >10% decrease in oxygenation saturation from mixed 
venous blood (SvO2) and increase of A-a gradient or decrease in PaO2/FiO2 ratio
3
. If signs of severe 
endotoxaemia developed such as MAP < 50% of baseline and or a gradient of <10 mmHg between 
MAP and MPAP being a sign of impending haemodynamic collapse, before the completion of the 
calculated LPS dose, the infusion, was stopped and the animal was monitored. The assessment of 
endotoxaemia and monitoring data during the early cohort of sheep has been published with the 
base model
3
. If the animal decompensated further, euthanasia was indicated for as previously 
210 
 
reported
2
.   After monitoring the effects of LPS the sheep proceeded for the requirements of the 
primary study outside the scope of this report. The sheep were subsequently euthanized thereafter 
and managed as previously described
2
. 
Statistical methods  
One hundred and five sheep were categorised into two main groups based on outcomes of 
susceptibility to LPS i.e. the more LPS susceptible n=41 (titrated LPS dose group), and the less 
susceptible n= 64 (fixed LPS dose group). Animals that received placebo as the priming event, 
those that were used for optimisation of experimental processes and those that experienced adverse 
effects or those that were used as untreated controls were excluded from analysis. Body weight data 
of the two groups of sheep were checked for normality using D'Agostino & Pearson omnibus 
normality test. The mean, median, standard deviations of the weights of sheep were determined and 
tabulated. The titrated LPS dose group were further categorised into two sub-groups based on 
desirable production traits from the findings of the breeding backgrounds of the sheep. LPS dose 
differences between the titrated LPS, and fixed LPS groups of sheep were compared. LPS doses of 
the two sub-groups of the titrated LPS group of sheep were compared against each other, and 
against the sheep of the unknown trait (less susceptible group) using unpaired two-tailed t-test and 
one-way analysis of variance (ANOVA). All p-values were two-sided and less than 0.05 was 
considered statistically significant. All statistical calculations were performed using GraphPad 
PRISM 6 software (GraphPad Software, La Jolla, CA).  
Results 
Animal backgrounds, selection and study design  
A total of 105 Merino ewes were enrolled in an ongoing primary study between January 2009 and 
May 2012 (Table A7.1). The animals were procured in 6 batches during this period from two 
different vendors corresponding to the dates of the experiments of 27 Jan to 18 Jun 2009; 06 Oct to 
10 Dec 2009; 02 Feb to 30 Mar 2010; 16 Aug 2011 to 06 Mar 2012; 23 Jul 2012 to 28 Nov 2012; 
and 07 Mar 2012 to 21 May 2013. The last two batches comprising 41 sheep were sourced from the 
Commonwealth Scientific and Industrial Research Organisation (CSIRO) FD McMaster Laboratory 
(Armidale, NSW, Australia). The CSIRO sheep (CSIROS) were agisted jointly as a flock in an open 
pasture commercial farm at Mt Cotton on the outskirts of South-East Brisbane with 64 fine-wool 
resident Merino ewes that had earlier been sourced from a sale yard vendor (Sale yard sourced 
sheep [SYSS]) at a commercial livestock market (The Australian Livestock Markets Association 
Inc., Warwick, QLD, Australia). All the sheep were to be used as part of, and a continuation of 
previously described primary studies
3,9
. It was found that the CSIROS group had two production 
traits namely an endoparasite resistant line (Parasite RL), and a wool production line (Wool PL). 
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The Parasite RL sheep were identified by ear tag numbers below 200 (A0***) and the Wool PL 
sheep tag numbers were the ones over 3 thousand (A3***) (Table 1). After the randomisation 
processes for the primary study, of the 105 enrolled sheep, 76 were allocated to be treated (primed) 
with LPS. The LPS primed animals constituted the study subjects for this report (Figure A7.2). 
Agisted together were also several other sheep of mixed ages, gender (wethers) and breeds such as 
Border Leicester cross breeds belonging to other projects of the animal facility. 
 
Figure A7.2. The total number of Merino (105) ewes that were enrolled to study the priming 
effects of Escherichia coli lipopolysaccharide (LPS) between 27/01/2009 and 21/05/2013. 
Further background studies showed that the ewes were purchased from two vendors: 
Commonwealth Scientific and Industrial Research Organisation (CSIRO) FD McMaster Laboratory 
(Armidale, NSW, Australia)(CSIROS), and The Australian Livestock Markets Association Inc., 
(Warwick, QLD, Australia) (SYSS). For this study, only 76 ewes that received LPS priming were 
included. After 3 ewes were excluded (1 had no weight recorded, 1 had no LPS dose recorded and 1 
suffered an adverse event) of CSIROS, were ewes that had been selected for two production traits 
comprising of the internal parasite resistant line (Parasite RL [n=27]), and the wool production line 
(Wool PL [11]).    The sheep that received saline placebo (n=18), those that were used for 
optimisation of experimental procedures (n=4), those that had adverse events (n=1), those with 
missing data (n=2) and untreated sheep used as controls (n=4) were excluded from data analysis for 
this report. 
Housing and husbandry 
Husbandry practices prior to agistment 
There were certain standard husbandry operations that took place every year for CSIROS. All 
animals were grazed in paddocks on natural grass with improved pastures and not housed indoors. 
They were supplemented with grain in drought conditions when and if necessary. The animals were 
vaccinated against caseous lymphadenitis (CLA) and clostridial diseases according to standard 
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practices and vaccine manufacturer’s instructions. Mobs of sheep had monthly faecal monitoring 
for gastrointestinal worm eggs. Samples were taken at random from a few sheep in the mob. Then 
the whole mob was drenched with proprietary anthelmintics if it was necessary. The sheep were all 
shorn once a year, as weaners in September and as adults in July. The animals were crutched in 
February to March. The animals were monitored for external parasites and treated if indicated. All 
treatments were mob based and not individual animal based. Husbandry operations for the SYSS 
were not available. 
Husbandry practices during agistment 
The commercial farm where the sheep were agisted had a dog-proof perimeter wire fencing, 
improved pastures, natural shade from trees and the animals had free access to fresh drinking water 
(Figure A7.3). At the time of agistment of the last two batches of sheep (CSIROS), pasture feed was 
supplemented with processed proprietary sheep pellets (RIVERINA HOBBY FARM PELLETS, 
West End, QLD, Australia) when required once every couple of days. The farm had a purpose built 
shed with raised grated wooden floors to allow free drainage of urine and droppings (Figure A7.4). 
Sheep handling infrastructure including, mustering pens, crush, weighing sling, sheering gear and a 
loading rump were available (Figure A7.5).  
 
Figure A7.3. Part of a paddock of a 
commercial farm that sheep were agisted 
between 27/01/2009 and 21/05/2013 on behalf 
of Queensland University of Technology 
Medical Engineering Facility (QUT-MERF) 
for experimental studies. 
Note the improved pasture in the foreground and the dog-proof fencing to the right of the 
photograph to protect the sheep from predatory dog attacks. 
 
 
Figure A7.4. A purpose built mustering pen 
at a commercial farm that was used by 
Queensland University of Technology 
Medical Engineering Facility (QUT-MERF) 
for agistment of experimental sheep. Note the 
raised wooden grate flooring to allow free 
drainage of urine and droppings. 
213 
 
 
Figure A7.5. An ewe suspended on 
a sling while being weighed at 
purpose built shed at a commercial 
farm that was used by Queensland 
University of Technology Medical 
Engineering Facility (QUT-MERF) 
for agistment of experimental 
sheep. Other sheep handling 
infrastructure at the property (not 
pictured) included a crush, sheering 
gear and a loading rump. 
The husbandry operations at the farm included routine drenching with triple combination drench as 
per veterinary and manufacturer’s advice for the control and treatment of internal parasites and for 
selenium and cobalt supplementation for sheep. The triple drench (TRIGUARD®, Merial, NSW, 
Australia) contained (Abamectin 1.0 g/L, Oxfendazole 22.7 g/L, Levamisole hydrochloride 33.9 
g/L, Sodium selenate (selenium) 0.5 g/L and Cobalt disodium EDTA 2.2 g/L. Ectoparasites were 
controlled with Amitraz 125g/L (TAKTIC® EC, Virbac Animal Health, Milpera, NSW, Australia) 
diluted at 2ml / L of water and sprayed onto the sheep according to manufacturer’s 
recommendations. The sheep were also regularly treated with ivermectin (IVOMEC Injection®, 
Merial, NSW, Australia), for added protection against sucking lice and gastrointestinal worms.  The 
sheep had regular veterinary checks, hoof care and were shorn at the end of winter. At the time of 
the field visit to the farm, one sheep was found to have a paralysis tick (ixodes holocyclus) on the 
neck. After removal of the tick, the sheep was treated conservatively and recovered fully within 3 
days. 
When the sheep were transferred to holding pens at animal facility (usually two weeks prior to 
experiments), they were fed high quality lucern chaff. The last two batches of sheep (CSIROS) 
were fed pellets at 100-300g/head/day in addition to chaff. This heightened level of nutrition was 
not associated with any recorded health issues. 
Anaesthesia and experimental outcomes of LPS priming 
In the experiments involving the first four batches of sheep, the animals were premedicated with 
butorphanol (0.5 mg/kg iv) and midazolam (0.5 mg/kg iv). General anaesthesia was induced with 
ketamine (5 mg/kg iv) and maintained by ketamine (8 mg/kg/hr iv)/midazolam (0.7 mg/kg/hr iv). 
Anaesthesia was supplemented with boluses of butorphanol titrated to effect as required. In the last 
two batches of sheep, the animals were premedicated with buprenorphine (0.01mg/kg iv) and 
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midazolam (0.5 mg/kg iv).  Anaesthesia was induced with alfaxalone (3 mg/kg iv) and maintained 
with ketamine (up to 5 mg/kg/hr iv)/, midazolam (up to 0.5 mg/kg/hr iv), fentanyl (5 µg/kg/hr) and 
alfaxalone (4-6 mg/kg/hr) combination. From the induction of anaesthesia to the baseline time point 
of the primary study (Figure A7.1), all the seep received Hartmann's Solution at 15 mL/kg/hr iv, 
and then dropped to 1 mL/kg/hr iv thereafter. Of the 76 sheep that were challenged with LPS, 
animals that exhibited higher susceptibility to, and those that exhibited less susceptibility to the 
effects of LPS resulted in being equally split into two groups. There was a significant difference (p 
= 0.02) in their normally distributed weights between the groups (Figure A7.6). Table A7.2 shows 
the descriptive statistics of the two groups of sheep based on susceptibility to LPS.  
Table A7.2. Weight groups of sheep that exhibited selective susceptibility to E.coli LPS. 
Weight Parameter 
LPS dose group of sheep by weight (kg) 
Fixed LPS dose Titrated LPS dose 
Number of sheep in group 38 38 
Minimum 25.7 30.3 
Maximum 50 53.5 
Median   36 39.5 
Mean 36.3 39.5 
Standard Deviation 6.1 5.6 
Standard Error of Mean 0.98 0.93 
D'Agostino & Pearson omnibus normality test 
Passed normality test (α=0.05)? Yes Yes 
P value summary Ns Ns 
Legend: There was a significant difference (p = 0.0211, two tailed t test) between the 
weights of sheep that got a fixed LPS dose and those that got a titrated LPS dose. 
There was a significant difference (p<0.001) in mean LPS dose required for priming the immune 
system between the two groups of sheep (Table A7.3). Table A7.4 shows the two groups of sheep 
based on animal production traits. The more susceptible sheep required considerably small doses of 
LPS  based on defined criteria of haemodynamic instability for priming the immune system 
compared to the less LPS susceptible (more resistant) sheep that received a fixed dose of LPS 
(Figure A7.7). The Parasite RL sheep showed marginally higher resistance to LPS challenge 
compared to the Wool PL sheep, and SYSS showed even considerably higher and unmatched 
resistance to LPS (Figure A7.8). 
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Table A7.3. Sheep that exhibited selective susceptibility to E. coli LPS.  
Group based  
on LPS Susceptibility 
No. of 
Sheep 
Weight 
(Mean± SD)(kg) Total LPS dose (µg/kg) 
Fixed LPS dose 38 36.31 ± 6.07 15 
Titrated LPS dose 38 39.51 ± 5.75 3.4±3.6 
Legend: Sheep that received a fixed dose LPS to prime their immune system were less 
susceptible to effects of endotoxin than those that required LPS to be titrated. SD=Standard 
deviation. 
Regarding archived samples for future use were samples of serum, plasma and formalin fixed 
/mounted tissue samples for the SYSS. In addition, CSIROS archived tissue samples preserved for 
deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) analysis which SYSS did not have.  
Table A7.4. Merino ewes from the same mob with two production traits (endoparasite 
resistance and wool production) treated with a titrated dose of E. coli LPS.    
 
Parameter 
Sheep selection trait 
Endoparasite resistance Wool production 
Number of sheep (n) 27 11 
Weight (kg) ± SD (Range) 38 ± 5.6 (23.2 - 30.3) 43 ± 4.5 (35.5 - 49.8) 
LPS dose (µg/kg) ± SD (Range) 4.2 ± 4.0 (1.12 - 15) 1.3 ± 0.2 (1.02 – 1.69) 
Legend: Sheep selected for endoparasite resistance and were more tolerant to the effects of 
endotoxin than those selected for wool production. SD=Standard deviation. 
 
 
Figure A7.6. Merino ewes from the same mob that showed selective resistance to Escherichia 
coli lipopolysaccharide (LPS) endotoxin challenge. The sheep that were less resistant to the 
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effects of LPS (< resistant) were sourced from the Commonwealth Scientific and Industrial 
Research Organisation (CSIRO) FD McMaster Laboratory (Armidale, NSW, Australia)(CSIROS). 
The sheep that were more resistant to the effects of LPS (> resistant) were sourced from The 
Australian Livestock Markets Association Inc., (Warwick, QLD, Australia) (SYSS). There was a 
significant difference (p<0.001) between CSIROS and SYSS on the amount to LPS required to 
cause endotoxaemia. 
Discussion 
There is growing need and recognition for using large animals for purposes of research and 
teaching
2
. This study was a retrospective, observational assessment of experimental animals and 
presents associations suggested to be involved with lipopolysaccharide susceptibility/resistance in 
experimental sheep from previously published transfusion model research on acute pulmonary 
injury. The first thing that comes into the minds of readers about this paper is that although it deals 
with an interesting topic, there are concerns because of lack of any genetic or physiological 
(haematological, immunological or biochemical) data that would fully support the observations that 
some sheep appear to be more susceptible to the effects of E. coli LPS endotoxin than others despite 
being the same age and breed. The observations made in this report were made with those 
background concerns in mind, but would then raise the question of how the base model of the 
primary study
3
 was validated without the need for a complete biochemical panel or genetic analysis 
of the ovine model. Obviously, having the necessary data to support all observations is good 
science; however it is not always possible due to inherent challenges facing retrospective studies 
and logistical constraints. This then calls for the question that what lessons can be learnt from the 
validated base model referred to in this study?  
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Figure A7.7. Merino ewes from the same mob 
showing selective resistance to Escherichia 
coli lipopolysaccharide (LPS) endotoxin.   
There was a significant difference (p<0.001) in 
mean 
 
Figure A7.8. Outcomes of Merino ewes with 
different selection traits challenged with 
Escherichia coli lipopolysaccharide (LPS) 
endotoxin. The sheep that were sourced from 
the Commonwealth Scientific and Industrial 
Research Organisation FD McMaster 
Laboratory (Armidale, NSW, Australia) 
(CSIROS) were found to be of two selection 
traits:   Endoparasite resistant line (Parasite RL) 
and Wool production line (Wool PL).  
The Parasite RL (a) appeared to have an edge (p<0.02) of resistance to LPS challenge over the 
Wool PL (b): Sheep selected for wool production.  The sheep of an unknown trait (SYSS) that were 
sourced from The Australian Livestock Markets Association Inc., (Warwick, QLD, Australia) 
showed considerable resistance to LPS challenge (c) compared to a CSIROS (a, b). There were 
significant differences in LPS dose (Mean ± SD) between a and c (p<0.0001), and b and c 
(p<0.0001). 
This report provides a snapshot of the effects of E. coli LPS endotoxin injected into batches of 
sheep that were procured over a study period of nearly 3½ years. From the observations of the 
apparent selective susceptibility of the sheep to E. coli LPS, it would seem that the primary study 
required “approximately 2 year-old healthy female sheep” to be supplied by the host animal facility 
over a protracted period of time for the purposes of continuing studies based on an earlier model
3
.  
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The primary study had taken steps to minimise the effects of seasonal variation by allocating the 
sheep to the various arms of the experiment through randomisation. As it turned out, the possibility 
of having sheep from different backgrounds and having sheep of different traits may not have been 
considered and factored into the methods. It is now evident multiple confounding factors may have 
contributed to the observed variability of the effects of endotoxin in sheep from the same mob.  
The husbandry practices of CSIROS were well documented. The vendor had records for this cohort 
of sheep and standard operating procedures were in place. This group of sheep were essentially 
from a controlled breeding colony, which explains why information on the two desirable animal 
production traits of endoparasite resistance (Parasite RL) and wool production line (Wool PL) were 
traceable. From the observations so far, it appears that the Parasite RL were more resistant to the 
effects of LPS than the Wool PL. On the other hand, it can however be argued that perhaps the 
variability could have been due to un-optimised LPS dose, considering that the CSIROS response to 
LPS was much different, compared to that of SYSS, and that the experimental team was still 
readjusting to the drastic response of CSIROS to endotoxin.  
Regarding feeding, Australia is known to have a history of many climate related challenges that 
affects many agricultural industries as the latter are climate reliant
10
. Grazing sheep on natural grass 
with improved pastures certainly makes a great deal of economic sense and it is associated with 
optimal productivity
10-12
. Grain supplementation during drought conditions is a well-recognised 
practise in sheep husbandry despite the associated shortcomings such as such as lactic acidosis 
(grain poisoning) and enterotoxaemia
13-17
. During supplementation, feed is provided to animals in 
order to improve their performance and, in some cases to allow the pasture to improve
18
.  
As with animal health, caseous lymphadenitis (CLA) is a disease of immense economic importance 
in sheep production worldwide. In Australia, sheep are routinely vaccinated against CLA
19-23
. It is 
also a recommended practice to vaccinate sheep against clostridial diseases such as botulism, black 
leg, black disease, tetanus and enterotoxaemia
24-27
. Without pre-purchase records of SYSS, it is not 
possible to comment on any husbandry practices related to that cohort of sheep, except for known 
sheep growing practises in Australia. It is reasonable however to assume that since this group of 
sheep was grown on open pasture and having been at a sale yard, it is quite possible that  they had 
some form of active immunity that could, at least in part, explain the relative resistance to LPS as 
compared to CSIROS.    
In sheep husbandry, in addition to disease, a major cause of stock losses is attributable to predation 
by feral or wild canines if there are no control measures in place
28-31
. The commonest native wild 
predators for sheep in Australia are dingoes. The property at which the sheep were agisted in this 
report, had dog-proof fencing – which may have worked to keep away grown up dingoes as well. 
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Perhaps as an added measure to protect sheep in similar establishments, donkeys could be kept 
alongside the sheep as recent reports have suggested that donkeys can be very effective deterrents to 
wild dogs and dingoes when reared together with sheep
32-34
. The addition of donkeys in a colony of 
research sheep would probably attract additional layers of concerns of their welfare, safety around 
people and their “non-native or feral” status as donkeys are considered introduced pests in 
Australia.  
The control of ectoparasites was based on established principles of management targeting specific 
parasites, to prevent animal welfare issues and ill health
35-37
. The targeted external parasites were 
flies, ticks, lice and mites. Even with prevention strategies in place, paralysis ticks in Queensland 
could still pose a risk to animals as in that one asymptomatic sheep that had a paralysis tick.  
During the pre-anaesthetic period, interestingly, the heightened level of nutrition at the animal 
holding facility leading up to the experiments for CSIROS was not associated with any metabolic 
disturbances that are usually seen when sheep are suddenly introduced to a high carbohydrate 
source. This may suggest that this cohort of sheep were probably accustomed to a high plane of 
feeding prior to agistment. As the sheep were fasted for 24h with free access to water until 
approximately 2 hours prior to anaesthetic induction
2
, it is quite possible that CSIROS were not 
accustomed to their food being withheld for that long. Except for pre-anaesthetic veterinary 
physical examination, pre-anaesthetic or pre-interventional laboratory investigations were not 
included in the primary study.  Baseline samples for the primary study were collected after 
induction of anaesthesia and after invasive instrumentation (Figure A7.1). Without a pre-anaesthetic 
laboratory panel, it is not possible to objectively determine the metabolic status or reference point of 
the experimental animal prior to any interventions for downstream studies that routinely require 
pre-interventional parameters. It can be argued that CSIROS were probably in a physiological state 
of negative energy balance prior to the experiments – a predisposition that may have contributed to 
the sheep to be comparatively susceptible to the effects of LPS.  
The preparation of sheep for anaesthesia and physiological monitoring to enable the assessment of 
LPS priming and experimental outcomes were well optimised. However, there were concerns about 
the alterations in the protocol for premedication and general anaesthesia in the course of the 
experiments. These alterations may have influenced the outcome of LPS assessment. For example, 
the individual roles of ketamine and alfaxalone as anaesthetics on the effects of LPS in sheep are 
unknown.  Ketamine has long been known to increase the vascular tone in sheep
38
; it is therefore 
plausible to assert that the type of anaesthetic may have contributed to the observed selective 
susceptibility to LPS in sheep as the LPS endotoxaemia assessment was heavily reliant on the 
assessment of haemodynamic parameters.    
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There were some shortcomings worth noting in the study. Based on the findings of this report, 
caution ought to be exercised before arriving at the conclusion that there was selective resistance to 
LPS endotoxin in sheep with similar characteristics. This is because certain procedures were not 
standardised. Albeit the sheep were of the same breed, they had different backgrounds, 
environmental conditions, vendors and production traits. There was also variability in the 
anaesthetic protocol as expounded in the preceding section. Other than the variability noted in the 
experimental subjects, there were no published studies on basic serum/plasma biochemistry on the 
validation studies of the model for which the primary study
3
 was based on. The confounding factors 
of time, age, transportation, stress, and interventions prior to sampling may not have been fully 
accounted for. The study was gender biased - no males were recruited.  Perhaps the most crucial set 
back is that there was no pre-anaesthetic laboratory work factored into the primary study. In 
veterinary practice, sampling for baseline parameters prior to any intervention is widely considered 
as a standard operating procedure. Samples for RNA and DNA analysis for future studies were not 
uniformly collected across the board. The archived samples may therefore not be suitable for 
planned comprehensive comparative proteogenomic studies of SYSS and CSIROS because no pre-
interventional samples that could act individual subjects’ controls were collected. Only archived 
serum and plasma samples could be of use in future comparative studies for all the sheep. 
Haemodynamic (MPAP, MAP, SvO2, CCO), respiratory ([A-a] gradient, PaO2/FiO2 ratio, arterial 
blood gas analysis), haematology, serum/plasma biochemistry and urinalysis findings are not 
available for reasons beyond the purpose of this report.  
Finally, as a future perspective, in order to fully determine if selective susceptibility to E. coli 
endotoxin in sheep is apparent, all the sources of variation identified and discussed in this report 
need to be taken into consideration and minimised. This research could benefit from more concrete 
mechanistic support for genetic, epigenetic, immune, and/or other factor involvement. It is 
important to strongly consider exploring potential innate immune factors to support the assertion of 
selective susceptibility to endotoxin. Baseline samples and parameters should be taken before any 
form of intervention is done to represent the “normal” state or of the experimental animal. The 
analysis of baseline samples will therefore act as a benchmark for comparison with outcomes of 
interventions downstream. The present discussion is heavily focused on experimental animal use in 
research as these factors are proposed as being crucial in the development of optimum large animal 
experimental methods for better study outcomes. Detailed attention to mechanisms of variable 
immune recognition of LPS should also be taken into consideration by way of further studies. With 
this in mind, studies are planned to develop a method that will first establish the normal circulating 
acellular proteome, followed by validation of the method using samples from LPS primed sheep, 
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potentially identifying  acute phase acute phase proteins (APP) as recently published
1
.  
Conclusions 
In conclusion, cautiously taking all observations into perspective, some merino sheep appear to be 
more susceptible to the effects of E. coli LPS endotoxin than others despite being the same age and 
breed. It should be noted that the observations that have been advanced in the current study are 
potentially interesting physiological and/or pathophysiological findings that warrant subsequent 
exploration of genetic, epigenetic, innate immune system involvement. Genetic and physiological 
data are needed in order to fully back these observations – calling for further studies and the 
inclusion of such data to the methods of protracted large animal models with potential translational 
applications. Sheep brought up under hardy conditions may be more resistant to the effects of 
endotoxin than those grown under more optimal conditions. It appears that sheep that have the 
endoparasite resistance trait may also be resistant to E. coli LPS compared to sheep with the wool 
production trait.   There are a variety of known mitigating environmental and unknown epigenetic 
factors that need to be taken into consideration when designing protracted large animal experiments 
as they can influence the host’s outcomes in regards to exposure to endotoxin. These observations 
could be relevant in understanding the relative importance of phenotype and managemental 
differences, and could set a foundation for further proteogenomic studies on plasma and serum to 
elucidate the apparent variation in LPS susceptibility in sheep. Individual genetic characteristics 
may also contribute in defining and predicting response to an infection challenge in sheep. The 
clues in understanding of the mechanism of the selection to LPS morbidity in sheep could be due to 
changes in plasma/serum proteins, whose elucidation may help to understand similar pathology in 
other mammals, including humans. 
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Table A7.1. Ewes used by Queensland University of Technology for a project from January 
2009 - May 2013. 
Date Experiment Sheep 
Weight 
(kg) Treatment 
LPS dose 
(µg/kg) 
27-Jan-09 1 582 40 LPS @ 8 ug/kg/min 240 
10-Feb-09 2 571 54 LPS @ 1 ug/kg/min 30 
03-Mar-09 3 619 33 LPS @ 0.5 ug/kg/min 15 
17-Mar-09 4 625 40 LPS @ 0.5 ug/kg/min 15 
18-Mar-09 5 613 34 LPS @ 0.5 ug/kg/min 15 
19-Mar-09 6 617 40 LPS @ 0.5 ug/kg/min 15 
24-Mar-09 7 618 43 LPS @ 0.5 ug/kg/min 15 
25-Mar-08 8 624 34 N/A 
 26-Mar-09 9 605 48 N/A 
 07-Apr-09 10 612 37 LPS @ 0.5 ug/kg/min 15 
08-Apr-09 11 608 30 LPS @ 0.5 ug/kg/min 15 
09-Apr-09 12 622 45 saline (30mL) 0 
14-Apr-09 13 602 37 LPS @ 0.5 ug/kg/min 15 
16-Apr-09 14 620 46 LPS @ 0.5 ug/kg/min 15 
21-Apr-09 15 621 42 saline (30mL) 0 
23-Apr-09 16 611 39 saline (30mL) 0 
28-Apr-09 17 665 41 saline (30mL) 0 
30-Apr-09 18 677 44 saline (30mL) 0 
05-May-09 19 673 46 saline (30mL) 0 
07-May-09 20 706 40 saline (30mL) 0 
12-May-09 21 702 47 N/A 
 14-May-09 22 703 33 saline (30mL) 0 
02-Jun-09 23 698 37 LPS @ 0.5 ug/kg/min 15 
03-Jun-09 24 697 36 LPS @ 0.5 ug/kg/min 15 
04-Jun-09 25 699 ‡ N/A 
 09-Jun-09 26 701 45 LPS @ 0.5 ug/kg/min 15 
11-Jun-09 27 745 36 LPS @ 0.5 ug/kg/min 15 
16-Jun-09 28 719 39 LPS @ 0.5 ug/kg/min 15 
18-Jun-09 29 710 43 LPS @ 0.5 ug/kg/min 15 
06-Oct-09 30 729 38 LPS @ 0.5 ug/kg/min 15 
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Date Experiment Sheep 
Weight 
(kg) Treatment 
LPS dose 
(µg/kg) 
27-Oct-09 31 704 40 N/A 
 29-Oct-09 32 720 40 saline (30mL) 0 
10-Nov-09 33 711 37 LPS @ 0.5 ug/kg/min 15 
12-Nov-09 34 742 46 saline (30mL) 0 
19-Nov-09 35 667 39.2 saline (30mL) 0 
24-Nov-09 36 708 33 LPS @ 0.5 ug/kg/min 15 
26-Nov-09 37 713 40 N/A 
 01-Dec-09 38 670 43 LPS @ 0.5 ug/kg/min 15 
03-Dec-09 39 671 45 LPS @ 0.5 ug/kg/min 15 
08-Dec-09 40 714 37.5 LPS @ 0.5 ug/kg/min 15 
10-Dec-09 41 764 54 saline (30mL) 0 
2-Feb-10 42 773 37 saline (30mL) 0 
4-Feb-10 43 792 38.4 saline (30mL) 0 
9-Feb-10 44 789 46 saline (30mL) 0 
11-Feb-10 45 781 39 saline (30mL) 0 
16-Feb-10 46 786 35.5 LPS @ 0.5 ug/kg/min 15 
23-Feb-10 47 780 33 saline (30mL) 0 
25-Feb-10 48 A252 36 LPS @ 0.5 ug/kg/min 15 
2-Mar-10 49 794 31 LPS @ 0.5 ug/kg/min 15 
4-Mar-10 50 778 38 LPS @ 0.5 ug/kg/min 15 
9-Mar-10 51 805 50 LPS @ 0.5 ug/kg/min 15 
11-Mar-10 52 820 36 LPS @ 0.5 ug/kg/min 15 
16-Mar-10 53 815 48 LPS @ 0.5 ug/kg/min 15 
18-Mar-10 54 814 34 LPS @ 0.5 ug/kg/min 15 
23-Mar-10 55 816 41 saline (30mL) 0 
30-Mar-10 56 828 26 LPS @ 0.5 ug/kg/min 15 
16-Aug-11 57 1100 30.5 LPS @ 0.5 ug/kg/min 15 
18-Aug-11 58 1101 30.1 LPS @ 0.5 ug/kg/min 15 
23-Aug-11 59 1098 29.2 LPS @ 0.5 ug/kg/min 15 
30-Aug-11 60 1067 33.7 LPS @ 0.5 ug/kg/min 15 
27-Feb-12 61 1190 29.2 LPS @ 0.5 ug/kg/min 15 
27-Feb-12 62 1186 27.9 LPS @ 0.5 ug/kg/min 15 
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Date Experiment Sheep 
Weight 
(kg) Treatment 
LPS dose 
(µg/kg) 
6-Mar-12 63 1195 25.7 LPS @ 0.5 ug/kg/min 15 
6-Mar-12 64 1192 29.6 LPS @ 0.5 ug/kg/min 15 
23-Jul-12 ‡ 09A0066 29.3 N/A Terminated 
14-Aug-12 65 09A0079 32 LPS titration 15 
14-Aug-12 66 09A0016 30.3 LPS titration 15 
16-Aug-12 67 09A0126 31.8 LPS titration 7.67 
16-Aug-12 68 09A0092 31 LPS titration 3.75 
7-Sep-12 69 09A0113 34.9 LPS titration 1.5 
7-Sep-12 70 09A0100 33.7 LPS titration 3.75 
13-Sep-12 71 09A0035 36.4 LPS titration 7.67 
13-Sep-12 72 09A0021 38.7 LPS titration 7.67 
20-Sep-12 73 09A0074 34.1 LPS titration 7.67 
20-Sep-12 74 09A0037 36.4 LPS titration 7.67 
17-Oct-12 75 09A0140 33.6 LPS titration 5.95 
17-Oct-12 76 09A0102 33.5 LPS titration 5.37 
24-Oct-12 77 09A0039 38.2 LPS titration 3.92 
24-Oct-12 78 09A0072 40.5 LPS titration 2.22 
31-Oct-12 79 09A0064 40.5 LPS titration 1.98 
31-Oct-12 80 09A0076 38.8 LPS titration 1.8 
1-Nov-12 81 09A0071 43.7 LPS titration 1.37 
1-Nov-12 82 09A0073 43 LPS titration 1.4 
8-Nov-12 83 09A0096 39.8 LPS titration 1.5 
-Nov-12 84 09A0078 36.2 LPS titration 1.38 
9-Nov-12 85 09A0093 35 LPS titration 1.43 
9-Nov-12 86 09A0071 33.2 LPS titration 1.2 
27-Nov-12 87 09A0114 41.2 LPS titration 1.7 
27-Nov-12 88 09A0116 45 LPS titration 1.33 
28-Nov-12 89 09A3023 39.5 LPS titration 1.27 
28-Nov-12 90 09A3032 40 LPS titration 1.25 
7-Mar-13 91 09A3061 39.5 LPS titration 1.43 
7-Mar-13 92 1187 ‡ LPS titration 1.43 
17-Apr-13 93 09A3192 39.8 LPS titration 1.5 
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Date Experiment Sheep 
Weight 
(kg) Treatment 
LPS dose 
(µg/kg) 
17-Apr-13 94 09A3084 43.1 LPS titration 1.62 
18-Apr-13 95 09A3157 35.5 LPS titration 1.69 
18-Apr-13 96 09A3153 32 LPS titration ‡ 
9-May-13 97 09A3190 45.1 LPS titration 1.55 
9-May-13 98 09A0127 45.6 LPS titration 1.32 
10-May-13 99 09A0117 47.1 LPS titration 1.27 
10-May-13 100 09A3063 46.9 LPS titration 1.17 
20-May-13 101 09A3159 45.5 LPS titration 1.1 
20-May-13 102 09A3204 49.8 LPS titration 1.1 
21-May-13 103 09A3021 48.9 LPS titration 1.02 
21-May-13 104 09A0079 53.5 LPS titration 1.12 
Legend: Experiment details (date of experiment, experiment number, sheep identification 
and treatment) of ewes (n = 105) that were agisted as a mob at a commercial farm for 
Queensland University of Technology Medical Engineering Facility (QUT-MERF). The 
sheep were purchased from 2 separate vendors: The Australian Livestock Markets 
Association Inc., (Warwick, QLD, Australia) – for experiments 1-64, and 92; and the 
Commonwealth Scientific and Industrial Research Organisation (CSIRO) FD McMaster 
Laboratory (Armidale, NSW, Australia) – for the terminated experiment, experiments 65-
91 and 93-104.  Key: LPS = Lipopolysaccharide from Escherichia coli; N/A = No 
treatment given: control experiments; ‡ = missing data.  Experiments 1 & 2 were used for 
LPS optimisation experiments. All experiments in bold were excluded from the analysis of 
the results of the present report. 
 
 
  
230 
 
APPENDIX 7.1. Steps for generating a retention time (RT) calibration curve 
 
Highlight and select calibration peptides, followed by the steps 1 and 2 and apply it – 3. The RT 
calibration curve can be accessed by clicking 4 in the main home screen. 
APPENDIX 7.2. Entering SWATH-MS processing settings 
 
How SWATH-MS processing settings (red arrow) for the PSL in PeakView
®
 Software user 
interface were entered. Sample .wiff files 1 were loaded, followed by steps 2, 3, 4 and 5 above.  
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APPENDIX 7.3 List of proteins that were quantitated by SWATH-MS analysis in plasma of endotoxaemic sheep 
Table A7.5. The UniProtKB accession numbers, gene names, NCBI names, protein status, UniProtKB names and fold change values of 243 sheep 
plasma proteins that altered during E. coli lipopolysaccharide-induced endotoxaemia. Fold change represents how the quantity of protein changed from 
before and after 75 minutes of acute endotoxaemia based on their protein peak area comparisons that were processed in MarkerView™ Software 
(SCIEX).     
UniProtKB 
Accession 
Gene Name NCBI Name Protein 
Status 
UniProtKB Name Fold 
Change 
W5PD76_SHEEP TRMT11 tRNA methyltransferase 11 homolog Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=TRMT11 PE=4 SV=1 
16.2 
W5PUH0_SHEEP FAM105A Family with sequence similarity 105 
member A 
Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=FAM105A PE=4 
SV=1 
15.9 
W5QJ60_SHEEP LOC101116576 Sentrin-specific protease 8-like Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=LOC101116576 
PE=4 SV=1 
6.2 
W5QGD1_SHEEP LDHB L-lactate dehydrogenase Predicted L-lactate dehydrogenase OS=Ovis aries 
GN=LDHB PE=3 SV=1 
6.0 
W5PJD1_SHEEP KMT2A Lysine methyltransferase 2A Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=KMT2A PE=4 SV=1 
5.1 
W5Q2A5_SHEEP FAM13B Family with sequence similarity 13 
member B  
Predicted Uncharacterised protein OS=Ovis aries 
GN=FAM13B PE=4 SV=1 
4.4 
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UniProtKB 
Accession 
Gene Name NCBI Name Protein 
Status 
UniProtKB Name Fold 
Change 
W5QDU3_SHEEP TRDV2 T cell receptor delta variable 2  Predicted Uncharacterised protein OS=Ovis aries 
GN=TRDV2 PE=4 SV=1 
3.1 
W5PHP2_SHEEP EEF1A1 Elongation factor 1-alpha 1-like Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries PE=4 SV=1 
2.8 
W5Q754_SHEEP TTN Titin Predicted Uncharacterised protein OS=Ovis aries 
GN=TTN PE=4 SV=1 
2.7 
W5PV69_SHEEP HIST2H2AB Histone cluster 2 H2A family member 
b 
Predicted Histone H2A OS=Ovis aries 
GN=HIST2H2AB PE=3 SV=1 
2.6 
W5P084_SHEEP CERS4 Ceramide synthase 4 Predicted Uncharacterised protein OS=Ovis aries 
GN=CERS4 PE=4 SV=1 
2.6 
W5PZ55_SHEEP PPBP Platelet basic protein Predicted C-X-C motif chemokine OS=Ovis aries 
GN=PPBP PE=3 SV=1 
2.5 
W5PZT2_SHEEP ANGPTL6 Angiopoietin like 6 Predicted Uncharacterised protein OS=Ovis aries 
GN=ANGPTL6 PE=4 SV=1 
2.5 
W5Q0L2_SHEEP SERPINA5 Serpin family A member 5 Predicted Uncharacterised protein OS=Ovis aries 
GN=SERPINA5 PE=3 SV=1 
2.5 
W5PZT3_SHEEP LECT2 Leukocyte cell derived chemotaxin 2 Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=LECT2 PE=4 SV=1 
2.4 
W5PA83_SHEEP PRR14 proline rich 14 Predicted Uncharacterised protein OS=Ovis aries 
GN=PRR14 PE=4 SV=1 
2.3 
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UniProtKB 
Accession 
Gene Name NCBI Name Protein 
Status 
UniProtKB Name Fold 
Change 
W5P323_SHEEP GPI glucose-6-phosphate isomerase  Predicted Glucose-6-phosphate isomerase OS=Ovis 
aries GN=GPI PE=3 SV=1 
2.3 
W5NYP1_SHEEP WC11 Antigen WC1.1 Predicted Uncharacterised protein OS=Ovis aries 
PE=4 SV=1 
2.2 
G3LUQ4_SHEEP CSN1S1 Casein alpha s1 Predicted Alpha s1 casein OS=Ovis aries 
GN=CSN1S1 PE=4 SV=1 
2.2 
A2P2G7_SHEEP VH VH region Predicted VH region (Fragment) OS=Ovis aries 
GN=VH PE=2 SV=1 
2.2 
W5P082_SHEEP IGF2 Insulin like growth factor 2 Predicted Insulin-like growth factor II OS=Ovis 
aries GN=IGF2 PE=3 SV=1 
2.2 
W5PKA9_SHEEP F5 F5 coagulation factor V Predicted Uncharacterised protein OS=Ovis aries 
GN=F5 PE=3 SV=1 
2.2 
W5P8V3_SHEEP LGI2 Leucine rich repeat LGI family 
member 2 
Predicted Uncharacterised protein OS=Ovis aries 
GN=LGI2 PE=4 SV=1 
2.2 
W5NVP3_SHEEP CHAT choline O-acetyltransferase Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=CHAT PE=3 SV=1 
2.2 
W5NXM6_SHEEP PTX3 Pentraxin 3  Predicted Uncharacterised protein OS=Ovis aries 
GN=PTX3 PE=4 SV=1 
2.1 
W5Q7C7_SHEEP PSMA2 proteasome subunit alpha 2 Predicted Proteasome subunit alpha type OS=Ovis 
aries GN=PSMA2 PE=3 SV=1 
2.1 
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UniProtKB 
Accession 
Gene Name NCBI Name Protein 
Status 
UniProtKB Name Fold 
Change 
W5PEL2_SHEEP OGN Osteoglycin Predicted Uncharacterised protein OS=Ovis aries 
GN=OGN PE=4 SV=1 
2.1 
W5PIG6_SHEEP ENO1 Enolase 1 Predicted Uncharacterised protein OS=Ovis aries 
GN=ENO1 PE=3 SV=1 
2.0 
K4P494_SHEEP CST3 Cystatin C Predicted Cystatin OS=Ovis aries GN=CST3 PE=2 
SV=1 
1.9 
W5P915_SHEEP LOC101107619 Short palate, lung and nasal 
epithelium carcinoma-associated 
protein 2B-like 
Predicted Uncharacterised protein OS=Ovis aries 
GN=LOC101107619 PE=4 SV=1 
1.9 
W5Q0X5_SHEEP LOC101115576 Serpin A3-5 Predicted Uncharacterised protein OS=Ovis aries 
GN=LOC101115576 PE=3 SV=1 
1.9 
W5PGE9_SHEEP IGHA immunoglobulin alpha heavy chain Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries PE=4 SV=1 
1.9 
W5P293_SHEEP CPEB4 cytoplasmic polyadenylation element 
binding protein 4 
Predicted Uncharacterised protein OS=Ovis aries 
GN=CPEB4 PE=4 SV=1 
1.9 
W5Q0R1_SHEEP SHBG Sex hormone binding globulin Predicted Uncharacterised protein OS=Ovis aries 
GN=SHBG PE=4 SV=1 
1.9 
W5NS74_SHEEP ACAA1 Acetyl-CoA acyltransferase 1 Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=ACAA1 PE=3 SV=1 
1.9 
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UniProtKB 
Accession 
Gene Name NCBI Name Protein 
Status 
UniProtKB Name Fold 
Change 
W5Q2E1_SHEEP LUM Lumican Predicted Uncharacterised protein OS=Ovis aries 
GN=LUM PE=4 SV=1 
1.9 
W5NVM6_SHEEP LOC101119889 Ig heavy chain V region PJ14-like Predicted Uncharacterised protein OS=Ovis aries 
GN=LOC101119889 PE=4 SV=1 
1.8 
W5PEI4_SHEEP KLKB1 Kallikrein B1 Predicted Uncharacterised protein OS=Ovis aries 
GN=KLKB1 PE=3 SV=1 
1.8 
B5B304_SHEEP CFH Complement factor H Predicted Complement factor H (Fragment) 
OS=Ovis aries GN=CFH PE=2 SV=1 
1.8 
W5PAJ9_SHEEP APOM Apolipoprotein M Predicted Uncharacterised protein OS=Ovis aries 
GN=APOM PE=4 SV=1 
1.8 
W5Q124_SHEEP LOC101119509 Serpin A3-8 Predicted Uncharacterised protein OS=Ovis aries 
GN=LOC101119509 PE=3 SV=1 
1.7 
W5P481_SHEEP COL1A1 Collagen type I alpha 1 chain  Predicted Uncharacterised protein OS=Ovis aries 
GN=COL1A1 PE=4 SV=1 
1.7 
W5PDG3_SHEEP GAPDH Glyceraldehyde-3-phosphate 
dehydrogenase 
Predicted Glyceraldehyde-3-phosphate 
dehydrogenase OS=Ovis aries 
GN=GAPDH PE=3 SV=1 
1.7 
W5QBB1_SHEEP C8G Complement component C8 gamma 
chain, partial 
Predicted Uncharacterised protein OS=Ovis aries 
PE=4 SV=1 
1.7 
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UniProtKB 
Accession 
Gene Name NCBI Name Protein 
Status 
UniProtKB Name Fold 
Change 
W5P880_SHEEP PRG4 Proteoglycan 4 Predicted Uncharacterised protein OS=Ovis aries 
GN=PRG4 PE=4 SV=1 
1.7 
W5PHI7_SHEEP LOC101116892 Serpin A3-1-like Predicted Uncharacterised protein OS=Ovis aries 
GN=LOC101116892 PE=3 SV=1 
1.7 
W5Q868_SHEEP RFX4 Regulatory factor X4 Predicted Uncharacterised protein OS=Ovis aries 
GN=RFX4 PE=4 SV=1 
1.6 
W5NSA6_SHEEP A2M Alpha-2-macroglobulin Predicted Uncharacterised protein OS=Ovis aries 
GN=A2M PE=4 SV=1 
1.6 
W5P4C6_SHEEP F12 Coagulation factor XII Predicted Uncharacterised protein OS=Ovis aries 
GN=F12 PE=3 SV=1 
1.6 
W5QH54_SHEEP FETUB Fetuin B Predicted Uncharacterised protein OS=Ovis aries 
GN=FETUB PE=4 SV=1 
1.6 
W5PJZ1_SHEEP SERPING1 Serpin family G member 1 Predicted Uncharacterised protein OS=Ovis aries 
GN=SERPING1 PE=3 SV=1 
1.6 
W5NXW9_SHEEP IGHM Transcription factor binding to IGHM 
enhancer 3 
Predicted Uncharacterised protein OS=Ovis aries 
GN=IGHM PE=4 SV=1 
1.6 
W5PF69_SHEEP C2CD4C C2 calcium dependent domain 
containing 4C 
Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=C2CD4C PE=4 SV=1 
1.6 
F2YQ13_SHEEP GSN Gelsolin Predicted Gelsolin isoform b OS=Ovis aries 
GN=GSN PE=2 SV=1 
1.6 
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UniProtKB 
Accession 
Gene Name NCBI Name Protein 
Status 
UniProtKB Name Fold 
Change 
W5PZF0_SHEEP PF4 Platelet factor 4 Predicted C-X-C motif chemokine OS=Ovis aries 
GN=PF4 PE=3 SV=1 
1.6 
W5NQW4_SHEEP LOC101104482 alpha-1-macroglobulin-like Predicted Uncharacterised protein OS=Ovis aries 
GN=LOC101104482 PE=4 SV=1 
1.6 
W5Q5A6_SHEEP FGG Fibrinogen gamma chain Predicted Uncharacterised protein OS=Ovis aries 
GN=FGG PE=4 SV=1 
1.5 
W5P8R7_SHEEP FCGBP Fc fragment of IgG binding protein Predicted Uncharacterised protein OS=Ovis aries 
GN=FCGBP PE=4 SV=1 
1.5 
O46544_SHEEP C3 Complement C3 Predicted Complement component C3 (Fragment) 
OS=Ovis aries GN=C3 PE=2 SV=1 
1.5 
W5PJ97_SHEEP APOA2 Apolipoprotein A2 Predicted Uncharacterised protein OS=Ovis aries 
GN=APOA2 PE=4 SV=1 
1.5 
W5PQK6_SHEEP TLN1 Talin 1 Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=TLN1 PE=4 SV=1 
1.5 
W5PXI3_SHEEP AFM Afamin Predicted Uncharacterised protein OS=Ovis aries 
GN=AFM PE=4 SV=1 
1.5 
W5PBY0_SHEEP C4BPA Complement component 4 binding 
protein alpha 
Predicted Uncharacterised protein OS=Ovis aries 
GN=C4BPA PE=4 SV=1 
1.5 
W5PVL4_SHEEP MBL2 Mannose-binding lectin (protein C) 2, 
soluble 
Predicted Uncharacterised protein OS=Ovis aries 
GN=MBL2 PE=4 SV=1 
1.5 
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UniProtKB 
Accession 
Gene Name NCBI Name Protein 
Status 
UniProtKB Name Fold 
Change 
W5NSF6_SHEEP RARRES2 Retinoic acid receptor responder 2 Predicted Uncharacterised protein OS=Ovis aries 
GN=RARRES2 PE=4 SV=1 
1.5 
W5PNS6_SHEEP TDRD7 Tudor domain containing 7 Predicted Uncharacterised protein OS=Ovis aries 
GN=TDRD7 PE=4 SV=1 
1.5 
W5P663_SHEEP ENO3 Enolase 3 Predicted Uncharacterised protein OS=Ovis aries 
GN=ENO3 PE=3 SV=1 
1.5 
W5PID9_SHEEP C9 Complement C9 Predicted Uncharacterised protein OS=Ovis aries 
GN=C9 PE=4 SV=1 
1.5 
Q06AV9_SHEEP CD14 CD14 molecule Predicted Monocyte differentiation antigen CD14 
OS=Ovis aries GN=CD14 PE=2 SV=1 
1.4 
W5QHZ5_SHEEP LOC106990772 Ig kappa chain - sheep Predicted Uncharacterised protein OS=Ovis aries 
PE=4 SV=1 
1.4 
W5NWX6_SHEEP APOC3 Apolipoprotein C3 Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=APOC3 PE=4 SV=1 
1.4 
W5NX51_SHEEP APOA1 Apolipoprotein A-1 Predicted Uncharacterised protein OS=Ovis aries 
GN=APOA1 PE=3 SV=1 
1.4 
W5P7S6_SHEEP ORM1 Orosomucoid 1 Predicted Alpha-1-acid glycoprotein OS=Ovis aries 
GN=ORM1 PE=3 SV=1 
1.4 
W5PJR0_SHEEP LOC101120613 Serum amyloid A-4 protein Predicted Serum amyloid A protein OS=Ovis aries 
GN=LOC101120613 PE=3 SV=1 
1.4 
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UniProtKB 
Accession 
Gene Name NCBI Name Protein 
Status 
UniProtKB Name Fold 
Change 
W5NV14_SHEEP IGL immunoglobulin V lambda chain Predicted Uncharacterised protein OS=Ovis aries 
PE=4 SV=1 
1.4 
W5Q4Q3_SHEEP SERPIND1 serpin family D member 1 Predicted Uncharacterised protein OS=Ovis aries 
GN=SERPIND1 PE=3 SV=1 
1.4 
W5PQI4_SHEEP EDEM2 ER degradation enhancing alpha-
mannosidase like protein 2 
Predicted alpha-1,2-Mannosidase OS=Ovis aries 
GN=EDEM2 PE=3 SV=1 
1.4 
W5PCA0_SHEEP ALDOB Aldolase, fructose-bisphosphate B Predicted Fructose-bisphosphate aldolase OS=Ovis 
aries GN=ALDOB PE=3 SV=1 
1.3 
W5PCG1_SHEEP TTC39C Tetratricopeptide repeat domain 39C Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=TTC39C PE=4 SV=1 
1.3 
W5NY46_SHEEP PON1 Paraoxonase 1 Predicted Uncharacterised protein OS=Ovis aries 
GN=PON1 PE=4 SV=1 
1.3 
W5NQ46_SHEEP FGB Fibrinogen beta chain Predicted Fibrinogen beta chain OS=Ovis aries 
GN=FGB PE=4 SV=1 
1.3 
W5PYG2_SHEEP VNN1 Vanin 1 Predicted Uncharacterised protein OS=Ovis aries 
GN=VNN1 PE=4 SV=1 
1.3 
W5QA64_SHEEP LOC101119895 Protein HP-20 homolog Predicted Uncharacterised protein OS=Ovis aries 
GN=LOC101119895 PE=4 SV=1 
1.3 
W5PD62_SHEEP CPB2 Carboxypeptidase B2 Predicted Uncharacterised protein OS=Ovis aries 
GN=CPB2 PE=4 SV=1 
1.3 
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Gene Name NCBI Name Protein 
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UniProtKB Name Fold 
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W5P5I0_SHEEP CFI Complement factor I Predicted Uncharacterised protein OS=Ovis aries 
GN=CFI PE=3 SV=1 
1.3 
W5P6F4_SHEEP C5 Complement C5 Predicted Uncharacterised protein OS=Ovis aries 
GN=C5 PE=4 SV=1 
1.3 
W5PDR5_SHEEP C8A Complement C8 alpha chain Predicted Uncharacterised protein OS=Ovis aries 
GN=C8A PE=4 SV=1 
1.3 
W5QCP9_SHEEP COL6A3 Collagen type VI alpha 3 chain Predicted Uncharacterised protein OS=Ovis aries 
GN=COL6A3 PE=4 SV=1 
1.3 
W5NTT7_SHEEP COL1A2 Collagen type I alpha 2 chain Predicted Uncharacterised protein OS=Ovis aries 
GN=COL1A2 PE=4 SV=1 
1.3 
W5PD71_SHEEP CRP Pentaxin Predicted Pentaxin OS=Ovis aries GN=CRP PE=3 
SV=1 
1.3 
W5PTR4_SHEEP SERPINC1 Serpin family C member 1 Predicted Antithrombin-III OS=Ovis aries 
GN=SERPINC1 PE=3 SV=1 
1.3 
A6NBZ0_SHEEP C3 Complement component C3d  Predicted Complement component 3d (Fragment) 
OS=Ovis aries PE=2 SV=1 
1.3 
W5P101_SHEEP A1BG Alpha-1-B glycoprotein Predicted Uncharacterised protein OS=Ovis aries 
GN=A1BG PE=4 SV=1 
1.3 
W5PDG4_SHEEP HMCN2 Hemicentin 2 Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=HMCN2 PE=4 SV=1 
1.2 
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W5PFP1_SHEEP LTF Lactotransferrin Predicted Uncharacterised protein OS=Ovis aries 
GN=LTF PE=3 SV=1 
1.2 
A2P2H6_SHEEP VH Ig mu heavy chain V region precursor Predicted VH region (Fragment) OS=Ovis aries 
GN=VH PE=2 SV=1 
1.2 
W5PDE5_SHEEP LOC101120001 Zona pellucida sperm-binding protein 
3 receptor-like 
Predicted Uncharacterised protein OS=Ovis aries 
GN=LOC101120001 PE=4 SV=1 
1.2 
W5PLQ1_SHEEP LOC101111190 Hepatitis A virus cellular receptor 1-
like 
Predicted Uncharacterised protein OS=Ovis aries 
GN=LOC101111190 PE=4 SV=1 
1.2 
W5NYF4_SHEEP PGLYRP2 Peptidoglycan recognition protein 2 Predicted Uncharacterised protein OS=Ovis aries 
GN=PGLYRP2 PE=4 SV=1 
1.2 
W5PFC9_SHEEP LOC101117129 inhibitor of carbonic anhydrase-like  Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=LOC101117129 
PE=4 SV=1 
1.2 
W5Q9D5_SHEEP VTN Vitronectin Predicted Uncharacterised protein OS=Ovis aries 
GN=VTN PE=4 SV=1 
1.2 
W5QH45_SHEEP KNG1 Kininogen 1 Predicted Uncharacterised protein OS=Ovis aries 
GN=KNG1 PE=4 SV=1 
1.2 
W5PDJ6_SHEEP GPX3 Glutathione peroxidase 3 Predicted Glutathione peroxidase (Fragment) 
OS=Ovis aries GN=GPX3 PE=3 SV=1 
1.2 
242 
 
UniProtKB 
Accession 
Gene Name NCBI Name Protein 
Status 
UniProtKB Name Fold 
Change 
W5QH50_SHEEP HRG Histidine rich glycoprotein Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=HRG PE=4 SV=1 
1.2 
W5QAB1_SHEEP HPX Hemopexin Predicted Uncharacterised protein OS=Ovis aries 
GN=HPX PE=4 SV=1 
1.2 
APOE_SHEEP APOE Apolipoprotein E Exists Apolipoprotein E OS=Ovis aries 
GN=APOE PE=2 SV=1 
1.2 
D6PZY4_SHEEP fH Fumarate hydratase Predicted Factor H (Fragment) OS=Ovis aries 
GN=fH PE=2 SV=1 
1.2 
TTHY_SHEEP TTR Transthyretin Exists Transthyretin OS=Ovis aries GN=TTR 
PE=2 SV=1 
1.2 
W5Q6C4_SHEEP GCLM Glutamate-cysteine ligase modifier 
subunit  
Predicted Uncharacterised protein OS=Ovis aries 
GN=GCLM PE=4 SV=1 
1.2 
W5NY95_SHEEP C2 Complement C2 Predicted Uncharacterised protein OS=Ovis aries 
GN=C2 PE=3 SV=1 
1.2 
W5PF71_SHEEP KPNB1 Karyopherin subunit beta 1 Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=KPNB1 PE=4 SV=1 
1.2 
W5PG63_SHEEP VWF von Willebrand factor Predicted Uncharacterised protein OS=Ovis aries 
GN=VWF PE=4 SV=1 
1.2 
243 
 
UniProtKB 
Accession 
Gene Name NCBI Name Protein 
Status 
UniProtKB Name Fold 
Change 
W5QJ65_SHEEP GALNT16 Polypeptide N-
acetylgalactosaminyltransferase 16 
Predicted Polypeptide N-
acetylgalactosaminyltransferase 
(Fragment) OS=Ovis aries 
GN=GALNT16 PE=3 SV=1 
1.2 
W5PXX3_SHEEP F13B Coagulation factor XIII B chain Predicted Uncharacterised protein OS=Ovis aries 
GN=F13B PE=4 SV=1 
1.2 
W5NRR7_SHEEP SERPINA7 Serpin family A member 7 Predicted Thyroxine-binding globulin OS=Ovis 
aries GN=SERPINA7 PE=3 SV=1 
1.2 
W5PGZ8_SHEEP APOF Apolipoprotein F Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=APOF PE=4 SV=1 
1.2 
W5PVM3_SHEEP MYOC Myocilin Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=MYOC PE=4 SV=1 
1.2 
W5P3B1_SHEEP PNLDC1 PARN like, ribonuclease domain 
containing 1 
Predicted Uncharacterised protein OS=Ovis aries 
GN=PNLDC1 PE=4 SV=1 
1.2 
W5PF65_SHEEP TF Serotransferrin Predicted Uncharacterised protein OS=Ovis aries 
GN=TF PE=3 SV=1 
1.2 
W5QBW5_SHEEP LBP Lipopolysaccharide binding protein Predicted Uncharacterised protein OS=Ovis aries 
GN=LBP PE=4 SV=1 
1.2 
W5NUX8_SHEEP C4 Complement C4 precursor Predicted Uncharacterised protein OS=Ovis aries 
PE=4 SV=1 
1.2 
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W5PSQ7_SHEEP IGL Immunoglobulin lambda light chain Predicted Uncharacterised protein OS=Ovis aries 
PE=4 SV=1 
1.2 
W5QA54_SHEEP LOC101119629 Protein HP-25 homolog 2 Predicted Uncharacterised protein OS=Ovis aries 
GN=LOC101119629 PE=4 SV=1 
1.2 
I1WXR3_SHEEP SERPINA1 Serpin family A member 1 Predicted Alpha-1-antitrypsin transcript variant 1 
OS=Ovis aries GN=SERPINA1 PE=2 
SV=1 
1.1 
W5PLC2_SHEEP CSN2 casein beta Predicted Beta-casein OS=Ovis aries GN=CSN2 
PE=3 SV=1 
1.1 
W5PZG5_SHEEP OCRL OCRL, inositol polyphosphate-5-
phosphatase 
Predicted Uncharacterised protein OS=Ovis aries 
GN=OCRL PE=4 SV=1 
1.1 
W5NTW3_SHEEP ITIH1 Inter-alpha-trypsin inhibitor heavy 
chain 1 
Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=ITIH1 PE=4 SV=1 
1.1 
W5PHU4_SHEEP UBAP1 Ubiquitin associated protein 1 Predicted Uncharacterised protein OS=Ovis aries 
GN=UBAP1 PE=4 SV=1 
1.1 
W5P812_SHEEP AMBP Alpha-1-microglobulin/bikunin 
precursor 
Predicted Uncharacterised protein OS=Ovis aries 
GN=AMBP PE=4 SV=1 
1.1 
W5PH45_SHEEP NUP205 Nucleoporin 205 Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=NUP205 PE=4 SV=1 
1.1 
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ALBU_SHEEP ALB Albumin Exists Serum albumin OS=Ovis aries GN=ALB 
PE=1 SV=1 
1.1 
W5PGT9_SHEEP IGHE Immunoglobulin epsilon-chain Predicted Uncharacterised protein OS=Ovis aries 
GN=IGHE PE=4 SV=1 
1.1 
X4ZFS1_SHEEP AdipoQ Adiponectin, C1Q and collagen 
domain containing 
Predicted Adiponectin OS=Ovis aries GN=AdipoQ 
PE=2 SV=1 
1.1 
W5PW21_SHEEP ITIH2 Inter-alpha-trypsin inhibitor heavy 
chain 2 
Predicted Uncharacterised protein OS=Ovis aries 
GN=ITIH2 PE=4 SV=1 
1.1 
W5QC38_SHEEP LOC101119975 Tubulin alpha-1A chain Predicted Uncharacterised protein OS=Ovis aries 
GN=LOC101119975 PE=1 SV=1 
1.1 
Q29439_SHEEP C4 Complement 4 Predicted Complement component C4 (Fragment) 
OS=Ovis aries GN=C4 PE=4 SV=1 
1.1 
W5P3J3_SHEEP C1S Complement C1s Predicted Uncharacterised protein OS=Ovis aries 
GN=C1S PE=3 SV=1 
1.1 
W5Q9A2_SHEEP AZGP1 Alpha-2-glycoprotein 1, zinc-binding Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=AZGP1 PE=3 SV=1 
1.1 
W5PDN3_SHEEP SPTBN2 Spectrin beta chain, non-erythrocytic 
2 
Predicted Uncharacterised protein OS=Ovis aries 
GN=SPTBN2 PE=4 SV=1 
1.1 
W5PHP8_SHEEP LRG1 Leucine rich alpha-2-glycoprotein 1 Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=LRG1 PE=4 SV=1 
1.1 
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W5PUE9_SHEEP ZSCAN2 Zinc finger and SCAN domain 
containing 2 
Predicted Uncharacterised protein OS=Ovis aries 
GN=ZSCAN2 PE=4 SV=1 
1.1 
W5NZ47_SHEEP RBP4 Retinol binding protein 4 Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=RBP4 PE=4 SV=1 
1.1 
W5Q002_SHEEP PLAG1 PLAG1 zinc finger Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=PLAG1 PE=4 SV=1 
1.1 
W5Q5D7_SHEEP CCDC18 Coiled-coil domain containing 18 Predicted Uncharacterised protein OS=Ovis aries 
GN=CCDC18 PE=4 SV=1 
1.1 
C8BKD1_SHEEP F2 Coagulation factor II, thrombin Predicted Prothrombin OS=Ovis aries GN=F2 PE=2 
SV=1 
1.1 
W5QI29_SHEEP ECM1 Extracellular matrix protein 1 Predicted Uncharacterised protein OS=Ovis aries 
GN=ECM1 PE=4 SV=1 
1.1 
W5QHZ8_SHEEP IGK Immunoglobulin kappa-4 light chain 
variable region 
Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries PE=4 SV=1 
1.1 
ANXA2_SHEEP ANXA2 Annexin A2 Exists Annexin A2 OS=Ovis aries GN=ANXA2 
PE=1 SV=1 
1.1 
CERU_SHEEP CP Ceruloplasmin Exists Ceruloplasmin OS=Ovis aries GN=CP 
PE=2 SV=1 
1.1 
W5PN97_SHEEP CLEC3B C-type lectin domain family 3 
member B 
Predicted Uncharacterised protein OS=Ovis aries 
GN=CLEC3B PE=4 SV=1 
1.1 
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W5PSH4_SHEEP LOC105614527 immunoglobulin lambda-6b light 
chain variable region [Ovis aries] 
Predicted Uncharacterised protein OS=Ovis aries 
PE=4 SV=1 
1.1 
W5PDQ9_SHEEP C1QC complement C1q C chain Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=C1QC PE=4 SV=1 
1.1 
W5PTS4_SHEEP RNASE4 ribonuclease A family member 4 Predicted Uncharacterised protein OS=Ovis aries 
GN=RNASE4 PE=3 SV=1 
1.1 
W5PIC9_SHEEP BST1 bone marrow stromal cell antigen 1 Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=BST1 PE=4 SV=1 
1.1 
W5NYJ9_SHEEP AGT Angiotensinogen (Fragment)  Predicted Angiotensinogen (Fragment) OS=Ovis 
aries GN=AGT PE=3 SV=1 
1.1 
W5P791_SHEEP ASXL3 Additional sex combs like 3, 
transcriptional regulator 
Predicted Uncharacterised protein OS=Ovis aries 
GN=ASXL3 PE=4 SV=1 
1.1 
W5P1J8_SHEEP AOC3 Primary amine oxidase, lung isozyme Predicted Amine oxidase OS=Ovis aries 
GN=LOC101113086 PE=3 SV=1 
1.1 
W5P0Q4_SHEEP LOC101102413 Haptoglobin Predicted Uncharacterised protein OS=Ovis aries 
GN=LOC101102413 PE=3 SV=1 
1.1 
W5Q961_SHEEP LOC101107947 Apolipoprotein F-like Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=LOC101107947 
PE=4 SV=1 
1.0 
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W5PXI0_SHEEP SHANK1 SH3 and multiple ankyrin repeat 
domains 1 
Predicted Uncharacterised protein OS=Ovis aries 
GN=SHANK1 PE=4 SV=1 
1.0 
W5QDP8_SHEEP FBLN1 Fibulin 1 Predicted Fibulin-1 OS=Ovis aries GN=FBLN1 
PE=3 SV=1 
1.0 
W5NX96_SHEEP ATRN Attractin Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=ATRN PE=4 SV=1 
1.0 
W5PD84_SHEEP F10 Coagulation factor X Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=F10 PE=3 SV=1 
1.0 
W5Q268_SHEEP APOH Apolipoprotein H Predicted Uncharacterised protein OS=Ovis aries 
GN=APOH PE=4 SV=1 
1.0 
W5PE53_SHEEP C8B complement C8 beta chain Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=C8B PE=4 SV=1 
1.0 
W5QDG8_SHEEP FN1 Fibronectin 1 Predicted Uncharacterised protein OS=Ovis aries 
GN=FN1 PE=4 SV=1 
1.0 
W5QAA1_SHEEP SFN Stratifin Predicted 14-3-3 protein sigma OS=Ovis aries 
GN=SFN PE=3 SV=1 
1.0 
W5PTL2_SHEEP CFP Complement factor properdin Predicted Uncharacterised protein OS=Ovis aries 
GN=CFP PE=4 SV=1 
1.0 
W5P3Q3_SHEEP LOC100101238 Regakine 1-like protein Predicted C-C motif chemokine OS=Ovis aries 
GN=LOC100101238 PE=3 SV=1 
1.0 
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W5NX95_SHEEP IGL Ig lambda chain V-I region NIG-64 Predicted Uncharacterised protein OS=Ovis aries 
PE=4 SV=1 
1.0 
W5P1X9_SHEEP ALDOA Aldolase, fructose-bisphosphate A Predicted Fructose-bisphosphate aldolase OS=Ovis 
aries GN=ALDOA PE=3 SV=1 
1.0 
A4ZVY9_SHEEP B2M Beta-2-microglobulin Predicted Beta-2-microglobulin OS=Ovis aries 
GN=B2M PE=2 SV=1 
1.0 
W5Q2T6_SHEEP IGF1 Insulin like growth factor 1 Predicted Insulin-like growth factor I OS=Ovis aries 
GN=IGF1 PE=3 SV=1 
1.0 
W5Q9W2_SHEEP IGL Immunoglobulin lambda-2b light 
chain variable region 
Predicted Uncharacterised protein OS=Ovis aries 
PE=4 SV=1 
1.0 
W5QH56_SHEEP AHSG Alpha-2-HS-glycoprotein (Fragment) Predicted Alpha-2-HS-glycoprotein (Fragment) 
OS=Ovis aries GN=AHSG PE=4 SV=1 
1.0 
W5P9V5_SHEEP PIGR Polymeric immunoglobulin receptor Predicted Uncharacterised protein OS=Ovis aries 
GN=PIGR PE=4 SV=1 
1.0 
W5PHP7_SHEEP LOC101117146 Serpin A3-7-like Predicted Uncharacterised protein OS=Ovis aries 
GN=LOC101117146 PE=3 SV=1 
1.0 
W5NRG7_SHEEP ITIH4 Inter-alpha-trypsin inhibitor heavy 
chain family member 4 
Predicted Uncharacterised protein OS=Ovis aries 
GN=ITIH4 PE=4 SV=1 
1.0 
MYG_SHEEP MB Myoglobin Exists Myoglobin OS=Ovis aries GN=MB PE=1 
SV=2 
1.0 
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W5PXU6_SHEEP SERPINF1 Serpin family F member 1 Predicted Uncharacterised protein OS=Ovis aries 
GN=SERPINF1 PE=3 SV=1 
1.0 
W5QGP4_SHEEP APOD Apolipoprotein D Predicted Uncharacterised protein OS=Ovis aries 
GN=APOD PE=3 SV=1 
1.0 
W5NWM2_SHEEP APOA4 Apolipoprotein A4 Predicted Uncharacterised protein OS=Ovis aries 
GN=APOA4 PE=3 SV=1 
1.0 
IBP4_SHEEP IGFBP4 Insulin like growth factor binding 
protein 4 
Predicted Insulin-like growth factor-binding protein 
4 OS=Ovis aries GN=IGFBP4 PE=1 
SV=1 
1.0 
Q1A2D1_SHEEP HBBK Beta-K globin chain Predicted Beta-K globin chain OS=Ovis aries 
GN=HBBK PE=3 SV=1 
1.0 
W5QA07_SHEEP LOC101119384 Protein HP-25 homolog 1 Predicted Uncharacterised protein OS=Ovis aries 
GN=LOC101119384 PE=4 SV=1 
1.0 
W5PH95_SHEEP IGH1 Immunoglobulin gamma-1 chain Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries PE=4 SV=1 
1.0 
B7SH79_SHEEP NFIL3 Nuclear factor, interleukin 3 regulated Predicted Nuclear factor interleukin-3-regulated 
protein OS=Ovis aries GN=NFIL3 PE=2 
SV=1 
1.0 
W5Q517_SHEEP PCOLCE Procollagen C-endopeptidase 
enhancer 
Predicted Uncharacterised protein OS=Ovis aries 
GN=PCOLCE PE=4 SV=1 
1.0 
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W5P1W2_SHEEP FOLR3 Folate receptor alpha Predicted Uncharacterised protein OS=Ovis aries 
GN=FOLR3 PE=4 SV=1 
1.0 
W5PQ53_SHEEP ICOSLG inducible T-cell costimulator ligand Predicted Uncharacterised protein OS=Ovis aries 
GN=ICOSLG PE=4 SV=1 
0.9 
W5NU33_SHEEP TREML1 triggering receptor expressed on 
myeloid cells like 1 
Predicted Uncharacterised protein OS=Ovis aries 
GN=TREML1 PE=4 SV=1 
0.9 
W5QBV7_SHEEP CD44 CD44 molecule (Indian blood group) Predicted Uncharacterised protein OS=Ovis aries 
GN=CD44 PE=4 SV=1 
0.9 
W5PTG9_SHEEP GC GC, vitamin D binding protein Predicted Uncharacterised protein OS=Ovis aries 
GN=GC PE=4 SV=1 
0.9 
W5Q5H8_SHEEP FGA Fibrinogen alpha chain Predicted Fibrinogen alpha chain OS=Ovis aries 
GN=FGA PE=4 SV=1 
0.9 
W5PH81_SHEEP C7 Complement C7 Predicted Uncharacterised protein OS=Ovis aries 
GN=C7 PE=4 SV=1 
0.9 
W5P3R3_SHEEP PLG Plasminogen Predicted Plasminogen OS=Ovis aries GN=PLG 
PE=3 SV=1 
0.9 
W5PZI1_SHEEP LOC101113728 Clusterin Predicted Clusterin OS=Ovis aries 
GN=LOC101113728 PE=3 SV=1 
0.9 
W5Q7Z7_SHEEP DSP Desmoplakin Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=DSP PE=4 SV=1 
0.9 
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W5PJA0_SHEEP CUTA CutA divalent cation tolerance 
homolog 
Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=CUTA PE=4 SV=1 
0.9 
W5PSM6_SHEEP HABP2 Hyaluronan binding protein 2 Predicted Uncharacterised protein OS=Ovis aries 
GN=HABP2 PE=3 SV=1 
0.9 
W5NV16_SHEEP IGH Immunoglobulin heavy chain 
precursor 
Predicted Uncharacterised protein OS=Ovis aries 
PE=4 SV=1 
0.9 
W5PPQ8_SHEEP JCHAIN Joining chain of multimeric IgA and 
IgM 
Predicted Uncharacterised protein OS=Ovis aries 
GN=JCHAIN PE=4 SV=1 
0.9 
W5QI15_SHEEP IGK Immunoglobulin kappa-1 light chain 
variable region 
Predicted Uncharacterised protein OS=Ovis aries 
PE=4 SV=1 
0.8 
W5P229_SHEEP MASP2 Mannan binding lectin serine 
peptidase 2 
Predicted Uncharacterised protein OS=Ovis aries 
GN=MASP2 PE=3 SV=1 
0.8 
W5PTU7_SHEEP CA2 Carbonic anhydrase 2 Predicted Carbonic anhydrase 2 (Fragment) 
OS=Ovis aries GN=CA2 PE=4 SV=1 
0.8 
CBG_SHEEP SERPINA6 Serpin family A member 6 Predicted Corticosteroid-binding globulin OS=Ovis 
aries GN=SERPINA6 PE=2 SV=1 
0.8 
W5QHR3_SHEEP RMND5A Required for meiotic nuclear division 
5 homolog A 
Predicted Uncharacterised protein OS=Ovis aries 
GN=RMND5A PE=4 SV=1 
0.8 
W5Q9K0_SHEEP TTC25 Tetratricopeptide repeat domain 25 Predicted Uncharacterised protein OS=Ovis aries 
GN=TTC25 PE=4 SV=1 
0.8 
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W5QGG0_SHEEP TFRC Transferrin receptor Predicted Uncharacterised protein OS=Ovis aries 
GN=TFRC PE=4 SV=1 
0.8 
C0LQH2_SHEEP IGFBP Insulin like growth factor binding 
protein 2 
Predicted Insulin-like growth factor-binding 
protein-3 OS=Ovis aries GN=IGFBP-3 
PE=2 SV=1 
0.8 
W5Q9P7_SHEEP CFL1 Cofilin 1 Predicted Cofilin-1 (Fragment) OS=Ovis aries 
GN=CFL1 PE=3 SV=1 
0.8 
W5PGT6_SHEEP C6 Complement C6 Predicted Uncharacterised protein OS=Ovis aries 
GN=C6 PE=4 SV=1 
0.8 
W5PLL2_SHEEP F9 Coagulation factor IX Predicted Coagulation factor IX OS=Ovis aries 
GN=F9 PE=3 SV=1 
0.8 
HBBF_SHEEP LOC101106199 Hemoglobin fetal subunit beta  Exists Hemoglobin fetal subunit beta OS=Ovis 
aries PE=1 SV=1 
0.8 
W5PVH9_SHEEP HGFAC HGF activator Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=HGFAC PE=3 SV=1 
0.8 
W5QH21_SHEEP MASP1 Mannan binding lectin serine 
peptidase 1 
Predicted Uncharacterised protein OS=Ovis aries 
GN=MASP1 PE=3 SV=1 
0.8 
W5PB46_SHEEP PLTP Phospholipid transfer protein Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=PLTP PE=4 SV=1 
0.8 
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W5PAL4_SHEEP LOC105612802 CD5 antigen-like isoform X1 Predicted Uncharacterised protein OS=Ovis aries 
PE=4 SV=1 
0.7 
W5PLH8_SHEEP KAZN Kazrin, periplakin interacting protein Predicted Uncharacterised protein OS=Ovis aries 
GN=KAZN PE=4 SV=1 
0.7 
W5Q7J0_SHEEP APOB Apolipoprotein B Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=APOB PE=4 SV=1 
0.7 
W5PSK4_SHEEP IGL Immunoglobulin lambda-like 
polypeptide 1  
Predicted Uncharacterised protein OS=Ovis aries 
PE=4 SV=1 
0.7 
W5PTS2_SHEEP MAMDC2 MAM domain containing 2 Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=MAMDC2 PE=4 
SV=1 
0.7 
W5Q6N9_SHEEP AP3B1 Adaptor related protein complex 3 
beta 1 subunit 
Predicted AP-3 complex subunit beta OS=Ovis 
aries GN=AP3B1 PE=3 SV=1 
0.7 
W5PXC8_SHEEP SERPINF2 Serpin family F member 2 Predicted Uncharacterised protein OS=Ovis aries 
GN=SERPINF2 PE=3 SV=1 
0.7 
W5QCY7_SHEEP SPP2 Secreted phosphoprotein 2 Predicted Secreted phosphoprotein 24 OS=Ovis 
aries GN=SPP2 PE=4 SV=1 
0.7 
D7RIF5_SHEEP ACTB Actin beta Predicted Beta-actin variant 2 OS=Ovis aries 
GN=ACTB PE=2 SV=1 
0.6 
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W5PBX6_SHEEP ARHGEF17 Rho guanine nucleotide exchange 
factor 17 
Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=ARHGEF17 PE=4 
SV=1 
0.6 
W5PHM6_SHEEP ZNF512B Zinc finger protein 512B Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=ZNF512B PE=4 
SV=1 
0.6 
W5NSH2_SHEEP ITIH3 Inter-alpha-trypsin inhibitor heavy 
chain 3 
Predicted Uncharacterised protein OS=Ovis aries 
GN=ITIH3 PE=4 SV=1 
0.6 
W5PIW6_SHEEP PRTN3 Myeloblastin Predicted Uncharacterised protein OS=Ovis aries 
GN=PRTN3 PE=3 SV=1 
0.6 
Q28745_SHEEP HBA1 Alpha globin chain Predicted Alpha globin chain OS=Ovis aries PE=3 
SV=1 
0.6 
W5Q7R8_SHEEP JUP Junction plakoglobin Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=JUP PE=4 SV=1 
0.5 
Q1KYZ7_SHEEP HBBA Haemoglobin, beta Predicted Beta-A globin chain OS=Ovis aries 
GN=HBBA PE=3 SV=1 
0.5 
W5PJ66_SHEEP CFD Complement factor D Predicted Uncharacterised protein OS=Ovis aries 
GN=CFD PE=3 SV=1 
0.5 
W5Q4Z3_SHEEP IGFALS Insulin like growth factor binding 
protein acid labile subunit 
Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=IGFALS PE=4 SV=1 
0.5 
256 
 
UniProtKB 
Accession 
Gene Name NCBI Name Protein 
Status 
UniProtKB Name Fold 
Change 
W5QD16_SHEEP MYL1 Myosin light chain 1 Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=MYL1 PE=4 SV=1 
0.5 
W5QGQ3_SHEEP LOC101102714 Lysozyme C, milk isozyme Predicted Uncharacterised protein OS=Ovis aries 
GN=LOC101102714 PE=3 SV=1 
0.5 
W5PSC8_SHEEP FBLN5 Fibulin 5 Predicted Uncharacterised protein OS=Ovis aries 
GN=FBLN5 PE=4 SV=1 
0.5 
W5Q0V2_SHEEP BTD Biotinidase Predicted Uncharacterised protein (Fragment) 
OS=Ovis aries GN=BTD PE=4 SV=1 
0.4 
W5NR06_SHEEP LOC101108086 Histone H2B type 1 Predicted Histone H2B OS=Ovis aries 
GN=LOC101108086 PE=3 SV=1 
0.4 
W5Q9K1_SHEEP QSOX1 Quiescin sulfhydryl oxidase 1 Predicted Sulfhydryl oxidase OS=Ovis aries 
GN=QSOX1 PE=4 SV=1 
0.4 
A0A0F6YFJ0_SHEEP LOC100134870 Beta-C globin Predicted Beta-C globin OS=Ovis aries PE=3 SV=1 0.4 
W5PQH2_SHEEP ANPEP Alanyl aminopeptidase, membrane Predicted Uncharacterised protein OS=Ovis aries 
GN=ANPEP PE=4 SV=1 
0.3 
 
